<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 67 MARYLAND HEALTHCHOICE PROGRAM | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.67/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.67/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|67|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|67" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.67"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 67 MARYLAND HEALTHCHOICE PROGRAM | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.67/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.67/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|67" data-search-heading="">
                  <span title="Subtitle 67 MARYLAND HEALTHCHOICE PROGRAM">Subtitle 67 MARYLAND HEALTHCHOICE PROGRAM</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|67">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.67">Subtitle 67 MARYLAND HEALTHCHOICE PROGRAM</h1>
                <h2 id="/us/md/exec/comar/10.67.01" data-order="|10|67|01|" data-ref-path="10|67|01" class="h__chapter">Chapter 01 Maryland Medicaid Managed Care Program: Definitions</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> adopted effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> amended as an emergency provision effective July 1, 1997 (24:16 Md. R. 1151); emergency status expired December 31, 1997</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> amended as an emergency provision effective April 7, 1998 (25:9 Md. R. 676); amended permanently effective June 29, 1998 (25:13 Md. R. 993)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> amended as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 31, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> amended as an emergency provision effective July 1, 2000 (27:15 Md. R. 1397); amended permanently effective October 16, 2000 (27:20 Md. R. 1838)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">Regulation .01</a> amended effective December 25, 2000 (27:25 Md. R. 2281); February 18, 2002 (29:3 Md. R. 220); February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01#B" title="">Regulation .01B</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01#B" title="">Regulation .01B</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01#B" title="">Regulation .01B</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01#B" title="">Regulation .01B</a> amended effective December 19, 2005 (32:25 Md. R. 1941); April 10, 2006 (33:7 Md. R. 668); November 6, 2006 (33:22 Md. R. 1732); June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01#B" title="">Regulation .01B</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01#B" title="">Regulation .01B</a> amended effective October 5, 2009 (36:20 Md. R. 1528); April 19, 2010 (37:8 Md. R. 615); December 24, 2012 (39:25 Md. R. 1612); October 14, 2013 (40:20 Md. R. 1652); October 28, 2013 (40:21 Md. R. 1775); April 28, 2014 (41:8 Md. R. 471); February 16, 2015 (42:3 Md. R. 316); March 14, 2016 (43:5 Md. R. 385); August 29, 2016 (43:17 Md. R. 955); April 10, 2017 (44:7 Md. R. 355); February 26, 2018 (45:4 Md. R. 205); December 31, 2018 (45:26 Md. R. 1244); August 26, 2019 (46:17 Md. R. 726)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.62" title="Chapter 62 Separate Children’s Health Insurance Program (CHIP) and CHIP Health Services Initiative Eligibility">COMAR 10.09.62</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01#B" title="">Regulation .01B</a> amended effective June 13, 2022 (49:12 Md. R. 641); November 13, 2023 (50:22 Md. R. 974); August 5, 2024 (51:15 Md. R. 707); June 9, 2025 (52:11 Md. R 532)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§15-101 and 15-103(b), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.01.01" data-order="|10|67|01|.01|" data-ref-path="10|67|01|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#A">A.</span> Except as expressly limited, in COMAR 10.67.01.12 the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(1)">(1)</span> “ACOG guidelines” means the American College of Obstetricians and Gynecologists' Guidelines for Perinatal Care that specify the recommended periodicity and content of prenatal, perinatal, and postpartum care, and are incorporated by reference in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">COMAR 10.67.04.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(2)">(2)</span> “Acquired immune deficiency syndrome (AIDS)” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.52.06.01#B" title="">COMAR 10.52.06.01B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)">(3)</span> “Action” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(a)">(a)</span> Denial or limited authorization of a requested service, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(a)(i)">(i)</span> The type or level of service;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(a)(ii)">(ii)</span> Requirements for medical necessity;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(a)(iii)">(iii)</span> Appropriateness;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(a)(iv)">(iv)</span> Setting; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(a)(v)">(v)</span> Effectiveness of a covered benefit.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(b)">(b)</span> Reduction, suspension, or termination of a previously authorized service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(c)">(c)</span> Denial, in whole or part, of payment for a service, except for administrative denials of unclean claims;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(d)">(d)</span> Failure to provide services in a timely manner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(e)">(e)</span> Failure of an MCO to act within the required time frames; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(f)">(f)</span> The denial of an enrollee's request to dispute a financial liability, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(f)(i)">(i)</span> Cost sharing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(f)(ii)">(ii)</span> Copayments;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(f)(iii)">(iii)</span> Premiums;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(f)(iv)">(iv)</span> Deductibles;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(f)(v)">(v)</span> Coinsurance; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(3)(f)(vi)">(vi)</span> Other enrollee financial liabilities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(4)">(4)</span> “Activities of daily living” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, bathing, feeding, toileting, dressing, and ambulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(5)">(5)</span> “Adjusted clinical group (ACG)” means a method for categorizing individuals into a case mix category based on the diagnoses assigned by their clinicians over a predetermined period of time.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(6)">(6)</span> Administrative Services Organization.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(6)(a)">(a)</span> “Administrative services organization (ASO)” means an organization with which the Department contracts to assist in the management of behavioral health services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(6)(b)">(b)</span> “Administrative services organization” does not mean an organization that directly provides health care services to waiver-eligible individuals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(7)">(7)</span> “Advanced practice nurse” means a nurse practitioner, nurse midwife, nurse anesthetist, or nurse psychotherapist who is licensed and certified under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.01" title="Chapter 01 Examination and Licensure">COMAR 10.27.01</a></p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(8)">(8)</span> “Aged” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.02#B" title="">COMAR 10.09.24.02B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(9)">(9)</span> “AIDS payment category” means one of the two payment categories represented as individual rate cells within the rate table set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B(4)(b)" title="">COMAR 10.67.04.19B(4)(b)</a> to which enrollees with AIDS are assigned pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B(2)(c)(ii)" title="">COMAR 10.67.04.19B(2)(c)(ii)</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(10)">(10)</span> “Alcohol abuse” has the meaning stated in Health-General Article, §8-101(e), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(11)">(11)</span> “Ancillary services” means diagnostic and somatic therapeutic services, including but not limited to radiology, laboratory services, cardiac diagnostics, neurology diagnostics, occupational therapy, physical therapy, durable medical equipment, disposable medical supplies, audiology, speech therapy, and cardiac rehabilitation therapy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(12)">(12)</span> “Annual quality assurance (QA) audit” means a systems performance review and a clinical care review.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(13)">(13)</span> “Appeal” means a request for review of an action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(14)">(14)</span> “Applicant” means an entity that seeks approval from the Department to operate as a managed care organization in the Maryland Medicaid Managed Care Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(15)">(15)</span> “Benefits package” means a set of health care services to which an MCO's enrollees are entitled, when the services are medically necessary, and which the MCO delivers to its enrollees either through providers with which it has employment or contractual relationships, or through reimbursement for services provided to the MCO's enrollees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(16)">(16)</span> “Blind” means having a condition in which a person is certified by an ophthalmologist as having either central visual acuity of 20/200 or less in the better eye with correcting glasses, or a field defect in which the peripheral field has contracted to such an extent that the widest diameter of the visual field subtends an angular distance of no greater than 20 degrees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(17)">(17)</span> “Business day” means any day except Saturday, Sunday, or a holiday on which State offices are closed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(18)">(18)</span> “Caller abandonment rates” means the percentage of calls terminated by callers without speaking to a live operator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(19)">(19)</span> “Caller average hold time” means an average amount of time a call is on hold after being answered.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(20)">(20)</span> “Caller service level” means the speed of answering the telephone.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(21)">(21)</span> “Capitation payment” means the sum of money paid in advance on a monthly per capita basis by the Department for a fixed benefit package.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(22)">(22)</span> “CARF” means the Commission on Accreditation of Rehabilitation Facilities (also known as the Rehabilitation Accreditation Commission), which is an organization that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(22)(a)">(a)</span> Establishes quality standards for rehabilitative services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(22)(b)">(b)</span> Determines, in the context of its accreditation process, the extent to which rehabilitative service providers are in compliance with CARF quality standards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(23)">(23)</span> “Case management” means, assessing, planning, coordinating, monitoring, and arranging the delivery of medically necessary health-related services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(24)">(24)</span> “Case management contractor” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, the Department's designee, or a subcontractor of the designee, which provides case management to participants assigned to it by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(25)">(25)</span> “Case manager” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, the individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(25)(a)">(a)</span> Is employed by the Department's designee or a case management contractor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(25)(b)">(b)</span> Is assigned by a case management contractor to manage the care of some or all of the participants assigned to that case management contractor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(25)(c)">(c)</span> Participates in the meetings of the interdisciplinary team;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(25)(d)">(d)</span> Is responsible for the development of an individual's case management plan by the interdisciplinary team;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(25)(e)">(e)</span> Is responsible for implementing the participant's case management plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(25)(f)">(f)</span> Is responsible for modifying the case management plan when information regarding a change in the participant's condition or status is received.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(26)">(26)</span> “CDS license” means the State licensure authorizing a health care practitioner to prescribe controlled dangerous substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(27)">(27)</span> “Certified nursing assistant” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, an individual:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(27)(a)">(a)</span> Certified as a nursing assistant by the Maryland Board of Nursing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(27)(b)">(b)</span> Who performs nursing tasks delegated by a registered nurse or licensed practical nurse pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(28)">(28)</span> “Child in State-supervised care” means a waiver-eligible child who is in the care and custody of a State agency pursuant to a court order or a voluntary placement agreement, including, but not limited to, waiver-eligible children:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(28)(a)">(a)</span> Under the supervision of the Department of Juvenile Services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(28)(b)">(b)</span> In kinship or foster care under the Department of Human Services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(28)(c)">(c)</span> In residential treatment centers or psychiatric hospitals for the first 30 days after admission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(29)">(29)</span> “Child with a special health care need” means an individual younger than 21 years old, regardless of marital status, suffering from a moderate to severe chronic health condition:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(29)(a)">(a)</span> With significant potential or actual impact on health and ability to function;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(29)(b)">(b)</span> Which requires special health care services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(29)(c)">(c)</span> Which is expected to last longer than 6 months.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(29-1)">(29-1)</span> “CHIP Health Services Initiative” means services offered to improve the health of low-income children pursuant to 5 U.S.C. §2105(a)(1)(D)(ii) of the Social Security Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(30)">(30)</span> “Chronic hospital” has the meaning stated in COMAR 10.09.06.01B(4).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(31)">(31)</span> “Clinical care review” means a review of the quality of clinical health care delivered by an MCO, which is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(31)(a)">(a)</span> Required by federal law; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(31)(b)">(b)</span> A component of an annual quality assurance (QA) audit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(32)">(32)</span> “CMS” means Centers for Medicare and Medicaid Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(33)">(33)</span> “Cold call marketing” means any unsolicited personal contact by the MCO with a potential enrollee for the purpose of marketing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(33-1)">(33-1)</span> “Collaborative Care Model” means the Psychiatric Collaborative Care Model, a patient-centered, evidence-based approach for integrating physical and behavioral health services in primary care settings that includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(33-1)(a)">(a)</span> Care coordination and management;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(33-1)(b)">(b)</span> Regular, systematic monitoring and treatment using a validated clinical rating scale;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(33-1)(c)">(c)</span> Regular, systematic psychiatric or substance use disorder caseload reviews, or both; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(33-1)(d)">(d)</span> Regular, systematic consultation for patients who do not show clinical improvement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(34)">(34)</span> “Commissioner” means the Maryland Insurance Commissioner of the Maryland Insurance Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(35)">(35)</span> “Community-based substance abuse program” means a program that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(35)(a)">(a)</span> Is certified by the Office of Health Care Quality (OHCQ); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(35)(b)">(b)</span> Provides services in community settings not regulated by the Health Services Cost Review Commission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(36)">(36)</span> “Complaint” means an expression of dissatisfaction that results in either an appeal or a grievance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(37)">(37)</span> “Contract year” means the period of time to which the Maryland Medicaid Managed Care Program agreement between the Department and an MCO applies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(38)">(38)</span> “Core service agency (CSA)” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08" title="Chapter 08 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services">COMAR 10.67.08</a>, the county or multicounty authority, designated under Health-General Article, Title 10, Subtitle 12, Annotated Code of Maryland, and approved by the Department, that is responsible for planning, managing, and monitoring publicly funded mental health services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(39)">(39)</span> “Corporation” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(39)(a)">(a)</span> An entity formed under and meeting the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gca&amp;section=2-101" title="">Corporations and Associations Article, §2-101 </a>et seq., Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(39)(b)">(b)</span> A foreign corporation registered with the Maryland Department of Assessments and Taxation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(40)">(40)</span> “County” means a county of this State and, unless expressly provided otherwise, Baltimore City.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(40-1)">(40-1)</span> “Credibility adjustment” means an adjustment to the MLR for a partially credible MCO to account for a difference between the actual and target MLRs that may be due to random statistical variation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(41)">(41)</span> “Days” means, unless otherwise expressly indicated, calendar days.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(42)">(42)</span> “DEA license” means the federal license authorizing a health care practitioner to prescribe controlled substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(42-1)">(42-1)</span> “Definitive drug test” means drug screening tests that include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(42-1)(a)">(a)</span> The ability to identify individual drugs and distinguish between structural isomers, but not necessarily stereoisomers, using:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(42-1)(a)(i)">(i)</span> Gas chromatography or mass spectrometry; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(42-1)(a)(ii)">(ii)</span> Liquid chromatography or mass spectrometry;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(42-1)(b)">(b)</span> Qualitative or quantitative results;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(42-1)(c)">(c)</span> All source types for specimen selection;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(42-1)(d)">(d)</span> Specimen validity testing, per day, 122 or more drug classes including metabolites, if performed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(43)">(43)</span> “Department” means the Maryland Department of Health, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.01" title=".01 Definitions.">COMAR 10.09.36.01</a>, or its authorized agents acting on behalf of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(44)">(44)</span> “Diagnostic evaluation services (DES)” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.32.01#B" title="">COMAR 10.09.32.01B</a>, and includes the services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.32.04#A" title="">COMAR 10.09.32.04A</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(45)">(45)</span> Direct Medical Education Costs (DME Costs).</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(45)(a)">(a)</span> “Direct medical education costs (DME costs)” means costs associated with providing graduate medical education that are measurable using accounting data.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(45)(b)">(b)</span> “Direct medical education costs (DME costs)” includes, but is not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(45)(b)(i)">(i)</span> Salaries;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(45)(b)(ii)">(ii)</span> Supervision costs; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(45)(b)(iii)">(iii)</span> Allocated overhead.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(46)">(46)</span> “Disabled” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.02#B" title="">COMAR 10.09.24.02B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(47)">(47)</span> “Early and Periodic Screening, Diagnosis, and Treatment (EPSDT)” means the provision, to individuals younger than 21 years old, of preventive health care pursuant to 42 CFR §441.50 et seq. (1981), and other health care services, diagnostic services, and treatment services that are necessary to correct or ameliorate defects and physical and mental illnesses and conditions discovered by EPSDT screening services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(48)">(48)</span> “Emergency medical condition” means a medical condition characterized by sudden onset and symptoms of sufficient severity, including severe pain, that the absence of immediate medical attention could reasonably be expected by a prudent lay person, who possesses an average knowledge of health and medicine, to result in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(48)(a)">(a)</span> Placing the patient's health, or with respect to a pregnant woman, the health of the woman or unborn child in serious jeopardy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(48)(b)">(b)</span> Serious impairment to bodily functions; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(48)(c)">(c)</span> Serious dysfunction of any bodily organ or part.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(49)">(49)</span> “Emergency services” means those health care services that are provided in a hospital emergency facility after the sudden onset of a medical condition that manifests itself by symptoms of sufficient severity, including severe pain, that the absence of immediate medical attention could reasonably be expected by a prudent lay person, who possesses an average knowledge of health and medicine, to result in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(49)(a)">(a)</span> Placing the patient's health, or with respect to a pregnant woman, the health of the woman, or her unborn child, in serious jeopardy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(49)(b)">(b)</span> Serious impairment to bodily functions; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(49)(c)">(c)</span> Serious dysfunction of any bodily organ or part.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(50)">(50)</span> “Encounter data” means information documenting a service to an enrollee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(51)">(51)</span> “Enrollee” has the meaning indicated in Health-General Article, §15-101(b), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(52)">(52)</span> “EPSDT-certified provider” means a physician or nurse practitioner who is certified by the Department's EPSDT program to provide comprehensive well-child services according to the Department's periodicity schedule and program standards to enrollees younger than 21 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(53)">(53)</span> “EPSDT comprehensive well-child services” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(53)(a)">(a)</span> All the screening services provided by an EPSDT-certified provider that are required or recommended on the EPSDT periodicity schedule; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(53)(b)">(b)</span> Health care services to diagnose, treat, or refer problems or conditions discovered during the comprehensive well-child service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(54)">(54)</span> “EPSDT partial or interperiodic well-child service” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(54)(a)">(a)</span> A well-child service provided at times different than those outlined in the EPSDT periodicity schedule; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(54)(b)">(b)</span> Any encounter by a health care practitioner necessary to diagnose or identify a condition and recommend a course of treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(55)">(55)</span> “EPSDT periodicity schedule” means the Departmentally approved list of required or recommended preventive health care services which are to be performed at specified ages.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(56)">(56)</span> “Evaluations” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, a determination of the health status of a patient in a patient's home or any other appropriate setting by a licensed professional for the purpose of designing an individual plan of care which incorporates the modalities of treatment which will promote optimal functional ability and recuperation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(57)">(57)</span> “External quality review organization (EQRO)” means a utilization and quality control peer review entity or a private review agent meeting the requirements of §1902(a)(30) of the Social Security Act, 42 U.S.C. §1396a(a)(30), which performs an independent external review of health care services furnished under a contract under §1903(m) of the Social Security Act, 42 U.S.C. §1396b.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(58)">(58)</span> “Family planning” means providing individuals with the information and means to prevent unwanted pregnancy and maintain reproductive health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(59)">(59)</span> “Federally qualified health center (FQHC)” means a clinic which either:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(59)(a)">(a)</span> Receives a grant under §329, 330, or 340 of the Public Health Services Act, 42 U.S.C. §254c;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(59)(b)">(b)</span> Meets the requirements for a grant under §329, 330, or 340 of the Public Health Services Act, 42 U.S.C. §254c; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(59)(c)">(c)</span> Qualifies as a FQHC pursuant to a waiver from the Secretary of the U.S. Department of Health and Human Services of one or more of the requirements for receiving a grant under §329, 330, or 340 of the Public Health Services Act, 42 U.S.C. §254c.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(60)">(60)</span> “Fiscal year (FY)” means the time period beginning the preceding July 1 and ending on June 30 of the referenced year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(61)">(61)</span> “Free-standing birth center” means a free-standing facility not associated with a hospital that provides nurse midwife services under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Subtitle 6, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(61-1)">(61-1)</span> “Full credibility” means a standard for which the experience of an MCO is determined to be sufficient for the calculation of an MLR with a minimal chance that the difference between the actual and target MLR is not statistically significant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(62)">(62)</span> “Graduate medical education (GME)” means the training of physician interns and residents after completion of a medical degree program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(63)">(63)</span> “Graduate medical education costs (GME costs)” means the amount it costs a hospital to train physician interns and residents after their completion of a medical degree program, including both direct medical education costs and indirect medical education costs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(64)">(64)</span> “Grievance” means an expression of dissatisfaction about any matter other than an action, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(64)(a)">(a)</span> The quality of care or services provided, and aspects of interpersonal relationships such as rudeness of a provider or employee;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(64)(b)">(b)</span> Failure to respect the enrollee's rights regardless of whether remedial action is requested; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(64)(c)">(c)</span> A dispute over an extension of time proposed by the MCO to make an authorized decision.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(65)">(65)</span> “HCQIS” means the Health Care Quality Improvement System produced by the Centers for Medicare and Medicaid Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(66)">(66)</span> “Health care service” has the meaning stated in Health-General Article, §19-132, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(67)">(67)</span> “HealthChoice Financial Monitoring Report (HFMR)” means an annual financial report of an MCO's MMMCP-related activities during a specified calendar year that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(67)(a)">(a)</span> Is submitted to the Department by an MCO pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15" title=".15 Data Collection and Reporting.">COMAR 10.67.04.15</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(67)(b)">(b)</span> Serves as a supplemental schedule to an MCO's quarterly and annual reports to the Maryland Insurance Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(67)(c)">(c)</span> Includes a completed HFMR form provided by the Department and any supplemental schedules required by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(68)">(68)</span> “Health home” means a provider designated to offer enhanced care coordination and management services to individuals affected by, or at risk for, chronic conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(69)">(69)</span> “Health maintenance organization (HMO)” has the meaning stated in Health-General Article, §19-701, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(70)">(70)</span> Health Service Needs Information.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(70)(a)">(a)</span> “Health service needs information” means an instrument to identify new Maryland Medicaid Managed Care Program enrollees who require immediate or specialized health care services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(70)(b)">(b)</span> “Health service needs information” does not mean an initial health screen performed by an MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(71)">(71)</span> “HEDIS” means the Healthcare Effectiveness Data Information Set, a set of indicators of managed care plan performance developed by the National Committee for Quality Assurance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(72)">(72)</span> “Hepatitis C” means having one of the following as a primary, secondary, tertiary, or level 4 diagnosis:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(72)(a)">(a)</span> 070.41 — Acute or Unspecified Hepatitis C with hepatic coma;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(72)(b)">(b)</span> 070.44 — Chronic Hepatitis C with hepatic coma;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(72)(c)">(c)</span> 070.51 — Acute or unspecified Hepatitis C without mention of hepatic coma; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(72)(d)">(d)</span> 070.54 — Chronic Hepatitis C without mention of hepatic coma.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(73)">(73)</span> “Hepatitis C plan risk factor” means an MCO-specific risk adjustment factor reflecting the level of risk associated with the proportion of the MCO's HIV/AIDS enrollees who also have Hepatitis C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(74)">(74)</span> “HIPAA” means the Health Insurance Portability and Accountability Act, a federal law enacted on August 21, 1996, whose purpose is to improve the efficiency and effectiveness of the health care system by standardizing the electronic exchange of administrative and financial data, provide security requirements for transmitted information, and protect the privacy of identifiable health information.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(75)">(75)</span> “Historical diagnostic period” means the time period under consideration for the cumulative chronological determination of an enrollee's Hepatitis C status and ending:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(75)(a)">(a)</span> For the initial rate adjustment period, on June 30 of the calendar year before the rate year; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(75)(b)">(b)</span> For the mid-year rate adjustment period, on December 31 of the calendar year before the rate year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(76)">(76)</span> “HIV” means infection with the human immunodeficiency virus.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(77)">(77)</span> “HIV/AIDS” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(77)(a)">(a)</span> Infection with the human immunodeficiency virus; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(77)(b)">(b)</span> Acquired immune deficiency syndrome.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(78)">(78)</span> “HIV/AIDS enrollee” means an enrollee who is infected with HIV or has AIDS and is assigned to an HIV or AIDS payment category.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(79)">(79)</span> “HIV payment category” means one of the four payment categories represented as individual rate cells within the rate tables set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">COMAR 10.67.04.19B(4)(a)</a> and (b), to which enrollees with HIV are assigned pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B(1)(c)(ii)" title="">COMAR 10.67.04.19B(1)(c)(ii)</a> or (2)(c)(i).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(80)">(80)</span> “Home”, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.53" title="Chapter 53 Early and Periodic Screening, Diagnosis, and Treatment: Nursing Services for Individuals Younger than 21 Years Old">COMAR 10.09.53</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(81)">(81)</span> “Home health agency” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, an agency licensed by the Department in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.10" title="Chapter 10 Home Health Agencies">COMAR 10.07.10</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(82)">(82)</span> “Home health aide” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, an individual who meets all the conditions of participation specified in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(82)(a)">(a)</span> 42 CFR §484.36; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(82)(b)">(b)</span> <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(83)">(83)</span> “Homeless person” means an individual who, as defined by §340 of the Public Health Services Act, lacks housing, without regard to whether an individual is a member of a family, including an individual:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(83)(a)">(a)</span> Who is a resident in transitional housing; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(83)(b)">(b)</span> Whose primary residence during the night is a supervised public or private facility that provides temporary living accommodations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(84)">(84)</span> “Hospital” has the meaning stated in Health-General Article, §19-301, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(85)">(85)</span> “HSCRC” means the Health Services Cost Review Commission, an independent agency functioning in the Department with the powers and duties set forth in Health-General Article, §19-201 et seq., Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(86)">(86)</span> “Indirect medical education costs (IME costs)” means costs associated with providing graduate medical education that, although not measurable using accounting data, are subject to assessment by application of a regression analysis methodology that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(86)(a)">(a)</span> Estimates teaching hospitals' extra costs attributable to factors including, but not necessarily limited to the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(86)(a)(i)">(i)</span> Lower productivity of inexperienced residents, and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(86)(a)(ii)">(ii)</span> Adoption of advanced technology; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(86)(b)">(b)</span> Controls, where possible, for confounding variables such as differences in:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(86)(b)(i)">(i)</span> Area labor costs,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(86)(b)(ii)">(ii)</span> Uncompensated care, and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(86)(b)(iii)">(iii)</span> Case mix.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(87)">(87)</span> “Individualized education program (IEP)” means a written description of special education and related services developed by a multidisciplinary team to be implemented to meet the individual needs of a child pursuant to COMAR 13A.05.01.09.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(88)">(88)</span> “Individualized family service plan (IFSP)” means a written plan for providing early intervention and other services to an eligible child and the child's family pursuant to COMAR 13A.13.01.02B.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(89)">(89)</span> “Individual with a developmental disability” means an individual who, as defined in P.L. 101-330, Americans with Disabilities Act of 1990, 42 U.S.C. §12101 et seq., has a physical or mental impairment arising before the age of 22, except for the sole diagnosis of mental disorder, that substantially limits one or more major life activities, and which may include, but is not limited to, an intellectual disability, specific learning disabilities, head injury, epilepsy, and muscular dystrophy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(90)">(90)</span> “Individual with a physical disability” means an individual who, as defined in P.L. 101-330, the Americans with Disabilities Act of 1990, 42 U.S.C. §12101 et seq., has a physical impairment, either sensory or motor, that substantially limits one or more major life activities, and which may include, but is not limited to, orthopedic impairment, vision, speech, or hearing impairment, cerebral palsy, epilepsy, muscular dystrophy, multiple sclerosis, cancer, heart disease, HIV/AIDS, and tuberculosis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(91)">(91)</span> “Initial health screen” means the comprehensive evaluation performed by the PCP, that includes a comprehensive history and physical examination to determine the new enrollee's baseline health status and health needs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(92)">(92)</span> “Initial rate adjustment period” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>-3A.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(93)">(93)</span> “Inmate” means an individual who is serving time for a criminal offense and is confined involuntarily in State or federal prisons, jail, detention centers, or other penal facilities or who has been placed on home detention.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(94)">(94)</span> Institution for Mental Disease.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(94)(a)">(a)</span> “Institution for mental disease (IMD)” means a hospital, nursing facility, or other institution of more than 16 beds that is primarily engaged in providing diagnosis, treatment, or care of persons with mental diseases or substance abuse problems, including medical attention, nursing care, and related health care services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(94)(b)">(b)</span> “Institution for mental disease (IMD)” includes the following categories of facilities, if the particular facility has more than 16 beds:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(94)(b)(i)">(i)</span> Psychiatric hospitals;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(94)(b)(ii)">(ii)</span> Residential treatment centers;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(94)(b)(iii)">(iii)</span> In the context of admissions of enrollees who are 21 years old or older, intermediate care facilities-alcoholic (ICF-A) facilities; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(94)(b)(iv)">(iv)</span> Residential drug-free treatment programs.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(94)(c)">(c)</span> “Institution for mental disease” does not include intermediate care facilities-alcoholic (ICF-A) facilities, except in the context of admission of enrollees who are 21 years old or older.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(95)">(95)</span> “Interdisciplinary team” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, the group convened and conducted by the case manager, consisting of the case manager and relevant service providers, that established the case management plan under the overall direction and coordination of the case manager and in consultation with the participant and, when applicable, the participant's family.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(96)">(96)</span> “Intermediate care facility for individuals with intellectual disabilities or persons with related conditions (ICF/IID)” means a residential facility providing care and services for individuals with an intellectual disability or developmental disabilities, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(96-1)">(96-1)</span> “Limited English proficiency” means the special need status of potential enrollees and enrollees who do not speak English as their primary language and who have a limited ability to read, write, speak, or understand English, and are therefore eligible to receive language assistance for a particular type of service, benefit, or encounter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(97)">(97)</span> “Local access area” means the local geographical area, as identified by the zip code groupings in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06#D" title="">COMAR 10.67.05.06D</a>, that is located within the relevant MCOs service area and in which the relevant enrollee resides.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(98)">(98)</span> “Local transportation grantee agency” means the county entity, usually the local health department, that receives transportation grant funds pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.19" title="Chapter 19 Transportation Grants">COMAR 10.09.19</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(99)">(99)</span> “Long-term care facility” means a chronic hospital, a chronic rehabilitation hospital, a nursing facility, or a special pediatric hospital.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(100)">(100)</span> Long-Term Care Services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(100)(a)">(a)</span> “Long-term care services” means the medical and support services required by an individual who, due to chronic illness or mental or physical disability, requires long-term care facility services over an extended period of time.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(100)(b)">(b)</span> “Long-term care services” includes services provided to a patient in a long-term care facility after the 30th day of continuous care following the enrollee's admission to the facility.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(100)(c)">(c)</span> “Long-term care services” do not include services provided to an enrollee admitted to a long-term care facility for a stay of less than 31 days of continuous care following the enrollee's admission to the facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(101)">(101)</span> “Loss ratio” means the ratio of an MCO's:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(101)(a)">(a)</span> Net medical expenses plus medical management expenses which:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(101)(a)(i)">(i)</span> Are quantified according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>-4;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(101)(a)(ii)">(ii)</span> Relate solely to the MCO's MMMCP line of business; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(101)(a)(iii)">(iii)</span> Are incurred during a specified period; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(101)(b)">(b)</span> Net revenues which:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(101)(b)(i)">(i)</span> Relate solely to the MCO's MMMCP line of business; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(101)(b)(ii)">(ii)</span> Are earned during the same specified period in which the expenses referenced in §B(98)(a) of this regulation are incurred.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(102)">(102)</span> “Managed care organization (MCO)” has the meaning stated in Health-General Article, §15-101, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(103)">(103)</span> “Marketing” means any communication, from an MCO to a Medicaid recipient who is not enrolled in that MCO, that can reasonably be interpreted as intended to influence the recipient:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(103)(a)">(a)</span> To enroll in that particular MCO; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(103)(b)">(b)</span> To not enroll in or to disenroll from another MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(104)">(104)</span> “Marketing materials” means materials that are produced in any medium, by or on behalf of an MCO, that can reasonably be interpreted as intended to market to potential enrollees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(105)">(105)</span> “Maryland Children's Health Program” means the State program for uninsured, low-income children with federal matching funds provided under Title XXI of the Social Security Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(106)">(106)</span> “Maryland Medicaid Managed Care Program (MMMCP)” means the Medicaid reform program established in this subtitle, as authorized by Health-General Article, Title 15, Subtitle 1, Annotated Code of Maryland, and by a §1115 waiver issued by the federal government.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(107)">(107)</span> “Medicaid” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.02" title=".02 Definitions.">COMAR 10.09.24.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(108)">(108)</span> “Medical Assistance” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.02" title=".02 Definitions.">COMAR 10.09.24.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(109)">(109)</span> “Medical day care for adults” means a program of medically supervised, health-related services provided in an ambulatory setting to medically handicapped adults who, due to their degrees of impairment, need health maintenance and restorative services supportive to their community living.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(110)">(110)</span> “Medical day care for children” means a program of medically supervised health-related services provided in an ambulatory setting to children with complex medical needs who do not require 24-hour inpatient care, but, due to their specialized medical needs, cannot be managed in a typical day care setting.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(111)">(111)</span> “Medical expense” means costs incurred by an MCO in connection with providing health care services to its enrollees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(111-1)">(111-1)</span> “Medical loss ratio (MLR)” means a formula that measures the ratio of MCO spending on medical and related benefits compared to revenue, to ensure MCOs are spending a sufficient amount of their premium revenue on medical expenses and other high-impact initiatives.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(112)">(112)</span> “Medically necessary” means that the service or benefit is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(112)(a)">(a)</span> Directly related to diagnostic, preventive, curative, palliative, rehabilitative, or ameliorative treatment of an illness, injury, disability, or health condition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(112)(b)">(b)</span> Consistent with current accepted standards of good medical practice;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(112)(c)">(c)</span> The most cost efficient service that can be provided without sacrificing effectiveness or access to care; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(112)(d)">(d)</span> Not primarily for the convenience of the consumer, the consumer's family, or the provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(113)">(113)</span> “Medically needy” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.02" title=".02 Definitions.">COMAR 10.09.24.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(114)">(114)</span> “Medical management expense” means costs incurred by an MCO in connection with outreach and utilization management activities as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>-4.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(115)">(115)</span> “Medical necessity” means what is medically necessary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(115-1)">(115-1)</span> “Medically underserved area” means an area designated by the Health Resources and Services Administration (HRSA) as having shortages of primary care, dental care, or mental health providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(116)">(116)</span> “Medicare” means the federal program that provides benefits to the aged and disabled under Title XVIII of the Social Security Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(117)">(117)</span> “MIA” means the Maryland Insurance Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(118)">(118)</span> “Mid-year rate adjustment period” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>-4A.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(119)">(119)</span> “MIEMSS” means the Maryland Institute for Emergency Medical Service Systems.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(119-1)">(119-1)</span> “MLR reporting year” means a period of 12 months consistent with the rating period selected by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(120)">(120)</span> “Model Waiver Program” means the Home Care for Disabled Children under a Model Waiver as established in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.27" title="Chapter 27 Home Care for Disabled Children Under a Model Waiver">COMAR 10.09.27</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(120-1)">(120-1)</span> “National Diabetes Prevention Program” means an evidence-based diabetes prevention program established by the Centers for Disease Control and Prevention.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(121)">(121)</span> “Net medical expenses” means an MCO's total medical expenses less reinsurance recoveries.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(122)">(122)</span> “Net revenues” means an MCO's total revenues less reinsurance premiums.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(123)">(123)</span> “Network” has the same meaning as “provider panel”, as specified in this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(123-1)">(123-1)</span> “Network provider” means a provider that is a member of the MCOs provider panel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(123-2)">(123-2)</span> “No credibility” means a standard for which the experience of an MCO is determined to be insufficient for the calculation of an MLR.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(123-3)">(123-3)</span> “Non-claims costs” means expenses for administrative services other than:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(123-3)(a)">(a)</span> Incurred claims;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(123-3)(b)">(b)</span> Expenditures on activities that improve health care quality;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(123-3)(c)">(c)</span> Licensing and regulatory fees; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(123-3)(d)">(d)</span> Federal and State taxes.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(124)">(124)</span> “Nursing facility” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.10.01#B" title="">COMAR 10.09.10.01B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(125)">(125)</span> Nutritional Counseling.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(125)(a)">(a)</span> “Nutritional counseling” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, the review of the patient's nutritional status and advice on its improvement when medically necessary.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(125)(b)">(b)</span> “Nutritional counseling” includes family education provided by either a licensed dietitian or licensed nutritionist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(126)">(126)</span> “Nutritional supplements” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, enteral feeding which is either the sole source of nutrition or a supplement which enhances the physical well-being of the patient and is medically indicated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(127)">(127)</span> “Ombudsman or ombudsman program” has the meaning stated in Health-General Article, §15-101(g), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(128)">(128)</span> “Orthotic device” means rigid and semi-rigid devices used for the purpose of supporting a weak or misaligned body member or restricting or eliminating motion in a diseased or injured part of the body.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(129)">(129)</span> “Out-of-plan provider” means a provider that is neither the employee nor the subcontractor of the enrollee's assigned MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(130)">(130)</span> “Outreach services” means efforts to contact enrollees and bring them into care, as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.03" title=".03 Access Standards: Outreach.">COMAR 10.67.05.03</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131)">(131)</span> “Overpayment” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131)(a)">(a)</span> Any payment made by the Program to a provider in excess of the correct Program payment amount for a service; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131)(b)">(b)</span> Any payment for services under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a> made by the Program or an MCO which at the time of payment, or at a subsequent date, is determined to be inappropriate, inaccurate or in excess of the correct amount of the procedural code billed, for reasons including but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131)(b)(i)">(i)</span> Improper claiming;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131)(b)(ii)">(ii)</span> Lack of medical necessity;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131)(b)(iii)">(iii)</span> Unacceptable practices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131)(b)(iv)">(iv)</span> Fraud, waste, or abuse; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131)(b)(v)">(v)</span> Provider mistake.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(131-1)">(131-1)</span> “Partial credibility” means a standard for which the experience of an MCO is determined to be sufficient for the calculation of an MLR but with a non-negligible chance that the difference between the actual and target medical loss ratios is statistically significant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(132)">(132)</span> “Peer review organization” means an organization qualified by the Centers for Medicare and Medicaid Services in accordance with 42 CFR 462 that reviews health care practitioners, and the health care services they order or furnish, utilizing other practitioners from the same field of practice.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(133)">(133)</span> “Personal care” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.20.01#B" title="">COMAR 10.09.20.01B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)">(134)</span> “Plan of care” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, the document which governs a participant's care management, and which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(a)">(a)</span> Includes the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(a)(i)">(i)</span> Case management assessment report;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(a)(ii)">(ii)</span> Interdisciplinary plan of care; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(a)(iii)">(iii)</span> Case management plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)">(b)</span> Is composed of the participant's health status and needs for medical, health-related, housing, and social services including, but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(i)">(i)</span> All pertinent diagnoses;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(ii)">(ii)</span> Functional status;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(iii)">(iii)</span> Type, frequency, and duration of services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(iv)">(iv)</span> Treatment goals for each type of service;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(v)">(v)</span> Medication;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(vi)">(vi)</span> Social support structure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(vii)">(vii)</span> Current service providers;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(viii)">(viii)</span> Assigned level of care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(ix)">(ix)</span> Diet;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(x)">(x)</span> Current living arrangement; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(b)(xi)">(xi)</span> Emergency plan, if appropriate; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(134)(c)">(c)</span> Is established in consultation with the interdisciplinary team.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(135)">(135)</span> “Postpartum” means within 2 months after delivery of a child.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(136)">(136)</span> “Poststabilization care services” means covered services, related to an emergency medical condition, that are provided after an enrollee is stabilized in order to maintain the stabilized condition, or under the circumstances described in 42 CFR §438.114(e), as amended, to improve or resolve the enrollee's condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(137)">(137)</span> “Potential enrollee” means a Medicaid recipient who is determined eligible for the HealthChoice program but is not yet an enrollee of a specific MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(138)">(138)</span> “Practitioner” means an individual who is licensed, certified, or otherwise authorized under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, or under the laws of the District of Columbia or a state contiguous to Maryland, to provide health care services in the ordinary course of business or practice of a profession or in an approved education or training program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(139)">(139)</span> “Preauthorization”, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.53" title="Chapter 53 Early and Periodic Screening, Diagnosis, and Treatment: Nursing Services for Individuals Younger than 21 Years Old">COMAR 10.09.53</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140)">(140)</span> “Pregnant” means the period beginning with conception and ending at delivery.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140-1)">(140-1)</span> “Presumptive drug tests” means drug screening tests that include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140-1)(a)">(a)</span> Any number of drug classes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140-1)(b)">(b)</span> Any number of devices;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140-1)(c)">(c)</span> Sample validation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140-1)(d)">(d)</span> The use of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140-1)(d)(i)">(i)</span> Direct optical observation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140-1)(d)(ii)">(ii)</span> Instrument assisted direct optical observation; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(140-1)(d)(iii)">(iii)</span> Instrumented chemistry analyzers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(141)">(141)</span> “Primary care” means medical care that addresses a patient's general health needs, including the coordination of the patient's health care, with the responsibility for the prevention of disease, promotion and maintenance of health, treatment of illness, maintenance of the enrollee's health records, and referral for medically necessary specialty care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(142)">(142)</span> “Primary care provider (PCP)” means a practitioner who is the primary coordinator of care for the enrollee, and whose responsibility it is to provide accessible, continuous, comprehensive, and coordinated health care services covering the full range of benefits required by the Maryland Medicaid Managed Care Program, as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(143)">(143)</span> “Primary care residency slots” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.11" title="Chapter 11 Maryland Medicaid Managed Care Program: Contribution to Graduate Medical Education Costs">COMAR 10.67.11</a>, positions in a teaching hospital's residency program occupied after completion of a medical degree program by physicians who have trained in family medicine, internal medicine, pediatrics, or obstetrics and gynecology.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(144)">(144)</span> “Primary mental health services” means the clinical evaluation and assessment of mental health services needed by an individual and the provision of services or referral for additional services as deemed medically necessary by a primary care provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(145)">(145)</span> “Private duty nursing” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, skilled nursing services for recipients who require more individual and continuous care than is available under the Medicaid State Plan, and which are provided by a registered nurse or a licensed practical nurse, in a recipient's own home or another setting when normal life activities take the recipient outside his or her home.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(146)">(146)</span> “Program”, unless the context indicates otherwise, has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.01#B" title="">COMAR 10.09.36.01B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(147)">(147)</span> “Progress note” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, a signed and dated written notation by the home care nurse, home health aide, or certified nursing assistant which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(147)(a)">(a)</span> Summarizes facts about the care given and the participant's response during a given period of time;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(147)(b)">(b)</span> Specifically addresses the established goals of treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(147)(c)">(c)</span> Is consistent with the participant's case management plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(147)(d)">(d)</span> Is written during the course of care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(148)">(148)</span> “Prosthetic device” means an artificial device to replace, in whole or in part, a leg, an arm, an eye, or breast, including surgical brassiere.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(149)">(149)</span> “Provider” has the same meaning as “health care provider”, as stated in Health-General Article, §19-132, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(150)">(150)</span> “Provider panel” means that group of providers employed by the MCO or with which the MCO contracts to provide services to the MCO's enrollees under the MCO's health benefit plan, which is at least equivalent to the benefits specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(151)">(151)</span> “Public institution” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.02" title=".02 Definitions.">COMAR 10.09.24.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(152)">(152)</span> “Quality assurance plan (QAP)” means a document or series of documents that set forth an MCO's strategy for systematically monitoring, evaluating, and improving all facets of MCO operations, including, but not limited to, clinical health care delivery, enrollee assistance and outreach services, and administrative services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(153)">(153)</span> “Rare and expensive case management” means the method of health care delivery provided to individuals with rare and expensive conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(154)">(154)</span> “Rare and expensive condition” means a medical diagnosis or condition identified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(155)">(155)</span> “Rate adjustment period” has the meaning stated in COMAR 10.67.02.19-4A.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(155-1)">(155-1)</span> “Rate year” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>-4A.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(156)">(156)</span> “Readily accessible” means electronic information and services which comply with modern accessibility standards such as:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(156)(a)">(a)</span> Section 508 guidelines;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(156)(b)">(b)</span> Section 504 of the Rehabilitation Act; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(156)(c)">(c)</span> W3C's Web Content Accessibility Guidelines (WCAG) 2.0 AA and successor versions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(157)">(157)</span> “Reasonable allowable costs” means costs that are related to the provision of covered Medicaid services and are determined to be allowable in accordance with Medicare principles of reasonable cost reimbursement in 42 CFR 413, subject to the limitations specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.08.05#C" title="">COMAR 10.09.08.05C</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(158)">(158)</span> “Recipient” or “Program recipient” means an individual who is certified as eligible to receive Medical Assistance benefits, as provided in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24" title="Chapter 24 Medical Assistance Eligibility">COMAR 10.09.24</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(159)">(159)</span> “REM optional services” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, the services which meet the general requirements under Regulation .08 and are listed in Regulations .10 and .11 of that chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(160)">(160)</span> “School-based health center (SBHC)” means a provider located on school grounds that meets the requirements set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.76" title="Chapter 76 School-Based Health Centers (SBHC)">COMAR 10.09.76</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(161)">(161)</span> “Secretary” means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(162)">(162)</span> “Self-referral services” are the health care services listed in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">COMAR 10.67.06.28</a> for which, under specified circumstances, the MCO is required to pay, without any requirement of referral by the PCP or MCO, when the enrollee accesses the service through a provider other than the enrollee's PCP.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(162-1)">(162-1)</span> “Separate CHIP Program” means the program for targeted low-income children established under Title XXI of the Social Security Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(163)">(163)</span> “Service area” means a geographical area, comprised of one or more of Maryland's counties, with each selected county included in its entirety.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(164)">(164)</span> “Service year” in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>-4, means the calendar year in which an MCO incurs the expenses reported pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#E(5)(c)" title="">COMAR 10.67.04.15E(5)(c)</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(165)">(165)</span> “Somatic care” means medical care that addresses an individual's physical health care needs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(166)">(166)</span> “Special needs population” means a group of recipients who share a special health care need as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04" title=".04 Special Needs Populations.">COMAR 10.67.04.04</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(167)">(167)</span> “Special rehabilitation hospital” has the meaning stated in Health-General Article, §19-307(a)(iii), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(168)">(168)</span> “Specialty behavioral health services” means any behavioral health services other than primary behavioral health services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(169)">(169)</span> “Specialty care” means health care services that are either outside the PCP's scope of practice or, in the judgment of the PCP, are not services that the PCP customarily provides, is specifically trained for, or is experienced in.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(170)">(170)</span> “Specialty care residency slots” means, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.11" title="Chapter 11 Maryland Medicaid Managed Care Program: Contribution to Graduate Medical Education Costs">COMAR 10.67.11</a>, positions in a teaching hospital's residency program occupied after completion of a medical degree program by physicians who have trained in specialties other than family medicine, internal medicine, pediatrics, or obstetrics and gynecology.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(171)">(171)</span> “Spend down” means a procedure by which an individual applying for Medical Assistance who is otherwise ineligible due to excess income becomes eligible by deducting incurred medical expenses from excess income.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(172)">(172)</span> “State fair hearing” means a hearing, conducted by the Office of Administrative Hearings, for the purpose of ensuring the right of recipients to be treated in a fair and unbiased manner in their efforts to resolve disputes with the Department or an MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(173)">(173)</span> “Subcontract” means a written agreement between an MCO and a third party, under which the third party performs any one or more of the MCO's obligations required by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(174)">(174)</span> “Subcontractor” means an individual or entity that has a contract with an MCO that relates directly or indirectly to the performance of the MCOs obligations under its contract with the Department; provided, however, that a contract does not by itself cause an MCOs network provider to be a subcontractor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(175)">(175)</span> “Substantial minority” means an ethnic or linguistic group that comprises 5 percent or more of the Medicaid population in the county to be served.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(176)">(176)</span> “Supplemental Security Income (SSI)” means a federally administered program providing benefits to needy aged, blind, and disabled individuals under Title XVI of the Social Security Act, 42 U.S.C. §1381 et seq.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(177)">(177)</span> “Systems performance review (SPR)” means an assessment, as a component of the quality assurance (QA) audit, of quality assurance operations taking place in the MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(178)">(178)</span> “Teaching hospital” means a hospital that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(178)(a)">(a)</span> Had HSCRC-approved rates for FY 1995 that included an allowance for GME costs; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(178)(b)">(b)</span> During the contract year, operates a graduate medical education program that is accredited by the Accreditation Council for Graduate Medical Education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(179)">(179)</span> “Temporary Cash Assistance (TCA)” means a form of cash assistance provided, pursuant to Article 88A, §44A et seq., Annotated Code of Maryland, to assistance units which are technically and financially eligible.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(180)">(180)</span> “Tertiary care” means health care services provided by highly specialized health care providers which are usually diagnostic or therapeutic in nature and often require highly sophisticated technological and support facilities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(181)">(181)</span> “Urgent care” means health care services for a medical condition that manifests itself by symptoms of sufficient severity that the absence of medical attention within 48 hours could reasonably be expected, by a prudent layperson who possesses an average knowledge of health and medicine, to result in an emergency medical condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(182)">(182)</span> “Waiver-eligible” means an individual who qualifies for enrollment in the Maryland Medicaid Managed Care Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(183)">(183)</span> “Whistleblower” means an individual who exposes any kind of information or activity that alleges any violation of regulation, statute, contract, policy, or unethical behavior that may be indicative of an individual or entity committing fraud, waste, or abuse against the Medicaid program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.01.01#B(184)">(184)</span> “Witness”, in the context of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>, has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.53" title="Chapter 53 Early and Periodic Screening, Diagnosis, and Treatment: Nursing Services for Individuals Younger than 21 Years Old">COMAR 10.09.53</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.02" data-order="|10|67|02|" data-ref-path="10|67|02" class="h__chapter">Chapter 02 Maryland Medicaid Managed Care Program: Eligibility and Enrollment</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01" title=".01 Eligibility.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06" title=".06 Disenrollment.">.06</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730);adopted permanently effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01" title=".01 Eligibility.">Regulation .01</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#A" title="">Regulation .01A</a> amended effective April 19, 2010 (37:8 Md. R. 615); March 14, 2016 (43:5 Md. R. 385); August 29, 2016 (43:17 Md. R. 955)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#B" title="">Regulation .01B</a> amended effective February 18, 2002 (29:3 Md. R. 220); April 9, 2007 (34:7 Md. R. 698); November 5, 2007 (34:22 Md. R. 1977); December 24, 2012 (39:25 Md. R. 1612); October 14, 2013 (40:20 Md. R. 1652); April 28, 2014 (41:8 Md. R. 471); February 16, 2015 (42:3 Md. R. 316); May 22, 2017 (44:1 Md. R. 472)</p>
                  <p>Regulation .01C amended effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p>Regulation .01C repealed effective December 20, 2004 (31:25 Md. R. 1790)</p>
                  <p>Regulation.02 amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.02" title=".02 Enrollment.">Regulation .02</a> amended effective February 18, 2002 (29:3 Md. R. 220); October 22, 2018 (45:21 Md. R. 973)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.02#A" title="">Regulation .02A</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.02#A" title="">Regulation .02A</a> amended effective June 30, 2008 (35:13 Md. R. 1180); February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.02#D" title="">Regulation .02D</a>, E amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.02#F" title="">Regulation .02F</a> amended effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p>Regulations .02H and .06F amended as an emergency provision effective July 1, 1997 (24:16 Md. R. 1151); emergency status expired December 31, 1997</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.02#H" title="">Regulation .02H</a> amended effective February 9, 1998 (25:3 Md. R. 144); February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.02#I" title="">Regulation .02I</a> amended effective December 24, 2012 (39:25 Md. R. 1612)</p>
                  <p>Regulation .02L adopted effective June 25, 2001 (28:12 Md. R. 1109)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.03" title=".03 Health Service Needs Information.">Regulation .03</a> amended effective October 28, 2013 (40:21 Md. R. 1775); April 28, 2014 (41:8 Md. R. 471); February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p>Regulation.04 amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p>Regulation.04 amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.04" title=".04 Assignment to Primary Care Provider (PCP).">Regulation .04</a> amended effective December 24, 2012 (39:25 Md. R. 1612)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.04#C" title="">Regulation .04C</a> amended effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p>Regulations .05 amended effective February 18, 2002 (29:3 Md. R. 220); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation.05B amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.05#E" title="">Regulation .05E</a> amended effective October 22, 2018 (45:21 Md. R. 973)</p>
                  <p>Regulation.05F, G amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p>Regulation .05G, H adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p>Regulation .05G, H repealed effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06" title=".06 Disenrollment.">Regulation .06</a> amended effective June 25, 2001 (28:12 Md. R. 1109); February 18, 2002 (29:3 Md. R. 220); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p>Regulation.06A amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#A" title="">Regulation .06A</a>, B amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#A" title="">Regulation .06A</a>, D amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#B" title="">Regulation .06B</a> amended effective February 6, 2012 (39:2 Md. R. 141); October 14, 2013 (40:20 Md. R. 1652); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#B" title="">Regulation .06B</a>, F amended as an emergency provision effective January 1, 2001 (28:4 Md. R. 414)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#B" title="">Regulation .06B</a>, F amended effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#F" title="">Regulation .06F</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#F" title="">Regulation .06F</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#F" title="">Regulation .06F</a> amended effective April 9, 2007 (34:7 Md. R. 698); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#G" title="">Regulation .06G</a> adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#G" title="">Regulation .06G</a> amended effective April 28, 2014 (41:8 Md. R. 471); February 16, 2015 (42:3 Md. R. 316); February 1, 2016 (42:23 Md. R. 1434)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#H" title="">Regulation .06H</a> adopted effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p>Regulation .06I adopted effective February 1, 2016 (42:23 Md. R. 1434)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.63" title="Chapter 63 Community Violence Prevention Services">COMAR 10.09.63</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01" title=".01 Eligibility.">Regulation .01</a> amended effective November 13, 2023 (50:22 Md. R. 974)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#A" title="">Regulation .01A</a> amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#E" title="">Regulation .06E</a> amended effective November 18, 2019 (46:23 Md. R. 1065)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, Annotated Code of Maryland</p>
                </section>
                <div class="table_wrap">
                  <table class="layout-table">
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">Regulations</td>
                        <td/>
                        <td data-vertical-align="middle">Sections</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.01</td>
                        <td data-vertical-align="middle">..........</td>
                        <td data-vertical-align="middle">15-103(b)(3), (4), and (6)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.02—.04</td>
                        <td data-vertical-align="middle">..........</td>
                        <td data-vertical-align="middle">15-103(b)(16)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.05</td>
                        <td data-vertical-align="middle">..........</td>
                        <td data-vertical-align="middle">15-103(b)(23)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.06</td>
                        <td data-vertical-align="middle">..........</td>
                        <td data-vertical-align="middle">15-103(b)(3) and (23)</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <h3 id="/us/md/exec/comar/10.67.02.01" data-order="|10|67|02|.01|" data-ref-path="10|67|02|.01" class="h__section">.01 Eligibility.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A">A.</span> Criteria. Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.02.01#B" title="">§B of this regulation</a>, a Program participant shall be enrolled in the Maryland Medicaid Managed Care Program, described in this chapter, if the participant is eligible for receipt of Medical Assistance benefits by qualifying:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(1)">(1)</span> As categorically needy or medically needy under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24" title="Chapter 24 Medical Assistance Eligibility">COMAR 10.09.24</a>, unless the participant is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(1)(a)">(a)</span> 65 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(1)(b)">(b)</span> Newly eligible and 64 1/2 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(1)(c)">(c)</span> Eligible to receive Medicare benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(1)(d)">(d)</span> Determined medically needy under a spend down; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(1)(e)">(e)</span> Otherwise certified for a period of less than 9 months;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(2)">(2)</span> For the Pregnant Women and Children's Program on or after January 1, 1997; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(3)">(3)</span> For the Maryland Children’s Health Program on or after July 1, 1998; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#A(4)">(4)</span> For the Separate CHIP Program and CHIP Health Services Initiative on or after July 1, 2023.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B">B.</span> A participant is not eligible for the Maryland Medicaid Managed Care Program if the participant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(1)">(1)</span> Has been, or is expected to be, continuously institutionalized for more than:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(1)(a)">(a)</span> 90 successive days in a long-term care facility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(1)(b)">(b)</span> 30 successive days in an institution for mental disease (IMD);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(2)">(2)</span> Is institutionalized in an intermediate care facility for individuals with intellectual disabilities or persons with related conditions (ICF/IID);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(3)">(3)</span> Is enrolled in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(3)(a)">(a)</span> Home Care for Disabled Children under a Model Waiver, pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.27" title="Chapter 27 Home Care for Disabled Children Under a Model Waiver">COMAR 10.09.27</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(3)(b)">(b)</span> The Family Planning Waiver Program pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.58" title="Chapter 58 Family Planning Program">COMAR 10.09.58</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(3)(c)">(c)</span> The Employed Individuals with Disabilities Program pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.41" title="Chapter 41 Employed Individuals with Disabilities">COMAR 10.09.41</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(4)">(4)</span> Is a child receiving adoption subsidy who is covered under the parent's private insurance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(5)">(5)</span> Is a child under State supervision receiving adoption subsidy who lives outside of the State;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(6)">(6)</span> Is a child in an out-of-State placement; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.01#B(7)">(7)</span> Is an inmate as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01" title=".01 Definitions.">COMAR 10.67.01.01</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.02.02" data-order="|10|67|02|.02|" data-ref-path="10|67|02|.02" class="h__section">.02 Enrollment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A">A.</span> The Department shall make available through its website and upon request provide a paper copy of the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(1)">(1)</span> Materials regarding each MCO providing services in the eligible individual’s county of residence including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(1)(a)">(a)</span> Information about how to access the provider directory and drug formulary, with instructions for how to request paper copies if needed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(1)(b)">(b)</span> A schedule of the benefits offered, including any benefits offered beyond the basic required package described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(1)(c)">(c)</span> Which, if any, benefits are provided directly by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(1)(d)">(d)</span> If applicable, a list of services that the MCO does not provide, reimburse for, or provide coverage of, because of moral or religious objections, and information about where and how to obtain these services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(1)(e)">(e)</span> The requirements for each MCO to provide adequate access to covered services, including the network adequacy standards established in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05" title="Chapter 05 Maryland Medicaid Managed Care Program: Access">COMAR 10.67.05</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(1)(f)">(f)</span> Quality and performance indicators for each MCO, including enrollee satisfaction; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(2)">(2)</span> Materials about the managed care program, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(2)(a)">(a)</span> The MCO enrollment and disenrollment process; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(2)(b)">(b)</span> The basic features of managed care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(3)">(3)</span> Any forms necessary to select an MCO; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#A(4)">(4)</span> The toll-free telephone number of the enrollment unit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#B">B.</span> Only the Department, or its designee, is authorized to enroll individuals into MCOs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#C">C.</span> A participant found eligible for Maryland Medicaid under 42 U.S.C §1902(a)(10)A(i) shall be assigned to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#C(1)">(1)</span> The MCO the participant chooses at the time of application; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#C(2)">(2)</span> If the participant does not choose, an MCO with available capacity that is accepting new participants in the participant’s service area.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#D">D.</span> Except for a participant found eligible as described in <a class="internal-link " href="/us/md/exec/comar/10.67.02.02#C" title="">§C of this regulation</a>, a participant, including a child in foster care or kinship care, shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#D(1)">(1)</span> Have 28 days from the day the Department mails its eligibility notification in which to select an MCO; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#D(2)">(2)</span> Be assigned to an MCO with available capacity that is accepting new participants in the participant’s service area.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#E">E.</span> All Managed Care Program eligible family members who live in the same household shall be assigned to the same MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#F">F.</span> Newborns.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#F(1)">(1)</span> A newborn shall be automatically enrolled from birth in its biological mother’s MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#F(2)">(2)</span> The MCO is responsible for the newborn’s health care from birth until the newborn enrolls into another MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#F(3)">(3)</span> A newborn, automatically assigned to its biological mother’s MCO, is not eligible to change MCOs for family unity as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#A(1)(b)" title="">COMAR 10.67.02.06A(1)(b)</a> and (c) during the first 90 days of enrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#G">G.</span> Effective Date of Enrollment. Enrollment in an MCO shall be effective at 12:01 a.m. on the 10th calendar day beginning with the day on which the Department notifies the MCO of the enrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#H">H.</span> Upon the approval of the Department and the MCO, a participant may select an MCO that does not serve the participant’s service area.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.02#I">I.</span> The Department or its designee shall submit the enrollee's choice of PCP to the enrollee's selected MCO at the time of enrollment.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.02.03" data-order="|10|67|02|.03|" data-ref-path="10|67|02|.03" class="h__section">.03 Health Service Needs Information.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.03#A">A.</span> The Department, MCO, or agents of the Department or MCO shall attempt to complete the health service needs information at the time of enrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.03#B">B.</span> The Department shall transmit any information obtained from health service needs information to the enrollee’s MCO within 5 business days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.03#C">C.</span> Upon its receipt and review of the health service needs information, an MCO shall take appropriate action to ensure that a new enrollee, who needs special or immediate health care services, as identified by the health service needs information, receives them in a timely manner.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.03#D">D.</span> If the Department does not transmit health services needs information for an enrollee to the MCO within 10 days of enrollment, the MCO shall make at least two attempts to conduct an initial screening of the enrollee’s needs, within 90 days of the effective date of enrollment. At least one of these attempts shall be during non-working hours.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.03#E">E.</span> The Department shall inform an enrollee identified in connection with the health service needs information as having a behavioral health problem that the individual may self-refer to the behavioral health ASO for services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">10.09.80</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.02.04" data-order="|10|67|02|.04|" data-ref-path="10|67|02|.04" class="h__section">.04 Assignment to Primary Care Provider (PCP).</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#A">A.</span> Within 10 days of the notification of enrollment of a new enrollee or within 10 days of any event that requires a change in an existing enrollee's PCP, an MCO shall notify the enrollee of the enrollee's PCP assignment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#B">B.</span> A Program recipient with no previous affiliation with any of the providers on the MCO's primary care provider panel who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#B(1)">(1)</span> Indicates a preference for a participating PCP during the enrollment process shall be assigned to that PCP unless the MCO documents in writing, for good cause, its inability to assign the enrollee to that PCP; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#B(2)">(2)</span> Fails to make known any preference for a PCP shall be assigned to a PCP whose location satisfies the access standards specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06#E" title="">COMAR 10.67.05.06E</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#C">C.</span> Before changing an enrollee’s PCP, the MCO shall obtain the Department’s approval at least 60 days before the reassignment is effective unless:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#C(1)">(1)</span> The PCP has decided to stop practicing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#C(2)">(2)</span> The PCP has terminated the relationship with an enrollee due to the enrollee’s behavior;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#C(3)">(3)</span> The change is requested by the enrollee; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.04#C(4)">(4)</span> The age limits of the PCP's practice no longer meet the needs of the enrollee.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.02.05" data-order="|10|67|02|.05|" data-ref-path="10|67|02|.05" class="h__section">.05 Reassignment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#A">A.</span> Once every 12 months, a Program recipient may elect to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#A(1)">(1)</span> Maintain enrollment with the recipient's current MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#A(2)">(2)</span> Enroll in another MCO in the recipient's local access area; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#A(3)">(3)</span> Enroll in an MCO outside the recipient’s local access area, upon the approval of the Department and the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#B">B.</span> The Department shall notify the enrollee no less than 60 days before the start of each new enrollment period.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#C">C.</span> The Department shall reassign into the same MCO from which the recipient was last enrolled any recipient disenrolled from an MCO who, within 120 days of disenrollment, regains:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#C(1)">(1)</span> Eligibility for Medicaid; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#C(2)">(2)</span> Maryland Medicaid Managed Care Program eligibility lost for any of the reasons listed in <a class="internal-link " href="/us/md/exec/comar/10.67.02.06#B" title="">Regulation .06B of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#D">D.</span> The MCO shall assign the recipient to the primary care provider of record at the time of the recipient's disenrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.05#E">E.</span> A Program participant who has been disenrolled from an MCO because the Department terminated the MCO's contract shall be assigned to another MCO subject to <a class="internal-link " href="/us/md/exec/comar/10.67.02.02#D" title="">Regulation .02D of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.02.06" data-order="|10|67|02|.06|" data-ref-path="10|67|02|.06" class="h__section">.06 Disenrollment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A">A.</span> Enrollee-Initiated Disenrollment for Cause.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)">(1)</span> An enrollee may disenroll from an MCO and enroll into another MCO if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(a)">(a)</span> The enrollee moves to a county that is not served by the enrollee's present MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(b)">(b)</span> The family members are enrolled in different MCOs and the adult enrollee requests that other family members be enrolled in one of the MCOs in which another family member is currently enrolled;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(c)">(c)</span> The enrollee requests enrollment into the MCO that contracts with the PCP of any other family member who is not a HealthChoice enrollee;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(d)">(d)</span> The enrollee moves or becomes homeless, creating a transportation hardship that may be resolved by enrollment into another MCO serving the enrollee's new local access areas;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(e)">(e)</span> The enrollee requests a change of MCO within 90 days after the termination of the enrollee's primary care provider's (PCP's) contract if the PCP's contract with the enrollee's MCO, MCO's medical management group, or its subcontractors is terminating for the following reasons:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(e)(i)">(i)</span> By the MCO for reasons other than the quality of care or the PCP's failure to comply with contractual requirements related to quality assurance activities; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(e)(ii)">(ii)</span> The MCO's reduction of PCP's reimbursement to the extent that the reduction in rate is greater than the actual change in capitation paid to the MCO by the Department, and the MCO and PCP's inability to negotiate a mutually acceptable rate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(f)">(f)</span> The enrollee is automatically assigned to an MCO or it is the enrollee's initial enrollment in an MCO as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(f)(i)">(i)</span> Only one request during the first 90 days of automatic assignment or initial enrollment into an MCO; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(f)(ii)">(ii)</span> The enrollee is not hospitalized at the time of the request;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(g)">(g)</span> The MCO terminates its contract with the Department in which case:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(g)(i)">(i)</span> The MCO shall provide written notice to the recipient at least 60 days before the date on which the MCO will exit the HealthChoice Program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(g)(ii)">(ii)</span> The MCO shall include in the notice the name and provider number of the PCP assigned to the recipient and the telephone number of the enrollment broker;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(g)(iii)">(iii)</span> The Department shall send a notice to every enrollee of the MCO regarding the MCO's termination of its contract with the Department, at least 30 days before the effective date of the termination of the contract;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(g)(iv)">(iv)</span> An enrollee shall have at least 30 days before the effective date of the MCO's contract termination with the Department to choose another MCO, or will be assigned to another MCO; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(g)(v)">(v)</span> An enrollee may choose another MCO one additional time within at least 90 days after reenrollment into the new MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(h)">(h)</span> The MCO is acquired by another entity in which case:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(h)(i)">(i)</span> The MCO shall provide written notice to the recipient at least 60 days before the date on which the MCO will exit the HealthChoice Program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(h)(ii)">(ii)</span> The MCO shall include in the notice the name and provider number of the PCP assigned to the recipient and the telephone number of the enrollment broker;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(h)(iii)">(iii)</span> The Department shall send a notice to every enrollee of the MCO regarding the change in ownership, 30 days before the effective date of the change of ownership;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(h)(iv)">(iv)</span> An enrollee shall have 30 days before the change of ownership to disenroll from the MCO into another participating MCO;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(h)(v)">(v)</span> If an enrollee does not choose to disenroll in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.02.06#A(1)(f)(ii)" title="">§A(1)(f)(ii) of this regulation</a>, the enrollee will be reenrolled in the newly purchased MCO; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(h)(vi)">(vi)</span> An enrollee may choose another MCO one additional time within at least 90 days after reenrollment in the newly purchased MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(i)">(i)</span> The MCO does not, because of moral or religious objections, cover the service the enrollee seeks;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(j)">(j)</span> All of the following apply:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(j)(i)">(i)</span> The enrollee needs related services to be performed at the same time;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(j)(ii)">(ii)</span> Not all related services are available within the network; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(j)(iii)">(iii)</span> The enrollee's PCP or other provider determines that receiving the services separately would subject the enrollee to unnecessary risk; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(1)(k)">(k)</span> The Department imposes the intermediate sanction specified in 42 CFR §438.702(a) and (b), as amended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(2)">(2)</span> The Department shall provide timely notification to the affected MCO of an enrollee's intention to disenroll under <a class="internal-link " href="/us/md/exec/comar/10.67.02.06#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(3)">(3)</span> The Department shall allow disenrollments, subject to the Department's approval, for other reasons, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(3)(a)">(a)</span> Poor quality of care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(3)(b)">(b)</span> Lack of access to services covered under the contract; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(3)(c)">(c)</span> Access to providers experienced in dealing with the enrollee's health care needs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#A(4)">(4)</span> Enrollees shall make an oral or written request to the Department's enrollment agent for disenrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B">B.</span> Department-Initiated Disenrollment. The Department shall disenroll from an MCO an enrollee:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(1)">(1)</span> Subject to the MCO or long-term care facility obtaining the Department’s determination that the enrollee’s institutionalization has been medically necessary, who has been continuously institutionalized for a period of more than 90 successive days in a long-term care facility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(2)">(2)</span> Upon admission to an intermediate care facility for individuals with intellectual disabilities or persons with related conditions (ICF/IID);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(3)">(3)</span> Determined eligible for rare and expensive case management pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69" title="Chapter 69 Maryland Medicaid Managed Care Program: Rare and Expensive Case Management">COMAR 10.09.69</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(4)">(4)</span> Who loses Medicaid eligibility or who changes to an assistance category not eligible for MCO enrollment, subject, however, to <a class="internal-link " href="/us/md/exec/comar/10.67.02.01" title=".01 Eligibility.">Regulation .01 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(5)">(5)</span> Upon the termination of the contract between the enrollee's MCO and the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(6)">(6)</span> Who has died;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(7)">(7)</span> Who has not been validly enrolled in the MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(8)">(8)</span> Who is 65 years old or older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(9)">(9)</span> Who is an inmate of a public institution, including a State operated institution or facility; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#B(10)">(10)</span> Who is eligible to receive Medicare benefits.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#C">C.</span> The Department may disenroll individuals from an MCO which the Maryland Insurance Administration has put into rehabilitation or liquidation pursuant to Health-General Article, §15-102.2, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#D">D.</span> MCO Initiated Disenrollment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#D(1)">(1)</span> An MCO may request disenrollment of an enrollee who has:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#D(1)(a)">(a)</span> Moved outside of the MCO's service area; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#D(1)(b)">(b)</span> Become ineligible for continued enrollment for one of the reasons specified in <a class="internal-link " href="/us/md/exec/comar/10.67.02.06#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#D(2)">(2)</span> An MCO may not request disenrollment as specified in 42 CFR §438.56(b)(2), as amended.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E">E.</span> Effective Date of Disenrollment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(1)">(1)</span> Except as specified in §E(2)—(6) of this regulation, an enrollee's disenrollment is effective on the 10th calendar day after the enrollee selects a new MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(2)">(2)</span> An enrollee's disenrollment shall take effect:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(2)(a)">(a)</span> Immediately when the enrollee dies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(2)(b)">(b)</span> From the first day of the month following the month that the enrollee lost Medicaid eligibility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(2)(c)">(c)</span> On the first day of the month following the month in which the Department receives the required notification, when the enrollee permanently relocates outside of the State; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(2)(d)">(d)</span> From the first day of the month following the month in which the Department verifies an enrollee is an inmate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(3)">(3)</span> When an enrollee becomes eligible for Medicare, the enrollee’s disenrollment from the MCO is effective on the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(3)(a)">(a)</span> First day of the month following the month in which the Program receives notice of Medicare eligibility; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(3)(b)">(b)</span> Last day of the month before the month in which the enrollee turns 65 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(4)">(4)</span> Termination of enrollment resulting from termination of the contract between the Department and an MCO shall be effective on the date the Department terminates the contract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(5)">(5)</span> Termination of enrollment resulting from the MCO being placed into rehabilitation or liquidation by the Maryland Insurance Administration shall be effective on the date the Department notifies the MCO of the disenrollment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#E(6)">(6)</span> In the case of an enrollee's death, the Department has the right to recover any capitation payments made on behalf of an enrollee for the period beginning on the date of death.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#F">F.</span> An MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#F(1)">(1)</span> Make a good faith effort to give written notice to the Department when enrollees have the right to change MCOs under <a class="internal-link " href="/us/md/exec/comar/10.67.02.06#A(1)(e)" title="">§A(1)(e) of this regulation</a> 90 days before the effective date of the termination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#F(2)">(2)</span> Provide the Department with a list of the affected enrollees in a format specified by the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#F(3)">(3)</span> If applicable, provide the termination survey required under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#B(4)" title="">COMAR 10.67.04.17B(4)</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#G">G.</span> The Department shall notify enrollees who may change MCOs under <a class="internal-link " href="/us/md/exec/comar/10.67.02.06#A(1)(e)" title="">§A(1)(e) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.02.06#H">H.</span> At the Department’s discretion, an MCO may be required to reimburse the Department for the costs associated with the mailing of the notifications in <a class="internal-link " href="/us/md/exec/comar/10.67.02.06#G" title="">§G of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.03" data-order="|10|67|03|" data-ref-path="10|67|03" class="h__chapter">Chapter 03 Maryland Medicaid Managed Care Program: MCO Application</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.01" title=".01 Repealed.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.11" title=".11 Management Information System and Data Reporting.">.11</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.01" title=".01 Repealed.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.11" title=".11 Management Information System and Data Reporting.">.11</a> adopted effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.01" title=".01 Repealed.">Regulation .01</a> repealed effective December 27, 2010 (37:26 Md. R. 1787)</p>
                  <p>Regulation .02C repealed effective April 16, 2012 (39:7 Md. R. 492)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.03#F" title="">Regulation .03F</a>, G amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.03#H" title="">Regulation .03H</a> amended effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.03#T" title="">Regulation .03T</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.04" title=".04 Financial Solvency.">Regulation .04</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.04#F" title="">Regulation .04F</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.05" title=".05 Access and Capacity.">Regulation .05</a> amended effective October 28, 2013 (40:21 Md. R. 1775); February 16, 2015 (42:3 Md. R. 316); February 1, 2016 (42:23 Md. R. 1434)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.05#A" title="">Regulation .05A</a> amended effective December 27, 2010 (37:26 Md. R. 1787); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.06" title=".06 Access and Capacity: Benefits and Appointments.">Regulation .06</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.06" title=".06 Access and Capacity: Benefits and Appointments.">Regulation .06</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.06#E" title="">Regulation .06E</a> amended effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.06#G" title="">Regulation .06G</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.07#A" title="">Regulation .07A</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.07#E" title="">Regulation .07E</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.08" title=".08 National Committee on Quality Assurance (NCQA) Accreditation.">Regulation .08</a> repealed effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.08" title=".08 National Committee on Quality Assurance (NCQA) Accreditation.">Regulation .08</a> adopted effective December 24, 2012 (39:25 Md. R. 1612)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.09" title=".09 Quality Assurance System — General.">Regulation .09</a> amended effective April 19, 2010 (37:8 Md. R. 615); December 27, 2010 (37:26 Md. R. 1787)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.09#G" title="">Regulation .09G</a> amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.09#K" title="">Regulation .09K</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.10#C" title="">Regulation .10C</a>, D amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.11" title=".11 Management Information System and Data Reporting.">Regulation .11</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.11#C" title="">Regulation .11C</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.64" title="Chapter 64 Collaborative Care Model">COMAR 10.09.64</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03.03#I" title="">Regulation .03I</a> amended effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article §§15-102 and 15-103, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.03.01" data-order="|10|67|03|.01|" data-ref-path="10|67|03|.01" class="h__section">.01 Repealed.</h3>
                <h3 id="/us/md/exec/comar/10.67.03.02" data-order="|10|67|03|.02|" data-ref-path="10|67|03|.02" class="h__section">.02 Application.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.02#A">A.</span> When applying for participation in the Maryland Medicaid Managed Care Program as an MCO, an applicant shall submit an application to the Secretary in the form that the Secretary requires.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.02#B">B.</span> An applicant may omit from its application any information or documents that it has previously submitted to the Department, if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.02#B(1)">(1)</span> The information or documents are up to date; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.02#B(2)">(2)</span> The applicant identifies in its application the information and documents that it has omitted.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.03" data-order="|10|67|03|.03|" data-ref-path="10|67|03|.03" class="h__section">.03 Organization, Operations, and Financing.</h3>
                <p>Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.03.02#B" title="">Regulation .02B of this chapter</a>, an MCO applicant shall include the following information or descriptions in its application:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#A">A.</span> An indication whether the applicant is an operating HMO with a certificate of authority from the Maryland Insurance Administration;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#B">B.</span> A written legal history of the applicant, specific as to dates and parties involved, that includes, but is not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#B(1)">(1)</span> Predecessor corporations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#B(2)">(2)</span> Mergers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#B(3)">(3)</span> Reorganizations; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#B(4)">(4)</span> Changes of ownership;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#C">C.</span> A copy of the articles of incorporation of the applicant, and any amendments to it, certified by the Maryland Department of Assessments and Taxation;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#D">D.</span> A copy of the applicant's current bylaws, certified by the appropriate corporate officer;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#E">E.</span> A written description providing a reason if the applicant has ever defaulted on a contract or otherwise had a contract terminated;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#F">F.</span> If the applicant is an HMO, the most recent annual loss ratio report provided to the Maryland Insurance Administration pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=5-605" title="">Insurance Article, §5-605, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#G">G.</span> A copy of the applicant's business plan provided to the Maryland Insurance Administration pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=5-605" title="">Insurance Article, §5-605, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#H">H.</span> Evidence of compliance with Maryland Workers' Compensation Law, as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#H(1)">(1)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.03.03#H(2)" title="">§H(2) of this regulation</a>, the applicant shall submit:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#H(1)(a)">(a)</span> The policy number of its Workers' Compensation insurance coverage; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#H(1)(b)">(b)</span> The name of its Workers' Compensation insurance carrier; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#H(2)">(2)</span> If self-insured, the applicant shall submit a certificate of compliance evidencing employee coverage under Workers' Compensation Law, as provided in <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gle/gle.pdf" title="">Labor and Employment Article, Title 9, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I">I.</span> The names, addresses, and official capacities of the managing employees or other individuals responsible for the conduct of the affairs of the applicant, including concise position descriptions and background, citing education, training, and experience, for, but not limited to, the applicant's:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(1)">(1)</span> Chief Executive Officer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(2)">(2)</span> Chief Medical Officer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(3)">(3)</span> Chief Information Officer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(4)">(4)</span> Chief Financial Officer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(5)">(5)</span> Chief Quality Officer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(6)">(6)</span> Clinical Operations Manager;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(7)">(7)</span> Chief Operating Officer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(8)">(8)</span> Marketing Director;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(9)">(9)</span> Program Integrity Director;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(10)">(10)</span> Health Equity Director;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(11)">(11)</span> Chief Compliance Officer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(12)">(12)</span> Appeals and Grievances Manager;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(13)">(13)</span> Provider Relations Manager;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(14)">(14)</span> Special Needs Coordinator, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04" title=".04 Special Needs Populations.">COMAR 10.67.04.04</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#I(15)">(15)</span> Newborn Coordinator, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.27" title=".27 Newborn Coordinator.">COMAR 10.67.04.27</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#J">J.</span> A full disclosure of the extent and nature of any contracts or arrangements, including any possible conflicts of interest between the applicant and any individual specified in <a class="internal-link " href="/us/md/exec/comar/10.67.03.03#I" title="">§I of this regulation</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#K">K.</span> The name and address of each person with a 5 percent or more ownership or controlling interest in the applicant or in any subcontractor or supplier in which the applicant has direct or indirect ownership of 5 percent or more, including identifying whether any person named is related to any other named person as either spouse, parent, child, or sibling;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#L">L.</span> A list of any subcontractors or suppliers owned by the applicant, indicating the percent of financial interest held;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#M">M.</span> A history of any subcontractors with whom the applicant has had business transactions totaling more than $25,000 during the 12-month period ending on the date of application;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#N">N.</span> A description of the applicant's corporate and organizational structure, and an organizational chart, with detailed lines of authority indicating the relationships among the board of directors, the administrative component, and the medical and health service delivery component of the applicant including, but not limited to, staff positions responsible for the plan's key management functions enumerated in <a class="internal-link " href="/us/md/exec/comar/10.67.03.03#I" title="">§I of this regulation</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#O">O.</span> A description of all current contractual relationships between the applicant and subcontractors for administrative/management, health, and marketing services, including the subcontractors' names;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#P">P.</span> A description of any contracts the applicant intends to enter into before beginning operation as an MCO;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#Q">Q.</span> The name of any person or persons holding an ownership or controlling interest in excess of 5 percent in the applicant, or who is an agent or managing employee of the applicant, who has been subject to a conviction as defined at 42 U.S.C. §1320a-7(i), or a sanction for a Program-related offense;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#R">R.</span> Copies of all standard subcontracts with service and administrative providers who are not salaried employees of the applicant, including identification of any provision in subcontracts which differ from the standard subcontract;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#S">S.</span> A description of the method by which the applicant will accomplish cost avoidance or recovery in the case of third-party liability; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#T">T.</span> Copies of the applicant’s written Medicaid marketing plan including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#T(1)">(1)</span> A description of how the applicant plans to address the special access provisions in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01#D" title="">COMAR 10.67.05.01D</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#T(2)">(2)</span> Sample version of all material and communication the applicant would like to distribute to potential enrollees, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#T(2)(a)">(a)</span> Brochures;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#T(2)(b)">(b)</span> Fact sheets; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.03#T(2)(c)">(c)</span> Posters.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.04" data-order="|10|67|03|.04|" data-ref-path="10|67|03|.04" class="h__section">.04 Financial Solvency.</h3>
                <p>An applicant that is not a Maryland certified HMO shall include in its application the following information or descriptions:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#A">A.</span> A table labeled "Insurance Coverage", specifying the applicant's coverage in insurance types including, but not limited to, reinsurance, risk of insolvency, medical malpractice, general liability, and fidelity bond, and detailing the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#A(1)">(1)</span> Carrier;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#A(2)">(2)</span> Entity covered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#A(3)">(3)</span> Description of coverage including deductibles, coinsurance, and minimum and maximum benefits;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#A(4)">(4)</span> Premium in effect;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#A(5)">(5)</span> Any additional policies to cover new risks associated with anticipated MCO functions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#A(6)">(6)</span> Any other pertinent arrangements;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#B">B.</span> Evidence of the applicant's insurance for general liability and medical malpractice in the minimum amounts of $1,000,000 per loss and $3,000,000 in the aggregate;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#C">C.</span> Evidence that the applicant has on hand sufficient liquid funds or a reasonably adequate cash flow to meet all organizational and administrative expenses incurred or expected to be incurred before commencing operations;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#D">D.</span> An explanation detailing how the applicant would, if approved, protect itself from insolvency;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#E">E.</span> A description of how the applicant would, if approved, limit its financial risk;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#F">F.</span> Document that the applicant has deposited, in a trust account with the State treasury, $100,000 in cash or government securities of the type described in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=5-701" title="">Insurance Article, §5-701(b), Annotated Code of Maryland</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#G">G.</span> A financial statement audited by an independent certified public accountant of the financial condition of the applicant, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#G(1)">(1)</span> Assets, liabilities, and minimum tangible net equity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#G(2)">(2)</span> A prospective budget and expected cash flow analysis of the applicant for the first 24 months of its anticipated operation demonstrating financial stability based on reasonable assumptions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#G(3)">(3)</span> Any other financial information required by the Commissioner to adequately conduct financial examination of an applicant; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.04#H">H.</span> A power of attorney executed by the applicant appointing the Commissioner and the Commissioner's authorized deputies as the true and lawful attorney of the applicant in and for the State upon which may be served all lawful process in any action, proceeding, or cause of action arising in this State against the applicant regarding the solvency and financial condition of the applicant.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.05" data-order="|10|67|03|.05|" data-ref-path="10|67|03|.05" class="h__section">.05 Access and Capacity.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A">A.</span> An MCO applicant shall include in its application the following information or descriptions:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(1)">(1)</span> A map or maps showing the county or counties in which the applicant proposes to provide health care services, and the service area boundaries.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(2)">(2)</span> The name and address of each of the applicant's service delivery sites, and, if applicable, the type of facility licensure of each site, grouped by county;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(3)">(3)</span> If the applicant is an HMO, the applicant's total prepaid enrollment or client population as of the date of application, with a breakdown by payment source, including Medicare, Medicaid, commercial group, commercial individual, and other enrollment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(4)">(4)</span> If the applicant is an HMO, the total of the applicant's current unduplicated fee-for-service patient count, with a breakdown by payment source, including Medicaid, Medicare, commercial group, commercial individual, and other patients (including self-pay);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(5)">(5)</span> The name and address of each of the applicant's primary and specialty care providers, provided in a format specified by the Department, for distribution to recipients in enrollment packets;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)">(6)</span> The following information, grouped by medical specialty and county, regarding each individual practitioner, including primary care providers and specialists, who will act as a health care provider for the applicant:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(a)">(a)</span> Name, address, and practice location or locations, including a separate line for each location;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(b)">(b)</span> State licensure number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(c)">(c)</span> Specialty, if applicable, indicating the type of services to be provided on behalf of the applicant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(d)">(d)</span> Whether the provider will be a primary care provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(e)">(e)</span> A description of the practitioner's employment relationship to the applicant, including, but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(e)(i)">(i)</span> A salaried employee;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(e)(ii)">(ii)</span> A subcontractor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(e)(iii)">(iii)</span> An employee of a subcontractor; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(e)(iv)">(iv)</span> Any other form of contractual or employment relationship;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(6)(f)">(f)</span> Any restrictions as to age of patients or numbers of enrollees the provider will serve;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(7)">(7)</span> The procedures for assuring proper credentialing and recredentialing of providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(8)">(8)</span> Documentation that the MCO applicant is able to meet the access standards set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05" title="Chapter 05 Maryland Medicaid Managed Care Program: Access">COMAR 10.67.05</a> in each service area the MCO applicant plans to enter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(9)">(9)</span> Documentation of any reasons for which they are unable to meet the access requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05" title="Chapter 05 Maryland Medicaid Managed Care Program: Access">COMAR 10.67.05</a> in any service area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(10)">(10)</span> For each primary care practice location, a specification of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(10)(a)">(a)</span> The name, address, and hours of operation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(10)(b)">(b)</span> The staffing at each location, expressed in full-time equivalencies and grouped by medical specialty; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#A(11)">(11)</span> Written protocols detailing how the applicant will provide 24-hour per day, 7-day per week coverage for emergency medical situations, including compliance with MIEMSS protocols and the federal Emergency Medical Treatment and Active Labor Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#B">B.</span> The service area in <a class="internal-link " href="/us/md/exec/comar/10.67.03.05#A(1)" title="">§A(1) of this regulation</a> shall include at least two underserved counties as defined in <a class="internal-link " href="/us/md/exec/comar/10.67.03.05#C" title="">§C of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#C">C.</span> An underserved county is a county in which less than three current MCOs are participating and accepting new enrollments.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.05#D">D.</span> If there are no underserved counties, applications will not be accepted.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.06" data-order="|10|67|03|.06|" data-ref-path="10|67|03|.06" class="h__section">.06 Access and Capacity: Benefits and Appointments.</h3>
                <p>An MCO applicant shall include in its application the following information or descriptions:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#A">A.</span> Written evidence of the applicant's preparedness to provide benefits equivalent to the benefit level mandated by the Maryland Medical Assistance Program as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05" title="Chapter 05 Maryland Medicaid Managed Care Program: Access">COMAR 10.67.05</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#B">B.</span> A description of any benefits the applicant proposes to provide in addition to those required by the Maryland Medicaid Managed Care Program, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#B(1)">(1)</span> Whether there are any limitations on these services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#B(2)">(2)</span> The name, medical specialty, location, and employment status as enumerated in Regulation .05F(5) of this chapter, of any providers rendering additional services;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#C">C.</span> A copy of the written procedures specifying how an enrollee may select and change primary care providers;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#D">D.</span> A written explanation of the applicant's plan to provide adequate case management and continuity of care, including its policies and procedures concerning:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#D(1)">(1)</span> Case management;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#D(2)">(2)</span> Making appointments;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#D(3)">(3)</span> Appointment no-shows;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#D(4)">(4)</span> Follow-up for appointment no-shows who are at-risk patients; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#D(5)">(5)</span> Referral claims and reimbursement for authorized noncontractual and out-of-plan provider services;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#E">E.</span> Documentation of the applicant's preparedness to collaborate with providers of self-referral services, and reimburse at the Department's established fee-for-service rate, for permissible self-referred services as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">COMAR 10.67.06.28</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#F">F.</span> Documentation of the applicant's preparedness to provide the full range of EPSDT services;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#G">G.</span> Documentation of the applicant’s preparedness to work with the Department’s behavioral health ASO for coordination of somatic care, behavioral health care, and all appropriate drug utilization review.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#H">H.</span> A written explanation of the prospective MCO's plan for providing monthly updates to primary care providers of the enrollees assigned to them;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#I">I.</span> Documentation of the applicant's plan to satisfy statutory requirements that enrollees be notified of due dates for obtaining immunizations, examinations, and other wellness services;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#J">J.</span> Documentation of how the applicant will provide timely access to health care services, including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#J(1)">(1)</span> Waiting time for telephone calls to be answered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#J(2)">(2)</span> Obtaining appointments; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#J(3)">(3)</span> Waiting times in practitioners' offices;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#K">K.</span> Documentation of access provisions to address the needs of enrollees who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#K(1)">(1)</span> Do not speak English;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#K(2)">(2)</span> Are deaf; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#K(3)">(3)</span> Have one or more physical, mental, or developmental disabilities;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L">L.</span> The applicant's proposed written utilization management program that specifies, at a minimum, policies and procedures for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L(1)">(1)</span> Referral processes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L(2)">(2)</span> Services requiring preauthorization, including mechanisms for ensuring consistent application and requesting provider consultation when appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L(3)">(3)</span> Criteria for determining medical necessity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L(4)">(4)</span> Provider responsibilities for utilization management activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L(5)">(5)</span> Case management processes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L(6)">(6)</span> Utilization tracking mechanisms and the determination of over-utilization and under-utilization of health care services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L(7)">(7)</span> Integration of activities with quality improvement for provider profiling; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#L(8)">(8)</span> Appeals and grievance processes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#M">M.</span> The applicant's proposal to establish and utilize a consumer advisory board, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#M(1)">(1)</span> The anticipated composition of the board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#M(2)">(2)</span> Identifying staff responsible for serving board needs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#M(3)">(3)</span> Proposed mechanisms by which the board will furnish the MCO with regular enrollee input;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#N">N.</span> A written description of the applicant's proposed member services unit, including a consumer services hotline, describing how the applicant will use this:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#N(1)">(1)</span> As an information source for enrollees;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#N(2)">(2)</span> To respond to enrollees' needs and requests in a timely manner; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#N(3)">(3)</span> To facilitate enrollees' access to needed health care services, including how the hotline will function as a point of entry for complaint resolution and internal grievance procedures;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#O">O.</span> A written Enrollee Outreach Plan that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#O(1)">(1)</span> Describes how the MCO intends to comply with the outreach, quality assurance, and provision of health care services requirements of Health-General Article, §15-103(b)(9), Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#O(2)">(2)</span> To the extent that the materials are relevant to the requirements of <a class="internal-link " href="/us/md/exec/comar/10.67.03.06#O(1)" title="">§O(1) of this regulation</a>, may incorporate by reference written materials provided by the applicant in response to other elements of its application; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#P">P.</span> Documentation of any service the MCO elects not to provide, reimburse for, or provide coverage of, because of a moral or religious objection, which shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#P(1)">(1)</span> Be provided to the Department whenever an MCO adopts the policy during the term of the contract;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#P(2)">(2)</span> Be consistent with the provisions of 42 CFR §438.10, as amended; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.06#P(3)">(3)</span> Be provided to enrollees within 90 days after adopting the policy with respect to any particular service.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.07" data-order="|10|67|03|.07|" data-ref-path="10|67|03|.07" class="h__section">.07 Access and Capacity: Contracts and Provider Applications.</h3>
                <p>An MCO applicant shall include in its application the following information or descriptions:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#A">A.</span> A description of the applicant's hiring and subcontracting policies, which shall correspond to the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-112" title="">Insurance Article, §15-112, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#B">B.</span> A blank copy of the provider application form;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#C">C.</span> Documentary assurances that the applicant and its health care providers furnish access on a nondiscriminatory basis, in accordance with State and federal law, to all of their enrollees regardless of gender, race, age, religion, national origin, physical or mental disability, or type of illness or condition;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#D">D.</span> If the applicant is an HMO that will require its panel providers to participate in the MCO, documentation of the mechanism the MCO will use to make an equitable distribution of enrollees among its panel providers so that no provider is assigned a disproportionate number of enrollees;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#E">E.</span> Written evidence of the applicant's organizational capacity to provide special programs adequate to meet the individual needs of all enrollees, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#E(1)">(1)</span> Outreach;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#E(2)">(2)</span> Case management;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#E(3)">(3)</span> Home visiting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#E(4)">(4)</span> Disease management;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#E(5)">(5)</span> Prevention and wellness education; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#E(6)">(6)</span> All Medicaid-covered services required to comply with State statutes and regulations mandating health and behavioral health services for children in State-supervised care;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#F">F.</span> A written explanation of the applicant's plan for ensuring that each primary and specialty care provider receives a copy of the MCO's Medicaid requirements manual, and any other information necessary to facilitate full compliance with all federal and State Medicaid requirements within 2 weeks after the provider has entered into a contract or has begun employment with the MCO, and updated as necessary thereafter; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.07#G">G.</span> A description of the applicant's plan to accommodate the cultural and ethnic diversity of the populations to be served.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.08" data-order="|10|67|03|.08|" data-ref-path="10|67|03|.08" class="h__section">.08 National Committee on Quality Assurance (NCQA) Accreditation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.08#A">A.</span> Effective July 1, 2012, an MCO applicant shall obtain NCQA health plan accreditation within 2 years of their effective date as an MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.08#B">B.</span> Effective January 1, 2025, an MCO shall obtain NCQA health equity accreditation within 2 years of their effective date as an MCO.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.09" data-order="|10|67|03|.09|" data-ref-path="10|67|03|.09" class="h__section">.09 Quality Assurance System — General.</h3>
                <p>An applicant shall include in its application the following information or descriptions:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#A">A.</span> The applicant's proposed quality assurance plan, that contains, at a minimum, all elements specified by Health-General Article, §15-103(b)(9)(i), Annotated Code of Maryland;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#B">B.</span> A description of any written procedures or protocols regarding physician and nursing care practice the applicant intends to use;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#C">C.</span> A description of the applicant's peer review committee structure and process;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#D">D.</span> A copy of the applicant's case management plan;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#E">E.</span> A description of all mechanisms to be used to ensure the quality of any services, including administrative and clinical, that the applicant intends to delegate to subcontractors;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#F">F.</span> The name and a description of the published standards or guidelines for maintenance of medical records the applicant will follow;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#G">G.</span> A description of how providers will be apprised of medical records, utilization review, and case management requirements;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#H">H.</span> A description of the applicant's system for ensuring inclusion in the medical record of reports of health care services or diagnostic testing performed in a referral setting;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#I">I.</span> A written description of the applicant's internal review system for the handling, monitoring, and resolution of provider complaints, grievances, and appeals;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#J">J.</span> Evidence of an adequate system for medical record retention and retrieval that meets, at minimum, all requirements of Health-General Article, §15-103(b)(9)(xiv), Annotated Code of Maryland;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#K">K.</span> Documentary evidence that the applicant requires school-based clinics to provide information concerning health care services provided to their enrollees;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#L">L.</span> A copy of the applicant's practice guidelines used to assist practitioners in approaching health care issues in a systematic, appropriate manner;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#M">M.</span> A copy of the applicant's health education plan;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N">N.</span> A written description of the applicant's complaint resolution protocol, which shall, at minimum:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(1)">(1)</span> Include an internal grievance procedure by which an enrollee who is dissatisfied with the applicant or its providers may seek recourse within the applicant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(2)">(2)</span> Specify what constitutes a grievance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(3)">(3)</span> Provide for prompt resolution of complaints;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(4)">(4)</span> Require participation in the grievance process by individuals within the MCO who have the authority to require corrective action;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(5)">(5)</span> Specify how the MCO will handle formal appeals by enrollees;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(6)">(6)</span> Include a form that enrollees will use when filing a grievance, including foreign language versions for any substantial minorities in the applicant's proposed MCO service area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(7)">(7)</span> Identify the steps in the grievance process, and what personnel will be responsible for receiving, processing, monitoring, and responding to grievances;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(8)">(8)</span> Specify how the enrollee will be informed that the enrollee's grievance is being investigated, and the protocols by which grievances will be resolved;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(9)">(9)</span> Describe what methods will be used to inform enrollees about the operation of the grievance procedure; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#N(10)">(10)</span> Describe whether manual or automated processes will be used to track enrollees' complaints, determine any patterns of complaints, and report findings to the proposed MCO's quality assurance or quality improvement system; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.09#O">O.</span> A copy of the MCO's provider education plan.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.10" data-order="|10|67|03|.10|" data-ref-path="10|67|03|.10" class="h__section">.10 Special Needs Populations.</h3>
                <p>An MCO applicant shall include in its application the following information or descriptions:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#A">A.</span> A narrative description of the clinical expertise and experience of the MCO's network for special needs populations in a format specified by the Department;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#B">B.</span> Written evidence of the applicant's ability to comply with specific quality access, data, and performance measurements to satisfy the general requirements for all special needs populations specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04" title=".04 Special Needs Populations.">COMAR 10.67.04.04</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#C">C.</span> Written evidence, including treatment protocols, of the applicant’s ability to provide the range of clinical and support services specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05" title=".05 Special Needs Populations — Children with Special Health Care Needs.">COMAR 10.67.04.05</a>—.10 and .13, to ensure appropriate and coordinated services to the following special populations:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#C(1)">(1)</span> Children with special health care needs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#C(2)">(2)</span> Individuals with a physical disability;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#C(3)">(3)</span> Individuals with a developmental disability;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#C(4)">(4)</span> Pregnant and postpartum women;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#C(5)">(5)</span> Individuals who are homeless; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#C(6)">(6)</span> Individuals with HIV/AIDS; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.10#D">D.</span> Referral protocols that demonstrate the conditions under which PCPs will make the arrangements for children with special health care needs to be referred to MCO specialty care networks and when appropriate the behavioral health ASO for services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">10.09.80</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.03.11" data-order="|10|67|03|.11|" data-ref-path="10|67|03|.11" class="h__section">.11 Management Information System and Data Reporting.</h3>
                <p>An MCO applicant shall include in its application the following information or descriptions:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A">A.</span> A description of the applicant's management information system, including, but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A(1)">(1)</span> Capacities, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A(1)(a)">(a)</span> The ability to generate and transmit electronic claims data consistent with the Medicaid Statistical Information System (MSIS) requirements or successor systems;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A(1)(b)">(b)</span> The ability to collect and report data on enrollee and provider characteristics and on all services furnished to enrollees through an encounter data system;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A(1)(c)">(c)</span> The ability to screen the data collected for completeness, logic, and consistency; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A(1)(d)">(d)</span> The ability to collect and report data from providers in standardized formats using secure information exchanges and technologies utilized for Medicaid quality improvement and care coordination efforts;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A(2)">(2)</span> Software;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A(3)">(3)</span> Characteristics; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#A(4)">(4)</span> Ability to interface with other systems;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#B">B.</span> A description of the applicant's operational procedures for generating service-specific encounter data;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#C">C.</span> Evidence of the applicant's ability to report, on a monthly basis, service-specific encounter data in UB04 or CMS1500 format;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#D">D.</span> A description of the applicant's operational procedures for generating financial reports, including, but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#D(1)">(1)</span> Annual audits;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#D(2)">(2)</span> Annual financial statements; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#D(3)">(3)</span> Quarterly unaudited financial statements;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#E">E.</span> Evidence of the applicant’s ability to collect and report all data necessary to derive indicators for Healthcare Effectiveness Data and Information Set (HEDIS); and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.03.11#F">F.</span> A description of the applicant’s procedures for verifying the accuracy and timeliness of reported data, including data from network providers the MCO was compensating on the basis of capitation payments or other payment arrangements that are not fee-for-service.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04" data-order="|10|67|04|" data-ref-path="10|67|04" class="h__chapter">Chapter 04 Maryland Medicaid Managed Care Program: Managed Care Organizations</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23" title=".23 Marketing.">.23</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23" title=".23 Marketing.">.23</a> adopted effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">Regulation .01</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p>Regulations .02C, .04C, .08, .11, .15, .17A, .18, .20B, and .22C amended and Regulation .11-1 adopted as an emergency provision effective July 1, 1997 (24:16 Md. R. 1151); emergency status expired December 31, 1997</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02" title=".02 Conditions for Participation.">Regulation .02</a> amended effective February 9, 1998 (25:3 Md. R. 144); November 1, 1999 (26:22 Md. R. 1692); February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02" title=".02 Conditions for Participation.">Regulation .02</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02" title=".02 Conditions for Participation.">Regulation .02</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#G" title="">Regulation .02G</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#G" title="">Regulation .02G</a> and H amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p>Regulation .03P amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p>Regulation .03T adopted effective February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03" title=".03 Quality Assessment and Improvement.">Regulation .03</a> repealed and new Regulation .03 adopted effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04#C" title="">Regulation .04C</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05" title=".05 Special Needs Populations — Children with Special Health Care Needs.">Regulation .05</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05" title=".05 Special Needs Populations — Children with Special Health Care Needs.">Regulation .05</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05#K" title="">Regulation .05K</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08" title=".08 Special Needs Populations — Pregnant and Postpartum Women.">Regulation .08</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08" title=".08 Special Needs Populations — Pregnant and Postpartum Women.">Regulation .08</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#B" title="">Regulation .10B</a> amended effective February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> amended as an emergency provision effective July 1, 2000 (27:15 Md. R. 1397); amended permanently effective October 16, 2000 (27:20 Md. 1838)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> amended effective February 18, 2002 (29:3 Md. R.220); December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .11-1 and .11-2 adopted February 9, 1998 (25:3 Md. R. 144)</p>
                  <p>Regulation .11-1 and .11-2E amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p>Regulations .11-1 and .11-2 amended as an emergency provision effective July 1, 2000 (27:15 Md. R. 1397); amended permanently effective October 16, 2000 (27:20 Md. R. 1838)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15" title=".15 Data Collection and Reporting.">Regulation .15</a> amended effective February 9, 1998 (25:3 Md. R. 144); December 25, 2000 (27:25 Md. R. 2281); February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#B" title="">Regulation .15B</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#D" title="">Regulation .15D</a>, E amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.16" title=".16 Repealed.">Regulation .16</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#A" title="">Regulation .17A</a> amended effective February 9, 1998 (25:3 Md. R. 144); December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#B" title="">Regulation .17B</a> amended effective February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18" title=".18 Third-Party Liability.">Regulation .18</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18-1" title=".18-1 MCO Reimbursement — GME Exclusion.">Regulation .18-1</a> adopted as an emergency provision effective April 7, 1998 (25:9 Md. R. 676); adopted permanently effective June 29, 1998 (25:13 Md. R. 993)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18-1" title=".18-1 MCO Reimbursement — GME Exclusion.">Regulation .18-1</a> amended effective December 25, 2000 (27:25 Md. R.2281)</p>
                  <p>Regulation .18-1C adopted effective November 1, 1999 (26:22 Md. R. 1692)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); emergency status extended at 26:1 Md. R. 17, 26:6 Md. R. 480, and 26:8 Md. R. 614; emergency status expired May 1, 1999</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective May 1, 1999 (26:9 Md. R. 727 and 26:10 Md. R. 794); emergency status expired November 1, 1999</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective November 1, 1999 (26:22 Md. R. 1692)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 25, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective December 25, 2000 (27:25 Md. R.2281)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#A" title="">Regulation .19A</a> amended as an emergency provision effective March 31, 2001 (28:7 Md. R. 685); emergency status extended at 28:22 Md. R. 1931 and 29:4 Md. R. 413</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#D" title="">Regulation .19D</a> amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-1" title=".19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.">.19-1</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">.19-3</a> adopted as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 25, 2000</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-1" title=".19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.">.19-1</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-4" title=".19-4 MCO Medical Loss Ratio.">.19-4</a> adopted effective December 25, 2000 (27:25 Md. R. 2281)</p>
                  <p>Regulations .19-1 and .19-2 repealed and new Regulation .19-1 adopted effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-1" title=".19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.">Regulation .19-1</a> repealed as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); repealed permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p>Regulations .19-3 and .19-4 amended and recodified to be new Regulations .19-2 and .19-3 effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-4" title=".19-4 MCO Medical Loss Ratio.">Regulation .19-4</a> adopted effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulations .19-5 and.19-6 adopted as an emergency provision effective March 31, 2001 (28:7 Md. R. 685); emergency status extended at 28:22 Md. R. 1931; emergency status extended at 29:4 Md. R. 413</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">Regulation .20</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">Regulation .20</a> amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#B" title="">Regulation .20B</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">Regulation .21</a> amended effective December 25, 2000 (27:25 Md. R. 2281); December 24, 2001 (28:25 Md. R. 2190); July 7, 2003 (30:13 Md. R. 854)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended as an emergency provision effective May 1, 1999 (26:9 Md. R. 727 and 26:10 Md. R. 794); emergency status expired November 1, 1999</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 25, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; adopted permanently effective June 25, 2001 (28:12 Md. R. 1109)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22#A" title="">Regulation .22A</a> amended and F—J adopted effective November 1, 1999 (26:22 Md. R. 1692)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22#C" title="">Regulation .22C</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p>Regulations .24 and .25 adopted as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.24" title=".24 Repealed.">Regulation .24</a> amended as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 25, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.24" title=".24 Repealed.">Regulation .24</a> amended effective December 25, 2000 (27:25 Md. R.2281); December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .24-1 adopted as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 31, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.26" title=".26 Time Period for Termination of Provider Agreement.">Regulation .26</a> adopted effective February 18, 2002 (29:3 Md. R. 220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.27" title=".27 Newborn Coordinator.">Regulation .27</a> adopted effective February 18, 2002 (29:3 Md. R. 220)</p>
                  <p>——————</p>
                  <p>Chapter revised effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">Regulation .01</a> repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .01B amended effective December 27, 2010 (37:26 Md. R. 1787)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02" title=".02 Conditions for Participation.">Regulation .02</a> amended effective June 30, 2008 (35:13 Md. R. 1180); April 28, 2014 (41:8 Md. R. 471); February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#G" title="">Regulation .02G</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#G" title="">Regulation .02G</a>, J, X amended effective November 7, 2016 (43:22 Md. R. 1221)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#K" title="">Regulation .02K</a> amended effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#O" title="">Regulation .02O</a>, S amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p>Regulation .02V amended effective December 27, 2010 (37:26 Md. R. 1787)</p>
                  <p>Regulation .02Z adopted effective November 5, 2007 (34:22 Md. R. 1977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#C" title="">Regulation .02C</a>C amended effective October 5, 2009 (36:20 Md. R. 1528); March 14, 2016 (43:5 Md. R. 385)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#D" title="">Regulation .02D</a>D adopted effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#E" title="">Regulation .02E</a>E adopted effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#K" title="">Regulation .02K</a>, L amended effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#F" title="">Regulation .02F</a>F adopted effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03" title=".03 Quality Assessment and Improvement.">Regulation .03</a> amended effective February 12, 2018 (45:3 Md. R. 156)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#A" title="">Regulation .03A</a>, B amended effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#B" title="">Regulation .03B</a> amended effective December 19, 2005 (32:25 Md. R. 1941); April 9, 2007 (34:7 Md. R. 698); November 5, 2007 (34:22 Md. R. 1977); June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#B" title="">Regulation .03B</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#B" title="">Regulation .03B</a> amended effective October 5, 2009 (36:20 Md. R. 1528); April 19, 2010 (37:8 Md. R. 615); December 27, 2010 (37:26 Md. R. 1787); February 6, 2012 (39:2 Md. R. 141); December 24, 2012 (39:25 Md. R. 1613); December 12, 2013 (40:24 Md. R. 2017); August 29, 2016 (43:17 Md. R. 955); November 7, 2016 (43:22 Md. R. 1221); December 31, 2018 (45:26 Md. R. 1245)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04#B" title="">Regulation .04B</a> amended effective April 10, 2006 (33:7 Md. R. 668); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04#C" title="">Regulation .04C</a> amended effective June 30, 2008 (35:13 Md. R. 1180); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05#I" title="">Regulation .05I</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05#G" title="">Regulation .05G</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05#K" title="">Regulation .05K</a> amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.06#C" title="">Regulation .06C</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08" title=".08 Special Needs Populations — Pregnant and Postpartum Women.">Regulation .08</a> amended effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08#C" title="">Regulation .08C</a>, E amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08#I" title="">Regulation .08I</a> amended effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08#K" title="">Regulation .08K</a> amended effective April 10, 2006 (33:7 Md. R. 668)</p>
                  <p>Regulation .08M repealed effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#C" title="">Regulation .10C</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#D" title="">Regulation .10D</a> amended effective April 10, 2006 (33:7 Md. R. 668)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#E" title="">Regulation .10E</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#F" title="">Regulation .10F</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .11E amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p>Regulation .11F amended effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p>Regulation .11G amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p>Regulation .11-1 repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .11-2 repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.12#B" title="">Regulation .12B</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .12D repealed effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.13#F" title="">Regulation .13F</a> amended effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.14" title=".14 Referral to Behavioral Health ASO.">Regulation .14</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.14#A" title="">Regulation .14A</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15" title=".15 Data Collection and Reporting.">Regulation .15</a> amended effective February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#B" title="">Regulation .15B</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#C" title="">Regulation .15C</a> amended effective April 9, 2007 (34:7 Md. R. 698)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#D" title="">Regulation .15D</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#E" title="">Regulation .15E</a> amended effective December 19, 2005 (32:25 Md. R. 1941); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#F" title="">Regulation .15F</a> amended effective April 10, 2006 (33:7 Md. R. 668)</p>
                  <p>Regulation .15L adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.16" title=".16 Repealed.">Regulation .16</a> repealed effective November 5, 2007 (34:22 Md. R. 1977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17" title=".17 Subcontractual Relationships.">Regulation .17</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#A" title="">Regulation .17A</a> amended effective November 6, 2006 (33:22 Md. R. 1732); June 30, 2008 (35:13 Md. R. 1180); February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#B" title="">Regulation .17B</a> amended effective April 10, 2006 (33:7 Md. R. 668); June 30, 2008 (35:13 Md. R. 1180); October 5, 2009 (36:20 Md. R. 1528); February 1, 2016 (42:23 Md. R. 1434)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18#H" title="">Regulation .18H</a> amended effective November 5, 2007 (34:22 Md. R. 1977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18#I" title="">Regulation .18I</a>, J adopted effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective April 1, 2005 (32:9 Md. R. 847); amended permanently effective July 18, 2005 (32:14 Md. R. 1276)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective April 15, 2013 (40:7 Md. R. 611)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#A" title="">Regulation .19A</a>, B amended as an emergency provision effective January 1, 2008 (35:3 Md. R. 286); amended permanently effective June 16, 2008 (35:12 Md. R. 1120)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#A" title="">Regulation .19A</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended effective December 20, 2004 (31:25 Md. R.1790); December 19, 2005 (32:25 Md. R. 1941); April 10, 2006 (33:7 Md. R. 669)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended as an emergency provision effective July 1, 2006 (33:20 Md. R. 1610); amended permanently effective October 23, 2006 (33:21 Md. R. 1675)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended as an emergency provision effective January 1, 2007 (34:4 Md. R. 396); amended permanently effective April 9, 2007 (34:7 Md. R. 699)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended as an emergency provision effective September 14, 2007 (34:21 Md. R. 1911); amended permanently effective November 19, 2007 (34:23 Md. R. 2027)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended effective January 12, 2009 (36:1 Md. R. 21); July 27, 2009 (36:15 Md. R. 1166); January 25, 2010 (37:2 Md. R. 67); June 14, 2010 (37:12 Md. R. 800); December 27, 2010 (37:26 Md. R. 1788); April 4, 2011 (37:8 Md. R. 431);  April 30, 2012 (39:8 Md. R. 534); December 10, 2012 (39:24 Md. R. 1577); July 7, 2014 (41:13 Md. R. 752); February 16, 2015 (42:3 Md. R. 316); October 26, 2015 (42:21 Md. R. 1301); May 9, 2016 (43:9 Md. R. 530); February 27, 2017 (44:4 Md. R. 253); March 26, 2018 (45:6 Md. R. 319); August 26, 2019 (46:17 Md. R. 726)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#D" title="">Regulation .19D</a> amended as an emergency provision effective February 11, 2004 (31:5 Md. R. 446); amended permanently effective May 24, 2004 (31:10 Md. R. 795)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#D" title="">Regulation .19D</a> amended effective June 14, 2010 (37:12 Md. R. 800); October 26, 2015 (42:21 Md. R. 1301); February 27, 2017 (44:4 Md. R. 253); March 26, 2018 (45:6 Md. R. 319)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-1" title=".19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.">Regulation .19-1</a> adopted as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); adopted permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> amended effective June 19, 2006 (33:12 Md. R. 997); April 9, 2007 (34:7 Md. R. 698); June 14, 2010 (37:12 Md. R. 800); April 30, 2012 (39:8 Md. R. 534)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> repealed effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> adopted effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p>Regulation .19-3A, B amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p>Regulation .19-3A, B amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p>Regulation .19-3B amended effective December 24, 2012 (39:25 Md. R. 1613); February 3, 2014 (41:2 Md. R. 91)</p>
                  <p>Regulation .19-3C amended effective February 27, 2017 (44:4 Md. R. 253)</p>
                  <p>Regulation .19-3C, D amended effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p>Regulation .19-5 adopted effective December 19, 2005 (32:25 Md. R. 1941)</p>
                  <p>Regulation .19-5 repealed and new Regulation .19-5 adopted effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p>Regulation .19-5F amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .19-5G amended effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p>Regulation .19-5H amended effective April 19, 2010 (37:8 Md. R. 615); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">Regulation .20</a> amended effective August 8, 2011 (38:16 Md. R. 945); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a> amended effective April 10, 2006 (33:7 Md. R. 668); November 5, 2007 (34:22 Md. R. 1977); December 24, 2012 (39:25 Md. R. 1613); October 28, 2013 (40:21 Md. R. 1775); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a>, B amended effective November 6, 2006 (33:22 Md. R. 1732); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a>, D amended effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#B" title="">Regulation .20B</a>, C amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#C" title="">Regulation .20C</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#E" title="">Regulation .20E</a> adopted effective August 29, 2016 (43:17 Md. R. 955)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">Regulation .21</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">Regulation .21</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21#B" title="">Regulation .21B</a> amended effective June 19, 2006 (33:12 Md. R. 997); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22#C" title="">Regulation .22C</a>, D amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23" title=".23 Marketing.">Regulation .23</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23#C" title="">Regulation .23C</a> amended effective November 7, 2016 (43:22 Md. R. 1221)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23#D" title="">Regulation .23D</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23#D" title="">Regulation .23D</a> amended effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.24" title=".24 Repealed.">Regulation .24</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.24" title=".24 Repealed.">Regulation .24</a> repealed effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.25#B" title="">Regulation .25B</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p>Regulation .28 adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p>Regulation .28 amended effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p>Regulation .28 repealed effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.65" title="Chapter 65 Maryland Medicaid Managed Care Program: Managed Care Organizations">COMAR 10.09.65</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#B" title="">Regulation .03B</a> amended effective April 19, 2021 (48:8 Md. R. 309)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#D" title="">Regulation .15D</a> amended effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.25#B" title="">Regulation .25B</a> amended effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.27#C" title="">Regulation .27C</a> amended effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p>——————</p>
                  <p>Chapter revised effective October 18, 2021 (48:21 Md. R. 889)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03-1" title=".03-1 HealthChoice Health Equity Incentive Program.">Regulation .03-1</a> repealed and new Regulation .03-1 adopted effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p>Regulation .03-2B amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p>Regulation .03-2L adopted effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p>Regulation .03-2L repealed and new Regulation .03-2 adopted effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p>Regulation .03-2M adopted effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#E" title="">Regulation .15E</a> amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#B" title="">Regulation .17B</a> amended effective June 13, 2022 (49:12 Md. R. 641)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18#K" title="">Regulation .18K</a> adopted effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective April 4, 2022 (49:7 Md. R. 468)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a>, D amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#D" title="">Regulation .19D</a> amended effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#E" title="">Regulation .19E</a> adopted effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p>Regulation .19-4A amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p>Regulation .19-4M, N amended effective June 13, 2022 (49:12 Md. R. 641) ​​</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a>, C amended effective June 24, 2024 (51:12 Md. R. 618)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104, 15-101, 15-102.3, and 15-103; Insurance Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-112" title="">15-112</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-605" title="">15-605</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-1008" title="">15-1008</a>; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.04.01" data-order="|10|67|04|.01|" data-ref-path="10|67|04|.01" class="h__section">.01 Incorporation by Reference — Repealed</h3>
                <h3 id="/us/md/exec/comar/10.67.04.02" data-order="|10|67|04|.02|" data-ref-path="10|67|04|.02" class="h__section">.02 Conditions for Participation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#A">A.</span> An MCO shall have sufficient provider capacity to provide health care services to Program recipients residing in a geographic region no smaller in size than one county or the City of Baltimore.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#B">B.</span> An MCO shall comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36" title="Chapter 36 General Medical Assistance Provider Participation Criteria">COMAR 10.09.36</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#C">C.</span> An MCO shall enter a memorandum of understanding with each local health department (LHD) in its service area addressing the method by which the MCO and the LHD will collaborate and communicate on matters of mutual interest and concern, including but not limited to the responsibility of the LHD for contact tracing for sexually transmitted diseases and directly observed therapy for tuberculosis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D">D.</span> Assurance Against Insolvency.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(1)">(1)</span> An MCO shall be actuarially sound.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(2)">(2)</span> An applicant shall possess an initial surplus in the amount of $1,500,000 as specified in Health-General Article, §15-102.4(a)(2)(ii), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(3)">(3)</span> If the Commissioner determines and reports to the Secretary that the applicant has an initial surplus that is at least $1,250,000 but less than $1,500,000, before approval the Department shall designate funds in trust sufficient to provide an initial surplus of $1,500,000.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(4)">(4)</span> If the Commissioner determines and reports to the Secretary that the applicant's initial surplus is less than $1,250,000 before approval the Department may, at its discretion, designate funds in trust in an amount equal to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(4)(a)">(a)</span> The sum of the amounts due to the owners of the applicant from the Department for Medicaid services provided on a fee-for-service basis, so long as the owners of the applicant have waived in writing their right to receive Medicaid payments until such time as the Department is permitted to remove its funds from the trust account pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#D(6)" title="">§D(6) of this regulation</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(4)(b)">(b)</span> If a financial guarantor with sufficient net worth and an adequate history of generating net income agrees to pay claims against the MCO in the case of insolvency, the difference between $1,250,000 and the applicant's initial surplus.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(5)">(5)</span> If, in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#D(4)" title="">§D(4) of this regulation</a>, the Department designates funds sufficient to increase the applicants initial surplus to $1,250,000, the Department shall designate $250,000 in trust for the applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(6)">(6)</span> Funds designated by the Secretary pursuant to §D(3)(5) of this regulation shall remain in trust until such time as the Commissioner has determined that the MCO meets the minimum statutory surplus requirements based on the MCOs annual report submitted pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=5-605" title="">Insurance Article, §5-605, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(7)">(7)</span> Before approval of an applicant, the Secretary shall notify the Commissioner whether the Secretary has placed any money in trust under this section.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(8)">(8)</span> In the event of insolvency, the MCO shall cover continuation of services to enrollees for the duration of the period for which capitation payment has been made.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(9)">(9)</span> An MCO shall meet the solvency standards established by the State for private HMOs, or be licensed or certified by the State as a risk-bearing entity except if the MCO:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(9)(a)">(a)</span> Is a public entity; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(9)(b)">(b)</span> Is, or is controlled by, one or more federally qualified health centers and meets the solvency standards established by the State for those centers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(9)(c)">(c)</span> Has its solvency guaranteed by the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E">E.</span> Health Care Delivery. An MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(1)">(1)</span> Provide the services set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a> promptly and continuously, consistent with good medical practice and community professional standards;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(2)">(2)</span> Conform with and fulfill the requirements of 42 CFR §422.128, as amended, and provide adult enrollees with written information on advance directives which shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(2)(a)">(a)</span> Include a description of applicable State law; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(2)(b)">(b)</span> Reflect a change in State law as soon as possible, but not later than 90 days after the effective date of the change.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)">(3)</span> Provide each enrollee within 10 days of notification to the MCO of the enrollees enrollment with a distinctive, durable identification card, clearly indicating the bearer to be a member of the MCO and containing, at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)(a)">(a)</span> The enrollee's Medicaid number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)(b)">(b)</span> The MCO's consumer services hotline telephone number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)(c)">(c)</span> The Department's enrollee hotline telephone number; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)(d)">(d)</span> Enrollee's assigned primary care provider's name and telephone number;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(4)">(4)</span> Provide enrollees, within 30 days before the intended effective date, written notice when there is a significant change in the nature or location of services provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)">(5)</span> Provide on the card required in <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#E(3)" title="">§E(3) of this regulation</a>, on a separate prescription benefit card, or other technology, prescription billing information that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(a)">(a)</span> Complies with the standards set forth in the National Council for Prescription Drug Programs pharmacy ID card prescription benefit card implementation guide at the time of issuance of the card or other technology; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)">(b)</span> Includes, at a minimum, the following data elements:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)(i)">(i)</span> The name or identifying trademark of the MCO;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)(ii)">(ii)</span> The name and identification number of the recipient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)(iii)">(iii)</span> The telephone number that providers may call for pharmacy benefit assistance; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)(iv)">(iv)</span> All electronic transaction routing information and other numbers required by the MCO or its benefit administrator to process a prescription claim electronically.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F">F.</span> An MCO:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(1)">(1)</span> Shall comply with the standards in P.L. 101-336, Americans with Disabilities Act of 1990, 42 U.S.C. §12101 et seq.;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(2)">(2)</span> May not discriminate against an enrollee on any basis, including, but not limited to, age, sex, race, creed, color, marital status, sexual orientation, gender identity, national origin, physical or mental handicap, health status, or need for health care services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)">(3)</span> Shall prepare and make available all publications in a manner consistent with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01#A" title="">COMAR 10.67.05.01A</a>, including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)(a)">(a)</span> Provider directories;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)(b)">(b)</span> Enrollee handbooks;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)(c)">(c)</span> Health education materials; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)(d)">(d)</span> Informational brochures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#G">G.</span> An MCO shall maintain enrollee medical records in compliance with Health-General Article, §4-301 et seq., Annotated Code of Maryland, and the utilization control requirement of 42 CFR Part 456, as amended.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#H">H.</span> An MCO shall permit the enrollment of a waiver-eligible Program recipient who is enrolled by the Department or who selects the MCO, unless the MCO's enrollment meets or exceeds any enrollment limits mutually agreed to by the Department and the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I">I.</span> MCO Local Access Area Participation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(1)">(1)</span> Effective January 1, 2014, an MCO shall open in all local access areas located within the same county in which the MCO chooses to participate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(2)">(2)</span> The MCO shall provide written notification to the Department of the MCO's intent to participate and accept new enrollees in each of the counties by September 15 for the next calendar year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(3)">(3)</span> The MCO's decision to accept new enrollees is in effect from January 1 to December 31 unless the Department decides there is adequate justification to waive this requirement, which includes, but is not limited to, a rate cut or an MCO exit from the market.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(4)">(4)</span> Unless the Department approves a shorter time frame, an MCO that exits the Program during the calendar year shall submit their exit transition plan to the Department 120 days prior to the effective date of the exit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(5)">(5)</span> If the MCO has not participated in a county for a period of 12 or more consecutive months, the MCO may participate and accept new enrollees in that county by notifying the Department at least 30 days before accepting new enrollees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(6)">(6)</span> An MCO that voluntarily freezes for new enrollments in a county shall remain frozen in that county for the remainder of the calendar year and the following calendar year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(7)">(7)</span> If system modifications require longer than 30 days to implement, the effective date may be extended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(8)">(8)</span> The MCO shall follow the access standards specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06" title=".06 Geographical Access.">COMAR 10.67.05.06</a> and .05-1.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#J">J.</span> In counties where the MCO decides to stop accepting new enrollees, the MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#J(1)">(1)</span> Continue to accept enrollees who regain eligibility within 120 days of becoming ineligible for the Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#J(2)">(2)</span> Accept newborns if the mother is an MCO member at the time of birth; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#J(3)">(3)</span> Accept the family members of enrollees enrolled with the MCO before the effective date that the MCO stopped accepting new enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#K">K.</span> An HMO that is approved as an MCO and that requires its panel providers to participate in an MCO shall submit for review by the Secretary its plan to assure the equitable distribution of enrollees and to ensure that a provider is not assigned a disproportionate number of enrollees, as required by Health-General Article, §15-102.5, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#L">L.</span> An MCO shall comply with the provisions of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-112" title="">Insurance Article, §15-112, Annotated Code of Maryland</a> when credentialing providers, and during the credentialing process the MCO:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#L(1)">(1)</span> May not discriminate against particular providers that serve high-risk populations or specialize in conditions that require costly treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#L(2)">(2)</span> May not employ or contract with providers excluded from participation in federal health care programs under either §1128 or 1128A of the Social Security Act; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#L(3)">(3)</span> Shall give the affected providers written notice of the reason for its decision if the MCO declines to include the providers in its network.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M">M.</span> The requirements of <a class="internal-link " href="/us/md/exec/comar/10.67.04.17#A(2)" title="">Regulation .17A(2) of this chapter</a>, or <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#L(1)" title="">§L(1) of this regulation</a>, may not be construed to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(1)">(1)</span> Require an MCO to contract with providers beyond the number necessary to meet the needs of its enrollees;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(2)">(2)</span> Preclude an MCO from using different reimbursement amounts:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(2)(a)">(a)</span> For different specialties; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(2)(b)">(b)</span> For different practitioners in the same specialty; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(3)">(3)</span> Preclude an MCO from establishing measures that are designed to maintain quality of services and control costs, consistent with its responsibilities to enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N">N.</span> Disclosure of Provider Incentive Plans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N(1)">(1)</span> An MCO shall disclose to the Department the information on its provider incentive plans listed in 42 CFR §417.479(h)(1):</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N(1)(a)">(a)</span> Prior to approval of its contract or agreement; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N(1)(b)">(b)</span> Upon the contract's or agreement's anniversary or renewal effective date.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N(2)">(2)</span> An MCO shall include in the disclosures required by <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#N(1)" title="">§N(1) of this regulation</a> information sufficient for the Department to determine whether the incentive plans meet the requirements of 42 CFR §417.479(d)(g) and, as applicable (i), when there exist compensation arrangements under which payment for designated health services furnished to an individual on the basis of a physician referral would otherwise be denied under §1903(a) of the Social Security Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#O">O.</span> When making a referral, an MCO shall use the uniform consultation referral form adopted by the Maryland Insurance Administration at <a class="internal-link no-wrap" href="/us/md/exec/comar/31.10.12.06" title=".06 General Provisions.">COMAR 31.10.12.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P">P.</span> An MCO shall meet all other requirements of applicable State and federal law including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(1)">(1)</span> Title VI of the Civil Rights Act of 1964;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(2)">(2)</span> Title IX of the Education Amendments of 1972 regarding education programs and activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(3)">(3)</span> The Age Discrimination Act of 1975;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(4)">(4)</span> The Rehabilitation Act of 1973;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(5)">(5)</span> Any laws regarding privacy and confidentiality;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(6)">(6)</span> Any laws that pertain to enrollee rights;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(7)">(7)</span> 45 CFR Part 74, as amended, including particular attention to requirements at 45 CFR §§74.42, 74.43, 74.44, 74.48, and 74. 53(a) and (b), and Appendix A; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(8)">(8)</span> Section 1557 of the Affordable Care Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#Q">Q.</span> An MCO shall meet all program integrity requirements as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07" title="Chapter 07 Maryland Medicaid Managed Care Program: Program Integrity">COMAR 10.67.07</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R">R.</span> The following applies to the Department's Health Home Program as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.33" title="Chapter 33 Health Homes">COMAR 10.09.33</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(1)">(1)</span> The MCO may not provide services that duplicate the CMS reimbursed health home services for members participating in the State's Health Home Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(2)">(2)</span> The State shall inform the MCO of members assigned to the State's Health Home Program so that the MCO can prepare to coordinate care with the health homes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(3)">(3)</span> The MCO shall provide a point of contact for the health homes to the State who shall share with all the enrolled health homes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(4)">(4)</span> The MCO shall make referrals to the health homes of members who meet the criteria for enrollment in the program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(5)">(5)</span> To facilitate this process, the State shall provide information to the MCO on all the enrolled health homes in the MCO's service areas; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(6)">(6)</span> The MCO shall assist the health homes as necessary in accessing somatic care services for health home recipients.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.03" data-order="|10|67|04|.03|" data-ref-path="10|67|04|.03" class="h__section">.03 Quality Assessment and Improvement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A">A.</span> An MCO shall have a continuous, systematic program designed to monitor, measure, evaluate, and improve the quality of health care services delivered to enrollees including individuals with special health care needs. At a minimum, the MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(1)">(1)</span> Comply with all applicable federal and State laws and regulations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(2)">(2)</span> Comply with all access and quality standards and levels of performance established by the Department including all standards for individuals with special health care needs in Regulations.04—.10 of this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)">(3)</span> Be able to provide the Department with timely accurate information in areas including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(a)">(a)</span> Provider networks;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(b)">(b)</span> Utilization of services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)">(c)</span> Identification and management of individuals with special health care needs, including but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(i)">(i)</span> Enrollees with HIV;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(ii)">(ii)</span> Pregnant women;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(iii)">(iii)</span> Enrollees with disabilities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(iv)">(iv)</span> Adult enrollees with diabetes;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(v)">(v)</span> Pediatric enrollees with asthma; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(vi)">(vi)</span> Children with special health care needs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B">B.</span> An MCO shall participate in all quality assessment activities required by the Department to determine if the MCO is providing medically necessary enrollee health care. These activities include, but are not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)">(1)</span> A Systems Performance Review (SPR) performed by an external quality review organization hired by the Department to assess an MCO’s structure and operations in order to determine its ability to provide health care to its enrollees as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)">(a)</span> The SPR shall include, but not be limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(i)">(i)</span> MCO's Quality Assessment and Improvement program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(ii)">(ii)</span> Enrollee rights;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(iii)">(iii)</span> Access and availability of services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(iv)">(iv)</span> Care management;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(v)">(v)</span> Enrollee outreach;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(vi)">(vi)</span> Utilization management and review; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(vii)">(vii)</span> MCO organization, operations, and financial management;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(b)">(b)</span> The results of the SPR shall be reported in draft to the MCOs for comment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(c)">(c)</span> MCO shall submit all comments and any required corrective action within 45 days of receipt of draft report; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(d)">(d)</span> The Department shall issue a final report of the SPR results;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(2)">(2)</span> The annual collection, validation, and evaluation of the latest approved version of the Healthcare Effectiveness Data and Information Set (HEDIS) in order to assess the access to and quality of services provided, in addition to any additional performance measures specified by the Department or CMS;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)">(3)</span> The annual collection and evaluation of a set of performance measures with targets as determined by the Department as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(a)">(a)</span> The composition of the core performance measures is listed in §B(3)(d)—(f) of this regulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(b)">(b)</span> Each year before the audit period begins, the Department shall identify and obtain public input on all measures to be collected as well as the target for each;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(c)">(c)</span> In accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10" title="Chapter 10 Maryland Medicaid Managed Care Program: Sanctions">COMAR 10.67.10</a>, MCOs may receive financial or other types of incentives or disincentives based on performance measure results;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)">(d)</span> Effective January 1, 2017, the core performance measures are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(i)">(i)</span> Adolescent well care visits;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(ii)">(ii)</span> Adult Body Mass Index (BMI) assessment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(iii)">(iii)</span> Ambulatory care for Supplemental Security Income (SSI) adults;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(iv)">(iv)</span> Ambulatory care for Supplemental Security Income (SSI) children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(v)">(v)</span> Breast cancer screening;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(vi)">(vi)</span> Childhood immunizations — Combo 3;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(vii)">(vii)</span> Comprehensive diabetes care — HbA1c testing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(viii)">(viii)</span> Controlling high blood pressure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(ix)">(ix)</span> Immunization for adolescents;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(x)">(x)</span> Lead screening for children 12—23 months old;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(xi)">(xi)</span> Asthma medication ratio;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(xii)">(xii)</span> Postpartum care; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(xiii)">(xiii)</span> Well child visits, 3—6 years old;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)">(e)</span> Effective January 1, 2019, the core performance measures are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(i)">(i)</span> Adolescent well care visits;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(ii)">(ii)</span> Ambulatory care for SSI adults;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(iii)">(iii)</span> Ambulatory care for SSI children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(iv)">(iv)</span> Asthma medication ratio;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(v)">(v)</span> Breast cancer screening;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(vi)">(vi)</span> Comprehensive diabetes care — HbA1c control (&lt;8.0%);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(vii)">(vii)</span> Controlling high blood pressure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(viii)">(viii)</span> Lead screening for children 12 through 23 months old; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(ix)">(ix)</span> Well child visits in the first 15 months of life;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)">(f)</span> Effective January 1, 2021, the core performance measures are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(i)">(i)</span> Adolescent well care visits;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(ii)">(ii)</span> Ambulatory care for SSI adults;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(iii)">(iii)</span> Ambulatory care for SSI children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(iv)">(iv)</span> Asthma medication ratio;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(v)">(v)</span> Breast cancer screening;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(vi)">(vi)</span> Comprehensive diabetes care — HbA1c control (&lt;8.0%);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(vii)">(vii)</span> Controlling high blood pressure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(viii)">(viii)</span> Lead screening for children 12 through 23 months old;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(ix)">(ix)</span> Postpartum care; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(x)">(x)</span> Well child visits in the first 15 months of life;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)">(g)</span> Starting with the 2019 performance measures, the Department shall implement the following methodology for imposing penalties and incentives:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(i)">(i)</span> There shall be three levels of performance;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(ii)">(ii)</span> Performance shall be evaluated separately for each measure, and each measure shall have equal weight;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(iii)">(iii)</span> On any of the measures in §B(3)(f)(i)—(ix) of this regulation for which the MCO does not meet the minimum target, as determined by the Department, a penalty of 1/9 of 1 percent of the total capitation amount paid to the MCO during the measurement year shall be collected;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(iv)">(iv)</span> The total amount of the penalties as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)" title="">§B(3)(h)(iii) of this regulation</a> may not exceed 1 percent of the total capitation amount paid to the MCO during the same measurement year;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(v)">(v)</span> On any of the measures in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(f)" title="">§B(3)(f) of this regulation</a> for which the MCO meets or exceeds the incentive target, as determined by the Department, the MCO shall be paid an incentive payment of up to 1/9 of 1 percent of the total capitation paid to the MCO during that measurement year;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(vi)">(vi)</span> The total amount of the incentive payments as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(v)" title="">§B(3)(h)(v) of this regulation</a> paid to the MCOs each year may not exceed the total amount of the penalties as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(g)(iii)" title="">§B(3)(g)(iii) of this regulation</a> collected from the MCOs in that same year, plus any additional funds allocated to the Department for a quality initiative; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(vii)">(vii)</span> Any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(v)" title="">§B(3)(h)(v) of this regulation</a> shall be distributed to the MCOs receiving the four highest normalized scores for Value Based Purchasing for all ten performance measures at a rate calculated by multiplying each MCO’s adjusted enrollment as of December 31 of the measurement year by a per enrollee amount;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)">(h)</span> Starting with the 2021 performance measures, the Department shall implement the following methodology for imposing penalties and incentives:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(i)">(i)</span> There shall be three levels of performance;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(ii)">(ii)</span> Performance shall be evaluated separately for each measure, and each measure shall have equal weight;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)">(iii)</span> On any of the measures in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(f)" title="">§B(3)(f) of this regulation</a> for which the MCO does not meet the minimum target, as determined by the Department, a penalty of 1/10 of 1 percent of the total capitation amount paid to the MCO during the measurement year shall be collected if the conditions in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iv)" title="">§B(3)(h)(iv) of this regulation</a> do not apply;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(iv)">(iv)</span> If the Department’s actuary determines that the MCO’s total capitation amount for the measurement year does not meet the actuarial soundness definition described in 42 CFR §438.4 after collection of the total penalty amount described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)" title="">§B(3)(h)(iii) of this regulation</a>, the Department’s actuary shall calculate the maximum penalty the Department shall apply that results in the MCO’s total capitation for the measurement year remaining actuarially sound;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(v)">(v)</span> If the MCO’s penalty amount is reduced as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iv)" title="">§B(3)(h)(iv) of this regulation</a>, the Department may impose any of the additional sanctions described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10" title="Chapter 10 Maryland Medicaid Managed Care Program: Sanctions">COMAR 10.67.10</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(vi)">(vi)</span> The total amount of the penalties as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)" title="">§B(3)(h)(iii) of this regulation</a> may not exceed 1 percent of the total capitation amount paid to the MCO during the same measurement year;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)">(vii)</span> On any of the measures in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(f)" title="">§B(3)(f) of this regulation</a> for which the MCO meets or exceeds the incentive target, as determined by the Department, the MCO shall be paid an incentive payment of up to 1/10 of 1 percent of the total capitation paid to the MCO during that measurement year;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(viii)">(viii)</span> The total amount of the incentive payments as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be paid to the MCOs with total amount of the penalties as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)" title="">§B(3)(h)(iii) of this regulation</a> collected from the MCOs in that same year, plus additional reserves in the HealthChoice Performance Incentive Fund if the total amount of the penalties collected is insufficient to pay the total amount of the incentive payments;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(ix)">(ix)</span> 40 percent of any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be distributed to the MCOs earning net incentives with the four highest normalized scores, at a rate calculated by multiplying each MCO’s adjusted enrollment as of December 31 of the measurement year by a per-enrollee amount;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(x)">(x)</span> MCOs earning net disincentives are ineligible to receive the funds described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(ix)" title="">§B(3)(h)(ix) of this regulation</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(xi)">(xi)</span> 25 percent of any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be distributed to the MCOs that the Department determines have demonstrated performance improvement in the measurement year, provided that the MCOs use the funding to target performance improvement in areas defined by the Department;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(xii)">(xii)</span> 25 percent of any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be retained for health improvement programs under the Maryland Medicaid Managed Care Program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(xiii)">(xiii)</span> 10 percent of any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be used to establish a reserve in the HealthChoice Performance Incentive Fund, to be used in any calendar year when the amount of penalties collected is insufficient to pay incentives earned by MCOs; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(xiv)">(xiv)</span> If the amount in the HealthChoice Performance Incentive Fund exceeds $5,000,000, the Department shall equally allocate the remaining 10 percent of funds for use in §B(3)(h)(ix)—(xii);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)">(i)</span> The adjusted enrollment amount in §§B(3)(g)(vii) and B(3)(h)(ix) of this regulation shall be calculated by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)(i)">(i)</span> Multiplying four times the enrollment of the MCO with the highest normalized score;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)(ii)">(ii)</span> Multiplying three times the enrollment of the MCO with the second highest normalized score;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)(iii)">(iii)</span> Multiplying two times the enrollment of the MCO with the third highest normalized score; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)(iv)">(iv)</span> Using the actual enrollment of the MCO with the fourth highest normalized score;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(j)">(j)</span> The per enrollee amount in §§B(3)(g)(vii) and B(3)(h)(ix) of this regulation shall be calculated by dividing the sum of the calculations in §B(3)(i)(i)—(iv) of this regulation into the funds remaining as described in §§B(3)(g)(vii) and B(3)(h)(ix) of this regulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(k)">(k)</span> The methodology described in §B(3)(a)—(j) of this regulation shall remain in effect through December 31, 2021;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(4)">(4)</span> An annual enrollee satisfaction survey using the latest version of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey tool, conducted by an NCQA-certified CAHPS vendor;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(5)">(5)</span> An annual Maryland Healthy Kids audit in order to determine the quality of the clinical care provided to all children younger than 21 years old enrolled in the HealthChoice Program as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(5)(a)">(a)</span> The audit shall include a review of a sample of medical records from each provider reviewed during the calendar year to assess clinical care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(5)(b)">(b)</span> The results of the audit that are below minimum EPSDT standards may result in corrective action required by both the provider and the MCO; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(5)(c)">(c)</span> The Department shall issue a final report of the audit results;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)">(6)</span> Performance improvement projects to be conducted by the MCOs that focus on clinical or nonclinical areas as determined by the Department or CMS and include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(a)">(a)</span> Measurement of performance using objective quality indicators;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(b)">(b)</span> Implementation of system interventions to achieve improvement in quality;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(c)">(c)</span> Evaluation of effectiveness of interventions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(d)">(d)</span> Planning and initiation of activities to sustain improvement; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(e)">(e)</span> Reporting of results to the Department or CMS; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(7)">(7)</span> Validation and evaluation of MCO provider networks to ensure compliance with the network adequacy and access standards set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05" title="Chapter 05 Maryland Medicaid Managed Care Program: Access">COMAR 10.67.05</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#C">C.</span> If an MCO is assessed as deficient in accordance with federal and State standards, the MCO shall submit a plan of corrective action to the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D">D.</span> An MCO shall provide the Department a copy of its most recent NCQA accreditation, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(1)">(1)</span> Accreditation status, survey type, and level;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(2)">(2)</span> Accreditation results, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(2)(a)">(a)</span> Recommended actions or improvements;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(2)(b)">(b)</span> Corrective action plans; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(2)(c)">(c)</span> Summaries of findings; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(3)">(3)</span> Expiration date of the accreditation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.03-1" data-order="|10|67|04|.03-1|" data-ref-path="10|67|04|.03-1" class="h__section">.03-1 HealthChoice Health Equity Incentive Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#A">A.</span> The Department shall award a defined amount of funding annually to MCOs based on the county of residence of their members and the socioeconomic disadvantage index described in this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B">B.</span> Socioeconomic Disadvantage Index.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)">(1)</span> The Department shall calculate a ranking for each service area in Maryland in accordance with the following domains:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)(a)">(a)</span> Community safety;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)(b)">(b)</span> Food security;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)(c)">(c)</span> Housing security; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)(d)">(d)</span> Transportation access.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(2)">(2)</span> The Department shall select component measures and calculate rankings that aggregate to the domains defined in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03-1#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(3)">(3)</span> Rankings shall range from first to twenty-fourth, with first being the lowest ranking for socioeconomic disadvantage and twenty-fourth being the highest ranking for socioeconomic disadvantage.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(4)">(4)</span> Each service area shall be assigned a single summary score by calculating the equal-weighted average across each service area’s domain rankings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#C">C.</span> The Department shall award available equity funding to MCOs serving members in Maryland service areas based on the following criteria:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#C(1)">(1)</span> Allocation of equity funding shall be made proportionally to the MCO’s membership in the service areas at the top quartile of the socioeconomic disadvantage index.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#C(2)">(2)</span> Funding for each calendar year shall be determined based on available funding in the Department’s budget and specified in the annual HealthChoice Managed Care Organization Agreement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#C(3)">(3)</span> The annual allocation for HealthChoice Health Equity Incentive Program shall be funded outside of managed care capitation rates.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#D">D.</span> Incentive funds awarded under the HealthChoice Health Equity Incentive Program are not appealable under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10" title="Chapter 10 Maryland Medicaid Managed Care Program: Sanctions">10.67.10</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.03-2" data-order="|10|67|04|.03-2|" data-ref-path="10|67|04|.03-2" class="h__section">.03-2 HealthChoice Population Health Incentive Program (PHIP).</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#A">A.</span> Effective January 1, 2022, the Department shall establish the HealthChoice Population Health Incentive Program (PHIP).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B">B.</span> An MCO may be eligible for an incentive payment for the following performance measures:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(1)">(1)</span> Ambulatory care visits for Supplemental Security Income (SSI) adults;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(2)">(2)</span> Ambulatory care visits for Supplemental Security Income (SSI) children;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(3)">(3)</span> HEDIS asthma medication ratio;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(4)">(4)</span> Hemoglobin A1c control for patients with diabetes — poor control (&gt;9.0%);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(5)">(5)</span> Lead screening measures:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(5)(a)">(a)</span> Lead screening measure for children 1223 months old; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(5)(b)">(b)</span> HEDIS lead screening in children;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(6)">(6)</span> HEDIS postpartum care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(7)">(7)</span> HEDIS risk of continued opioid use  &gt;=31 days covered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(8)">(8)</span> HEDIS timeliness of prenatal care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#C">C.</span> Each measure identified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03-2#B" title="">§B of this regulation</a> shall be valued equally at a proportional share of available incentive funds, except for measures §B(5)(a) and (b), which are each valued at half of the available incentive funds relative to one of the other measures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#D">D.</span> There shall be two rounds of potential incentive payments an MCO may earn.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#E">E.</span> Subject to budget approval, total PHIP funding shall be determined prior to the measurement year and included in the MCO contract.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#F">F.</span> All PHIP payments shall be funded independently from and outside of MCO capitation payments during a given calendar year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#G">G.</span> Each MCO shall be eligible for no more than 1 percent of the plan's measurement year capitation payments, excluding supplemental payments outside of capitation, as total payment from round one and round two.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#H">H.</span> If the Department determines that the score for any measure identified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03-2#B" title="">§B of this regulation</a> may not be comparable to the previous year's score due to alterations in measure specifications or other factors, the Department may exclude the measure from the PHIP and adjust the incentive valuation in accordance with the remaining performance measures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I">I.</span> Round One Incentives.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(1)">(1)</span> An MCO may earn two types of incentives in round one:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(1)(a)">(a)</span> A performance incentive payment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(1)(b)">(b)</span> An improvement incentive payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(2)">(2)</span> If an MCO does not report a performance measure or an MCO has a performance score of 0 percent, then the MCO is awarded no performance or improvement incentive payments for this measure.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)">(3)</span> Performance Incentive Payments for Round One.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(a)">(a)</span> Performance incentive payments shall be based on the following categories for each performance measure:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(a)(i)">(i)</span> Superlative performance, meaning the performance measure's score is at or above the 90th percentile of HEDIS Medicaid performance nationwide during the measurement year, or estimated 90th percentile among Maryland HealthChoice MCO performance for non-HEDIS performance measures;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(a)(ii)">(ii)</span> Very strong performance, meaning the performance measure's score is between the 75th and 89th percentiles, inclusive, of HEDIS Medicaid performance nationwide during the measurement year, or between the estimated 75th and 89th percentiles, inclusive, among Maryland HealthChoice MCO performance for non-HEDIS performance measures; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(a)(iii)">(iii)</span> Strong performance, meaning the performance measure's score is between the 50th and 74th percentiles, inclusive, of HEDIS Medicaid performance nationwide during the measurement year, or between the estimated 50th and 74th percentiles, inclusive, among Maryland HealthChoice MCO performance for non-HEDIS performance measures.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)">(b)</span> Payments for round one performance incentives shall be allocated as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)(i)">(i)</span> For superlative performance, an MCO may earn 100 percent of the incentive allocation for the performance measure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)(ii)">(ii)</span> For very strong performance, an MCO may earn 66.6 percent of the incentive allocation for the performance measure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)(iii)">(iii)</span> For strong performance, an MCO may earn 33.3 percent of the incentive allocation for the performance measure; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)(iv)">(iv)</span> Any MCO earning a performance measure score below the 50th percentile of HEDIS Medicaid performance nationwide during the measurement year on a HEDIS-based measure, or below the calculated 50th percentile among Maryland HealthChoice MCO performance for a non-HEDIS measure, shall be ineligible for a round one performance incentive payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)">(4)</span> Round One Improvement Incentive Payments.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(a)">(a)</span> An MCO may earn an improvement incentive payment of 33.3 percent of the incentive allocation for any performance measure if the following conditions are met:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(a)(i)">(i)</span> The MCO demonstrates improvement of at least 0.5 percentage points in the measure compared to the previous measurement year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(a)(ii)">(ii)</span> The performance measure score is at or above the 50th percentile of HEDIS Medicaid performance nationwide on a HEDIS-based measure, or the 50th percentile of Maryland HealthChoice MCO performance for a non-HEDIS measure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(b)">(b)</span> An MCO earning a superlative performance incentive payment for a performance measure is ineligible for an improvement incentive payment for the same measure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(c)">(c)</span> For any performance measures in which a lower score indicates stronger performance, year-over-year improvement is demonstrated by a reduction in the score for that measure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(d)">(d)</span> If an MCO is missing or zero-valued for a performance measure in the previous year, then no improvement incentive will be awarded in the measurement year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J">J.</span> Round Two Incentive Payments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(1)">(1)</span> An MCO may qualify for payments under round two if the following conditions are met:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(1)(a)">(a)</span> The MCO earned above 80 percent of possible round one incentives; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(1)(b)">(b)</span> The MCO did not have penalties applied during the measurement year for failure to meet the HEDIS MCO Performance Monitoring Policy included in the MCO contract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(2)">(2)</span> Any remaining funds that were unallocated during round one may be awarded to eligible MCOs in round two for a maximum incentive award of up to 1 percent of its total capitation payment during the PHIP measurement year, excluding supplemental payments outside of capitation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(3)">(3)</span> If any remaining funds that were unallocated during round one are not sufficient to settle all qualifying MCOs up to 1 percent of capitation in round two, then the leftover funds will be awarded proportionally among qualifying MCOs based on enrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#K">K.</span> If additional funds remain after both round one and round two, the Department may, within its discretion, allocate the funding as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#K(1)">(1)</span> Make additional payments to MCOs that are below 1 percent of capitation based on improvement or performance; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#K(2)">(2)</span> Place remaining funds into a nonlapsing pool.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#L">L.</span> Effective measurement year 2025, an MCO with penalties under the HEDIS MCO Performance Monitoring Policy included in the HealthChoice MCO Agreement shall be excluded from all rounds of PHIP for that measurement year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#M">M.</span> Incentives awarded under this regulation and exclusion from PHIP participation are not appealable under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10" title="Chapter 10 Maryland Medicaid Managed Care Program: Sanctions">COMAR 10.67.10</a>..</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.04" data-order="|10|67|04|.04|" data-ref-path="10|67|04|.04" class="h__section">.04 Special Needs Populations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#A">A.</span> An MCO shall provide health care services to enrollees who are members of special needs populations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B">B.</span> Special needs populations consist of the following non-mutually exclusive populations:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(1)">(1)</span> Children with special health care needs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(2)">(2)</span> Individuals with a physical disability;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(3)">(3)</span> Individuals with a developmental disability;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(4)">(4)</span> Pregnant and postpartum women;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(5)">(5)</span> Individuals who are homeless;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(6)">(6)</span> Individuals with HIV/AIDS; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(7)">(7)</span> Children in State-supervised care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C">C.</span> General Requirements for Special Needs Populations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(1)">(1)</span> An MCO shall demonstrate that its pediatric and adult primary care providers (PCPs) and specialists are clinically qualified based upon generally accepted community standards to provide or arrange for the provision of appropriate health care services to individuals who are members of a special needs population. The MCO shall submit to the Department referral protocols that demonstrate the conditions under which PCPs will make the arrangements for referrals to specialty care networks.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(2)">(2)</span> Clinical qualifications are to be determined through the MCO's credentialing and recredentialing processes, including a review of the provider's medical education, special training, and work history and experience.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(3)">(3)</span> Specialty and subspecialty providers shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(3)(a)">(a)</span> Have experience in treating individuals within a special needs population;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(3)(b)">(b)</span> Have experience in interdisciplinary medical management; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(3)(c)">(c)</span> Understand the relationship between somatic and behavioral health care issues and interventions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(4)">(4)</span> The MCO shall demonstrate the use of a primary care system of care delivery which includes a comprehensive plan of care for an enrollee who is a member of a special needs population and which uses a coordinated and continuous case management approach, involving the enrollee and, as appropriate, the enrollee's family, guardian, or caregiver, in all aspects of care, including primary, acute, tertiary, and home care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)">(5)</span> To meet the commitment outlined in <a class="internal-link " href="/us/md/exec/comar/10.67.04.04#C(4)" title="">§C(4) of this regulation</a>, an MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(a)">(a)</span> Provide case management services to adult and pediatric enrollees as appropriate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(b)">(b)</span> Have the capacity to perform home visits as part of the ongoing case management program and have the ability to respond to urgent care needs while in the enrollee's home;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(c)">(c)</span> Ensure that, if warranted, a case manager is assigned to an enrollee at the time of the initial health screen by the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(d)">(d)</span> Ensure that the PCP, who may also be the specialist, shall be the admitting or referring provider for all hospital admissions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(e)">(e)</span> Ensure that it will:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(e)(i)">(i)</span> Collaborate with inpatient facilities in facilitating preadmission and discharge planning, and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(e)(ii)">(ii)</span> Communicate all post-discharge home and community arrangements to the enrollee, the PCP, and, as appropriate, the enrollee's family, guardian, and caregiver;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(f)">(f)</span> Document the plan of care and treatment modalities provided to enrollees in special populations, assuring that the plan of care:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(f)(i)">(i)</span> Is updated at least annually, when the enrollee’s circumstances or needs change significantly, or at the enrollee’s request; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(f)(ii)">(ii)</span> Involves the enrollee and, as appropriate, the enrollee's family, guardian, and caregiver in care decisions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(g)">(g)</span> Be familiar with community and social support providers for the special populations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)">(6)</span> An MCO shall make documented outreach efforts to contact and educate enrollees who fail to appear for appointments or who have been noncompliant with a regimen of care. These efforts may include, but may not be limited to, notification:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(a)">(a)</span> By mail;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(b)">(b)</span> By telephone;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(c)">(c)</span> By email;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(d)">(d)</span> By text messaging; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(e)">(e)</span> Through face-to-face contact.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)">(7)</span> Referral to Local Health Department.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)(a)">(a)</span> An MCO shall make a written referral, or ensure that the enrollee's provider makes a written referral, to the local health department (LHD) for the county in which an enrollee resides, for assistance in bringing into care an enrollee for whom the MCO has been unsuccessful in its documented out-reach efforts pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.04#C(6)" title="">§C(6) of this regulation</a>, within 10 business days of whichever first occurs:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)(a)(i)">(i)</span> The third consecutive missed appointment; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)(a)(ii)">(ii)</span> The MCO or the enrollee's provider identifies the enrollee's repeated noncompliance with a regimen of care.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)(b)">(b)</span> The MCO may not include information about an enrollee's HIV status on the form used to refer an enrollee to the local health department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(8)">(8)</span> An MCO shall subject its decision to deny a service authorization request or to authorize a service in an amount, duration, or scope that is less than requested, for an enrollee who is a member of special needs population to utilization review that includes review by a health care professional who has appropriate clinical expertise in treating the enrollee's condition or disease.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)">(9)</span> An MCO shall identify a special needs coordinator, who shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(a)">(a)</span> Serve as a point of contact for health care services information and referral for members of special needs populations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(b)">(b)</span> Be skilled in communications with, and sensitive to the unique needs of, members of special needs populations, their families, guardians, and caregivers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(c)">(c)</span> Participate on the MCO's consumer advisory board, pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.12" title=".12 Consumer Advisory Board.">Regulation .12 of this chapter</a>, as a representative of special needs populations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(d)">(d)</span> Serve as a resource to MCO providers and enrollees on the requirements of P.L. 101-330, Americans with Disabilities Act of 1990, 42 U.S.C. §12101 et seq.; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(e)">(e)</span> Maintain a log of each denial of treatment and the outcome of the utilization review conducted pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.04#C(8)" title="">§C(8) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(10)">(10)</span> An MCO shall have mechanisms in place to allow enrollees with special health care needs to access a specialist directly as appropriate for the enrollee’s condition and identified needs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.05" data-order="|10|67|04|.05|" data-ref-path="10|67|04|.05" class="h__section">.05 Special Needs Populations — Children with Special Health Care Needs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating children with special health care needs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#B">B.</span> The Department shall maintain a record of the complaints received through the Department's enrollee and provider hotlines which involve the denial of care for children and review these complaint logs as part of its quality assurance system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#C">C.</span> An MCO shall demonstrate that its therapies provider network is adequate by demonstrating its:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#C(1)">(1)</span> Providers' pediatric specialties;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#C(2)">(2)</span> Collaboration with schools that provide IEP or IFSP services to its enrollees, where available; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#C(3)">(3)</span> Provision of family-focused services and development of family-focused plans of care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#D">D.</span> An MCO shall provide case management services to children with special health care needs as appropriate. For complex cases involving multiple medical interventions or social services, or both, a multidisciplinary team shall be used to review and develop the plan of care for special health care needs children.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#E">E.</span> An MCO shall provide coordinated care for special health care needs children in State-supervised care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#F">F.</span> An MCO shall refer child victims of alleged abuse, neglect, or sexual offense to an appropriate provider capable of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#F(1)">(1)</span> Determining if the alleged abuse, neglect, or sexual offense occurred;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#F(2)">(2)</span> Determining if medical intervention is needed; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#F(3)">(3)</span> Ensuring the preservation of evidence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#G">G.</span> An MCO shall ensure coordination with the Department’s Early and Periodic Screening, Diagnosis and Treatment (EPSDT) program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#H">H.</span> An MCO shall establish protocols for effecting medically necessary service referrals to specialty care providers for children with special health care needs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I">I.</span> The service referrals referenced in <a class="internal-link " href="/us/md/exec/comar/10.67.04.05#H" title="">§H of this regulation</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(1)">(1)</span> Include services intended to improve or preserve the continuing health and quality of life for children with special health care needs, regardless of the ability of the services to effect permanent cure; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)">(2)</span> Be made when the child is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)(a)">(a)</span> Identified as being at risk of a developmental delay by the developmental screen required by EPSDT;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)(b)">(b)</span> Experiencing a delay of 25 percent or more in any developmental area as measured by appropriate diagnostic instruments and procedures;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)(c)">(c)</span> Manifesting atypical development or behavior; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)(d)">(d)</span> Diagnosed with a physical or mental condition that has a high probability of resulting in developmental delay.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#J">J.</span> An MCO shall provide durable medical equipment to a special needs child in a timely manner.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#K">K.</span> When a child, who is an MCO enrollee, is diagnosed with a special health care need requiring a plan of care which includes specialty services, and that health care need was undiagnosed at the time of enrollment, the parent or guardian of that child may request approval from the MCO for a specific out-of-network specialty provider to provide those services when the MCO does not have a local in-network specialty provider with the same professional training and expertise who is reasonably available and provides the same service and modality, subject to the following provisions:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#K(1)">(1)</span> If the MCO denies the request for an out-of-network provider referral, the child's parent or guardian may initiate the complaint and appeal process set forth at <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05" title=".05 MCO Appeal Process for Enrollees.">COMAR 10.67.09.05</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#K(2)">(2)</span> If at any time the MCO decides to terminate or reduce services provided by the approved out-of-network provider, the child's parent or guardian may initiate the complaint and appeal process set forth at <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05" title=".05 MCO Appeal Process for Enrollees.">COMAR 10.67.09.05</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#K(3)">(3)</span> The MCO shall continue to cover the services of the out-of-network provider during the course of the appeal until such time as the Office of Administrative Hearings issues its decision.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.06" data-order="|10|67|04|.06|" data-ref-path="10|67|04|.06" class="h__section">.06 Special Needs Populations — Individuals with a Physical Disability.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating an individual with a physical disability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#B">B.</span> An MCO shall demonstrate that its providers for durable medical equipment and assistive technology provide the appropriate services and are clinically qualified to provide these services to the individual with a physical disability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#C">C.</span> Before placement of an individual with a physical disability into an intermediate or long-term care facility, an MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#C(1)">(1)</span> Recommend that an individual with a physical disability be transferred to an intermediate or long-term care facility only after assessing the needs of the individual and the ability of the MCO to meet these needs in the community as supplemented by other Medicaid services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#C(2)">(2)</span> Conduct a second opinion review of the case, performed by the MCO's medical director, before a transfer to an intermediate care facility or a long-term care facility is implemented; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#C(3)">(3)</span> If the MCO's medical director determines that the transfer to an intermediate or long- term care facility is medically necessary and that the expected stay will be greater than 30 days, obtain approval from the Department before making the transfer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#D">D.</span> An MCO shall utilize individuals with expertise in disabilities to review its marketing and informational forms and publications, which shall be provided in alternative formats with reasonable accommodation to people with a physical disability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#E">E.</span> An MCO shall provide education for the MCO's member services staff, triage staff, and case managers on special communications requirements for individuals with physical disabilities.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.07" data-order="|10|67|04|.07|" data-ref-path="10|67|04|.07" class="h__section">.07 Special Needs Populations — Individuals with a Developmental Disability.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.07#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating an individual with a developmental disability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.07#B">B.</span> An MCO shall ensure that its case managers have experience or training related to developmental disabilities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.07#C">C.</span> An MCO shall utilize individuals with expertise in disabilities to review its marketing and informational forms and publications, which shall be provided in alternative formats with reasonable accommodation to people with developmental disabilities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.07#D">D.</span> An MCO shall provide education for the MCO's member services staff, triage staff, and case managers on special communications requirements for individuals with developmental disabilities.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.08" data-order="|10|67|04|.08|" data-ref-path="10|67|04|.08" class="h__section">.08 Special Needs Populations — Pregnant and Postpartum Women.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating pregnant and postpartum women.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B">B.</span> An MCO shall ensure access to prenatal care for pregnant women and postpartum care for postpartum women by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B(1)">(1)</span> Scheduling an appointment for the first prenatal visit and seeing the woman within 10 days of request;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B(2)">(2)</span> Scheduling an appointment for a postpartum woman and seeing the woman within 10 days of request:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B(3)">(3)</span> Arranging for an adequate network of providers including obstetricians, gynecologists, perinatologists, neonatologists, anesthesiologists, and advanced practice nurses who are capable of addressing complex maternal and infant health issues; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B(4)">(4)</span> Linking a pregnant woman with a pediatric provider before delivery.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#C">C.</span> An MCO shall ensure that prenatal providers:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#C(1)">(1)</span> Complete a prenatal risk assessment, using an instrument approved by the Department, at the first prenatal visit; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#C(2)">(2)</span> Within 10 days of completing the prenatal risk assessment, forward this instrument to the local health department in the jurisdiction in which the pregnant enrollee lives.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#D">D.</span> The Department may not include questions about a woman's HIV infection status on the prenatal risk assessment instrument.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#E">E.</span> An MCO shall refer pregnant and postpartum women with a substance use disorder to the behavioral health ASO for substance use treatment within 24 hours of request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#F">F.</span> An MCO shall refer pregnant and postpartum women, infants, and children younger than 5 years old to the WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) Program, and shall provide to WIC necessary medical information to determine WIC nutritional eligibility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#G">G.</span> An MCO shall follow, at a minimum, the American College of Obstetricians and Gynecologists (ACOG) guidelines for pregnant and postpartum women.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#H">H.</span> An MCO shall provide risk-related medical and nonmedical preventive treatment services, including nutrition counseling by licensed nutritionists or dietitians and smoking cessation education and treatment for pregnant and postpartum women.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#I">I.</span> An MCO shall provide HIV counseling, including a risk assessment and information about possible transmission of HIV to the fetus.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#J">J.</span> An MCO shall offer its pregnant and postpartum enrollees voluntary HIV counseling and testing following the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#K">K.</span> An MCO shall arrange for the appropriate emergency transfer of pregnant women, newborns, and infants to tertiary care centers.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.09" data-order="|10|67|04|.09|" data-ref-path="10|67|04|.09" class="h__section">.09 Special Needs Populations — Homeless Individuals.</h3>
                <p>An MCO's initial health screen shall attempt to identify homeless individuals and link them to the appropriate provider of services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.10" data-order="|10|67|04|.10|" data-ref-path="10|67|04|.10" class="h__section">.10 Special Needs Populations — Individuals with HIV/AIDS.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating individuals with HIV/AIDS.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B">B.</span> HIV/AIDS Specialist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(1)">(1)</span> An MCO shall allow an enrollee with HIV/AIDS to choose an HIV/AIDS specialist for treatment and coordination of primary and specialty care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)">(2)</span> To qualify as an HIV/AIDS specialist, a health care provider shall be board certified in the field of infectious diseases by a member board of the American Board of Medical Specialties or:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)">(a)</span> Hold a current, valid, unrevoked, and unsuspended Maryland license or certification as a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)(i)">(i)</span> Doctor of medicine;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)(ii)">(ii)</span> Doctor of osteopathy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)(iii)">(iii)</span> Nurse practitioner; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)(iv)">(iv)</span> Physician's assistant being supervised by a medical doctor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(b)">(b)</span> Have provided direct, continuous, ongoing care for at least 20 patients with HIV over the past 2 years; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)">(c)</span> Have completed one of the following requirements:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)(i)">(i)</span> If a medical doctor, certified physician's assistant being supervised by a medical doctor, or doctor of osteopathy, at least 30 hours of HIV-related continuing medical education category I credits over the past 2 years;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)(ii)">(ii)</span> If a nurse practitioner, at least 30 hours of HIV-related continuing education units over the past 2 years;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)(iii)">(iii)</span> If a medical doctor, certified physician's assistant being supervised by a medical doctor, doctor of osteopathy, or a nurse practitioner, an accredited training program over the past year; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)(iv)">(iv)</span> If a medical doctor, certified physician's assistant being supervised by a medical doctor, doctor of osteopathy, or a nurse practitioner, has completed the American Academy of HIV Medicine (AAHIVM) credentialing examination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C">C.</span> AIDS Case Management Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)">(1)</span> An MCO shall ensure that an enrollee with HIV/AIDS receives case management services that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(a)">(a)</span> Link the enrollee with the full range of available benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)">(b)</span> Link the enrollee with any additional needed services including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(i)">(i)</span> Mental health services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(ii)">(ii)</span> Substance abuse services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(iii)">(iii)</span> Medical services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(iv)">(iv)</span> Social services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(v)">(v)</span> Financial services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(vi)">(vi)</span> Counseling services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(vii)">(vii)</span> Educational services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(viii)">(viii)</span> Housing services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(ix)">(ix)</span> Other required support services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(c)">(c)</span> Ensure timely and coordinated access to medically necessary levels of care that support continuity of care across the continuum of service providers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(d)">(d)</span> Are performed by licensed physicians, physician assistants, advanced practice nurses, registered nurses, social workers, or other individuals who are appropriately trained, experienced, and supervised by a licensed practitioner; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)">(e)</span> Include, but are not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(i)">(i)</span> Initial and ongoing assessment of the enrollee's needs and personal support systems, including the MCO offering an enrollee one face-to-face meeting during the initial assessment and documenting the enrollee's acceptance or declination of the face to face meeting;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(ii)">(ii)</span> Development of a comprehensive, individualized service plan, using a multidisciplinary approach;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(iii)">(iii)</span> Coordination of the services required to implement the plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(iv)">(iv)</span> Periodic reevaluation and adaptation of the plan as necessary over the life of the enrollee;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(v)">(v)</span> Development of an outreach system for the enrollee and family by which the case manager and primary care provider track services received, clinical outcomes, and the need for additional follow-up; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(vi)">(vi)</span> Serving as an effective enrollee advocate to resolve differences between the enrollee and providers of care pertaining to the course or content of therapeutic interventions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(2)">(2)</span> An enrollee diagnosed with HIV/AIDS shall be offered case management services by the MCO at any time after diagnosis. An enrollee who has previously refused these services may request case management from the MCO at any time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D">D.</span> Diagnostic Evaluation Service (DES) Assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(1)">(1)</span> An MCO shall offer a diagnostic evaluation service (DES) assessment annually and document the enrollee's acceptance or declination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(2)">(2)</span> The DES shall consist of a comprehensive medical and psychosocial assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(3)">(3)</span> A DES provider shall use assessment and care plan forms used by the Department for adult and pediatric assessments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(4)">(4)</span> An individual shall select a DES provider from an approved list of sites, and may select a DES provider which is not part of the individual's MCO if so desired.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(5)">(5)</span> An MCO and other qualified institutions may become DES providers as provided in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.32.03#C" title="">COMAR 10.09.32.03C</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#E">E.</span> An individual with HIV/AIDS who has a substance use disorder shall be referred to the behavioral health ASO for substance abuse treatment within 24 hours of request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#F">F.</span> Clinical Trials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#F(1)">(1)</span> An MCO may refer enrollees who are individuals with HIV/AIDS to facilities or organizations that can provide the enrollees' access to clinical trials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#F(2)">(2)</span> An MCO shall provide enrollees with HIV/AIDS access to clinical trials in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26" title=".26 Benefits — Primary Mental Health Services.">COMAR 10.67.06.26</a>-1.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.11" data-order="|10|67|04|.11|" data-ref-path="10|67|04|.11" class="h__section">.11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed</h3>
                <h3 id="/us/md/exec/comar/10.67.04.12" data-order="|10|67|04|.12|" data-ref-path="10|67|04|.12" class="h__section">.12 Consumer Advisory Board.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#A">A.</span> An MCO shall establish a consumer advisory board to facilitate the receipt of input from enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#B">B.</span> The consumer advisory board membership shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#B(1)">(1)</span> Consist of enrollees and enrollees' family members, guardians, or caregivers; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#B(2)">(2)</span> Be comprised of no less than one third representation from the MCO’s special needs populations, or their representatives and the MCO’s special needs coordinator.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#C">C.</span> The consumer advisory board shall meet at least 6 times a year.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.13" data-order="|10|67|04|.13|" data-ref-path="10|67|04|.13" class="h__section">.13 Children in State-Supervised Care.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#A">A.</span> An MCO shall provide or arrange to provide all Medicaid-covered services required to comply with State statutes and regulations mandating health and mental health services for children in State-supervised care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#B">B.</span> An MCO shall ensure the continuity and coordination of care, provided locally to the extent the services are available, to an enrollee who is a child in State-supervised care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#C">C.</span> An enrollee who is a child in State-supervised care who moves shall be disenrolled from the recipient's MCO and enrolled in an alternative MCO if the recipient's current MCO does not serve the geographic region to which the child has been relocated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#D">D.</span> An MCO shall expedite a change of providers within its provider panel upon the move of an enrollee who is a child in State-supervised care to a new geographic area served by the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#E">E.</span> On request of the responsible State or local agency, a child in State-supervised care may be disenrolled from the current MCO and enrolled in an MCO serving the group facility in which the child resides, members of the foster care family, or other children in foster care placement with the child.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#F">F.</span> Enrollee Self-Referral. An MCO shall permit the self-referral of a child in State-supervised care to an EPSDT certified provider for an initial examination, including a mental health screen, and shall pay for all portions of the examination except for the mental health screen, which shall be paid for by the Specialty Mental Health System.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#G">G.</span> Coordination with Responsible Agency. An MCO shall appoint a liaison to coordinate services to a child in State-supervised care with the responsible State or local agencies.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.14" data-order="|10|67|04|.14|" data-ref-path="10|67|04|.14" class="h__section">.14 Referral to Behavioral Health ASO.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#A">A.</span> An MCO is responsible for providing medically necessary primary behavioral health services to their enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#B">B.</span> An enrollee may self-refer to the behavioral health ASO for services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">10.09.80</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#C">C.</span> If an enrollee’s primary care physician determines that primary behavioral health services are not sufficient to meet the enrollee’s needs, the primary care physician shall refer the enrollee to the behavioral health ASO for services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">10.09.80</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#D">D.</span> If an MCO determines that primary behavioral health services are not sufficient to meet the enrollee’s needs, the MCO shall refer the enrollee to the behavioral health ASO for services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">10.09.80</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#E">E.</span> An MCO shall cooperate with the behavioral health ASO in developing referral procedures and protocols.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.15" data-order="|10|67|04|.15|" data-ref-path="10|67|04|.15" class="h__section">.15 Data Collection and Reporting.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#A">A.</span> An MCO shall notify the Department immediately when it has knowledge of an enrollee's death.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B">B.</span> Encounter Data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(1)">(1)</span> An MCO shall submit encounter data reflecting 100 percent of provider-enrollee encounters, in CMS1500 and UB04 format or an alternative format previously approved by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(2)">(2)</span> An MCO may use alternative formats including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(2)(a)">(a)</span> ASC X12N 837 and NCPDP formats; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(2)(b)">(b)</span> ASC X12N 835 format, as appropriate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)">(3)</span> An MCO shall submit encounter data that identifies the provider who delivers any items or services to enrollees at a frequency and level of detail to be specified by CMS and the Department, including, at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)(a)">(a)</span> Enrollee and provider identifying information;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)(b)">(b)</span> Service, procedure, and diagnoses codes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)(c)">(c)</span> Allowed, paid, enrollee responsibility, and third-party liability amounts; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)(d)">(d)</span> Service, claims submission, adjudication, and payment dates.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(4)">(4)</span> An MCO shall report encounter data within 60 calendar days after receipt of the claim from the provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(5)">(5)</span> An MCO shall submit encounter data utilizing a secure on-line data transfer system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#C">C.</span> Monthly Reports.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#C(1)">(1)</span> An MCO shall provide an updated list of the PCP's assigned enrollees to each PCP at least on a monthly basis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#C(2)">(2)</span> An MCO shall participate in the electronic enrollment reconciliation process to identify discrepancies in enrollment data between the Department and the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D">D.</span> Quarterly Reports. An MCO shall submit to the Department:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(1)">(1)</span> Within 30 calendar days of the close of each calendar quarter, quality assurance reports including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(1)(a)">(a)</span> Quality assurance committee meeting minutes reflecting major quality assurance corrective action plans, initiatives, and activities; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(1)(b)">(b)</span> An analysis of recipient appeal and grievance logs including significant trends or anomalies, what caused the trend or anomaly, and any actions taken to address the trend or anomaly;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(2)">(2)</span> Within 30 calendar days after the close of each calendar quarter, in the format specified by the Department, a list of all pre-service denials or reduction of services or benefits issued by the MCO or MCO subcontractors during the preceding quarter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(3)">(3)</span> Within 30 calendar days of the close of each calendar quarter, third-party liability collection activities as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18#D" title="">Regulation .18D of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(4)">(4)</span> In a format specified by the Department, amounts the MCO has cost-avoided and recovered and the number of cases the MCO has handled in each case area during the quarter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)">(5)</span> Not later than 45 days after the end of each quarterly rebate period, drug utilization data necessary for the Department to bill manufacturers for rebates in accordance with §1927(b)(1)(A) of the Social Security Act, that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(a)">(a)</span> Include, at a minimum, the following information by National Drug Code of each covered outpatient drug dispensed or covered by the MCO:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(a)(i)">(i)</span> Total number of units of each dosage form;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(a)(ii)">(ii)</span> Total number of units of each dosage strength; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(a)(iii)">(iii)</span> Total number of units of each dosage package size; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(b)">(b)</span> Distinguish utilization data for covered outpatient drugs that are subject to discounts under the 340B drug pricing program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(6)">(6)</span> Within 10 calendar days after the close of each calendar quarter, in the format specified by the Department, a list of all State fair hearing outcomes during the preceding quarter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E">E.</span> Annual Reports. Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.15#E(5)" title="">§E(5) of this regulation</a>, an MCO shall submit to the Department annually, within 90 days after the end of the calendar year:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(1)">(1)</span> A summary of the information contained in <a class="internal-link " href="/us/md/exec/comar/10.67.04.15#D(1)(b)" title="">§D(1)(b) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(2)">(2)</span> A report of the MCO's consumer advisory board outlining the board's activities and recommendations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(3)">(3)</span> A copy of the MCO's drug formulary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(4)">(4)</span> Any revisions to the MCOs quality assurance, utilization management, and case management plans;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)">(5)</span> HealthChoice Financial Monitoring Reports (HFMRs), including any supplemental schedules required by the Department:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(a)">(a)</span> In the format required by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(b)">(b)</span> Prepared according to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(b)(i)">(i)</span> The criteria, set forth in Regulation .19-5 of this chapter, for allocating MCO costs to HFMR expense categories; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(b)(ii)">(ii)</span> Reporting instructions provided by the Department for the HFMR form and any required supplemental schedules; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(c)">(c)</span> Submitted according to the following schedule:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(c)(i)">(i)</span> Services incurred from January 1 through December 31 of the prior year, reported through March 31 of the current year — due on May 15 of the current year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(c)(ii)">(ii)</span> Services incurred January 1 through December 31 of the prior year, reported through June 30 of the current year — due on September 1 of the current year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(6)">(6)</span> A detailed description of its drug utilization program activities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#F">F.</span> Unless the MCO is exempt for good cause, an MCO shall submit to the Department when requested the following reports for its enrollee/member services and provider/authorization/preauthorization lines:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#F(1)">(1)</span> Caller abandonment rates;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#F(2)">(2)</span> Caller service level rates; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#F(3)">(3)</span> Caller average hold time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G">G.</span> If the MCO exits the HealthChoice Program for any reason, including those listed in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#A(1)(e)" title="">COMAR 10.67.02.06A(1)(e)</a> and (f):</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G(1)">(1)</span> The MCO shall provide the Department with a list of enrollees and the name of each enrollee's PCP, at least 30 days before exiting the program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G(2)">(2)</span> On receiving the list provided by the MCO, the Department shall provide the list to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G(2)(a)">(a)</span> The health benefits exchange to assist and provide outreach to participants in selecting an MCO; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G(2)(b)">(b)</span> If permitted by State and federal law, the remaining MCOs for linking participants with a PCP.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#H">H.</span> Jurisdictional Reporting to Local Health Departments. The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#H(1)">(1)</span> Aggregate by jurisdiction the encounter data it receives from MCOs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#H(2)">(2)</span> Provide to local health departments jurisdiction-specific information based on aggregated encounter data for public health monitoring and assessment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#I">I.</span> For the purposes of Maryland Medicaid Managed Care Program administration or monitoring MCO performance pursuant to this chapter, the MCO shall supply other information as the Department may from time to time request, given a reasonable period of notice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#J">J.</span> Nonfederally qualified MCOs shall report a description of certain transactions with parties of interest, as described in §1903(m)(4)(A) of the Social Security Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#K">K.</span> Upon request, an MCO whose member has disenrolled shall transfer historical utilization data to the member's new MCO in the time frame and format specified by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.16" data-order="|10|67|04|.16|" data-ref-path="10|67|04|.16" class="h__section">.16 Repealed.</h3>
                <h3 id="/us/md/exec/comar/10.67.04.17" data-order="|10|67|04|.17|" data-ref-path="10|67|04|.17" class="h__section">.17 Subcontractual Relationships.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A">A.</span> Subcontracting Permitted.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(1)">(1)</span> Consistent with this regulation, an MCO may subcontract services that it is required to provide to its enrollees under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a> to a health care provider that is licensed, certified, or otherwise legally authorized to provide those services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(2)">(2)</span> An MCO may not discriminate for the participation, reimbursement, or indemnification of any provider who is acting within the scope of the provider's license or certification under applicable State law, solely on the basis of that license or certification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)">(3)</span> An MCO shall have written agreements with subcontractors that comply with 42 CFR §§438.214 and 455.105, as amended, and include at least the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(a)">(a)</span> A provision that the subcontractor be subject to all of the requirements to which the MCO is subject under its contract with the Department and pursuant to the Department's regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(b)">(b)</span> A clear description of the services to be performed under the subcontract sufficient to definitively inform the Department which of the MCO's obligations have been subcontracted;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(c)">(c)</span> A provision for the subcontractor's release to the MCO and to the Department, upon request, of any information necessary for the MCO to perform any of its contractual and regulatory obligations under its contract with the Department, including, but not limited to, its records, reporting, and quality assurance duties;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(d)">(d)</span> A provision requiring that the subcontractor complies with all State and federal requirements regarding audit, inspection, and evaluation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(e)">(e)</span> A provision that copies of the subcontractor's medical records pertaining to the MCO's enrollees shall be furnished to the MCO upon request for transfer to a subsequent provider in the event of a termination of the subcontract;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(f)">(f)</span> A provision to the effect that no termination of the subcontract shall be effective without prior written notice to the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(g)">(g)</span> An agreement that the subcontractor will look solely to the MCO for compensation for covered services provided to the MCO's enrollees under the subcontract;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(h)">(h)</span> An assurance that evidence of the subcontractor's professional liability coverage will be submitted annually to the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(i)">(i)</span> A provision that no assignment of the subcontract by the subcontractor is effective without prior written notice to the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(j)">(j)</span> If the subcontractor is authorized by the MCO to make referrals, a provision requiring the subcontractor to use the uniform consultation referral form adopted by the Maryland Insurance Administration at <a class="internal-link no-wrap" href="/us/md/exec/comar/31.10.12.06" title=".06 General Provisions.">COMAR 31.10.12.06</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(k)">(k)</span> A provision to the effect that each provision of the subcontract that is required under this section supersede and be controlling over any conflicting terms that appear in the subcontract;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(l)">(l)</span> A provision for revocation of the delegation of activities or obligations, or specifying other remedies in instances where the Department or the MCO determines that the subcontractor has not performed satisfactorily;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(m)">(m)</span> A provision stating that the MCO has the right to audit the subcontractor pursuant to 42 CFR §438.230(c)(3)(i) for 10 years from the final date of the contract period or from the date of completion of any audit, whichever is later; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(n)">(n)</span> A provision to the effect that all providers and subcontractors are subject to a grievance and appeal system consistent with the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09" title="Chapter 09 Maryland Medicaid Managed Care Program: MCO Dispute Resolution Procedures">COMAR 10.67.09</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(4)">(4)</span> An MCO may not subcontract for hospital services with a hospital or an entity related to a hospital unless that hospital is in compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.37.12" title="Chapter 12 Cross-Subsidization">COMAR 10.37.12</a> (fixed price contracting regulations).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)">(5)</span> An MCO may not prohibit or otherwise restrict a health care professional, acting within the lawful scope of practice, from advising or advocating on behalf of an enrollee who is the provider's patient for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)(a)">(a)</span> The enrollee's health status, medical care, or treatment options, including any alternative treatment that may be self-administered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)(b)">(b)</span> Any information the enrollee needs in order to decide among all relevant treatment options;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)(c)">(c)</span> The risks, benefits, and consequences of treatment or nontreatment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)(d)">(d)</span> The enrollee's right to participate in decisions regarding the enrollee's own health care, including the right to refuse treatment, and to express preferences about future treatment decisions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B">B.</span> Subcontractual Relations Reporting Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(1)">(1)</span> An MCO shall submit its standard subcontract to the Department for its approval at least 30 days in advance of the MCO entering into any subcontracts covered by this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(2)">(2)</span> An MCO shall submit to the Department for its prior approval material modifications to, or deviations from, its approved standard subcontract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(3)">(3)</span> An MCO shall submit to the Department a specification of procedures to be followed when reallocating responsibility in the event of a change in obligations in its approved standard subcontract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)">(4)</span> Network Provider Termination.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(a)">(a)</span> When an MCO and provider terminate their contract the MCO shall provide the Department with a written notice regarding the termination.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(b)">(b)</span> If the MCO is terminating the contract, the notice required in <a class="internal-link " href="/us/md/exec/comar/10.67.04.17#B(4)(a)" title="">§B(4)(a) of this regulation</a> shall be provided at the later of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(b)(i)">(i)</span> 30 calendar days before the effective date of the termination; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(b)(ii)">(ii)</span> 15 calendar days after receipt or issuance of the termination notice.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(c)">(c)</span> If the provider is terminating the contract, the notice required in <a class="internal-link " href="/us/md/exec/comar/10.67.04.17#B(4)(a)" title="">§B(4)(a) of this regulation</a> shall be provided within 15 days after the MCO receives the notice from the terminating provider.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)">(d)</span> If 50 to 99 enrollees are affected, the notice shall contain the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)(i)">(i)</span> Date of termination;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)(ii)">(ii)</span> Name or names of providers or subcontractors terminating;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)(iii)">(iii)</span> Number of enrollees affected; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)(iv)">(iv)</span> MCO's plan for transitioning enrollees to other providers.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(e)">(e)</span> If more than 99 enrollees are affected, the MCO shall provide the Department with a Department-approved termination survey.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(f)">(f)</span> In determining the number of enrollees affected under §B(4)(d) and (e) of this regulation, the MCO shall consider:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(f)(i)">(i)</span> For PCPs, the number of enrollees assigned to the PCP; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(f)(ii)">(ii)</span> For all other providers, the number of enrollees who are in active treatment or who have had an encounter with the provider in the previous 12 months.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)">(5)</span> Subcontractor Termination.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)">(a)</span> When an MCO terminates a subcontract impacting its operations, covered services, or enrollees, the MCO shall provide the Department with written notice regarding the termination that describes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)(i)">(i)</span> The dollar amount of the subcontract;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)(ii)">(ii)</span> The effect of the termination on MCO operations;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)(iii)">(iii)</span> The effect of the termination on MCO covered services or enrollees; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)(iv)">(iv)</span> The MCO’s plan to replace the subcontractor, if applicable.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(b)">(b)</span> If the termination of the subcontract impacts MCO operations, the notice required in <a class="internal-link " href="/us/md/exec/comar/10.67.04.17#B(5)(a)" title="">§B(5)(a) of this regulation</a> shall be provided at least 90 days before the effective date of the termination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#C">C.</span> By entering into a subcontract to provide health care services on behalf of an MCO, the subcontractor becomes subject to all the requirements concerning audits and inspections by the Department and other government agencies that are imposed upon the MCO by statute or regulation, or by its contract with the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#D">D.</span> An MCO shall monitor the performance of its subcontractors, including, but not limited to, the areas of enrollee and provider complaints, access issues, quality assurance activities, record keeping, and reporting requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#E">E.</span> An MCO shall report to the Department any material deviations from required procedures by its subcontractor which, in the MCO's judgment, can be expected to have a significant effect on quality of care, or on enrollees' ability to access care.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.18" data-order="|10|67|04|.18|" data-ref-path="10|67|04|.18" class="h__section">.18 Third-Party Liability.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#A">A.</span> An MCO is responsible for the identification of, and collection of, moneys owing from responsible third parties liable for the cost of medical care furnished by the MCO to enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#B">B.</span> Upon request from the Department or the U.S. Department of Health and Human Services, an MCO shall convey any information regarding third-party liability to the Department, to the U.S. Department of Health and Human Services, or to another MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#C">C.</span> The Department shall notify an MCO of any third-party liability identified during the course of eligibility determination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#D">D.</span> The MCO shall submit to the Department any new or changed third-party information in an automated format on a monthly basis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#E">E.</span> The Department shall provide the MCOs with any new or changed information on a monthly basis in an automated format.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F">F.</span> In order to facilitate the Department's and the U.S. Department of Health and Human Services' monitoring of its third-party liability collection activities, an MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F(1)">(1)</span> Submit to the Department, on a monthly basis, reports on third-party collections and activities during the month, including but not limited to amounts the MCO has cost-avoided and recovered and current accounts receivable for all third-party liability cases;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F(2)">(2)</span> Submit to the Department, on a quarterly basis and in a format specified by the Department, amounts the MCO has cost-avoided and recovered and the number of cases the MCO has handled in each case area during the quarter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F(3)">(3)</span> Cooperate in site inspections by either the Department or the U.S. Department of Health and Human Services for monitoring purposes; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F(4)">(4)</span> Submit a detailed report of third-party liability collection activities including, but not limited to, cost avoidance, recovered amounts, and current amounts receivable for cases selected by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#G">G.</span> When both the Department and an MCO have a right of subrogation, they shall coordinate settlement negotiation, ensuring that the funds available are prorated to allow sufficient compensation to settle each party's claim amount.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#H">H.</span> For insurance coverage identified by an MCO with a retroactive effective date, an MCO shall comply with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-1008" title="">Insurance Article, §15-1008, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#I">I.</span> An MCO may not deny a provider’s request for a preauthorization solely because a recipient has, or is thought to have, third-party insurance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#J">J.</span> The requirement in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18#I" title="">§I of this regulation</a> may not apply if an MCO has a process in place to ensure that a claim will not be denied for lack of preauthorization if the claim ultimately becomes the MCOs responsibility for one of the following reasons:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#J(1)">(1)</span> The recipient does not have third-party insurance; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#J(2)">(2)</span> The service received is a noncovered service under the third-party insurance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K">K.</span> If an MCO identifies another party as being responsible for retroactive denial of reimbursement, the MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(1)">(1)</span> Obtain a written statement from the third-party that includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(1)(a)">(a)</span> The name and address of the third party; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(1)(b)">(b)</span> Acknowledgment of responsibility for payment of the denied claim by the third party;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(2)">(2)</span> Send this written statement to the provider seeking reimbursement; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(3)">(3)</span> Provide this written statement or a summary report to the Department upon request.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.18-1" data-order="|10|67|04|.18-1|" data-ref-path="10|67|04|.18-1" class="h__section">.18-1 MCO Reimbursement — GME Exclusion.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A">A.</span> Capitation Rate Setting Methodology — Extraction of Graduate Medical Education Costs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)">(1)</span> Percentage of Teaching Hospitals' Rates Representing GME Costs. The Department, in consultation with the HSCRC, shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)">(a)</span> Determine the amount, expressed as a percentage, of payments by the Program that are attributable to GME, based on historic cost and discharge abstract data that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)(i)">(i)</span> Are specific to each individual teaching hospital;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)(ii)">(ii)</span> Are specific to Program recipients who would have been MCO-eligible if <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01" title="Chapter 01 Maryland Medicaid Managed Care Program: Definitions">COMAR 10.67.01</a>—.12 had been in effect at the time the activity reflected in the data occurred;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)(iii)">(iii)</span> Reflect services that would be, if performed during the contract year to which calculations utilizing a teaching hospital's GME percentage amount relate, included in the mandatory MCO benefits package described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)(iv)">(iv)</span> Represent activity in FY 1995; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(b)">(b)</span> For any teaching hospital that is not in compliance with the primary care and innovation requirements of COMAR 10.10.67.11, reduce the Program's payments to the hospital deemed to be attributable to GME pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(1)(a)" title="">§A(1)(a) of this regulation</a> by the hospital's noncompliance penalty percentage derived in accordance with COMAR 10.67.11.03C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)">(2)</span> GME Percentage Start-Up Adjustment. To ameliorate the impact on MCOs that historically have experienced low utilization of teaching hospitals, the Department shall, during the first 3 years of separate GME funding, reduce the GME percentage determined in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(1)" title="">§A(1) of this regulation</a> in the following amounts:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)(a)">(a)</span> FY 1999 ... 10 percent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)(b)">(b)</span> FY 2000 ... 6.7 percent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)(c)">(c)</span> FY 2001 ... 3.3 percent; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)(d)">(d)</span> FY 2002 and thereafter ... 0 percent.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)">(3)</span> Modifying GME Percentage to Maintain Budget Neutrality.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(a)">(a)</span> To maintain budget neutrality in the GME funding procedure established pursuant to this regulation and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.11" title="Chapter 11 Maryland Medicaid Managed Care Program: Contribution to Graduate Medical Education Costs">COMAR 10.67.11</a>, the Department may modify the GME percentages established pursuant to §A(1) and (2) of this regulation.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(b)">(b)</span> The Department may use the modified GME percentage authorized by <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(3)(a)" title="">§A(3)(a) of this regulation</a> to calculate non-GME teaching hospital costs pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)" title="">§A(4) of this regulation</a>, for the purpose of equalizing:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(b)(i)">(i)</span> The amount of GME costs to be excluded from capitation rates for the contract year pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)" title="">§A(4) of this regulation</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(b)(ii)">(ii)</span> The amount of GME allocation payments, determined pursuant to COMAR 10.67.11.03C.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(c)">(c)</span> Application of the GME percentage modification authorized in §A(3)(a) and (b) of this regulation does not affect the amount of the GME allocation payments made pursuant to COMAR 10.67.11.03C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)">(4)</span> GME Adjustment in Capitation Rate-Setting Methodology.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)(a)">(a)</span> Before determining the average historic costs assigned to the rate cells set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B of this chapter</a>, the Department shall, consistent with §A(1)—(3) of this regulation, deduct, for each rate cell, the dollar amount allocatable to GME contained in the Department's base year payments to teaching hospitals.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)(b)">(b)</span> The deduction referenced in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)(a)" title="">§A(4)(a) of this regulation</a> is calculated as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)(b)(i)">(i)</span> For each payment included in the base year data made by the Program to a teaching hospital in the contract year, the amount of the payment is multiplied by the hospital-specific GME percentage, established pursuant to §A(1)—(3) of this regulation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)(b)(ii)">(ii)</span> The dollar amount attributable to GME that is included in the base year payments, as identified by the procedure described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)(b)(i)" title="">§A(4)(b)(i) of this regulation</a>, is subtracted from the total amount of the payment to yield the non-GME portion of the payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)">(5)</span> Consistent with <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)" title="">§A(4) of this regulation</a>, the Department shall use the GME percentage rates calculated pursuant to §A(1)—(3) of this regulation for purposes of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)(a)">(a)</span> Calculating each teaching hospital's GME allocation payment amounts pursuant to COMAR 10.67.11.03C;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)(b)">(b)</span> Determining the amount of each ACG's average non-GME historic costs for grouping ACGs to make risk adjustment category assignments of the ACGs pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)(c)">(c)</span> Determining the amount of each demographic grouping's average non-GME historic costs; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)(d)">(d)</span> Determining, for each risk adjustment category and demographic grouping, the capitation rates set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B">B.</span> The Department shall use, in calculating the capitation rates set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B of this chapter</a>, a capitation rate-setting methodology that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(1)">(1)</span> Excludes the dollar amount allocatable to GME, consistent with the percentage of GME included in historic payments made by the Program to teaching hospitals that receive GME allocation payments in the contract year, based on calculations that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(1)(a)">(a)</span> Are consistent with <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A" title="">§A of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(1)(b)">(b)</span> Reflect any modifications made pursuant to §A(2) and (3) of this regulation to the percentage of the Program's historic payments made to teaching hospitals allocable to GME; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(1)(c)">(c)</span> Reflect the reduction of hospital-specific GME percentages, by operation of COMAR 10.67.11.03C and <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(1)(b)" title="">§A(1)(b) of this regulation</a>, to decrease the amount of GME allocation payments made, pursuant to COMAR 10.67.11.03B, to teaching hospitals that are not in compliance with the primary care and innovation requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.11" title="Chapter 11 Maryland Medicaid Managed Care Program: Contribution to Graduate Medical Education Costs">COMAR 10.67.11</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(2)">(2)</span> Reduces historic costs to reflect savings expected to result from a managed care delivery system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(3)">(3)</span> Includes a trend factor to account for cost differences between the base year and the contract year;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(4)">(4)</span> Excludes the dollar amount of historic payments determined, based on an aggregation of individual inpatients' payment data for the base year, to be avoidable by an MCO pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22 of this chapter</a>, had the services been furnished during the contract year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(5)">(5)</span> Beginning in FY 2000, takes into account Maryland Medicaid Managed Care Program enrollment of the newly eligible population entering the Program pursuant to the Maryland Children's Health Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.19" data-order="|10|67|04|.19|" data-ref-path="10|67|04|.19" class="h__section">.19 MCO Reimbursement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A">A.</span> Generally.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(1)">(1)</span> Payment to an MCO for each enrollee shall be at a fixed capitation rate, as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">§B(4) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(2)">(2)</span> An MCO shall be reimbursed at rates set forth in this regulation only for individuals enrolled under the Maryland Medicaid Managed Care Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(3)">(3)</span> The capitation rate paid to an MCO by the Department shall be accepted as payment in full for all benefits provided by the MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(4)">(4)</span> An MCO shall conform to the Department's computer coding requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(5)">(5)</span> A capitation payment may not be made to an MCO on behalf of an enrollee for whom capitation payment for the same period has been made to any other MCO having an agreement with the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(6)">(6)</span> The Department may consider a retroactive capitation payment to an MCO, if the MCO notifies the Department within 9 months of the first missed capitation payment for an enrollee for whom the MCO has not received all appropriate capitation payments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(7)">(7)</span> Monies collected by an MCO for third party liability, as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18" title=".18 Third-Party Liability.">Regulation .18 of this chapter</a>, are considered when calculating the capitation payments in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">§B(4) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B">B.</span> Capitation Rate-Setting Methodology.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)">(1)</span> Families and Children. Capitation rates for enrollees who are waiver-eligible based upon receipt of benefits through TCA or programs for medically needy families and children, including SOBRA children and Maryland Children's Health Program (MCHP), shall be established as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(a)">(a)</span> For enrollees eligible under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#A(1)" title="">COMAR 10.67.02.01A(1)</a> or (3), and for children eligible under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#A(2)" title="">COMAR 10.67.02.01A(2)</a> for whom the Department has sufficient clinical data, the Department shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(a)(i)">(i)</span> Determine an adjusted clinical group (ACG) assignment utilizing an enrollee's past diagnostic record;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(a)(ii)">(ii)</span> Utilizing aggregated enrollee ACG data, on an annual basis define a limited number of risk adjustment categories that reflect levels of relatively homogenous resource utilization by ACG assignment; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(a)(iii)">(iii)</span> Assign an enrollee to a risk adjustment category based upon the enrollee's ACG assignment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(b)">(b)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(1)(c)" title="">§B(1)(c) of this regulation</a>, for enrollees for whom the Department has insufficient data to generate an ACG assignment, the Department shall assign the enrollee to a risk adjustment category that reflects the enrollee's:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(b)(i)">(i)</span> Age, residence, and gender; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(b)(ii)">(ii)</span> Birth weight with respect to an enrollee born after December 31, 2004; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(c)">(c)</span> On the basis of the enrollee's residence, the Department shall assign:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(c)(i)">(i)</span> All SOBRA mothers enrolled pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#A(2)" title="">COMAR 10.67.02.01A(2)</a> to one of the two "SOBRA mother" payment categories set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">§B(4)(a) of this regulation</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(c)(ii)">(ii)</span> Enrollees with HIV to one of the two HIV payment categories set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">§B(4)(a) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)">(2)</span> Disabled. Capitation rates for enrollees who are waiver-eligible based upon receipt of benefits through SSI or as medically needy, aged, blind, or disabled shall be established as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(a)">(a)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(2)(c)" title="">§B(2)(c) of this regulation</a>, for enrollees for whom the Department has sufficient clinical data, the Department shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(a)(i)">(i)</span> Determine an adjusted clinical group (ACG) assignment utilizing an enrollee's diagnostic record;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(a)(ii)">(ii)</span> Utilizing aggregated enrollee ACG data, on an annual basis define a limited number of risk adjustment categories that reflect levels of nearly homogenous resource utilization by ACG assignment; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(a)(iii)">(iii)</span> Assign an enrollee to a risk adjustment category (RAC) based upon the enrollee's ACG assignment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(b)">(b)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(2)(c)" title="">§B(2)(c) of this regulation</a>, for enrollees for whom the Department has insufficient data to generate an ACG assignment, the Department shall assign the enrollee to a risk adjustment category that reflects the enrollee's age, residence, and gender; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(c)">(c)</span> On the basis of the enrollee's residence, the Department shall assign:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(c)(i)">(i)</span> Enrollees with HIV to one of the two HIV payment categories set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(b)" title="">§B(4)(b) of this regulation</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(c)(ii)">(ii)</span> Enrollees with AIDS to one of the two AIDS payment categories set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(b)" title="">§B(4)(b) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(3)">(3)</span> Supplemental Delivery/Newborn Payments.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(3)(a)">(a)</span> In addition to the monthly payment specified in §B(4)(a) or (b) of this regulation for an enrollee's payment category, the Department shall pay an MCO one supplemental payment per pregnancy in the amount specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(c)" title="">§B(4)(c) of this regulation</a>, upon delivery of one or more infants without regard to method, timing, or place of delivery.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(3)(b)">(b)</span> An MCO shall have 12 months from the date of delivery to bill for the supplemental payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)">(4)</span> Except to the extent of adjustments required by <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D" title="">§D of this regulation</a> or by Regulations .19-1 through 19-3 of this chapter, the Department shall make payments monthly at the rates specified in the following tables:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(a)">(a)</span> Rate Table for Families and Children Effective January 1, 2020—December 31, 2020.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-text-align="center">Under age 1 Birth Weight 1500 grams or less</td>
                        <td data-text-align="center">Both</td>
                        <td data-text-align="center">$10,545.89</td>
                        <td data-text-align="center">$9,424.40</td>
                        <td data-text-align="center">$9,791.62</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">Under age 1 Birth Weight over 1500 grams</td>
                        <td data-text-align="center" data-vertical-align="middle">Both</td>
                        <td data-text-align="center" data-vertical-align="middle">$540.93</td>
                        <td data-text-align="center" data-vertical-align="middle">$483.41</td>
                        <td data-text-align="center" data-vertical-align="middle">$502.25</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">15</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$212.56</td>
                        <td data-vertical-align="middle">$189.96</td>
                        <td data-vertical-align="middle">$197.36</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$179.94</td>
                        <td data-vertical-align="middle">$160.82</td>
                        <td data-vertical-align="middle">$167.07</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">614</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$128.11</td>
                        <td data-vertical-align="middle">$114.49</td>
                        <td data-vertical-align="middle">$118.95</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$130.65</td>
                        <td data-vertical-align="middle">$116.76</td>
                        <td data-vertical-align="middle">$121.31</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">1520</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$156.36</td>
                        <td data-vertical-align="middle">$139.73</td>
                        <td data-vertical-align="middle">$145.18</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$200.42</td>
                        <td data-vertical-align="middle">$179.11</td>
                        <td data-vertical-align="middle">$186.09</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">2144</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$313.97</td>
                        <td data-vertical-align="middle">$244.47</td>
                        <td data-vertical-align="middle">$259.96</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$423.37</td>
                        <td data-vertical-align="middle">$329.65</td>
                        <td data-vertical-align="middle">$350.54</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$649.86</td>
                        <td data-vertical-align="middle">$506.01</td>
                        <td data-vertical-align="middle">$538.07</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$710.21</td>
                        <td data-vertical-align="middle">$552.99</td>
                        <td data-vertical-align="middle">$588.03</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 400, 500, 600, 700, 900, 1000, 1100, 1200, 1300, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2800, 2900, 3000, 3100, 3200, 3300, 3400, 3500, 3800, 4210, 5100, 5110, 5200 5230, 5310, 5339</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 1F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$246.88</td>
                        <td data-vertical-align="middle">$192.23</td>
                        <td data-vertical-align="middle">$204.41</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1740, 1741, 1742, 1750, 2700, 3600, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4410, 4510, 4610, 4710, 4720, 4810, 5340</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 2F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$404.93</td>
                        <td data-vertical-align="middle">$315.29</td>
                        <td data-vertical-align="middle">$335.27</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4520, 4620, 4820</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 3F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$541.50</td>
                        <td data-vertical-align="middle">$421.63</td>
                        <td data-vertical-align="middle">$448.35</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 4F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$765.47</td>
                        <td data-vertical-align="middle">$596.02</td>
                        <td data-vertical-align="middle">$633.79</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4930, 5030, 5050</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 5F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,093.51</td>
                        <td data-vertical-align="middle">$851.45</td>
                        <td data-vertical-align="middle">$905.40</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5060</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 6F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,395.82</td>
                        <td data-vertical-align="middle">$1,086.83</td>
                        <td data-vertical-align="middle">$1,155.70</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5070</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 7F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,384.13</td>
                        <td data-vertical-align="middle">$1,856.36</td>
                        <td data-vertical-align="middle">$1,973.99</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 500, 600, 1100, 1600, 2000, 2400, 3400, 5100, 5110, 5200</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 1G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$95.15</td>
                        <td data-vertical-align="middle">$85.03</td>
                        <td data-vertical-align="middle">$88.34</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 400, 700, 900, 1000, 1200, 1300, 1710, 1711, 1712, 1800, 1900, 2100, 2200, 2300, 2800, 2900, 3000, 3100, 5310</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 2G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$120.44</td>
                        <td data-vertical-align="middle">$107.63</td>
                        <td data-vertical-align="middle">$111.83</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1720, 1721, 1722, 1731, 1732, 1730, 2500, 3200, 3300, 3500, 3800, 4210, 5230, 5339</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 3G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$155.94</td>
                        <td data-vertical-align="middle">$139.35</td>
                        <td data-vertical-align="middle">$144.78</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1740, 1741, 1742, 1750, 2700, 3600, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4410, 4510, 4610, 4710, 4720, 4810, 5340</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 4G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$216.35</td>
                        <td data-vertical-align="middle">$193.34</td>
                        <td data-vertical-align="middle">$200.87</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4520, 4620, 4820</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 5G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$333.86</td>
                        <td data-vertical-align="middle">$298.36</td>
                        <td data-vertical-align="middle">$309.98</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 6G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$412.16</td>
                        <td data-vertical-align="middle">$368.33</td>
                        <td data-vertical-align="middle">$382.68</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4930,4940, 5030, 5050, 5060, 5070</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 7G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,171.43</td>
                        <td data-vertical-align="middle">$1,046.85</td>
                        <td data-vertical-align="middle">$1,087.64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">SOBRA Mothers</td>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">$782.58</td>
                        <td data-vertical-align="middle">$609.35</td>
                        <td data-vertical-align="middle">$647.96</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with HIV</td>
                        <td data-text-align="center" data-vertical-align="middle">ALL</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,468.70</td>
                        <td data-vertical-align="middle">$2,468.70</td>
                        <td data-vertical-align="middle">$2,468.70</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(b)">(b)</span> Rate Table for Disabled Individuals Effective January 1, 2020— December 31, 2020.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM <br/>Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">Under Age 1</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$8,185.50</td>
                        <td data-vertical-align="middle">$8,185.50</td>
                        <td data-vertical-align="middle">$8,185.50</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">15</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$1,118.79</td>
                        <td data-vertical-align="middle">$1,118.79</td>
                        <td data-vertical-align="middle">$1,118.79</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$1,494.58</td>
                        <td data-vertical-align="middle">$1,494.58</td>
                        <td data-vertical-align="middle">$1,494.58</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">614</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$250.31</td>
                        <td data-vertical-align="middle">$250.31</td>
                        <td data-vertical-align="middle">$250.31</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$489.01</td>
                        <td data-vertical-align="middle">$489.01</td>
                        <td data-vertical-align="middle">$489.01</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1520</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$257.52</td>
                        <td data-vertical-align="middle">$257.72</td>
                        <td data-vertical-align="middle">$257.52</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$315.55</td>
                        <td data-vertical-align="middle">$315.55</td>
                        <td data-vertical-align="middle">$315.55</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">2144</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$837.74</td>
                        <td data-vertical-align="middle">$685.54</td>
                        <td data-vertical-align="middle">$717.57</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$829.48</td>
                        <td data-vertical-align="middle">$678.78</td>
                        <td data-vertical-align="middle">$710.49</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$2,287.81</td>
                        <td data-vertical-align="middle">$1,872.16</td>
                        <td data-vertical-align="middle">$959.63</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$2,675.35</td>
                        <td data-vertical-align="middle">$2,189.29</td>
                        <td data-vertical-align="middle">$2,291.58</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 1100, 1300, 1400, 1500, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1900, 2400, 2600, 2900, 3400, 5100, 5110, 5200, 5310</td>
                        <td data-vertical-align="middle">RAC 10</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$327.55</td>
                        <td data-vertical-align="middle">$268.04</td>
                        <td data-vertical-align="middle">$280.57</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 400, 500, 700, 900, 1000, 1200, 1740, 1741, 1742, 1750, 1751, 1752 1800, 2000, 2100, 2200, 2300, 2500, 2700, 2800, 3000, 3100, 3200, 3300, 3500, 3900, 4000, 4310, 5330</td>
                        <td data-vertical-align="middle">RAC 11</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$354.27</td>
                        <td data-vertical-align="middle">$289.90</td>
                        <td data-vertical-align="middle">$303.45</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 600, 1760, 1761, 1762, 3600, 3700, 4100, 4320, 4410, 4710, 4810, 4820</td>
                        <td data-vertical-align="middle">RAC 12</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$691.31</td>
                        <td data-vertical-align="middle">$565.71</td>
                        <td data-vertical-align="middle">$592.15</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 3800, 4210, 4220, 4330, 4420, 4720, 4910, 5320</td>
                        <td data-vertical-align="middle">RAC 13</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$810.19</td>
                        <td data-vertical-align="middle">$662.99</td>
                        <td data-vertical-align="middle">$693.97</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 4430, 4510, 4610, 5040, 5340</td>
                        <td data-vertical-align="middle">RAC 14</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,071.43</td>
                        <td data-vertical-align="middle">$876.77</td>
                        <td data-vertical-align="middle">$917.74</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1770, 1771, 1772, 4520, 4620, 4830, 4920, 5050</td>
                        <td data-vertical-align="middle">RAC 15</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,487.90</td>
                        <td data-vertical-align="middle">$1,217.58</td>
                        <td data-vertical-align="middle">$1,274.74</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4730, 4930, 5010</td>
                        <td data-vertical-align="middle">RAC 16</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,510.41</td>
                        <td data-vertical-align="middle">$1,235.99</td>
                        <td data-vertical-align="middle">$1,293.74</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5020, 5060</td>
                        <td data-vertical-align="middle">RAC 17</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,208.93</td>
                        <td data-vertical-align="middle">$1,807.61</td>
                        <td data-vertical-align="middle">$1,892.07</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5030, 5070</td>
                        <td data-vertical-align="middle">RAC 18</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$4,013.13</td>
                        <td data-vertical-align="middle">$3,284.02</td>
                        <td data-vertical-align="middle">$3,437.46</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with AIDS</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$4,968.09</td>
                        <td data-vertical-align="middle">$3,504.83</td>
                        <td data-vertical-align="middle">$3,504.83</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with HIV</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$4,255.37</td>
                        <td data-vertical-align="middle">$4,255.37</td>
                        <td data-vertical-align="middle">$4,255.37</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(c)">(c)</span> Rate Table for Supplemental Payments for Delivery/Newborn and Hepatitis C Therapy Effective January 1, 2020  December 31, 2020.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM<br/> Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">Supplemental Payment Cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn-all births except live birth weight 1,500 grams or less and gestational age of 21 weeks or more</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$17,039.19</td>
                        <td data-vertical-align="middle">$13,490.76</td>
                        <td data-vertical-align="middle">$14,736.04</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn - live birth weight 1,500 grams or less and a gestational age of 21 weeks or more</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$86,856.32</td>
                        <td data-vertical-align="middle">$86,856.32</td>
                        <td data-vertical-align="middle">$86,856.32</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn by same enrollee - subsequent live birth weight 1,500 grams or less with a gestational age less than 21 weeks or does not meet the requirements in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(i)" title="">§B(4)(i) of this regulation</a></td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$17,039.19</td>
                        <td data-vertical-align="middle">$13,490.76</td>
                        <td data-vertical-align="middle">$14,736.04</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Hepatitis C Therapy</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$15,662.46</td>
                        <td data-vertical-align="middle">$15,662.46</td>
                        <td data-vertical-align="middle">$15,662.46</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(d)">(d)</span> Rate Table for Childless Adult Population Effective January 1, 2020—December 31, 2020.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1944</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$389.33</td>
                        <td data-vertical-align="middle">$295.91</td>
                        <td data-vertical-align="middle">$342.16</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1944</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$476.88</td>
                        <td data-vertical-align="middle">$361.99</td>
                        <td data-vertical-align="middle">$418.56</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$1,069.91</td>
                        <td data-vertical-align="middle">$812.15</td>
                        <td data-vertical-align="middle">$939.07</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$1,039.04</td>
                        <td data-vertical-align="middle">$788.71</td>
                        <td data-vertical-align="middle">$911.97</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 400, 500, 600, 700, 900, 1000, 1100, 1200, 1300, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2800, 2900, 3000, 3100, 3200, 3300, 3400, 3500, 3800, 4210, 5100, 5110, 5200 5230, 5310, 5339</td>
                        <td data-vertical-align="middle">RAC 1H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$282.42</td>
                        <td data-vertical-align="middle">$247.88</td>
                        <td data-vertical-align="middle">$280.81</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1740, 1741, 1742, 1750, 2700, 3600, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4410, 4510, 4610, 4710, 4720, 4810, 5340</td>
                        <td data-vertical-align="middle">RAC 2H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$471.76</td>
                        <td data-vertical-align="middle">$414.07</td>
                        <td data-vertical-align="middle">$422.55</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4520, 4620, 4820</td>
                        <td data-vertical-align="middle">RAC 3H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$489.23</td>
                        <td data-vertical-align="middle">$429.40</td>
                        <td data-vertical-align="middle">$439.99</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-vertical-align="middle">RAC 4H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$899.28</td>
                        <td data-vertical-align="middle">$789.30</td>
                        <td data-vertical-align="middle">$763.22</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4930, 5030, 5050</td>
                        <td data-vertical-align="middle">RAC 5H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,155.28</td>
                        <td data-vertical-align="middle">$1,014.00</td>
                        <td data-vertical-align="middle">$955.15</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5060</td>
                        <td data-vertical-align="middle">RAC 6H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,639.97</td>
                        <td data-vertical-align="middle">$1,439.41</td>
                        <td data-vertical-align="middle">$1,234.70</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5070</td>
                        <td data-vertical-align="middle">RAC 7H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,477.09</td>
                        <td data-vertical-align="middle">$1,880.29</td>
                        <td data-vertical-align="middle">$2,174.15</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">HIV</td>
                        <td data-vertical-align="middle">19â64</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,991.40</td>
                        <td data-vertical-align="middle">$2,991.40</td>
                        <td data-vertical-align="middle">$2,991.40</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(e)">(e)</span> Rate Table for Families and Children Effective January 1, 2021—December 31, 2021.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">Under age 1 Birth Weight 1500 grams or less</td>
                        <td data-text-align="center" data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$10,801.56</td>
                        <td data-vertical-align="middle">$10,084.05</td>
                        <td data-vertical-align="middle">$10,367.99</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">Under age 1 Birth Weight over 1500 grams</td>
                        <td data-text-align="center" data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$531.06</td>
                        <td data-vertical-align="middle">$498.78</td>
                        <td data-vertical-align="middle">$509.74</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">15</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$213.82</td>
                        <td data-vertical-align="middle">$199.61</td>
                        <td data-vertical-align="middle">$205.23</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$176.22</td>
                        <td data-vertical-align="middle">$164.52</td>
                        <td data-vertical-align="middle">$169.15</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">614</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$112.91</td>
                        <td data-vertical-align="middle">$105.41</td>
                        <td data-vertical-align="middle">$108.37</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$106.03</td>
                        <td data-vertical-align="middle">$98.98</td>
                        <td data-vertical-align="middle">$101.77</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">1520</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$188.76</td>
                        <td data-vertical-align="middle">$176.22</td>
                        <td data-vertical-align="middle">$181.18</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$185.28</td>
                        <td data-vertical-align="middle">$172.97</td>
                        <td data-vertical-align="middle">$177.84</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">2144</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$296.27</td>
                        <td data-vertical-align="middle">$238.54</td>
                        <td data-vertical-align="middle">$256.08</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$410.17</td>
                        <td data-vertical-align="middle">$330.24</td>
                        <td data-vertical-align="middle">$354.54</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$727.80</td>
                        <td data-vertical-align="middle">$585.98</td>
                        <td data-vertical-align="middle">$629.09</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$681.00</td>
                        <td data-vertical-align="middle">$548.30</td>
                        <td data-vertical-align="middle">$588.63</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 400, 500, 600, 700, 900, 1000, 1100, 1200, 1300, 1400, 1500 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1741, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2600, 2700, 2800, 2900, 3000, 3100, 3200, 3300, 3900, 3400, 3500, 3800, 4210, 4610, 5100, 5110, 5200 5230, 5310, 5339</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 1F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$207.12</td>
                        <td data-vertical-align="middle">$166.76</td>
                        <td data-vertical-align="middle">$179.03</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1740, 1741, 1742, 1750, 2700, 3600, 1732, 1750, 1751, 1752, 1761, 2700, 3200, 3300, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4320, 4410, 4510, 4610, 4620, 4710, 4720, 4810, 5010, 5340</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 2F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$373.28</td>
                        <td data-vertical-align="middle">$300.54</td>
                        <td data-vertical-align="middle">$322.65</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4330, 4520, 4620, 4730, 4810, 4820,4910, 5020</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 3F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$571.66</td>
                        <td data-vertical-align="middle">$494.12</td>
                        <td data-vertical-align="middle">$460.27</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 0800, 1772, 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 4F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$735.65</td>
                        <td data-vertical-align="middle">$592.31</td>
                        <td data-vertical-align="middle">$635.87</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4920, 4930, 5030, 5050</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 5F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,044.18</td>
                        <td data-vertical-align="middle">$840.70</td>
                        <td data-vertical-align="middle">$902.55</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5030,5060</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 6F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,428.81</td>
                        <td data-vertical-align="middle">$1,150.40</td>
                        <td data-vertical-align="middle">$1,235.01</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5070</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 7F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,469.99</td>
                        <td data-vertical-align="middle">$1,988.70</td>
                        <td data-vertical-align="middle">$2,134.97</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 500, 600, 0400, 0900, 1100, 1300, 1600, 2000, 2400, 3400, 3900, 4000, 4100, 5100, 5110, 5200</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 1G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$78.17</td>
                        <td data-vertical-align="middle">$72.97</td>
                        <td data-vertical-align="middle">$75.03</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 400, 700, 900, 0100, 1000, 1200, 1300, 1400, 1500, 1710, 1711, 1712, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2600, 2800, 2900, 3000, 3100, 3400, 3500, 5310, 5321</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 2G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$109.00</td>
                        <td data-vertical-align="middle">$101.76</td>
                        <td data-vertical-align="middle">$104.63</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1200, 1711, 1712, 1720, 1721, 1722, 1731, 1732, 1730, 2500, 2700, 2900, 3200, 3300, 3500, 3600, 3700, 3800, 4210, 5230, 5311, 5339</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 3G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$152.99</td>
                        <td data-vertical-align="middle">$142.83</td>
                        <td data-vertical-align="middle">$146.85</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1721, 1722, 1740, 1741, 1742, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4410, 4510, 4520, 4610, 4710, 4720, 4810, 4332, 5340</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 4G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$221.94</td>
                        <td data-vertical-align="middle">$207.20</td>
                        <td data-vertical-align="middle">$213.03</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500,1731, 1732, 1741, 1750, 1751, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4520, 4620, 4820, 5010</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 5G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$381.05</td>
                        <td data-vertical-align="middle">$355.74</td>
                        <td data-vertical-align="middle">$365.76</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 0800, 1771, 1772, 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 6G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$443.16</td>
                        <td data-vertical-align="middle">$413.72</td>
                        <td data-vertical-align="middle">$425.37</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4930,4940, 5030, 5050, 5060, 5070</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 7G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,167.92</td>
                        <td data-vertical-align="middle">$1,090.34</td>
                        <td data-vertical-align="middle">$1,121.04</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">SOBRA Mothers</td>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">$756.99</td>
                        <td data-vertical-align="middle">$609.48</td>
                        <td data-vertical-align="middle">$654.31</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with HIV</td>
                        <td data-text-align="center" data-vertical-align="middle">ALL</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,772.07</td>
                        <td data-vertical-align="middle">$2,772.07</td>
                        <td data-vertical-align="middle">$2,772.07</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(f)">(f)</span> Rate Table for Disabled Individuals Effective January 1, 2021—December 31, 2021.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">Under Age 1</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$7,421.87</td>
                        <td data-vertical-align="middle">$7,421.87</td>
                        <td data-vertical-align="middle">$7,421.87</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">15</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$2,326.06</td>
                        <td data-vertical-align="middle">$2,326.06</td>
                        <td data-vertical-align="middle">$2,326.06</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$919.92</td>
                        <td data-vertical-align="middle">$919.92</td>
                        <td data-vertical-align="middle">$919.92</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">614</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$185.04</td>
                        <td data-vertical-align="middle">$185.04</td>
                        <td data-vertical-align="middle">$185.04</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$336.06</td>
                        <td data-vertical-align="middle">$336.06</td>
                        <td data-vertical-align="middle">$336.06</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1520</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$158.42</td>
                        <td data-vertical-align="middle">$158.42</td>
                        <td data-vertical-align="middle">$158.42</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$277.79</td>
                        <td data-vertical-align="middle">$277.79</td>
                        <td data-vertical-align="middle">$277.79</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">2144</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$721.14</td>
                        <td data-vertical-align="middle">$592.87</td>
                        <td data-vertical-align="middle">$649.45</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$789.07</td>
                        <td data-vertical-align="middle">$648.18</td>
                        <td data-vertical-align="middle">$710.04</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$2,317.01</td>
                        <td data-vertical-align="middle">$1,903.30</td>
                        <td data-vertical-align="middle">$2,084.95</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$2,708.00</td>
                        <td data-vertical-align="middle">$2,224.47</td>
                        <td data-vertical-align="middle">$2,436.77</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 0500, 0600, 0700, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1741, 1900, 2000, 2100, 2200, 2400, 2500, 2600, 2700, 2900, 3400, 3500, 3800, 5100, 5110, 5200, 5310, 5331</td>
                        <td data-vertical-align="middle">RAC 10</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$244.87</td>
                        <td data-vertical-align="middle">$201.15</td>
                        <td data-vertical-align="middle">$220.35</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 400, 500, 700, 900, 0300, 1000, 1400, 1200, 1712, 1732, 1740, 1741, 1742, 1750, 1751, 1752 1800, 1900, 2000, 2100, 2200, 2300, 2500, 2700, 2800, 3000, 3100, 3200, 3300, 3500, 3700, 3900, 4000, 4210, 4310, 4510, 4610, 4710, 5312, 5330</td>
                        <td data-vertical-align="middle">RAC 11</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$324.66</td>
                        <td data-vertical-align="middle">$266.89</td>
                        <td data-vertical-align="middle">$292.14</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 600, 0100, 1721, 1751, 1752, 1760, 1761, 1762, 2900, 3600, 3700, 4100, 4220, 4320, 4330, 4410, 4710, 4720, 4810, 4820, 5010, 5322</td>
                        <td data-vertical-align="middle">RAC 12</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$575.63</td>
                        <td data-vertical-align="middle">$472.85</td>
                        <td data-vertical-align="middle">$517.98</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 3800, 4100, 4210, 4220, 4330, 4410, 4420, 4520, 4620, 4720, 4730, 4820, 4910, 5020, 5320</td>
                        <td data-vertical-align="middle">RAC 13</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$815.35</td>
                        <td data-vertical-align="middle">$699.76</td>
                        <td data-vertical-align="middle">$733.69</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1771, 4420, 4430, 4510, 4610, 4830, 4910, 5040, 5332, 5340</td>
                        <td data-vertical-align="middle">RAC 14</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,152.30</td>
                        <td data-vertical-align="middle">$946.55</td>
                        <td data-vertical-align="middle">$1,036.89</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1770, 1771, 1772, 4430, 4520, 4620, 4830, 4920, 5050</td>
                        <td data-vertical-align="middle">RAC 15</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,527.61</td>
                        <td data-vertical-align="middle">$1,254.85</td>
                        <td data-vertical-align="middle">$1,374.61</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 0800, 4730, 4930, 5010, 5050</td>
                        <td data-vertical-align="middle">RAC 16</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,483.61</td>
                        <td data-vertical-align="middle">$1,465.14</td>
                        <td data-vertical-align="middle">$1,604.97</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5020, 5060</td>
                        <td data-vertical-align="middle">RAC 17</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,371.86</td>
                        <td data-vertical-align="middle">$1,948.35</td>
                        <td data-vertical-align="middle">$2,134.30</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5030, 5070, 5342</td>
                        <td data-vertical-align="middle">RAC 18</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$3,991.27</td>
                        <td data-vertical-align="middle">$3,278.61</td>
                        <td data-vertical-align="middle">$3,591.52</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with AIDS</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$5,003.30</td>
                        <td data-vertical-align="middle">$3,607.01</td>
                        <td data-vertical-align="middle">$3,607.01</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with HIV</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$4,554.33</td>
                        <td data-vertical-align="middle">$4,554.33</td>
                        <td data-vertical-align="middle">$4,554.33</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(g)">(g)</span> Rate Table for Supplemental Payments for Delivery/Newborn and Hepatitis C Therapy Effective January 1, 2021—December 31, 2021.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">Supplemental Payment Cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn-all births except live birth weight 1,500 grams or less and gestational age of 21 weeks or more</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$17,278.93</td>
                        <td data-vertical-align="middle">$12,566.25</td>
                        <td data-vertical-align="middle">$14,733.72</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn - live birth weight 1,500 grams or less and a gestational age of 21 weeks or more</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$93,700.08</td>
                        <td data-vertical-align="middle">$93,700.08</td>
                        <td data-vertical-align="middle">$93,700.08</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn by same enrollee - subsequent live birth weight 1,500 grams or less with a gestational age less than 21 weeks or does not meet the requirements in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(i)" title="">§B(4)(i) of this regulation</a></td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$17,278.93</td>
                        <td data-vertical-align="middle">$12,566.25</td>
                        <td data-vertical-align="middle">$14,733.72</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(h)">(h)</span> Rate Table for Childless Adult Population Effective January 1, 2021—December 31, 2021.</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">Age/RAC</td>
                        <td data-vertical-align="middle">Gender</td>
                        <td data-vertical-align="middle">PMPM Baltimore City</td>
                        <td data-vertical-align="middle">PMPM Montgomery County</td>
                        <td data-vertical-align="middle">PMPM Rest of State</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1944</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$405.20</td>
                        <td data-vertical-align="middle">$315.63</td>
                        <td data-vertical-align="middle">$346.25</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1944</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$484.26</td>
                        <td data-vertical-align="middle">$377.21</td>
                        <td data-vertical-align="middle">$413.81</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$1,142.43</td>
                        <td data-vertical-align="middle">$889.88</td>
                        <td data-vertical-align="middle">$976.21</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$1,144.65</td>
                        <td data-vertical-align="middle">$891.61</td>
                        <td data-vertical-align="middle">$978.11</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 400, 500, 600, 700, 900, 1000, 1100, 1200, 1300, 1500, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1741, 1742, 1752, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2700, 2800, 2900, 3000, 3100, 3200, 3300, 3400, 3500, 3800, 3900, 4000, 4210, 4310, 4510, 4710, 5100, 5110, 5200, 5230, 5310, 5339</td>
                        <td data-vertical-align="middle">RAC 1H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$248.20</td>
                        <td data-vertical-align="middle">$193.33</td>
                        <td data-vertical-align="middle">$212.09</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 0900, 1000, 1400, 1731, 1740, 1741, 1742, 1750, 1761, 1762, 2300, 2600, 2700, 3600, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4320, 4410, 4510, 4610, 4710, 4720, 4810, 4820, 5340</td>
                        <td data-vertical-align="middle">RAC 2H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$454.46</td>
                        <td data-vertical-align="middle">$353.99</td>
                        <td data-vertical-align="middle">$388.34</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1711, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4100, 4320, 4330, 4410, 4520, 4620, 4730, 4820, 5010, 5020</td>
                        <td data-vertical-align="middle">RAC 3H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$583.20</td>
                        <td data-vertical-align="middle">$454.27</td>
                        <td data-vertical-align="middle">$498.34</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 0800, 1751, 1772, 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-vertical-align="middle">RAC 4H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$863.24</td>
                        <td data-vertical-align="middle">$672.41</td>
                        <td data-vertical-align="middle">$737.65</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4920, 4930, 5030, 5050</td>
                        <td data-vertical-align="middle">RAC 5H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,249.46</td>
                        <td data-vertical-align="middle">$973.25</td>
                        <td data-vertical-align="middle">$1,067.68</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4930, 4940, 5060</td>
                        <td data-vertical-align="middle">RAC 6H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,680.86</td>
                        <td data-vertical-align="middle">$1,309.28</td>
                        <td data-vertical-align="middle">$1,436.31</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5070</td>
                        <td data-vertical-align="middle">RAC 7H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,579.16</td>
                        <td data-vertical-align="middle">$2,009.00</td>
                        <td data-vertical-align="middle">$2,203.91</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">HIV</td>
                        <td data-vertical-align="middle">19â64</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$3,135.78</td>
                        <td data-vertical-align="middle">$3,135.78</td>
                        <td data-vertical-align="middle">$3,135.78</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)">(i)</span> Interpretation of Rate Table for Families and Children. The table found at <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">§B(4)(a) of this regulation</a> shows capitation rates for individuals who are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)(i)">(i)</span> Waiver eligible based on receipt of benefits through TCA or programs for medically needy families and children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)(ii)">(ii)</span> SOBRA children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)(iii)">(iii)</span> SOBRA mothers; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)(iv)">(iv)</span> The Maryland Children's Health Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(j)">(j)</span> Interpretation of Rate Table for Disabled Individuals. The table found at <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(b)" title="">§B(4)(b) of this regulation</a> shows the capitation rates for individuals who are waiver-eligible based upon receipt of benefits through SSI or as medically needy, aged, blind, or disabled.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(k)">(k)</span> Interpretation of Rate Table for Supplemental Payment for Delivery/Newborn. The table found at <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(c)" title="">§B(4)(c) of this regulation</a> shows a supplemental payment made in connection with deliveries of MCO enrollees, regardless of the enrollee's payment category under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">COMAR 10.67.04.19B(4)(a)</a> or (b).</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(l)">(l)</span> Interpretation of Rate Tables in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">§B(4) of this regulation</a>. "PMPM" means the per member per month payment rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(5)">(5)</span> Consistent with the terms set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4" title=".19-4 MCO Medical Loss Ratio.">Regulation .19-4 of this chapter</a>, the Department may, in consultation with the Commissioner, adjust the capitation payment of an MCO if it determines that the MCO's loss ratio, not including any rebate received by the MCO is less than 85 percent.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#C">C.</span> The Department shall reimburse fee-for-service:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#C(1)">(1)</span> The Departmental share for any enrollee participating in the Stop Loss Program pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#C(2)">(2)</span> The cost of those services specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.06" title=".06 Requirements for Provider Qualification.">COMAR 10.09.69.06</a>.13 provided to the participant that have been authorized by the participant's case manager in accordance with the participant's plan of care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D">D.</span> Interim Rates Adjustments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(1)">(1)</span> Under the circumstances described in §D(2) and (3) of this regulation, the Department shall adjust the capitation rates set forth in §B(4)(a), (b), (e), and (f) of this regulation to reflect changes in service costs during the contract year due to an occurrence listed in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(2)" title="">§D(2) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)">(2)</span> The Department shall adjust the payment rates specified in §B(4)(a)(h) of this regulation to reflect service cost changes that qualify under <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(3)" title="">§D(3) of this regulation</a> and result from:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)(a)">(a)</span> An addition or deletion of services covered under the HealthChoice benefits package;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)(b)">(b)</span> An increase or decrease in Medicaid fee-for-service payment rates or copayments, if the MCOs are obligated to adjust their payment rates to providers as a result of those fee-for-service rate changes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)(c)">(c)</span> An increase or decrease in the inpatient charge per case as calculated by the change in the restated unit cost provided annually by the HSCRC as compared to the data originally provided; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)(d)">(d)</span> An increase or decrease in the outpatient charge per visit as calculated by the change in the restated unit cost provided annually by the HSCRC as compared to the data originally provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(3)">(3)</span> The Department shall make an interim rates adjustment if the effect of an occurrence listed in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(2)" title="">§D(2) of this regulation</a> is sufficient to result in program-wide overpayment or underpayment of at least 0.2 percent because of the difference between:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(3)(a)">(a)</span> Service cost projections used to develop the rates set forth in §B(4)(a), (b), (e), and (f) of this regulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(3)(b)">(b)</span> Service costs for the same period, taking into account an occurrence that is listed in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(2)" title="">§D(2) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(4)">(4)</span> The Department shall make any interim rate adjustments required by this section in amounts that are proportionate to the overpayments or underpayments described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(3)" title="">§D(3) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(5)">(5)</span> Provider rate adjustments as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(2)(b)" title="">§D(2)(b) of this regulation</a> may not require the MCOs to pay providers more than the Medicaid fee-for-service rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(6)">(6)</span> The Department shall make supplemental payments to an MCO that reflect increases in MCO provider payments for trauma services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.25.10" title="Chapter 10 Maryland Trauma Physician Services Fund">COMAR 10.25.10</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(7)">(7)</span> The Department shall make an interim rates adjustment in Calendar Years 2022, 2023, 2024, and 2025 to account for changes in acuity due to alterations in redetermination and enrollment processes related to COVID-19.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E">E.</span> Interim Rate Adjustment for Calendar Year 2025.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)">(1)</span> The Department shall re-open the capitation rates for interim rate adjustments in Calendar Year 2025 to revisit the following adjustments:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(a)">(a)</span> Risk adjustment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(b)">(b)</span> Trend;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(c)">(c)</span> Administration;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(d)">(d)</span> Regional factors; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(e)">(e)</span> Relational modeling.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(2)">(2)</span> To assist with the assessment, MCOs shall provide additional information to the Department upon request, including detailed claims data as well as a year-to-date HealthChoice Financial Monitoring Report for the calendar year.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.19-1" data-order="|10|67|04|.19-1|" data-ref-path="10|67|04|.19-1" class="h__section">.19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#A">A.</span> To reflect the higher level of risk associated with providing covered health care services pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a> to HIV/AIDS enrollees who also have Hepatitis C, the Department shall, to the extent provided by this regulation, make MCO-specific adjustments to payments for enrollees in HIV and AIDS payment categories to reflect the proportion of an MCO's HIV/AIDS enrollees who also have Hepatitis C.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B">B.</span> Identification of HIV/AIDS Enrollees with Hepatitis C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(1)">(1)</span> For each MCO, the Department shall consider historical encounter and fee-for-service data for enrollees assigned to HIV and AIDS payment categories:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(1)(a)">(a)</span> For the initial assessment period, as of June of the calendar year before the rate year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(1)(b)">(b)</span> For the mid-year assessment period, as of December of the calendar year before the rate year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(2)">(2)</span> For each MCO, the Department shall determine which of the HIV/AIDS enrollees meeting the criteria set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#B(1)" title="">§B(1) of this regulation</a> also have Hepatitis C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(3)">(3)</span> The Department shall use encounter and fee-for-service data documenting services provided to the HIV/AIDS enrollees identified in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#B(1)" title="">§B(1) of this regulation</a> for the appropriate historical diagnostic period:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(3)(a)">(a)</span> For the initial assessment period, through June of the calendar year before the rate year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(3)(b)">(b)</span> For the mid-year assessment period, through December of the calendar year before the rate year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C">C.</span> Methodology for Determining MCO-specific HIV and AIDS Case Mix Measures. For each MCO, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(1)">(1)</span> Based on encounter and fee-for-service data from the appropriate historical diagnostic period, classify the MCO's HIV/AIDS enrollees identified pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#B" title="">§B of this regulation</a> as either:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(1)(a)">(a)</span> Hepatitis C-infected; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(1)(b)">(b)</span> Hepatitis C-uninfected.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(2)">(2)</span> Average relative value for HIV and AIDS payment categories are as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(2)(a)">(a)</span> Apply weights reflecting costs associated with Hepatitis C-infected and Hepatitis C-uninfected enrollees in each HIV and AIDS payment category to the MCO-specific distribution of HIV/AIDS enrollees who are Hepatitis C-infected or Hepatitis C-uninfected, as determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(1)" title="">§C(1) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(2)(b)">(b)</span> For each MCO, use the results of the calculations specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(2)(a)" title="">§C(2)(a) of this regulation</a> to separately calculate an average relative value for each of the HIV and AIDS payment categories.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(3)">(3)</span> To determine an MCO's relative case mix factors, each MCO's relative values determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(2)(b)" title="">§C(2)(b) of this regulation</a> are divided by the overall average relative value determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(2)(a)" title="">§C(2)(a) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#D">D.</span> Methodology for MCO-Specific Case Mix-Adjusted HIV and AIDS Rates. For each MCO, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#D(1)">(1)</span> Calculate MCO-specific HIV and AIDS relative case mix factors for each HIV and AIDS payment group pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(3)" title="">§C(3) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#D(2)">(2)</span> Calculate MCO-specific HIV and AIDS rates for the rate adjustment period by multiplying the risk adjustment factor derived pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#D(1)" title="">§D(1) of this regulation</a> by the value specified for each HIV and AIDS payment group for the rate year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#D(3)">(3)</span> Apply a budget neutrality adjustment to the values derived pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#D(2)" title="">§D(2) of this regulation</a> so that the aggregate of payments to all MCOs pursuant to this regulation are equivalent to the aggregate of all payments that would be due to all MCOs in the absence of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E">E.</span> Case Mix Updates. The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E(1)">(1)</span> Update current enrollees' region of residence and enrollment categories by repeating the calculations in §§B—D of this regulation every 6 months using residence and enrollment data as of the enrollment month specified below:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E(1)(a)">(a)</span> For the initial assessment period of each rate year, June of the calendar year before the rate year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E(1)(b)">(b)</span> For the mid-year assessment period of each rate year, December of the calendar year before the rate year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E(2)">(2)</span> For rate adjustment periods beginning January 1 and July 1 of each rate year, use each MCO's updated Hepatitis C-infected and Hepatitis C-uninfected distribution to compute its risk adjusted HIV and AIDS payment rates for each rate adjustment period, as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#D" title="">§D of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.19-2" data-order="|10|67|04|.19-2|" data-ref-path="10|67|04|.19-2" class="h__section">.19-2 MCO Supplemental Payment for Transitional Encounter Data Adjustment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-2#A">A.</span> The Department may grant an adjustment to those MCOs for whom the uniform encounter data adjustment results in completeness factors that are below the Statewide average.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-2#B">B.</span> The encounter adjustment for each MCO shall be determined for the Family and Children RACs and for the Disabled RACs respectively.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.19-3" data-order="|10|67|04|.19-3|" data-ref-path="10|67|04|.19-3" class="h__section">.19-3 MCO-Specific Case Mix Adjustment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A">A.</span> Definitions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(1)">(1)</span> In this regulation, in addition to the definitions set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01" title="Chapter 01 Maryland Medicaid Managed Care Program: Definitions">COMAR 10.67.01</a>, the following terms have the meanings indicated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)">(2)</span> Terms Defined.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(a)">(a)</span> "Demographic rate cell" means a cell in one of the rates tables in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">Regulation .19B(4) of this chapter</a> to which an MCO's enrollees are assigned pursuant to Regulation .19B(1)(b) and B(2)(b) of this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(b)">(b)</span> "Initial rate adjustment period" means the 6-month period beginning January 1 of the rate year.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(c)">(c)</span> "Mid-year rate adjustment period" means the 6-month period beginning July 1 of the rate year.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(d)">(d)</span> "RAC rate cell" means a cell in one of the rates tables in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">Regulation .19B(4) of this chapter</a> to which an MCO's enrollees are assigned pursuant to Regulation .19B(1)(a) and (2)(a) of this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(e)">(e)</span> "Rate adjustment period" means a 6-month period within the rate year that includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(e)(i)">(i)</span> The initial rate adjustment period beginning January 1 of the rate year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(e)(ii)">(ii)</span> The mid-year rate adjustment period beginning July 1 of the rate year.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(f)">(f)</span> "Rate year" means the calendar year to which the rates calculated pursuant to this regulation apply.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(g)">(g)</span> "Risk Adjustment Category (RAC)" means a grouping of adjusted clinical groups (ACGs), each of which is associated with a similar level of risk.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(h)">(h)</span> "Risk assessment cohort" means each of the eight groupings of enrollees, assigned on the basis of their:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(h)(i)">(i)</span> Program eligibility category, either "families and children", as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(1)" title="">Regulation .19B(1) of this chapter</a>, or "disabled", as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(2)" title="">Regulation .19B(2) of this chapter</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(h)(ii)">(ii)</span> Region of residence category, either in "Baltimore City" or in the "rest of State"; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(h)(iii)">(iii)</span> Age category, either at least 1 year old but younger than 21 years old, or 21 years old or older.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(i)">(i)</span> "Risk assessment year" means the calendar year 2 years before the rate year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B">B.</span> For calculating an adjustment to MCO payment rates reflecting the relative level of risk of providing enrollees assigned to demographic rate cells covered health care services pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>, the Department shall, for each MCO, identify the enrollees to be considered as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)">(1)</span> For each rate adjustment period in the rate year, identify the current demographic enrollees for each MCO who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(a)">(a)</span> In the risk assessment year:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(a)(i)">(i)</span> Were certified eligible for the Program for at least 6 months;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(a)(ii)">(ii)</span> Were assigned to a demographic rate cell; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(a)(iii)">(iii)</span> As of June 30, were 1 year old or older; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(b)">(b)</span> In the calendar year before the rate year:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(b)(i)">(i)</span> For the initial rate adjustment period calculation for the rate year 2004, were enrolled in the MCO in March;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(b)(ii)">(ii)</span> For the initial rate adjustment period calculation for rate years after 2004, were enrolled in the MCO in June; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(b)(iii)">(iii)</span> For the mid-year rate adjustment period calculation, were enrolled in the MCO in December;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(2)">(2)</span> Assign each enrollee identified pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B(1)" title="">§B(1) of this regulation</a> into one of the eight risk assessment cohorts;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)">(3)</span> Make the determinations necessary for the assignments required by <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B(2)" title="">§B(2) of this regulation</a> consistent with the following time frames:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(a)">(a)</span> For an initial rate adjustment period calculation for the rate year 2004:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(a)(i)">(i)</span> An enrollee's eligibility category and region of residence as of March of the calendar year before the rate year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(a)(ii)">(ii)</span> An enrollee's age category as of March 31 of the calendar year before the rate year;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(b)">(b)</span> For an initial rate adjustment period calculation for rate years after 2004:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(b)(i)">(i)</span> An enrollee's eligibility category and region of residence as of June of the calendar year before the rate year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(b)(ii)">(ii)</span> An enrollee's age category as of June 30 of the calendar year before the rate year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(c)">(c)</span> For a mid-year rate adjustment period calculation:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(c)(i)">(i)</span> An enrollee's eligibility category and region of residence as of December of the calendar year before the rate year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(c)(ii)">(ii)</span> An enrollee's age category as of December 31 of the calendar year before the rate year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(4)">(4)</span> For calculating an MCO's case mix adjustment pursuant to this regulation, disregard any risk assessment cohorts to which fewer than 50 of an MCO's enrollees are assigned pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B(2)" title="">§B(2) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C">C.</span> Methodology for Determining MCO-specific RAC Case Mix Measures. For each MCO, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(1)">(1)</span> Based on encounter and fee-for-service data documenting services delivered during the risk assessment year, determine the diagnoses attributable to an MCO's enrollees identified pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(2)">(2)</span> Based on diagnoses in the risk assessment year, assign each enrollee identified pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a> to the appropriate risk adjustment category (RAC), consistent with the protocol set forth in Regulation .19B(1)(a) and (2)(a) of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(3)">(3)</span> Apply the RAC rates for the appropriate rate adjustment period to the RAC distribution determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#C(2)" title="">§C(2) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(4)">(4)</span> Using the results of the calculations specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#C(3)" title="">§C(3) of this regulation</a>, calculate an MCO's average RAC rates separately for each of the MCO's risk assessment cohorts derived in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(5)">(5)</span> To determine an MCO's relative RAC case mix factors, divide each of the MCO's average RAC rates determined in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#C(4)" title="">§C(4) of this regulation</a> by each overall average RAC rate for all MCOs for the same risk assessment cohort.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D">D.</span> Methodology for Determining MCO-specific Demographic Case Mix Measures. For each MCO, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D(1)">(1)</span> Determine the demographic distribution of its current enrollees as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D(2)">(2)</span> Apply the appropriate demographic rates for the rate adjustment period to the demographic distribution as determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#D(1)" title="">§D(1) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D(3)">(3)</span> Using the results of the calculations specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#D(2)" title="">§D(2) of this regulation</a>, calculate the MCO's average demographic rates separately for each of the MCO's risk assessment cohorts derived in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D(4)">(4)</span> To determine an MCO's relative demographic case mix factors, divide each of the MCO's average demographic rates determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#D(3)" title="">§D(3) of this regulation</a> by each of the overall average of demographic rates for all MCOs for the same risk assessment cohort.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E">E.</span> MCO-Specific Case Mix Adjusted Demographic Rates. The Department shall, for each MCO:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(1)">(1)</span> Calculate MCO-specific risk adjustment factors by dividing, for each risk assessment cohort, the relative RAC case mix factor determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#C" title="">§C of this regulation</a>, by the relative demographic case mix factor determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#D" title="">§D of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(2)">(2)</span> Modify the MCO-specific risk adjustment factor derived for each risk assessment cohort pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E(1)" title="">§E(1) of this regulation</a> as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(2)(a)">(a)</span> Reduce each risk adjustment factor that is higher than 1.1 to 1.1; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(2)(b)">(b)</span> Increase each risk adjustment factor that is lower than 0.9 to 0.9;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(3)">(3)</span> Subject to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E(4)" title="">§E(4) of this regulation</a>, calculate the MCO-specific demographic rates for the rate adjustment period by multiplying the risk adjustment factor for each risk assessment cohort, derived pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E(1)" title="">§E(1) of this regulation</a>, by the value specified in each demographic rate cell for the rate year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(4)">(4)</span> Apply a budget neutrality adjustment to the values derived in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E(3)" title="">§E(3) of this regulation</a> so that aggregate payments to all MCOs pursuant to this regulation are equivalent to the aggregate payments that would be due to all MCOs in the absence of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#F">F.</span> Case Mix Updates. The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#F(1)">(1)</span> Repeat the calculations described in §§C—E of this regulation every 6 months to update current MCO enrollees' region of residence, age, and enrollment categories as of the calendar year before the rate year, as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B(3)" title="">§B(3) of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#F(2)">(2)</span> For the rate adjustment periods beginning January 1 and July 1 of each rate year, use each MCO's updated RAC case mix measures and updated demographic case mix measures to compute its demographic rates for the rate adjustment period, as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E" title="">§E of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.19-4" data-order="|10|67|04|.19-4|" data-ref-path="10|67|04|.19-4" class="h__section">.19-4 MCO Medical Loss Ratio.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#A">A.</span> By September 1 of the second calendar year following the MLR reporting year, each MCO shall provide to the Department a completed MLR Reporting Template, including the MCO attestation and any additional documentation supporting the MLR reporting template.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#B">B.</span> The MLR experienced for each MCO in an MLR reporting year is the ratio of the numerator, as defined in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#D" title="">§D of this regulation</a>, to the denominator, as defined in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#E" title="">§E of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#C">C.</span> An MLR may be increased by a credibility adjustment, in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#G" title="">§G of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D">D.</span> Components of MLR — Numerator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(1)">(1)</span> The numerator of an MCO's MLR for an MLR reporting year is the sum of the MCO's incurred claims, the MCO's expenditures for activities that improve health care quality, and fraud prevention activities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)">(2)</span> Incurred Claims. Incurred claims include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(a)">(a)</span> Direct claims that the MCO paid to providers, including under capitated contracts with network providers, for services or supplies covered under the contract and services meeting the requirements of 42 CFR §438.3(e) provided to enrollees;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(b)">(b)</span> Unpaid claims liabilities for the MLR reporting year, including claims reported that are in the process of being adjusted or claims incurred but not reported;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(c)">(c)</span> Withholds from payments made to network providers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(d)">(d)</span> Claims that are recoverable for anticipated coordination of benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(e)">(e)</span> Claims payments recoveries received because of subrogation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(f)">(f)</span> Incurred but not reported claims based on past experience, and modified to reflect current conditions, such as changes in exposure or claim frequency or severity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(g)">(g)</span> Changes in other claims-related reserves; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(h)">(h)</span> Reserves for contingent benefits and the medical claim portion of lawsuits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(3)">(3)</span> An MCO shall deduct the following amounts from incurred claims:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(3)(a)">(a)</span> Overpayment recoveries received from network providers; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(3)(b)">(b)</span> Prescription drug rebates received and accrued.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(4)">(4)</span> An MCO shall include the following expenditures in incurred claims:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(4)(a)">(a)</span> The amount of incentive and bonus payments made, or expected to be made, to network providers; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(4)(b)">(b)</span> The amount of claims payments recovered through fraud reduction efforts, not to exceed the amount of fraud reduction expenses, and excluding activities specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#D(3)" title="">§D(3) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(5)">(5)</span> An MCO may include or deduct the following amounts from incurred claims:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(5)(a)">(a)</span> Net payments; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(5)(b)">(b)</span> Receipts related to State-mandated solvency funds;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(6)">(6)</span> An MCO shall exclude the following amounts from incurred claims:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(6)(a)">(a)</span> Non-claims costs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(6)(b)">(b)</span> Amounts paid to the State as remittance under <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#I" title="">§I of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(6)(c)">(c)</span> Amounts paid to network providers under to 42 CFR §438.6(d).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)">(7)</span> Non-claims costs as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#D(6)(a)" title="">§D(6)(a) of this regulation</a> include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)(a)">(a)</span> Amounts paid to third-party vendors for secondary network savings;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)(b)">(b)</span> Amounts paid to third-party vendors for network development, administrative fees, claims processing, and utilization management;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)(c)">(c)</span> Amounts paid, including amounts paid to a provider, for professional or administrative services that do not represent compensation or reimbursement for State plan services or services meeting the definition in 42 CFR §438.3(e) and provided to an enrollee; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)(d)">(d)</span> Fines and penalties assessed by regulatory authorities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(8)">(8)</span> Incurred claims paid by one MCO that are later assumed by another MCO shall be reported by the assuming MCO for the entire MLR reporting year, and no incurred claims for that MLR reporting year may be reported by the ceding MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(9)">(9)</span> An MCO shall include activities that improve health care quality in one of the following categories:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(9)(a)">(a)</span> An MCO activity that meets the requirements of 45 CFR §158.150(b) and is not excluded under 45 CFR §158.150(c);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(9)(b)">(b)</span> An MCO activity related to any EQR-related activity as described in 42 CFR §438.358(b) and (c); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(9)(c)">(c)</span> Any MCO expenditure that is related to Health Information Technology and meaningful use, meets the requirements placed on issuers found in 45 CFR §158.151, and is not considered incurred claims.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(10)">(10)</span> Excluding expenses for fraud reduction efforts in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#D(4)(b)" title="">§D(4)(b) of this regulation</a>, an MCO shall include expenditures on activities related to fraud prevention as adopted for the private market at 45 CFR part 158.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E">E.</span> Components of MLR  Denominator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(1)">(1)</span> The denominator of an MCO's MLR for an MLR reporting year shall equal the adjusted premium revenue. The adjusted premium revenue is the MCO's premium revenue minus the MCO's federal, State, and local taxes and licensing and regulatory fees and is aggregated in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#F" title="">§F of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)">(2)</span> Premium revenue includes the following for the MLR reporting year:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(a)">(a)</span> State capitation payments, developed in accordance with 42 CFR §438.4, to the MCO for all enrollees under a risk contract approved under 42 CFR §438.3(a), excluding payments made under 42 CFR §438.6(d);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(b)">(b)</span> State-developed, one-time payments, for specific life events of enrollees;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(c)">(c)</span> Other payments to the MCO approved under 42 CFR §438.6(b)(3);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(d)">(d)</span> Unpaid cost-sharing amounts that the MCO could have collected from enrollees under the contract, except those amounts the MCO can show it made a reasonable, but unsuccessful, effort to collect;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(e)">(e)</span> All changes to unearned premium reserves; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(f)">(f)</span> Net payments or receipts related to risk sharing mechanisms developed in accordance with 42 CFR §438.5 or 42 CFR §438.6.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)">(3)</span> Federal, State, and Local Taxes and Licensing and Regulatory Fees. Taxes and licensing and regulatory fees for the MLR reporting year include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(a)">(a)</span> Statutory assessments to defray the operating expenses of any State or federal department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(b)">(b)</span> Examination fees in lieu of premium taxes as specified by State law;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(c)">(c)</span> Federal taxes and assessments allocated to MCOs excluding federal income taxes on investment income and capital gains and federal employment taxes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)">(d)</span> State and local taxes and assessments including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(i)">(i)</span> Any industrywide (or subset) assessments, other than surcharges on specific claims, paid to the State or locality directly;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(ii)">(ii)</span> Guaranty fund assessments;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(iii)">(iii)</span> Assessments of State or locality industrial boards or other boards for operating expenses or for benefits to sick employed persons in connection with disability benefit laws or similar taxes levied by states;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(iv)">(iv)</span> State or locality income, excise, and business taxes other than premium taxes and State employment and similar taxes and assessments; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(v)">(v)</span> State or locality premium taxes plus State or locality taxes based on reserves, if in lieu of premium taxes; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(e)">(e)</span> Payments made by an MCO that are otherwise exempt from federal income taxes, for community benefit expenditures as defined in 45 CFR §158.162(c), limited to the highest of either:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(e)(i)">(i)</span> 3 percent of earned premium; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(e)(ii)">(ii)</span> The highest premium tax rate in the State for which the report is being submitted, multiplied by an MCO's earned premium in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(4)">(4)</span> The total amount of the denominator for an MCO, which is later assumed by another MCO, shall be reported by the assuming MCO for the entire MLR reporting year and no amount under this section for that year may be reported by the ceding MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F">F.</span> Allocation of Expense.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(1)">(1)</span> Each expense shall be included under only one type of expense, unless a portion of the expense fits under the definition of, or criteria for, one type of expense and the remainder fits into a different type of expense, in which case the MCO shall prorate the expense between types of expenses.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(2)">(2)</span> An MCO shall report on a pro-rata basis any expenditures that benefit multiple contracts or populations, or contracts other than those being reported.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(3)">(3)</span> Methods Used to Allocate Expenses.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(3)(a)">(a)</span> An MCO shall base allocation to each category on a generally accepted accounting method that is expected to yield the most accurate results.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(3)(b)">(b)</span> An MCO shall apportion shared expenses, including expenses under the terms of a management contract, pro rata to the contract incurring the expense.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(3)(c)">(c)</span> The reporting entity shall bear any expenses that relate solely to its operation and may not apportion its operating expenses to other entities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G">G.</span> Credibility Adjustment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(1)">(1)</span> An MCO may add a credibility adjustment to a calculated MLR if the MLR reporting year experience has partial credibility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(2)">(2)</span> An MCO shall add the credibility adjustment to the reported MLR calculation before calculating any remittances if required by the State as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#I" title="">§I of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(3)">(3)</span> An MCO may not add a credibility adjustment to a calculated MLR if the MLR reporting year experience has full credibility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(4)">(4)</span> If an MCO's experience has no credibility, it is presumed to meet or exceed the MLR calculation standards in this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(5)">(5)</span> MCOs shall use the base credibility factors CMS publishes on an annual basis that are developed according to the methodology in 42 CFR §438.8(h)(4).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#H">H.</span> Eligibility Groups.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#H(1)">(1)</span> MCOs shall aggregate data for all Medicaid eligibility groups covered under the contract with the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#H(2)">(2)</span> MCOs shall report, and the Department shall calculate, an annual MLR as described in this regulation separately for the childless adult population.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#H(3)">(3)</span> The Department may require separate reporting and a separate MLR calculation for additional populations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#I">I.</span> An MCO shall provide a remittance for an MLR reporting year if the MLR for that MLR reporting year does not meet the minimum MLR standard of 85 percent.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#J">J.</span> Newly Contracted MCOs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#J(1)">(1)</span> The Department may exclude an MCO that is newly contracted with the State from the requirements in this section for the first year of the MCO's operation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#J(2)">(2)</span> Newly contracted MCOs shall comply with the requirements in this section during the next MLR reporting year in which the MCO is in business with the State, even if the first year was not a full 12 months.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#K">K.</span> If the Department makes a retroactive change to the capitation payments for an MLR reporting year where the report has already been submitted to the Department, the MCO shall recalculate the MLR for all MLR reporting years affected by the change and submit a new report.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#L">L.</span> MCOs shall attest to the accuracy of the calculation of the MLR in accordance with requirements of this section when submitting its report to the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#M">M.</span> MCOs shall report fraud prevention activities as required by 42 CFR §438.8.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#N">N.</span> Notice and Appeal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#N(1)">(1)</span> Within 30 days of its receipt of the notice of a remittance being due to the Department, an MCO may appeal the remittance as a sanction pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.02" title=".02 Appeal.">COMAR 10.67.10.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#N(2)">(2)</span> An MCO's appeal does not stay the obligation of the MCO to remit the amount owed to the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.20" data-order="|10|67|04|.20|" data-ref-path="10|67|04|.20" class="h__section">.20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A">A.</span> MCO Payment for Self-Referred Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)">(1)</span> For undisputed claims that are submitted to the MCO within 6 months of the date of service, an MCO shall reimburse out-of-plan providers within 30 days for eligible services performed upon an enrollee who has self-referred:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(a)">(a)</span> To a school-based health clinic pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28#B" title="">COMAR 10.67.06.28B</a>, for services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07" title="Chapter 07 Maryland Medicaid Managed Care Program: Program Integrity">COMAR 10.67.07</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(b)">(b)</span> For family planning services, pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28#A" title="">COMAR 10.67.06.28A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(c)">(c)</span> For an initial medical examination for an enrollee who is a child in State-supervised care, pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.13#F" title="">Regulation .13F of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(d)">(d)</span> For one annual diagnostic and evaluation service visit for an enrollee diagnosed with human immunodeficiency virus or acquired immune deficiency syndrome (HIV/AIDS) pursuant to COMAR 10.67.06.28E;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(e)">(e)</span> For obstetric and gynecologic care provided to a pregnant woman, under the circumstances described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28#C" title="">COMAR 10.67.06.28C</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(f)">(f)</span> For an initial medical examination of a newborn when the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(f)(i)">(i)</span> Examination is performed in a hospital by an on-call physician; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(f)(ii)">(ii)</span> MCO failed to provide for the service before the newborn's discharge from the hospital.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(2)">(2)</span> An MCO shall reimburse out-of-plan providers to whom enrollees have self-referred for school-based services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07.03" title=".03 Reporting.">COMAR 10.67.07.03</a> and family planning services including office visits (CPT codes 9920199205 and 9921199215), preventive medicine office visits (CPT codes 9938399386 and 9939399396), and all FDA-approved contraceptive devices, methods and supplies, at the established Medicaid rates.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(3)">(3)</span> An MCO shall reimburse out-of-plan providers to whom enrollees have self-referred for an initial examination for a child in State-supervised care utilizing the Medicaid payment schedule for the following procedure codes:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>CPT code</th>
                        <th>Service Description</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <th>Initial Comprehensive Preventive Medicine (New Patient)</th>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99381</td>
                        <td data-vertical-align="middle">Infant (younger than 1 year old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99382</td>
                        <td data-vertical-align="middle">Early childhood (1—4 years old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99383</td>
                        <td data-vertical-align="middle">Late childhood (5—11 years old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99384</td>
                        <td data-vertical-align="middle">Adolescent (12—17 years old)</td>
                      </tr>
                      <tr>
                        <th>Periodic Comprehensive or Preventive Services (Established Patient)</th>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99391</td>
                        <td data-vertical-align="middle">Infant (younger than 1 year old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99392</td>
                        <td data-vertical-align="middle">Early childhood (1—4 years old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99393</td>
                        <td data-vertical-align="middle">Late childhood (5—11 years old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99394</td>
                        <td data-vertical-align="middle">Adolescent (12—17 years old)</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(4)">(4)</span> An MCO shall reimburse out-of-plan providers rendering pregnancy-related services, as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">COMAR 10.67.06.28</a>, at the Medicaid rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(5)">(5)</span> An MCO shall reimburse out-of-plan providers performing the DES for HIV/AIDS at the Medicaid rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(6)">(6)</span> An MCO may require enrollees to utilize in-plan providers for pharmacy and laboratory services ordered by out-of-plan providers of self-referral services, except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#A(7)" title="">§A(7) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(7)">(7)</span> An MCO shall reimburse out-of-plan providers at the Medicaid rate for medically necessary pharmacy and laboratory services when the pharmacy or laboratory service is provided:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(7)(a)">(a)</span> In connection with a self-referred service specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#A(1)" title="">§A(1) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(7)(b)">(b)</span> On-site by the out-of-plan provider at the same location that the self-referred service specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#A(1)" title="">§A(1) of this regulation</a> was delivered to the MCO's enrollee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(8)">(8)</span> An MCO shall reimburse out-of-plan providers for renal dialysis services in a Medicare-certified facility, at least the Medicaid rate, regardless of whether or not the MCO's preauthorization was secured.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(9)">(9)</span> An MCO shall reimburse out-of-plan providers under the circumstances described in COMAR 10.67.06.28G at a rate not less than the fee-for-service Medicaid rate for an initial medical examination of a newborn when the mother's MCO fails to provide for the service before the newborn is discharged from the hospital.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(10)">(10)</span> An MCO shall reimburse out-of-plan providers at the Medicaid fee-for-service rate for services performed in a free-standing birth center as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">COMAR 10.67.06.28</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(11)">(11)</span> An MCO shall reimburse out-of-plan doulas at the Medicaid fee-for-service rate for services performed during the prenatal, labor and delivery, and postpartum periods of pregnancy as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">COMAR 10.67.06.28</a> through December 31, 2025.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B">B.</span> MCO Payment for Emergency Services Provided at a Hospital. An MCO shall reimburse a hospital emergency facility and provider, which is not required to obtain prior authorization or approval for payment from an MCO in order to obtain reimbursement under this regulation, for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B(1)">(1)</span> Health care services that meet the definition of emergency services in Health-General Article, §19-701, Annotated Code of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B(2)">(2)</span> Medical screening services rendered to meet the requirements of the federal Emergency Medical Treatment and Active Labor Act;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B(3)">(3)</span> Medically necessary services if the MCO authorized, referred, or otherwise instructed the enrollee to use the emergency facility and the medically necessary services are related to the emergency condition; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B(4)">(4)</span> Medically necessary services that relate to the condition presented and that are provided by the provider in the emergency facility to the enrollee if the MCO fails to provide 24-hour access to a physician.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C">C.</span> MCO Payment to an Out-of-Network Federally Qualified Health Center for Services Immediately Required Due to an Unforeseen Illness, Injury, or Condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)">(1)</span> Effective October 1, 2010, an MCO shall reimburse an out-of-network federally qualified health center (FQHC) for services provided to an enrollee that are immediately required due to an unforeseen illness, injury, or condition if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(a)">(a)</span> The FQHC participates in the Medical Assistance Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(b)">(b)</span> The FQHC does not have a contract with the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(c)">(c)</span> The services are immediately required due to the enrollee's unforeseen illness, injury, or condition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(d)">(d)</span> The emergent services are provided on site at the FQHC; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(e)">(e)</span> The FQHC has, before rendering services, verified with the enrollee's primary care provider that the enrollee cannot be seen within a reasonable amount of time based on the severity of the enrollee's condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(2)">(2)</span> An MCO may require that the FQHC provide documentation that the FQHC has obtained the verification required under <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#C(1)(e)" title="">§C(1)(e) of this regulation</a>. An MCO is not required to reimburse an out-of-network FQHC for emergent services provided to an enrollee if the FQHC fails to provide the documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(3)">(3)</span> An MCO may require that the FQHC provide documentation that services were required for the reasons identified under <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#C(1)(c)" title="">§C(1)(c) of this regulation</a>. An MCO is not required to reimburse an out-of-network FQHC for emergent services provided to an enrollee if the FQHC fails to provide the documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(4)">(4)</span> The rate at which the MCO shall reimburse an out-of-network FQHC for services provided under <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#C(1)" title="">§C(1) of this regulation</a> shall be the rate identified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">COMAR 10.67.04.21</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(5)">(5)</span> For any reimbursement paid by an MCO under <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#C" title="">§C of this regulation</a>, the Program shall pay the MCO the difference between the rates identified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">COMAR 10.67.04.21</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.08.05" title=".05 Federally Qualified Health Center Services.">COMAR 10.09.08.05</a>-1.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#D">D.</span> MCO Payment for Provider Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#D(1)">(1)</span> An MCO shall pass on to providers any MCO rate adjustment that is specified by the Department for a fee increase.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#D(2)">(2)</span> For inpatient services performed in hospitals, an MCO shall pay all providers, regardless of the provider's contracting status, at least the Medicaid fee-for-service rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#D(3)">(3)</span> The MCO may not be required to pay providers more than the Medicaid fee-for-service rate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#E">E.</span> Payment for Hospital Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#E(1)">(1)</span> An MCO shall reimburse Maryland hospital providers on the basis of rates approved by the Maryland Health Services Cost Review Commission (HSCRC).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#E(2)">(2)</span> An MCO shall reimburse hospital administrative days at the Medicaid fee-for-service rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#E(3)">(3)</span> Upon the direction of the Department, an MCO shall reduce payments by 20 percent to a hospital located in a contiguous state or in the District of Columbia for services rendered to its enrollees, if the hospital has failed to supply appropriate discharge data to the Health Services Cost Review Commission.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.21" data-order="|10|67|04|.21|" data-ref-path="10|67|04|.21" class="h__section">.21 Payments to Federally Qualified Health Centers (FQHC).</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A">A.</span> FQHC’s shall be reimbursed under the Alternative Payment System (APS).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A(1)">(1)</span> The Department shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A(1)(a)">(a)</span> Pay the MCO a prospective payment based on encounter data; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A(1)(b)">(b)</span> Reconcile the prospective amount paid to the MCO with the MCO's actual expenditure amount, after receipt of MCO encounter data; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A(2)">(2)</span> MCOs shall reimburse any contracted FQHC, the FQHC’s rate established in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.08.05" title=".05 Federally Qualified Health Center Services.">COMAR 10.09.08.05</a>-1A.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#B">B.</span> For self-referred services described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">Regulation .20 of this chapter</a>, the MCO shall pay the FQHC’s usual rate in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.21#A" title="">§A of this regulation</a>, regardless of the FQHC’s contracted status with the MCO.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.22" data-order="|10|67|04|.22|" data-ref-path="10|67|04|.22" class="h__section">.22 Stop Loss Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#A">A.</span> An MCO shall qualify for protection under the Stop Loss Program if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#A(1)">(1)</span> It was participating in HealthChoice as of April 1, 1999;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#A(2)">(2)</span> It was unable to self-insure or obtain a contract with another entity for Stop Loss reinsurance after July 1, 1999; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#A(3)">(3)</span> By July 1, 1999, the MCO requested the Department to continue to provide Stop Loss Protection at a rate determined by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#B">B.</span> An MCO shall notify the Department that the acute inpatient hospital costs of an enrollee are expected to exceed the Stop Loss limit as soon as it knows that this is likely to occur.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#C">C.</span> Upon confirming eligibility for stop loss protection, the Department shall assume liability for reimbursement of 90 percent of accrued acute inpatient hospital charges according to established Medicaid fee-for-service rates for medically necessary acute inpatient treatment rendered to the enrollee above the stop loss limit throughout the remainder of the calendar year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#D">D.</span> An MCO shall remain financially liable for reimbursing 10 percent of accrued acute inpatient hospital charges for medically necessary treatment rendered to the enrollee above the stop loss limit throughout the remainder of the calendar year, and shall maintain full responsibility for the provision of health care services to the enrollee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#E">E.</span> At the beginning of the next calendar year, an MCO shall reassume full financial responsibility and full discretion for developing medical treatment plans for any enrollee who qualified for the Stop Loss Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#F">F.</span> The Department's Extended Stop Loss Period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#F(1)">(1)</span> If an inpatient enrollee remains hospitalized at the end of a calendar year and incurs acute hospital costs that exceed the Stop Loss limit into the following calendar year without interruption, the Department's stop loss period shall be extended until the end of that hospitalization.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#F(2)">(2)</span> The MCO shall remain financially liable for costs up to the Stop Loss limit for enrollees who remain hospitalized in an acute setting at the end of the calendar year as specified in §§A and D of this regulation until the enrollee is discharged.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#G">G.</span> For calendar year 2001 and beyond, the MCO shall submit the MCO's Stop Loss Reinsurance Plan or Self-Insurance Plan to the Maryland Insurance Administration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#H">H.</span> If an MCO chooses to have the Department provide its Stop Loss coverage, an adjustment will be made to the capitation amount the MCO is paid.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#I">I.</span> Upon the termination of the provider agreement between the enrollee's MCO and the Department, if an MCO has failed to fulfill its financial liability under this regulation, the Department shall assume responsibility only for costs that exceed the Stop Loss limit as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.22#C" title="">§C of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.23" data-order="|10|67|04|.23|" data-ref-path="10|67|04|.23" class="h__section">.23 Marketing.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#A">A.</span> An MCO may not have face-to-face or telephone contact with a recipient, or otherwise solicit a recipient who is not an enrollee of the MCO, unless authorized by the Department or the recipient initiates the contact.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B">B.</span> Subject to prior approval by the Department, an MCO may engage in marketing activities designed to make recipients aware of their availability, as well as any special services they offer. Unless they involve face-to-face solicitation, these marketing activities may involve campaigns using but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(1)">(1)</span> Television;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(2)">(2)</span> Radio;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(3)">(3)</span> Newspaper;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(4)">(4)</span> Informational booths at public events;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(5)">(5)</span> Billboards and other public displays;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(6)">(6)</span> Addressee-blind informational mailings, but only when mailed to the MCO's entire service area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(7)">(7)</span> Magazines;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(8)">(8)</span> Airborne marketing displays; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(9)">(9)</span> Public conveyances.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C">C.</span> An MCO may not engage in any cold call marketing, including activities using or involving any of the following mechanisms:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(1)">(1)</span> Direct marketing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(2)">(2)</span> Telephone solicitation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(3)">(3)</span> Door to door flyers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(4)">(4)</span> Email;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(5)">(5)</span> Texting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(6)">(6)</span> Material or financial incentives of any kind, with the exception of advertising trinkets such as balloons or pens that have an acquisition cost of $5 or less; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(7)">(7)</span> Influencing enrollment in conjunction with the sale or offer of private insurance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D">D.</span> Standards for Departmental Approval of MCO Advertising.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)">(1)</span> MCO advertising shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)(a)">(a)</span> Be based on documented fact;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)(b)">(b)</span> Identify all telephone numbers used that do not belong to the MCOs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)(c)">(c)</span> Include the statement, "'HealthChoice' is a program of the Maryland Department of Health"; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)(d)">(d)</span> Be at a fifth grade reading level.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)">(2)</span> MCO advertising may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)(a)">(a)</span> Be false or misleading;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)(b)">(b)</span> Ascribe to the MCO unique coverage or services that are otherwise required by State or federal law or regulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)(c)">(c)</span> Assert that a recipient shall enroll in the MCO in order to obtain benefits or in order not to lose benefits; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)(d)">(d)</span> Assert that the MCO is endorsed by CMS, the federal or State government or similar entity.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.24" data-order="|10|67|04|.24|" data-ref-path="10|67|04|.24" class="h__section">.24 Repealed.</h3>
                <h3 id="/us/md/exec/comar/10.67.04.25" data-order="|10|67|04|.25|" data-ref-path="10|67|04|.25" class="h__section">.25 Enrollee Outreach Plan.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#A">A.</span> An MCO shall submit to the Department, on an annual basis, a written enrollee outreach plan that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#A(1)">(1)</span> Describes how the MCO intends to comply, in the upcoming year, with the outreach requirements of Health-General Article, §15-103(b)(9), Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#A(2)">(2)</span> Provides evidence of the MCO's compliance during the previous year, with the outreach requirements of Health-General Article, §15-103(b)(9), Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#B">B.</span> Submission Date.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#B(1)">(1)</span> An MCO applicant shall submit its initial enrollee outreach plan, as part of its MCO application, as required by COMAR 10.09.64.06O.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#B(2)">(2)</span> An MCO shall submit by December 1 an enrollee outreach plan, including the information specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.25#A" title="">§A of this regulation</a>, to be reviewed as part of the triennial audit performed by an external quality review organization (EQRO).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#B(3)">(3)</span> For years in which the triennial EQRO audit is not performed, an MCO shall submit by April 30 any changes to the enrollee outreach plan, including the information specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.25#A" title="">§A of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.26" data-order="|10|67|04|.26|" data-ref-path="10|67|04|.26" class="h__section">.26 Time Period for Termination of Provider Agreement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.26#A">A.</span> An MCO may terminate its provider agreement with the State as provided in §§B—D of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.26#B">B.</span> The MCO shall provide written notification to the Department of the MCO's intent to terminate the MCO's provider agreement with the State for any given calendar year by the previous October 1.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.26#C">C.</span> An MCO that has previously terminated the provider agreement with the State and would like to sign a new agreement with the State, shall follow the application process as specified under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03" title="Chapter 03 Maryland Medicaid Managed Care Program: MCO Application">COMAR 10.67.03</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.26#D">D.</span> The Department may waive the requirement under <a class="internal-link " href="/us/md/exec/comar/10.67.04.26#B" title="">§B of this regulation</a> if the Department determines that the circumstances warrant, including but not limited to a reduction in rates outside the normal rate setting process or an MCO exit from the program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.04.27" data-order="|10|67|04|.27|" data-ref-path="10|67|04|.27" class="h__section">.27 Newborn Coordinator.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#A">A.</span> An MCO shall identify a newborn coordinator who shall be available to providers during the MCO's business hours as a contact for concerns related to eligibility and provision of services to newborns.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#B">B.</span> The newborn coordinator shall provide services for a newborn:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#B(1)">(1)</span> Whose mother is enrolled in the MCO on the date of the newborn's birth; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#B(2)">(2)</span> Who is enrolled or who is autoassigned to the MCO after birth.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C">C.</span> The newborn coordinator shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(1)">(1)</span> Research and confirm the assignment of an eligible newborn to a managed care organization;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(2)">(2)</span> Interface with the enrollment agent, the Department, the newborn coordinators of other MCOs, and the provider to resolve any eligibility issues involving multiple MCOs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(3)">(3)</span> Facilitate and confirm the selection of a primary care provider for an eligible newborn;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(4)">(4)</span> Request an MCO ID card for a newborn when necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(5)">(5)</span> Make retroactive PCP enrollments when necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(6)">(6)</span> Facilitate the resolution of claims for services provided to an eligible newborn;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(7)">(7)</span> Provide general guidance to providers and their office staff on newborn-related issues;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(8)">(8)</span> Coordinate with ancillary care providers to facilitate appropriate delivery of care and payment of claims; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(9)">(9)</span> Coordinate and authorize in-network care when the newborn does not yet appear in EVS or the MCO's system, or out-of-network care when the MCO cannot offer an appropriate in-network provider.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.05" data-order="|10|67|05|" data-ref-path="10|67|05" class="h__chapter">Chapter 05 Maryland Medicaid Managed Care Program: Access</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01" title=".01 Access Standards: Addressing Enrollees' Individualized Needs.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.08" title=".08 Emergency Services Access.">.08</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730); adopted permanently effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01" title=".01 Access Standards: Addressing Enrollees' Individualized Needs.">Regulation .01</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01#A" title="">Regulation .01A</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353); November 7, 2016 (43:22 Md. R. 1221)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01#B" title="">Regulation .01B</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.02" title=".02 Access Standards: Enrollee Handbook and Provider Directory.">Regulation .02</a> amended effective February 18, 2002 (29:3 Md. R. 220); June 30, 2008 (35:13 Md. R. 1180); February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.02#B" title="">Regulation .02B</a>, C amended effective August 29, 2016 (43:17 Md. R. 955)</p>
                  <p>Regulations .03 and .04 amended as an emergency provision effective July 1, 1997 (24:16 Md. R. 1151); emergency status expired December 31, 1997</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.03" title=".03 Access Standards: Outreach.">Regulation .03</a> amended effective February 9, 1998 (25:3 Md. R. 144); February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.03#D" title="">Regulation .03D</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.04" title=".04 Access Standards: Information for Providers.">Regulation .04</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.04#A" title="">Regulation .04A</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.04#A" title="">Regulation .04A</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.04#A" title="">Regulation .04A</a> amended effective April 19, 2010 (37:8 Md. R. 615); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.04#A" title="">Regulation .04A</a>, B amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.04#A" title="">Regulation .04A</a>, C amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.04#C" title="">Regulation .04C</a> amended effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.05" title=".05 Access Standards: PCPs and MCO's Provider Network.">Regulation .05</a> amended effective April 10, 2006 (33:7 Md. R. 668); June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.05#A" title="">Regulation .05A</a> amended effective June 25, 2001 (28:12 Md. R. 1109)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.05#A" title="">Regulation .05A</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.05#A" title="">Regulation .05A</a> amended effective February 16, 2015 (42:3 Md. R. 316); February 1, 2016 (42:23 Md. R. 1434)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.05#B" title="">Regulation .05B</a> amended effective April 19, 2010 (37:8 Md. R. 615); February 6, 2012 (39:2 Md. R. 141) August 29, 2016 (43:17 Md. R. 955); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.05-1" title=".05-1 Access Standards: Specialty Provider Network.">Regulation .05-1</a> adopted effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.05-1" title=".05-1 Access Standards: Specialty Provider Network.">Regulation .05-1</a> amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06" title=".06 Geographical Access.">Regulation .06</a> amended effective April 28, 2014 (41:8 Md. R. 471); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06#A" title="">Regulation .06A</a> amended effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06#B" title="">Regulation .06B</a> amended effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06#E" title="">Regulation .06E</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06#E" title="">Regulation .06E</a> amended effective April 9, 2007 (34:7 Md. R. 698); November 5, 2007 (34:22 Md. R. 1977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.07#A" title="">Regulation .07A</a> amended effective February 2, 2004 (31:2 Md. R. 82); April 19, 2010 (37:8 Md. R. 615); February 6, 2012 (39:2 Md. R. 141); October 28, 2013 (40:21 Md. R. 1775); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.07#A" title="">Regulation .07A</a>, D amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.07#B" title="">Regulation .07B</a>, C amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.07#B" title="">Regulation .07B</a>, D amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.07#B" title="">Regulation .07B</a>, C amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.08" title=".08 Emergency Services Access.">Regulation .08</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.08#B" title="">Regulation .08B</a>, F amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.09" title=".09 Access: Hospitals.">Regulation .09</a> adopted effective March 14, 2016 (43:5 Md. R. 385)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.09" title=".09 Access: Hospitals.">Regulation .09</a> amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.66" title="Chapter 66 Assistance in Community Integration Services">COMAR 10.09.66</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01#B" title="">Regulation .01B</a> amended effective June 13, 2022 (49:12 Md. R. 641)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.02#C" title="">Regulation .02C</a> amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.02#G" title="">Regulation .02G</a> amended effective June 13, 2022 (49:12 Md. R. 641)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.04#A" title="">Regulation .04A</a> amended effective June 13, 2022 (49:12 Md. R. 641)</p>
                  <p>Regulation .05-1A amended effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p>Regulation .05-1C amended effective October 18, 2021 (48:21 Md. R. 889); April 28, 2025 (52:8 Md. R. 359)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104, 15-102.1(b)(10), 15-102.3 and 15-103; Insurance Article §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-112" title="">15-112</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-605" title="">15-605</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-1008" title="">15-1008</a>; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.05.01" data-order="|10|67|05|.01|" data-ref-path="10|67|05|.01" class="h__section">.01 Access Standards: Addressing Enrollees' Individualized Needs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#A">A.</span> An MCO shall provide access to health care services and information in a manner that addresses the individualized needs of its enrollees, regardless of gender, sexual orientation, or gender identity, including, but not limited to, the delivery of services and information to enrollees:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#A(1)">(1)</span> In a culturally sensitive manner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#A(2)">(2)</span> At an appropriate reading comprehension level;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#A(3)">(3)</span> In the prevalent non-English languages identified by the State; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#A(4)">(4)</span> In a manner that accommodates individuals with disabilities consistent with the requirements of the Americans with Disabilities Act of 1990, P.L. 101-330, 42 U.S.C. §12101 et seq., and regulations promulgated under it.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B">B.</span> Special Access.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(1)">(1)</span> An MCO shall notify enrollees of the following services and make them available free of charge to the enrollee:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(1)(a)">(a)</span> Written materials in the prevalent non-English languages identified by the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(1)(b)">(b)</span> Written materials in alternative formats;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(1)(c)">(c)</span> Oral interpretation services in all non-English languages; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(1)(d)">(d)</span> Auxiliary aids and services, such as:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(1)(d)(i)">(i)</span> Teletypewriter/Telecommunication Device for the Deaf (TTY/TDD); and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(1)(d)(ii)">(ii)</span> American Sign Language.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(2)">(2)</span> An MCO shall include taglines in the prevalent non-English languages identified by the State with its written materials critical to obtaining services that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(2)(a)">(a)</span> Explain the availability of written translation or oral interpretation to understand the information provided; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#B(2)(b)">(b)</span> Provide the toll-free and TTY/TDD telephone number of the MCO’s customer service unit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#C">C.</span> Written Materials. An MCO shall provide all its written materials in the following manner:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#C(1)">(1)</span> Using language and a format that is easily understood;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#C(2)">(2)</span> In a font size no smaller than 12 point;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#C(3)">(3)</span> Available in alternative formats and through the provision of auxiliary aids and services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#C(4)">(4)</span> Available in an appropriate manner that takes into consideration the special needs of enrollees or potential enrollees with disabilities or limited English proficiency.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#D">D.</span> An MCO may provide enrollee information electronically so long as all of the following requirements are met:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#D(1)">(1)</span> The format is readily accessible;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#D(2)">(2)</span> The information is placed in a location on the MCO’s website that is prominent and readily accessible;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#D(3)">(3)</span> The information is provided in an electronic form which can be electronically retained and printed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#D(4)">(4)</span> The information is consistent with the content and language requirements of this section;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#D(5)">(5)</span> The enrollee is informed that the information is available in paper form without charge upon request; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.01#D(6)">(6)</span> Should the enrollee request it, the MCO provides the information in paper form within 5 business days.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.02" data-order="|10|67|05|.02|" data-ref-path="10|67|05|.02" class="h__section">.02 Access Standards: Enrollee Handbook and Provider Directory.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#A">A.</span> An MCO shall inform and educate its enrollees about:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#A(1)">(1)</span> Basic information about the MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#A(2)">(2)</span> The availability of health care services and how to access them;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#A(3)">(3)</span> The definitions of managed care terminology in accordance with 42 CFR 438.10(c)(4)(i); and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#A(4)">(4)</span> Enrollee's rights and responsibilities in the MCO, and that the exercise of those rights does not adversely affect the way the MCO, its providers, or the Department treats the enrollee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B">B.</span> An MCO shall, at the time of enrollment, and anytime upon request, furnish each enrollee with a copy of the MCOs enrollee handbook that includes all language in the template provided by the Department and the following current information:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(1)">(1)</span> The enrollee's rights and responsibilities in the MCO as described in 42 CFR §438.100(b)(1), as amended;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(2)">(2)</span> Information on how to access urgent care and emergency care services, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(2)(a)">(a)</span> What constitutes an emergency medical condition and emergency services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(2)(b)">(b)</span> The following facts:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(2)(b)(i)">(i)</span> Prior authorization is not required for these services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(2)(b)(ii)">(ii)</span> The enrollee has a right to use any hospital or other setting for emergency care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(3)">(3)</span> The services included in the MCO's benefits package, including optional benefits provided by the MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(4)">(4)</span> How and where to access any benefits provided by the State, including any cost sharing, and how transportation is provided;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(5)">(5)</span> The amount, duration, and scope of benefits available in sufficient detail to ensure that enrollees understand the benefits to which they are entitled;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(6)">(6)</span> The availability of behavioral health services that are not included in the MCOs benefits package, and how to access these services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(7)">(7)</span> Information on the availability of self-referral services as well as any restrictions on the enrollee's freedom of choice among network providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(8)">(8)</span> Information about how enrollees may obtain benefits from out-of-network providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(9)">(9)</span> Any policies and procedures necessary to facilitate accessing needed services in compliance with the Maryland Medicaid Managed Care Program, including any requirements for service authorizations or referrals for specialty care and for other benefits not furnished by the enrollee's primary care provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(10)">(10)</span> Information about the availability of EPSDT, prenatal care, family planning, and other wellness services, including education programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(11)">(11)</span> A statement that the MCO cannot require an enrollee to obtain a referral before choosing a family planning provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(12)">(12)</span> The process of selecting and changing the enrollee's primary care provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(13)">(13)</span> A description of any benefits the MCO offers in addition to those required by the Maryland Medicaid Managed Care Program, including applicable terms and conditions for accessing those benefits;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(14)">(14)</span> Information on how to access auxiliary aids and services, including additional information in alternative formats or languages;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(15)">(15)</span> The toll-free telephone number for member services, medical management, and any other unit providing services directly to enrollees, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(15)(a)">(a)</span> A description of each unit and number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(15)(b)">(b)</span> An explanation of how the phone numbers can be used to obtain information and assistance; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(15)(c)">(c)</span> An explanation of the MCOs internal grievance procedure.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(16)">(16)</span> Information regarding the importance of scheduling and maintaining appointments for preventive services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(17)">(17)</span> If applicable, a list of services that are not covered by the MCO because of moral or religious objections, and a statement that informs the enrollee that the State will provide information on how and where to obtain these services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(18)">(18)</span> The rule pertaining to poststabilization care services, as set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.05.08#G" title="">Regulation .08G of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(19)">(19)</span> Appeal, grievance, and fair hearing procedures and time frames that include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(19)(a)">(a)</span> The right to a State fair hearing, including the method for obtaining a hearing and the rules that govern representation at the hearing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(19)(b)">(b)</span> The right to file appeals and grievances;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(19)(c)">(c)</span> The requirements and time frames for filing an appeal or grievance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(19)(d)">(d)</span> The availability of assistance in the filing process;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(19)(e)">(e)</span> The toll-free numbers that the enrollee may use to file an appeal or grievance by phone;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(19)(f)">(f)</span> The fact that, if requested by the enrollee, the benefits will continue if the enrollee files an appeal or a request for a State fair hearing within the time frames specified for filing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(19)(g)">(g)</span> That the enrollee may be required to pay the cost of the services furnished while the appeal is pending, if the final decision is adverse to the enrollee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(20)">(20)</span> Any appeal rights the State chooses to make available to providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(21)">(21)</span> Advanced directives as set forth in 42 CFR §438.3(j)(1), as amended;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(22)">(22)</span> Information on how to report suspected fraud or abuse;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(23)">(23)</span> Additional information that is available upon request, including the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(23)(a)">(a)</span> Information on the structure and operation of the MCO; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(23)(b)">(b)</span> Physician incentive plans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#B(24)">(24)</span> Information on how to access or obtain the MCOs provider directory.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C">C.</span> Provider Directory.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)">(1)</span> An MCO shall provide enrollees with information regarding their provider networks including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(a)">(a)</span> Its primary care service locations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(b)">(b)</span> A listing of the MCOs hospital providers, of both inpatient and outpatient services, in the enrollee's county, their addresses, and services provided;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(c)">(c)</span> A listing of the MCOs pharmacy providers in the enrollee's county and their addresses; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)">(d)</span> A listing of the individual practitioners who are the MCOs primary and specialty care providers in the enrollee's county, grouped by medical specialty, giving:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(ii)">(ii)</span> Address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(iii)">(iii)</span> Practice location or locations;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(iv)">(iv)</span> Telephone number or numbers;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(v)">(v)</span> Website URL, as appropriate;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(vi)">(vi)</span> Any group affiliation, as appropriate;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(vii)">(vii)</span> Cultural and linguistic capabilities, including languages offered by the provider or a skilled medical interpreter at the provider’s offices, American Sign Language interpretation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(viii)">(viii)</span> An indication of whether the provider's office or facility has accommodations for physical disabilities, including offices, exam room or rooms and equipment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(ix)">(ix)</span> An indication of whether or not the provider is accepting new patients;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(x)">(x)</span> An indication of the age range of patients accepted or whether there is no age limit; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(1)(d)(xi)">(xi)</span> If applicable, how access to the provider is otherwise limited.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#C(2)">(2)</span> Upon request by an enrollee, an MCO shall furnish a paper copy of the provider directory.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#D">D.</span> An MCO shall notify all enrollees of their right to request and obtain the information listed in §§B and C of this regulation at least once a year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#E">E.</span> The Department may consider the information listed in §§B and C of this regulation to be provided if the MCO:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#E(1)">(1)</span> Mails a printed copy of the information to the enrollee's mailing address;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#E(2)">(2)</span> Provides the information by email after obtaining the enrollee's agreement to receive the information by email;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#E(3)">(3)</span> Posts the information on the MCOs website and advises the enrollee in paper or electronic form that the information is available on the internet and includes the applicable internet address, provided that enrollees with disabilities who cannot access this information online are provided auxiliary aids and services upon request at no cost; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#E(4)">(4)</span> Provides the information by any other method that can reasonably be expected to result in the enrollee receiving that information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#F">F.</span> An MCO shall update its online provider directory no later than 30 days after the MCO receives updated provider information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#G">G.</span> An MCO shall update its paper directory:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#G(1)">(1)</span> Monthly if the MCO does not have a mobile-enabled electronic directory; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#G(2)">(2)</span> Quarterly if the MCO has a mobile-enabled electronic directory.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.02#H">H.</span> An MCO shall make provider directories available on its website in a machine-readable file and format as specified by the Secretary for the U.S. Department of Health and Human Services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.03" data-order="|10|67|05|.03|" data-ref-path="10|67|05|.03" class="h__section">.03 Access Standards: Outreach.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#A">A.</span> An MCO is responsible for delivering needed health care services even when the enrollee is difficult to reach or misses appointments.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#B">B.</span> The assistance of local health departments in contacting and bringing into care enrollees who are difficult to reach or miss appointments is available for the specific categories of enrollees identified in this regulation, but only after the MCO has made documented attempts to contact and bring into care an enrollee who is difficult to reach or misses appointments before seeking the assistance of the local health department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#C">C.</span> Adults.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#C(1)">(1)</span> An MCO shall, before referring the enrollee to the local health department, make documented attempts to ensure that follow-up appointments are scheduled in accordance with the enrollee's treatment plan by attempting a variety of contact methods, which may include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#C(1)(a)">(a)</span> Written correspondence;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#C(1)(b)">(b)</span> Telephone contact; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#C(1)(c)">(c)</span> Face-to-face contact.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#C(2)">(2)</span> If the enrollee, due to impaired cognitive ability or psychosocial problems such as homelessness or other conditions, can be expected to have difficulty understanding the importance of treatment instructions or difficulty navigating the health care system, the MCO shall, after exhausting its best efforts to contact and bring into care the enrollee in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.05.03#C(1)" title="">§C(1) of this regulation</a>, make, or ensure that the enrollee's provider makes, a written referral to the local health department for its assistance within 10 business days of whichever first occurs:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#C(2)(a)">(a)</span> The third consecutive missed appointment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#C(2)(b)">(b)</span> The MCO or the enrollee's provider identifies the enrollee's repeated noncompliance with a regimen of care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D">D.</span> Child Younger than 2 Years Old Needing EPSDT Screening Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D(1)">(1)</span> An MCO shall ensure that appointments are scheduled in accordance with the EPSDT periodicity schedule or within 30 days of the MCO's receipt of the health risk assessment, whichever is less.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D(2)">(2)</span> If the enrollee fails to keep the appointment, the MCO shall ensure that a second appointment is scheduled within 30 days.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D(3)">(3)</span> If the enrollee misses the second appointment, a third appointment shall be scheduled within 30 days.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D(4)">(4)</span> For each scheduled appointment, the MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D(4)(a)">(a)</span> Provide written notice to the enrollee's parent, guardian, or caretaker of the appointment dates; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D(4)(b)">(b)</span> Attempt to notify the enrollee's parent, guardian, or caretaker of the appointment dates by telephone.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D(5)">(5)</span> If the enrollee misses the second appointment in a row, after the MCO has made the notification attempts required by <a class="internal-link " href="/us/md/exec/comar/10.67.05.03#C(1)" title="">§C(1) of this regulation</a>, the MCO shall, within 10 business days, make, or ensure that the enrollee's provider makes, a written referral to the local health department for its assistance in bringing the enrollee into care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#D(6)">(6)</span> After referral to the local health department, the MCO shall continue to work collaboratively with the local health department to bring the enrollee into care until the enrollee comes back into compliance with the EPSDT periodicity schedule.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#E">E.</span> Child Younger than 21 Years Old Needing Follow-up Treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#E(1)">(1)</span> An MCO shall ensure that an appointment for follow-up care is scheduled at a time interval appropriate to the enrollee's diagnosed condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#E(2)">(2)</span> If the enrollee fails to keep the appointment, the MCO shall reschedule the appointment for the enrollee to be seen within 30 days.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#E(3)">(3)</span> For each scheduled appointment, the MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#E(3)(a)">(a)</span> Provide written notice to the enrollee, or to the enrollee's parent, guardian, or caretaker, as appropriate, of the appointment dates by mail; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#E(3)(b)">(b)</span> Attempt to notify the enrollee, or the enrollee's parent, guardian, or caretaker, as appropriate, of the appointment dates by telephone.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#E(4)">(4)</span> If the enrollee misses the second consecutive follow-up appointment after the MCO has made the notification attempts required by <a class="internal-link " href="/us/md/exec/comar/10.67.05.03#C(1)" title="">§C(1) of this regulation</a>, the MCO shall, within 10 business days, make, or ensure that the enrollee's provider makes, a written referral to the local health department for its assistance in bringing the enrollee into care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#E(5)">(5)</span> After referral to the local health department, the MCO shall work collaboratively with the local health department to bring the enrollee into care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#F">F.</span> Pregnant or Postpartum Woman Needing Prenatal or Postpartum Care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#F(1)">(1)</span> Initial Visit. An MCO shall schedule an initial visit for the pregnant or postpartum enrollee to be seen within 10 days of her request for an appointment. If she fails to appear for the appointment, the MCO shall reschedule in a timely manner appropriate to her medical condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#F(2)">(2)</span> Follow-Up Appointments. After the enrollee has completed an initial visit that includes a comprehensive history, physical exam, and completion of the Maryland Prenatal Risk Assessment, the MCO shall ensure that appointments are scheduled for the enrollee in compliance with the periodicity schedule of the ACOG guidelines. If the enrollee fails to appear for a scheduled appointment, the MCO shall ensure that the appointment is rescheduled for the enrollee to be seen within 10 days.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#F(3)">(3)</span> For each scheduled appointment, the MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#F(3)(a)">(a)</span> Provide written notice to the enrollee of the appointment dates; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#F(3)(b)">(b)</span> Attempt to notify the enrollee of the appointment dates by telephone.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#F(4)">(4)</span> After making the attempts specified in <a class="internal-link " href="/us/md/exec/comar/10.67.05.03#F(3)" title="">§F(3) of this regulation</a>, if the MCO is unable to bring the enrollee into care within 30 days of the first missed appointment, the MCO shall, within 10 days of the last missed appointment, make, or ensure that the enrollee's provider makes, a written referral to the local health department for its assistance in bringing the enrollee into care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.03#F(5)">(5)</span> After referral to the local health department, the MCO shall work collaboratively with the local health department to bring the patient into care, until the enrollee comes back in compliance with the ACOG periodicity schedule.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.04" data-order="|10|67|05|.04|" data-ref-path="10|67|05|.04" class="h__section">.04 Access Standards: Information for Providers.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A">A.</span> An MCO shall develop and make available either electronically or by hard copy to all of its PCP and specialty care providers a Medicaid requirements manual, including periodic updates as appropriate, and shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(1)">(1)</span> Before distribution, file a copy of its manual with the Department for review;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(2)">(2)</span> Include in its manual the information necessary to facilitate the providers’ full compliance with federal and State Medicaid requirements, including information on:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(2)(a)">(a)</span> Medicaid statutes and regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(2)(b)">(b)</span> The benefits package, including optional benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(2)(c)">(c)</span> Access requirements, which, at a minimum, comply with the requirements of this chapter;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(2)(d)">(d)</span> Quality requirements, which shall, at a minimum, comply with the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03" title=".03 Quality Assessment and Improvement.">COMAR 10.67.04.03</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(2)(e)">(e)</span> Continuity of care requirements;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(2)(f)">(f)</span> Requirements for referral to specialist, ancillary, and other providers as necessary to provide the full range of medically necessary services that are covered by the Maryland Medicaid Managed Care Program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(2)(g)">(g)</span> The MCO’s practice guidelines as described in 42 CFR §438.236.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)">(3)</span> Inform the MCO’s primary and specialty care providers of their responsibility to provide or arrange for medically necessary accessible health care services that are continuous, comprehensive, and coordinated for each enrollee, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(a)">(a)</span> Preventive health services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(b)">(b)</span> Primary acute medical care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(c)">(c)</span> Chronic medical care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(d)">(d)</span> Consultation, referral, and follow-up in areas including medical specialties and child dental care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(e)">(e)</span> Referral for ancillary and support-related services including but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(e)(i)">(i)</span> Drug therapies;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(e)(ii)">(ii)</span> Diagnostic tests;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(e)(iii)">(iii)</span> Medical supplies;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(e)(iv)">(iv)</span> Durable medical equipment; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(e)(v)">(v)</span> Case management when appropriate for complex conditions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(f)">(f)</span> 24-hour per day, 7-day per week provider coverage for medically necessary services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(g)">(g)</span> Maintenance of a medical record, including records of referral arrangements and outcomes of those referrals; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(3)(h)">(h)</span> Detection of mental health problems or substance use disorder during routine or follow-up screening, to be treated either through the MCO or referred to the behavioral health ASO for services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(4)">(4)</span> Inform the providers of the following enrollee appeal, grievance, and fair hearing procedures and time frames:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(4)(a)">(a)</span> The enrollee's right to a State fair hearing, how to obtain a hearing, and representation rules at a hearing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(4)(b)">(b)</span> The enrollee's right to file appeals and grievances, and the enrollee's requirements and time frames for filing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(4)(c)">(c)</span> The availability of assistance in filing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(4)(d)">(d)</span> The toll-free numbers to file verbal appeals and grievances;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(4)(e)">(e)</span> The enrollee's right to request continuation of benefits during an appeal or State fair hearing filing, and that if the MCO action is upheld in a hearing, the enrollee may be liable for the cost of any continued benefits; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#A(4)(f)">(f)</span> The provider's right to appeal, on the enrollee's behalf, the failure of the MCO to cover a service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#B">B.</span> An MCO shall ensure that its PCP and specialty care providers receive adequate information regarding the Medicaid Program to facilitate full compliance with all federal and State Medicaid requirements. The MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#B(1)">(1)</span> Ensure that each PCP and specialty care provider receives, at the time they enter into a contract, a copy of the MCO's Medicaid requirements manual, and any other pertinent information; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#B(2)">(2)</span> Provide each PCP and specialty care provider, on an ongoing basis as appropriate, with periodic updates of the materials required to be provided under <a class="internal-link " href="/us/md/exec/comar/10.67.05.04#B(1)" title="">§B(1) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.04#C">C.</span> An MCO shall provide to each PCP an updated list of the PCP’s assigned enrollees monthly.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.05" data-order="|10|67|05|.05|" data-ref-path="10|67|05|.05" class="h__section">.05 Access Standards: PCPs and MCO's Provider Network.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A">A.</span> Primary Care Provider (PCP).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(1)">(1)</span> An MCO shall assign each enrollee to a primary care provider who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(1)(a)">(a)</span> Chosen by the enrollee from the MCO's panel of qualified providers; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(1)(b)">(b)</span> Chosen by the MCO from its panel of qualified providers if the enrollee has failed to choose a PCP.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(2)">(2)</span> An enrollee may request a change of PCP at any time if the PCP is within the recipient's current MCO's panel of providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(3)">(3)</span> With respect to enrollees younger than 21 years old, an MCO shall assign the enrollee to a PCP who is certified by the EPSDT program, unless the enrollee or the enrollee's parent, guardian, or caretaker, as appropriate, specifically requests assignment to a PCP who is not EPSDT-certified.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(4)">(4)</span> If the enrollee’s parent, guardian, or caretaker, as appropriate, chooses a non-EPSDT certified PCP in accordance to <a class="internal-link " href="/us/md/exec/comar/10.67.05.05#A(3)" title="">§A(3) of this regulation</a>, within 30 days of enrollment, the MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(4)(a)">(a)</span> Notify the parent, guardian, or caretaker, by letter, that a non-EPSDT certified PCP has been chosen; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(4)(b)">(b)</span> Include in the notification an explanation of the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(4)(b)(i)">(i)</span> EPSDT preventive screening services to which an enrollee is entitled according to the EPSDT periodicity schedule;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(4)(b)(ii)">(ii)</span> Importance of accessing the EPSDT preventive screening services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(4)(b)(iii)">(iii)</span> Process for requesting a change to an EPSDT-certified PCP to obtain preventive screening services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)">(5)</span> An MCO may include, as appropriate, any of the following practitioners to serve as the primary care provider for an enrollee:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(a)">(a)</span> General practitioner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(b)">(b)</span> Family practitioner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(c)">(c)</span> Internist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(d)">(d)</span> Pediatrician;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(e)">(e)</span> OB/GYN;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(f)">(f)</span> Physician assistant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(g)">(g)</span> Certified nurse midwife;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(h)">(h)</span> Nurse practitioner certified in any of the following areas of specialization:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(h)(i)">(i)</span> Adult;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(h)(ii)">(ii)</span> Pediatric;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(h)(iii)">(iii)</span> Geriatric;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(h)(iv)">(iv)</span> OB/GYN;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(h)(v)">(v)</span> School nurse; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(h)(vi)">(vi)</span> Family; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(5)(i)">(i)</span> A physician practicing in a specialty area other than those enumerated in §A(5)(b)—(e) of this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(6)">(6)</span> The enrollee's designated primary care provider (PCP) is the enrollee's primary coordinator of care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#A(7)">(7)</span> For female enrollees, if the enrollee's PCP is not a women's health specialist, the MCO shall provide direct access, without the need for a referral, to a women's health specialist within the MCO's network for covered services necessary to provide women's routine and preventive health care services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B">B.</span> Adequacy of Provider Network.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(1)">(1)</span> An MCO shall develop and maintain a complete network of adult and pediatric primary care, specialty care, ancillary service, vision, pharmacy, home health, and any other providers adequate to deliver the full scope of benefits as required by this chapter and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(2)">(2)</span> An MCO shall clearly define and specify referral requirements to specialty and other providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(3)">(3)</span> An MCO shall require the PCP to maintain records of referral arrangements, and the feedback and outcomes of those referrals, within each enrollee's medical records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(4)">(4)</span> An MCO shall maintain a list of its proposed and existing subcontracts with health care providers who are necessary to fulfill the MCO's service delivery obligations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(5)">(5)</span> An MCO shall provide a list of its subcontractor providers to the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(6)">(6)</span> An MCO shall ensure services are delivered in a culturally competent manner to all enrollees, including enrollees:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(6)(a)">(a)</span> With limited English proficiency;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(6)(b)">(b)</span> With diverse cultural and ethnic backgrounds; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(6)(c)">(c)</span> Of all genders, sexual orientations, and gender identities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(7)">(7)</span> For enrollees with physical or mental disabilities, an MCO shall ensure its network providers provide:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(7)(a)">(a)</span> Physical access;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(7)(b)">(b)</span> Reasonable accommodation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(7)(c)">(c)</span> Accessible equipment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(8)">(8)</span> Capacity.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(8)(a)">(a)</span> MCOs shall ensure adequate capacity and services, in compliance with 42 CFR §438.206(b)(1)(i), as amended.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(8)(b)">(b)</span> The Department shall assess the MCO's provider network and determine its capacity to serve waiver-eligible recipients in each local access area in its service area.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(8)(c)">(c)</span> Unless the MCO can establish to the Department's satisfaction the adequacy of a higher ratio, the Department shall determine the MCO's capacity with respect to any local access area by assuming that in-plan individual practitioners, based on full-time equivalency, will be assigned no more than the number of enrollees that is consistent with a 200:1 ratio of enrollee to practitioner in the local access area.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(8)(d)">(d)</span> The Department may not approve an enrollee-to-PCP ratio that is higher than 2,000:1.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(9)">(9)</span> To ensure compliance with the timely access requirements in <a class="internal-link " href="/us/md/exec/comar/10.67.05.07" title=".07 Access Standards: Clinical and Pharmacy Access.">Regulation .07 of this chapter</a>, an MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(9)(a)">(a)</span> Establish mechanisms to ensure that network providers comply with access requirements;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(9)(b)">(b)</span> Monitor regularly to determine compliance; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05#B(9)(c)">(c)</span> Take corrective action if there is a failure to comply.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.05-1" data-order="|10|67|05|.05-1|" data-ref-path="10|67|05|.05-1" class="h__section">.05-1 Access Standards: Specialty Provider Network.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A">A.</span> Standards and Regions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(1)">(1)</span> The Department shall review an MCOs specialty provider network for MCOs overall network as defined in this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)">(2)</span> Overall Network Standards.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(a)">(a)</span> An MCO shall meet either the time or distance standard set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.05.06#A" title="">Regulation .06A of this chapter</a> for core, major, and pediatric specialties.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)">(b)</span> The nine core specialties are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(i)">(i)</span> Cardiology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(ii)">(ii)</span> Otolaryngology (ENT);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(iii)">(iii)</span> Gastroenterology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(iv)">(iv)</span> Neurology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(v)">(v)</span> Oncology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(vi)">(vi)</span> Ophthalmology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(vii)">(vii)</span> Orthopedics;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(viii)">(viii)</span> Surgery; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(b)(ix)">(ix)</span> Urology.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(c)">(c)</span> The 6 major specialties are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(c)(i)">(i)</span> Allergy and immunology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(c)(ii)">(ii)</span> Dermatology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(c)(iii)">(iii)</span> Endocrinology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(c)(iv)">(iv)</span> Infectious disease;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(c)(v)">(v)</span> Nephrology; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(c)(vi)">(vi)</span> Pulmonology.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(d)">(d)</span> The 4 pediatric subspecialties are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(d)(i)">(i)</span> Cardiology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(d)(ii)">(ii)</span> Gastroenterology;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(d)(iii)">(iii)</span> Neurology; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#A(2)(d)(iv)">(iv)</span> Surgery.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#B">B.</span> If the Department determines that an MCO does not meet the requirements specified in §A(2)(b)(d) of this regulation, the MCO may provide additional information to support the adequacy of the MCO's specialty network before any action is taken by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.05-1#C">C.</span> If an MCO fails to meet the requirements established by this regulation, the Department may suspend the automatic assignment to the MCO of recipients who live in the affected local access area.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.06" data-order="|10|67|05|.06|" data-ref-path="10|67|05|.06" class="h__section">.06 Geographical Access.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A">A.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.05.06#C" title="">§C of this regulation</a>, an MCO shall develop and maintain a provider network that meets the following time and distance standards:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(1)">(1)</span> For adult and pediatric primary care, pharmacy, diagnostic laboratory and x-ray, and gynecology:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(1)(a)">(a)</span> In urban areas, within 15 minutes or 10 miles;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(1)(b)">(b)</span> In suburban areas, within 30 minutes or 20 miles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(1)(c)">(c)</span> In rural areas, within 40 minutes or 30 miles;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(2)">(2)</span> For prenatal care, as defined in <a class="internal-link " href="/us/md/exec/comar/10.67.05.06#B" title="">§B of this regulation</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(2)(a)">(a)</span> In urban areas, within 15 minutes or 10 miles;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(2)(b)">(b)</span> In suburban areas, within 30 minutes or 20 miles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(2)(c)">(c)</span> In rural areas, within 90 minutes or 75 miles;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(3)">(3)</span> For acute inpatient hospitals:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(3)(a)">(a)</span> In urban areas, within 20 minutes or 10 miles;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(3)(b)">(b)</span> In suburban areas, within 45 minutes or 30 miles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(3)(c)">(c)</span> In rural areas, within 75 minutes or 60 miles;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(4)">(4)</span> For core specialty types, as defined in Regulation .05-1A(2)(b) of this chapter:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(4)(a)">(a)</span> In urban areas, within 30 minutes or 15 miles;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(4)(b)">(b)</span> In suburban areas, within 60 minutes or 45 miles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(4)(c)">(c)</span> In rural areas, within 90 minutes or 75 miles;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(5)">(5)</span> For major specialty types, as defined in Regulation .05-1A(2)(c) of this chapter:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(5)(a)">(a)</span> In urban areas, within 30 minutes or 15 miles;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(5)(b)">(b)</span> In suburban areas, within 80 minutes or 60 miles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(5)(c)">(c)</span> In rural areas, within 110 minutes or 90 miles; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(6)">(6)</span> For pediatric subspecialty types, as defined in Regulation .05-1A(2)(d) of this chapter:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(6)(a)">(a)</span> In urban areas, within 30 minutes or 15 miles;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(6)(b)">(b)</span> In suburban areas, within 80 minutes or 60 miles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#A(6)(c)">(c)</span> In rural areas, within 250 minutes or 200 miles.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#B">B.</span> Prenatal Care Providers. For the purposes of provider network adequacy, prenatal care providers may include, but are not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#B(1)">(1)</span> Obstetricians;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#B(2)">(2)</span> Certified nurse midwives; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#B(3)">(3)</span> Family practitioners who provide prenatal care and perform deliveries.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#C">C.</span> If an MCO can otherwise demonstrate to the Department's satisfaction the adequacy of its provider network notwithstanding its inability to meet the requirements of <a class="internal-link " href="/us/md/exec/comar/10.67.05.06#A" title="">§A of this regulation</a>, the Department may, in its discretion, approve the network if special circumstances exist which, considered along with the overall strength of the MCO's network, establish that the Department's approval of the network will enhance recipients' overall access to quality health care services in the area to be served.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#D">D.</span> Geographical Access: Local Access Areas.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>Local Access Area</th>
                        <th>Zip Codes</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td>Allegany</td>
                        <td>21501, 21502, 21503, 21504, 21505, 21521, 21523, 21524, 21528, 21529, 21530, 21532, 21539, 21540, 21542, 21543, 21545, 21546, 21555, 21556, 21557, 21560, 21562, 21766</td>
                      </tr>
                      <tr>
                        <td>Anne Arundel North</td>
                        <td>20701, 20724, 20755, 21056, 21060, 21061, 21076, 21077, 21090, 21108, 21113, 21122, 21123, 21144, 21240</td>
                      </tr>
                      <tr>
                        <td>Anne Arundel South</td>
                        <td>20711, 20733, 20751, 20764, 20765, 20776, 20778, 20779, 21012, 21032, 21035, 21037, 21054, 21106, 21114, 21140, 21146, 21401, 21402, 21403, 21404, 21405, 21409</td>
                      </tr>
                      <tr>
                        <td>Baltimore City SE/Dundalk</td>
                        <td>21052, 21219, 21222, 21224, 21281</td>
                      </tr>
                      <tr>
                        <td>Baltimore City East</td>
                        <td>21202, 21203, 21205, 21213, 21231, 21287</td>
                      </tr>
                      <tr>
                        <td>Baltimore City North Central</td>
                        <td>21210, 21211, 21218</td>
                      </tr>
                      <tr>
                        <td>Baltimore City Northeast</td>
                        <td>21206, 21212, 21214, 21239</td>
                      </tr>
                      <tr>
                        <td>Baltimore City Northwest</td>
                        <td>21208, 21209, 21215, 21270</td>
                      </tr>
                      <tr>
                        <td>Baltimore City South</td>
                        <td>21225, 21226, 21230</td>
                      </tr>
                      <tr>
                        <td>Baltimore City West</td>
                        <td>21201, 21216, 21217, 21223</td>
                      </tr>
                      <tr>
                        <td>Baltimore County East</td>
                        <td>21021, 21022, 21027, 21051, 21087, 21128, 21156, 21162, 21220, 21221, 21236, 21237</td>
                      </tr>
                      <tr>
                        <td>Baltimore County North</td>
                        <td>21013, 21023, 21030, 21031, 21053, 21057, 21082, 21092, 21093, 21094, 21105, 21111, 21120, 21131, 21139, 21152, 21153, 21155, 21161, 21204, 21234, 21284, 21285, 21286</td>
                      </tr>
                      <tr>
                        <td>Baltimore County Northwest</td>
                        <td>21055, 21071, 21117, 21133, 21136, 21163, 21207, 21244, 21282</td>
                      </tr>
                      <tr>
                        <td>Baltimore County Southwest</td>
                        <td>21227, 21228, 21229</td>
                      </tr>
                      <tr>
                        <td>Calvert</td>
                        <td>20610, 20615, 20629, 20639, 20657, 20676, 20678, 20685, 20688, 20689, 20714, 20732, 20736, 20754, 20758</td>
                      </tr>
                      <tr>
                        <td>Caroline</td>
                        <td>21609, 21629, 21632, 21636, 21639, 21640, 21641, 21649, 21655, 21660, 21670</td>
                      </tr>
                      <tr>
                        <td>Carroll</td>
                        <td>21020, 21048, 21074, 21088, 21102, 21104, 21157, 21158, 21757, 21771, 21776, 21784, 21787, 21791</td>
                      </tr>
                      <tr>
                        <td>Cecil</td>
                        <td>21901, 21902, 21903, 21904, 21911, 21912, 21913, 21914, 21915, 21916, 21917, 21918, 21919, 21920, 21921, 21922, 21930</td>
                      </tr>
                      <tr>
                        <td>Charles</td>
                        <td>20601, 20602, 20603, 20604, 20611, 20612, 20616, 20617, 20622, 20625, 20632, 20637, 20640, 20643, 20645, 20646, 20658, 20661, 20662, 20664, 20675, 20677, 20682, 20693, 20695</td>
                      </tr>
                      <tr>
                        <td>Dorchester</td>
                        <td>21613, 21622, 21626, 21627, 21631, 21634, 21643, 21648, 21659, 21664, 21669, 21672, 21675, 21677, 21835, 21869</td>
                      </tr>
                      <tr>
                        <td>Frederick</td>
                        <td>21701, 21702, 21703, 21704, 21705, 21710, 21714, 21716, 21717, 21718, 21727, 21754, 21755, 21758, 21759, 21762, 21769, 21770, 21773, 21774, 21775, 21777, 21778, 21780, 21788, 21790, 21792, 21793, 21798</td>
                      </tr>
                      <tr>
                        <td>Garrett</td>
                        <td>21520, 21522, 21531, 21536, 21538, 21541, 21550, 21561</td>
                      </tr>
                      <tr>
                        <td>Harford East</td>
                        <td>21001, 21005, 21017, 21018, 21024, 21028, 21034, 21078, 21130</td>
                      </tr>
                      <tr>
                        <td>Harford West</td>
                        <td>21009, 21010, 21014, 21015, 21040, 21047, 21050, 21084, 21085, 21101, 21132, 21154, 21160</td>
                      </tr>
                      <tr>
                        <td>Howard County</td>
                        <td>20723, 20759, 20763, 20777, 20794, 21029, 21036, 21041, 21042, 21043, 21044, 21045, 21046, 21150, 21723, 21737, 21738, 21765, 21794, 21797</td>
                      </tr>
                      <tr>
                        <td>Kent</td>
                        <td>21610, 21620, 21635, 21637, 21645, 21646, 21650, 21661, 21667, 21678</td>
                      </tr>
                      <tr>
                        <td>Montgomery Mid-County</td>
                        <td>20812, 20813, 20814, 20815, 20816, 20817, 20818, 20824, 20825, 20827, 20830, 20832, 20833, 20848, 20849, 20850, 20851, 20852, 20853, 20854, 20855, 20857, 20859, 20889, 20891, 20892, 20895, 20896</td>
                      </tr>
                      <tr>
                        <td>Montgomery North</td>
                        <td>20837, 20838, 20839, 20841, 20842, 20847, 20871, 20872, 20874, 20875, 20876, 20877, 20878, 20879, 20880, 20882, 20883, 20884, 20885, 20886, 20898, 20997</td>
                      </tr>
                      <tr>
                        <td>Montgomery - Silver Spring</td>
                        <td>20860, 20861, 20862, 20866, 20868, 20901, 20902, 20903, 20904, 20905, 20906, 20907, 20908, 20910, 20911, 20912, 20913, 20914, 20915, 20916, 20918, 20990</td>
                      </tr>
                      <tr>
                        <td>Prince George's Northeast</td>
                        <td>20704, 20705, 20707, 20708, 20709, 20715, 20716, 20717, 20718, 20719, 20720, 20721, 20725, 20726, 20769</td>
                      </tr>
                      <tr>
                        <td>Prince George's Northwest</td>
                        <td>20703, 20706, 20710, 20712, 20722, 20731, 20737, 20738, 20740, 20741, 20742, 20743, 20768, 20770, 20771, 20780, 20781, 20782, 20783, 20784, 20785, 20787, 20788, 20789, 20791, 20792, 20797, 20799</td>
                      </tr>
                      <tr>
                        <td>Prince George's Southeast</td>
                        <td>20608, 20613, 20623, 20735, 20762, 20772, 20773, 20774, 20775</td>
                      </tr>
                      <tr>
                        <td>Prince George's Southwest</td>
                        <td>20607, 20744, 20745, 20746, 20747, 20748, 20749, 20750, 20752, 20753, 20757, 20790</td>
                      </tr>
                      <tr>
                        <td>Queen Anne's</td>
                        <td>21607, 21617, 21619, 21623, 21628, 21638, 21644, 21651, 21656, 21657, 21658, 21666, 21668</td>
                      </tr>
                      <tr>
                        <td>Somerset</td>
                        <td>21816, 21817, 21820, 21821, 21824, 21836, 21838, 21853, 21857, 21866, 21867, 21686, 21870, 21871, 21890</td>
                      </tr>
                      <tr>
                        <td>St. Mary's</td>
                        <td>20606, 20609, 20618, 20619, 20620, 20621, 20624, 20626, 20627, 20628, 20630, 20634, 20635, 20636, 20650, 20653, 20656, 20659, 20660, 20667, 20670, 20674, 20680, 20684, 20686, 20687, 20690, 20692</td>
                      </tr>
                      <tr>
                        <td>Talbot</td>
                        <td>21601, 21612, 21624, 21625, 21647, 21652, 21653, 21654, 21662, 21663, 21665, 21671, 21673, 21676, 21679</td>
                      </tr>
                      <tr>
                        <td>Washington</td>
                        <td>21711, 21713, 21715, 21719, 21720, 21721, 21722, 21733, 21734, 21740, 21741, 21742, 21746, 21750, 21756, 21767, 21779, 21781, 21782, 21783, 21795</td>
                      </tr>
                      <tr>
                        <td>Wicomico</td>
                        <td>21801, 20802, 21803, 21804, 21810, 21814, 21822, 21826, 21830, 21837, 21840, 21849, 21850, 21852, 21856, 21861, 21865, 21874, 21875</td>
                      </tr>
                      <tr>
                        <td>Worcester</td>
                        <td>21811, 21813, 21829, 21841, 21842, 21843, 21851, 21862, 21863, 21864, 21872</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E">E.</span> For purposes of this regulation:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(1)">(1)</span> Urban enrollment area includes Baltimore City;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)">(2)</span> Rural enrollment counties include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(a)">(a)</span> Allegany;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(b)">(b)</span> Calvert;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(c)">(c)</span> Caroline;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(d)">(d)</span> Cecil;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(e)">(e)</span> Charles;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(f)">(f)</span> Dorchester;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(g)">(g)</span> Frederick;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(h)">(h)</span> Garrett;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(i)">(i)</span> Kent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(j)">(j)</span> Queen Anne's;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(k)">(k)</span> Saint Mary's;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(l)">(l)</span> Somerset;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(m)">(m)</span> Talbot;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(n)">(n)</span> Washington;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(o)">(o)</span> Wicomico; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(2)(p)">(p)</span> Worcester; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(3)">(3)</span> Suburban enrollment counties include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(3)(a)">(a)</span> Baltimore County;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(3)(b)">(b)</span> Anne Arundel;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(3)(c)">(c)</span> Carroll;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(3)(d)">(d)</span> Harford;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(3)(e)">(e)</span> Howard;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(3)(f)">(f)</span> Montgomery; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.06#E(3)(g)">(g)</span> Prince George’s.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.07" data-order="|10|67|05|.07|" data-ref-path="10|67|05|.07" class="h__section">.07 Access Standards: Clinical and Pharmacy Access.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A">A.</span> Appointments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(1)">(1)</span> New Enrollees: Initial Appointment.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(1)(a)">(a)</span> On its receipt and review of the health service needs information of a new enrollee, an MCO shall take appropriate action to ensure that the new enrollee who needs special or immediate health care services, as identified by the health service needs information, receives them in a timely manner.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(1)(b)">(b)</span> Unless the new enrollee is assigned to a PCP who was the enrollee’s established provider of care immediately before the enrollee’s enrollment, and, consistent with any applicable periodicity schedule, the PCP concludes that no immediate initial appointment is necessary:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(1)(b)(i)">(i)</span> Unless a shorter time frame otherwise applies, the MCO shall ensure that a new enrollee's initial appointment is scheduled to occur within 90 days of the date of enrollment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(1)(b)(ii)">(ii)</span> Unless the PCP confirms that the enrollee has elected to continue prenatal care with her established provider pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28#C" title="">COMAR 10.67.06.28C</a>, the MCO shall ensure that an initial prenatal appointment is scheduled to occur within 10 days of the date that the MCO receives the enrollee's completed health risk assessment, or within 10 days of the enrollee's request for an appointment, whichever is sooner;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(1)(b)(iii)">(iii)</span> If the new enrollee is a person requesting family planning services, the MCO shall ensure that an initial appointment is scheduled to occur within 10 days of the date of the enrollee's request for an appointment; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(1)(b)(iv)">(iv)</span> If the new enrollee is identified to be at high risk by the health service needs information form, the MCO shall ensure that an initial appointment is scheduled to occur within 15 business days of the MCO’s receipt of the enrollee’s completed health risk assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(2)">(2)</span> Required Notice to Enrollees of Wellness Services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(2)(a)">(a)</span> An MCO shall notify its enrollees in writing of their due dates for obtaining wellness services, including but not limited to immunizations and examinations, in a timely manner.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(2)(b)">(b)</span> An MCO shall perform the notice required in <a class="internal-link " href="/us/md/exec/comar/10.67.05.07#A(2)(a)" title="">§A(2)(a) of this regulation</a> within 90 days of a new enrollee's enrollment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)">(3)</span> Appointment Guidelines.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(a)">(a)</span> An MCO shall develop specific guidelines that define how requests for appointments are arranged, which shall include a policy that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(a)(i)">(i)</span> On request, all family members needing appointments will be given appointment times that are approximately concurrent or consecutive, whenever practicable, to facilitate the enrollees' transportation to and from their appointments; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(a)(ii)">(ii)</span> When needed, enrollees will be afforded assistance in securing transportation to and from appointments, which shall include, when appropriate, contacting the local transportation grantee agency on behalf of the enrollee for the purpose of securing the enrollee's access to these services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)">(b)</span> An MCO shall have procedures that result in an interval between the enrollee's request for an appointment and the actual appointment time being consistent with the following standards:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)(i)">(i)</span> When <a class="internal-link " href="/us/md/exec/comar/10.67.05.07#A(3)(b)(i)" title="">§A(3)(b)(i) of this regulation</a> does not apply, well-child assessments shall be scheduled to be completed within 30 days of the request for an appointment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)(ii)">(ii)</span> Initial assessments of pregnant and postpartum women and individuals requesting family planning services shall be scheduled to be completed within 10 business days of the request for an appointment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)(iii)">(iii)</span> Individuals requesting urgent care shall be scheduled to be seen within 48 hours of the request;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)(iv)">(iv)</span> Requests for routine and preventative primary care appointments shall be scheduled to be performed within 30 days of the request;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)(v)">(v)</span> Requests for routine specialist follow-up appointments shall be scheduled to be performed within 30 days of the initial authorization from the enrollee's primary care provider, or sooner as deemed necessary by the primary care provider, whose office staff shall make the appointment directly with the specialist's office;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)(vi)">(vi)</span> At the discretion of the newborn's PCP, the initial visit for newborns shall be scheduled to be performed within 14 days of discharge from the hospital if no home visit has occurred;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)(vii)">(vii)</span> If a home visit has been provided, the initial visit for newborns shall be scheduled to be performed, at the discretion of the newborn's PCP, within 30 days of discharge from the hospital; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#A(3)(b)(viii)">(viii)</span> Requests for regular optometry, lab, and X-ray appointments shall be scheduled to be performed within 30 days of the request, and within 48 hours of the request for urgent care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#B">B.</span> An MCO shall respond in a timely manner to its enrollees' needs and requests, as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#B(1)">(1)</span> If the enrollee arrives early or on time for a scheduled appointment, waiting time to be seen for a regular office visit may not exceed 1 hour after the scheduled appointment time;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#B(2)">(2)</span> An MCO representative may not leave an enrollee's telephone call on hold for more than 10 minutes; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#B(3)">(3)</span> An MCO representative shall respond to patient inquiries as to whether or not to use emergency facilities within 30 minutes.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C">C.</span> Hours of Access for Clinical Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(1)">(1)</span> An MCO shall establish, or require its subcontractors to establish, a reasonable schedule of operating hours during which its service delivery sites are open to the MCO's enrollees as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(1)(a)">(a)</span> For the MCO's employee and subcontractor providers who are individual practitioners, operating hours shall be at least 20 hours per week and at least 3 days per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(1)(b)">(b)</span> For subcontractors who have contracted with the MCO as a group practice or facility, the operating hours shall be at least 35 hours per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(1)(c)">(c)</span> The distribution of the hours of service shall be consistent with enrollee utilization patterns, but is otherwise at the discretion of the MCO or its subcontractor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(1)(d)">(d)</span> The operating hours may not be less than:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(1)(d)(i)">(i)</span> The hours of operation offered to commercial enrollees; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(1)(d)(ii)">(ii)</span> The hours of operation offered to Medicaid fee-for-service, if the provider serves only Medicaid enrollees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)">(2)</span> Hours of Access for Pharmacy Services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)(a)">(a)</span> An MCO shall establish reasonable hours of access to pharmacy services, including weekend and evening hours, which are equivalent to the hours pharmacy services are generally available in the local access area to the public at large.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)(b)">(b)</span> If the MCO determines that weekend and evening pharmacy hours are not generally available in the local access area, it may request approval from the Department to offer only limited pharmacy hours as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.05.07#C(2)(c)" title="">§C(2)(c) of this regulation</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)(c)">(c)</span> To seek approval to offer limited pharmacy hours, an MCO shall make its request for approval to the Department, and shall include the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)(c)(i)">(i)</span> A specification of the geographical areas where the MCO intends to have limited pharmacy hours;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)(c)(ii)">(ii)</span> An explanation of why only limited pharmacy hours are available in these areas; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)(c)(iii)">(iii)</span> An identification of where its enrollees would have to go to secure prescriptions in the evenings and on weekends.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)(d)">(d)</span> Except as permitted in <a class="internal-link " href="/us/md/exec/comar/10.67.05.07#C(2)(e)" title="">§C(2)(e) of this regulation</a>, an MCO shall ensure that an enrollee receives at the time the prescription is dispensed to the enrollee any medically necessary disposable medical supplies or durable medical equipment needed by the enrollee to administer or monitor the enrollee's prescriptions.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#C(2)(e)">(e)</span> An MCO shall ensure that any disposable supplies or durable medical equipment necessary to administer or monitor an enrollee's prescriptions, if not available at the pharmacy at the time of the dispensing of the prescription, is received in a manner so as not to adversely affect the health of the enrollee, but not later than 24 hours.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#D">D.</span> Clinical Access Outside the MCO's Service Area.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#D(1)">(1)</span> Subject to <a class="internal-link " href="/us/md/exec/comar/10.67.05.07#D(2)" title="">§D(2) of this regulation</a>, an MCO shall be financially responsible for medically necessary emergency services delivered to its enrollees outside of the MCO's service area.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#D(2)">(2)</span> With the exception of emergency services, an MCO may require authorization before treatment for services delivered to its enrollees outside of the MCO's service area.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#D(3)">(3)</span> If the MCO’s provider network is unable to provide necessary services, covered under the contract, to an enrollee, the MCO shall adequately and timely cover these services out of network for as long as the MCO’s provider network is unable to provide them.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.07#E">E.</span> The Department may not impose any fines or other sanctions against an MCO for failure to comply with the waiting time standards in <a class="internal-link " href="/us/md/exec/comar/10.67.05.07#B" title="">§B of this regulation</a> unless there is evidence of a pattern of repeated violations by the MCO.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.08" data-order="|10|67|05|.08|" data-ref-path="10|67|05|.08" class="h__section">.08 Emergency Services Access.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#A">A.</span> An MCO shall develop and maintain policies and procedures for the adequate provision of emergency services for all its enrollees, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#A(1)">(1)</span> Instituting and monitoring a system for responding to enrollees' emergency medical conditions, with provisions for immediate attention to and appropriate disposition of emergency calls; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#A(2)">(2)</span> Informing and educating its enrollees in the procedures to be followed in the event of an emergency, whether within or outside of the MCO's service area.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#B">B.</span> An MCO shall provide medically necessary emergency services 24 hours per day, 7 days per week.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#C">C.</span> An MCO shall maintain an emergency telephone service, with a physician on call, for the purpose of rendering medical advice and authorizing care at other facilities when use of the MCO's own facilities is impractical.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#D">D.</span> An MCO may provide emergency services access through adequate and appropriate triage assessments performed by qualified medical professionals.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#E">E.</span> An MCO shall utilize the trauma triage and transfer protocols established through the Maryland Institute for Emergency Medical Services Systems (MIEMSS) as the basis for directing the severely injured enrollee to the most appropriate level designated trauma center.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#F">F.</span> An MCO shall reimburse, within 30 days of invoice, the undisputed claims of hospital emergency facilities and providers for the following services provided to the MCO's enrollees:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#F(1)">(1)</span> Emergency services, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01.01#B" title="">COMAR 10.67.01.01B</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#F(2)">(2)</span> Medical screening services based on the federal Emergency Medical Treatment and Active Labor Act (EMTALA);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#F(3)">(3)</span> If the MCO authorized, referred, or otherwise instructed the enrollee to use the emergency facility, medically necessary services that are related to the emergency condition, including poststabilization services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#F(4)">(4)</span> If the MCO fails to provide 24 hour access to a physician, medically necessary services that relate to the condition presented and that are provided by the provider in an emergency facility to the enrollee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G">G.</span> Poststabilization Services. The MCO may not require preapproval of, and is financially responsible for, poststabilization services obtained in or outside of the MCO's network and administered to maintain, improve, or resolve the enrollee's stabilized condition if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(1)">(1)</span> The MCO does not respond to a request for a preapproval within 1 hour;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(2)">(2)</span> The MCO cannot be contacted; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(3)">(3)</span> The MCO representative and the treating physician cannot reach an agreement concerning the enrollee's care, and an MCO physician is not available for consultation, in which case:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(3)(a)">(a)</span> The MCO shall give the treating physician the opportunity to consult with an MCO physician; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(3)(b)">(b)</span> The treating physician may continue care of the patient until a plan is reached or one of the following criteria is met:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(3)(b)(i)">(i)</span> An MCO physician with privileges at the treating hospital assumes responsibility for the enrollee's care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(3)(b)(ii)">(ii)</span> An MCO physician assumes responsibility for the enrollee's care through transfer;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(3)(b)(iii)">(iii)</span> An MCO representative and the treating physician reach an agreement concerning the enrollee's care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#G(3)(b)(iv)">(iv)</span> The enrollee is discharged.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#H">H.</span> An MCO may require that any continuing care be obtained from the MCO's providers or from providers approved by the MCO when the following conditions are satisfied:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#H(1)">(1)</span> The enrollee's medical condition is appropriately stabilized and permits transferring responsibility for the enrollee's care, without medically harmful consequences, to these providers; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.05.08#H(2)">(2)</span> The transfer is consistent with the requirements of the federal Emergency Medical Treatment and Active Labor Act (EMTALA).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.05.09" data-order="|10|67|05|.09|" data-ref-path="10|67|05|.09" class="h__section">.09 Access: Hospitals.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.09#A">A.</span> An MCO shall comply with the access standards specified in <a class="internal-link " href="/us/md/exec/comar/10.67.05.06#A" title="">Regulation .06A of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.05.09#B">B.</span> If an MCO’s service area includes a county that is designated as a medically underserved area and there is only one hospital in the county, the MCO shall include the hospital in its network.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.06" data-order="|10|67|06|" data-ref-path="10|67|06" class="h__chapter">Chapter 06 Maryland Medicaid Managed Care Program: Benefits</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01" title=".01 Required Benefits Package — In General.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.30" title=".30 Fertility Preservation.">.30</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730); adopted permanently effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01" title=".01 Required Benefits Package — In General.">Regulation .01</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01" title=".01 Required Benefits Package — In General.">Regulation .01</a> amended effective December 27, 2010 (37:26 Md. R. 1787); February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01#A" title="">Regulation .01A</a> amended effective November 6, 2006 (33:22 Md. R. 1732); February 27, 2017 (44:4	Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01#B" title="">Regulation .01B</a> amended effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01#C" title="">Regulation .01C</a> amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01#C" title="">Regulation .01C</a> amended effective August 16, 2004 (31:16 Md. R. 1255)</p>
                  <p>Regulations .01D, .04, .06, .07B, .10, .13, .21A, and .28 amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01#D" title="">Regulation .01D</a> amended effective December 19, 2005 (32:25 Md. R. 1941); October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.01#G" title="">Regulation .01G</a> adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.02" title=".02 Benefits — Primary Care Services.">Regulation .02</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.03#A" title="">Regulation .03A</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.03#A" title="">Regulation .03A</a> amended effective November 6, 2006 (33:22 Md. R. 1732); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04" title=".04 Benefits — Pharmacy Services.">Regulation .04</a> amended effective December 25, 2000 (27:25 Md. R. 2281); February 18, 2002 (29:3 Md. R. 220); February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04#A" title="">Regulation .04A</a>, C amended effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04#A" title="">Regulation .04A</a>, D amended effective November 6, 2006 (33:22 Md. R. 1732); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04#C" title="">Regulation .04C</a> amended effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04#D" title="">Regulation .04D</a> amended effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04#G" title="">Regulation .04G</a>, H adopted effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.05" title=".05 Benefits — Home Health Services.">Regulation .05</a> amended effective February 18, 2002 (29:3 Md. R. 220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.05#A" title="">Regulation .05A</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.06" title=".06 Benefits — Habilitation Services for Medicaid Expansion Populations">Regulation .06</a> amended as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); amended permanently effective December 25, 2000 (27:25 Md. R. 2281)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.06" title=".06 Benefits — Habilitation Services for Medicaid Expansion Populations">Regulation .06</a> repealed effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.06#A" title="">Regulation .06A</a> amended effective February 2, 2004 (31:2 Md. R. 82); December 20, 2004 (31:25 Md. R. 1790)</p>
                  <p>Regulations .07, .09, .10, and .27 amended as an emergency provision effective July 1, 1997 (24:16 Md. R. 1151); emergency status expired December 31, 1997</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.06" title=".06 Benefits — Habilitation Services for Medicaid Expansion Populations">Regulation .06</a> adopted effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.07" title=".07 Benefits — Inpatient Hospital Services.">Regulation .07</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.07#B" title="">Regulation .07B</a> amended effective December 24, 2012 (39:25 Md. R. 1613); February 27, 2017 (44:4	Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.07#F" title="">Regulation .07F</a> adopted effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.07#F" title="">Regulation .07F</a> amended effective April 10, 2006 (33:73 Md. R. 668)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.07#G" title="">Regulation .07G</a> adopted as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); adopted permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.07#H" title="">Regulation .07H</a> adopted as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.07#I" title="">Regulation .07I</a> adopted effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.08" title=".08 Benefits — Outpatient Hospital Services.">Regulation .08</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.09" title=".09 Benefits — Transplants.">Regulation .09</a> amended effective February 9, 1998 (25:3 Md. R. 144); November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.10" title=".10 Benefits — Substance Abuse Treatment Service — Repealed">Regulation .10</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.10" title=".10 Benefits — Substance Abuse Treatment Service — Repealed">Regulation .10</a> repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .10A amended effective February 2, 2004 (31:2 Md. R. 82); November 6, 2006 (33:22 Md. R. 1732); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p>Regulation .10C amended as an emergency provision effective February 11, 2004 (31:5 Md. R. 445); amended permanently effective April 12, 2004 (31:7 Md. R. 584)</p>
                  <p>Regulation .10C repealed effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.11" title=".11 Benefits — Diagnostic and Laboratory Services.">Regulation .11</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.11#B" title="">Regulation .11B</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.11#B" title="">Regulation .11B</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.12" title=".12 Benefits — Long-Term Care Facility Services.">Regulation .12</a> amended effective February 18, 2002 (29:3 Md. R. 220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.12" title=".12 Benefits — Long-Term Care Facility Services.">Regulation .12</a> amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.12" title=".12 Benefits — Long-Term Care Facility Services.">Regulation .12</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.12" title=".12 Benefits — Long-Term Care Facility Services.">Regulation .12</a> amended effective November 6, 2006 (33:22 Md. R. 1732); December 27, 2010 (37:26 Md. R. 1787); December 24, 2012 (39:25 Md. R. 1613); October 28, 2013 (40:21 Md. R. 1775); February 16, 2015 (42:3 Md. R. 316); February 27, 2017 (44:4	Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.13#A" title="">Regulation .13A</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.13#D" title="">Regulation .13D</a> adopted effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.14#A" title="">Regulation .14A</a>, C amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.14#C" title="">Regulation .14C</a> amended effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.15" title=".15 Benefits — Podiatry Services.">Regulation .15</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.15" title=".15 Benefits — Podiatry Services.">Regulation .15</a> amended effective November 6, 2006 (33:22 Md. R. 1732); November 7, 2016 (43:22 Md. R. 1221)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.16" title=".16 Benefits — Outpatient Rehabilitative Services.">Regulation .16</a> amended effective December 23, 2002 (29:25 Md. R. 1981); November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.17" title=".17 Benefits — Oxygen and Related Respiratory Equipment.">Regulation .17</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.18" title=".18 Benefits — Dialysis Services.">Regulation .18</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.19" title=".19 Benefits — Family Planning Services.">Regulation .19</a> amended effective November 6, 2006 (33:22 Md. R. 1732); November 5, 2007 (34:22 Md. R. 1977); February 26, 2018 (45:4 Md. R. 205); October 22, 2018 (45:21 Md. R. 973)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.20#A" title="">Regulation .20A</a> amended effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.20#B" title="">Regulation .20B</a> amended effective February 9, 1998 (25:3 Md. R. 144); February 18, 2002 (29:3 Md. R. 220); April 10, 2006 (33:7 Md. R. 668); December 24, 2012 (39:25 Md. R. 1613); April 28, 2014 (41:8 Md. R. 471); February 27, 2017 (44:4 Md. R. 252); October 22, 2018 (45:21 Md. R. 973)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.21#A" title="">Regulation .21A</a> amended effective November 6, 2006 (33:22 Md. R. 1732); November 5, 2007 (34:22 Md. R. 1977); October 5, 2009 (36:20 Md. R. 1528); April 19, 2010 (37:8 Md. R. 615); December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.21#D" title="">Regulation .21D</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.22" title=".22 Benefits — Case Management Services for HIV-Infected Individuals.">Regulation .22</a> amended effective November 6, 2006 (33:22 Md. R. 1732); April 9, 2007 (34:7 Md. R. 698)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.23" title=".23 Benefits — Hospice Care Services.">Regulation .23</a> amended effective February 18, 2002 (29:3 Md. R. 220); November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.24" title=".24 Benefits — Diabetes Prevention and Care Services.">Regulation .24</a> amended effective October 28, 2013 (40:21 Md. R. 1775); August 26, 2019 (46:17 Md. R. 726)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.24#A" title="">Regulation .24A</a>, C amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.24#C" title="">Regulation .24C</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.25" title=".25 Benefits — Blood and Blood Products.">Regulation .25</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26" title=".26 Benefits — Primary Mental Health Services.">Regulation .26</a> amended effective November 6, 2006 (33:22 Md. R. 1732); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-1" title=".26-1 Clinical Trial Items and Services — Coverage for Routine Costs.">Regulation .26-1</a> adopted as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); adopted permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-2" title=".26-2 Plastic and Restorative Surgery.">Regulation .26-2</a> adopted as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); adopted permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-3" title=".26-3 Gender- Affirming Treatment.">Regulation .26-3</a> adopted effective August 29, 2016 (43:17 Md. R. 955)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-4" title=".26-4 Audiology.">Regulation .26-4</a> adopted effective October 22, 2018 (45:21 Md. R. 973)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-5" title=".26-5 Remote Patient Monitoring.">Regulation .26-5</a> adopted effective October 22, 2018 (45:21 Md. R. 973)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27" title=".27 Benefits — Limitations.">Regulation .27</a> amended effective December 24, 2012 (39:25 Md. R. 1613); October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27#A" title="">Regulation .27A</a> amended effective October 26, 2015 (42:21 Md. R. 1301); August 29, 2016 (43:17 Md. R. 955); October 22, 2018 (45:21 Md. R. 973)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27#B" title="">Regulation .27B</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27#B" title="">Regulation .27B</a> amended as an emergency provision effective March 9, 1998 (25:7 Md. R. 525); amended permanently effective June 15, 1998 (25:12 Md. R. 947)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27#B" title="">Regulation .27B</a> amended effective November 1, 1999 (26:22 Md. R. 1692); December 25, 2000 (27:25 Md. R. 2281); December 23, 2002 (29:25 Md. R. 1981); February 2, 2004 (31:2 Md. R. 82); December 20, 2004 (31:25 Md. R. 1790)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27#B" title="">Regulation .27B</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27#B" title="">Regulation .27B</a> amended effective April 10, 2006 (33:73 Md. R. 668); November 6, 2006 (33:22 Md. R. 1732); November 5, 2007 (34:22 Md. R. 1977); June 30, 2008 (35:13 Md. R. 1180); April 19, 2010 (37:8 Md. R. 615); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">Regulation .28</a> amended effective April 19, 2010 (37:8 Md. R. 615); February 16, 2015 (42:3 Md. R. 316); April 10, 2017 (44:7 Md. R. 355)</p>
                  <p>Regulation .28D amended effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p>Regulation .28G amended effective November 6, 2006 (33:22 Md. R. 1732); April 9, 2007 (34:7 Md. R. 698)</p>
                  <p>Regulation .28H repealed effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .28H adopted effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p>Regulation .28H amended effective April 9, 2007 (34:7 Md. R. 698)</p>
                  <p>Regulation .28I adopted effective April 9, 2007 (34:7 Md. R. 698)</p>
                  <p>Regulation .28I, J amended effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p>Regulation .28K adopted effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.29#E" title="">Regulation .29E</a>—G adopted effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.30" title=".30 Fertility Preservation.">Regulation .30</a> repealed effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.31" title=".31 Benefits — Telemedicine Services.">Regulation .31</a> adopted effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.67" title="Chapter 67 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.09.67</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04" title=".04 Benefits — Pharmacy Services.">Regulation .04</a> amended effective May 1, 2023 (50:8 Md. R. 337)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.21#A" title="">Regulation .21A</a> amended effective February 21, 2022 (49:4 Md. R. 300)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26" title=".26 Benefits — Primary Mental Health Services.">Regulation .26</a> amended effective August 5, 2024 (51:15 Md. R, 707)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-1" title=".26-1 Clinical Trial Items and Services — Coverage for Routine Costs.">Regulation .26-1</a> amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-3" title=".26-3 Gender- Affirming Treatment.">Regulation .26-3</a> amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-6" title=".26-6 Mobile Integrated Health Services.">Regulation .26-6</a> adopted effective May 1, 2023 (50:8 Md. R. 337)​​</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26-7" title=".26-7 Social Determinants of Health.">Regulation .26-7</a> adopted effective November 13, 2023 (50:22 Md. R. 974)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27" title=".27 Benefits — Limitations.">Regulation .27</a> amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.27#A" title="">Regulation .27A</a> amended effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28#A" title="">Regulation .28A</a> amended effective June 24, 2024 (51:12 Md. R. 618)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.30" title=".30 Fertility Preservation.">Regulation .30</a> adopted effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, Title 15, Subtitle 1, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.06.01" data-order="|10|67|06|.01|" data-ref-path="10|67|06|.01" class="h__section">.01 Required Benefits Package — In General.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#A">A.</span> Except for non-covered services set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.06.27" title=".27 Benefits — Limitations.">Regulation .27 of this chapter</a> and the non-capitated services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08" title="Chapter 08 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services">COMAR 10.67.08</a>, an MCO shall provide its enrollees with a benefits package that includes the covered services specified in this chapter when these services are deemed to be medically necessary including services covered under the Maryland Medicaid State Plan in the amount, duration, and scope set forth in the State Plan and in accordance with 42 CFR §440.230.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#B">B.</span> An MCO shall ensure that the services provided are sufficient in amount, duration, or scope to reasonably achieve the purpose for which the services are furnished.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#C">C.</span> An MCO is not required to provide non-covered services even when the service is medically necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#D">D.</span> Any limitations set forth in this chapter on covered services are not applicable to services required by enrollees who are younger than 21 years old when it is shown that the services are medically necessary to correct or lessen health problems detected or suspected by EPSDT screening services, as described in <a class="internal-link " href="/us/md/exec/comar/10.67.06.20" title=".20 Benefits — EPSDT Services.">Regulation .20 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#E">E.</span> An MCO may place appropriate limits on a service on the basis of criteria applied under the State plan, such as medical necessity.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F">F.</span> Cost Sharing and Prohibitions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(1)">(1)</span> Except for the following, an MCO may not charge its enrollees any copayments, premiums, or cost sharing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(1)(a)">(a)</span> Up to a $3 copayment for brand-name drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(1)(b)">(b)</span> Up to a $1 copayment for generic drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(1)(c)">(c)</span> Any other charge up to fee-for-service limits as approved by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)">(2)</span> An MCO may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)(a)">(a)</span> Deny services to an individual who is eligible for services because of the individual's inability to pay the cost sharing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)(b)">(b)</span> Impose copayments for the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)(b)(i)">(i)</span> Family planning services and supplies;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)(b)(ii)">(ii)</span> Individuals younger than 21 years old;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)(b)(iii)">(iii)</span> Pregnant women;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)(b)(iv)">(iv)</span> Institutionalized individuals who are inpatients in long-term care facilities or other institutions; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)(b)(v)">(v)</span> Emergency services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#F(2)(c)">(c)</span> Arbitrarily deny or reduce the amount, duration, or scope of a required service solely because of diagnosis, type of illness, or condition of the enrollee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#G">G.</span> An MCO shall ensure that all health care services provided under this chapter are performed, to the extent required by law, by an appropriate health care provider who is licensed, certified, or otherwise legally authorized to practice or deliver the services in the state in which the service is provided.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.01#H">H.</span> An MCO shall provide for a second opinion from a qualified health care professional within the network, or, if necessary, arrange for the enrollee to obtain one outside the MCO network.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.02" data-order="|10|67|06|.02|" data-ref-path="10|67|06|.02" class="h__section">.02 Benefits — Primary Care Services.</h3>
                <p>An MCO shall provide to its enrollees medically necessary primary care services that are provided:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.02#A">A.</span> By the enrollee's PCP;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.02#B">B.</span> At the direction of the enrollee's PCP; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.02#C">C.</span> With respect to a primary care service that is self-referred pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">Regulation .28 of this chapter</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.02#C(1)">(1)</span> By an appropriate practitioner, acting within the scope of the practitioner's license, certification, or other legal authorization, and in accordance with the practitioner's training and experience; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.02#C(2)">(2)</span> By a clinic that furnishes health care services by or under the direction of a physician.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.03" data-order="|10|67|06|.03|" data-ref-path="10|67|06|.03" class="h__section">.03 Benefits — Physician and Advanced Practice Nurse Specialty Care Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.03#A">A.</span> An MCO shall provide to its enrollees medically necessary specialty care services that are outside of the enrollee's PCP's scope of practice, or, in the judgment of the enrollee's PCP, are not services that the PCP customarily provides, is specifically trained for, or is experienced in and are provided by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.03#A(1)">(1)</span> A physician or an advanced practice nurse, acting within the scope of the individual's license or certification, training, and experience;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.03#A(2)">(2)</span> A practitioner other than a physician or an advanced practice nurse when the practitioner is in a physician's employ, is under the physician's direct supervision, and performs the service within the scope of the practitioner's license, certification, or other legal authorization, for the purpose of assisting in the provision of the specialty care service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.03#A(3)">(3)</span> A clinic that furnishes health care services by or under the direction of a physician; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.03#A(4)">(4)</span> For enrollees who are younger than 21 years old, a doctor of dental medicine or dental surgery, if the services are surgical services that are also typically performed by physicians.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.03#B">B.</span> Notwithstanding <a class="internal-link " href="/us/md/exec/comar/10.67.06.03#A(2)" title="">§A(2) of this regulation</a>, specialty care services provided under Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04" title=".04 Benefits — Pharmacy Services.">.04</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.25" title=".25 Benefits — Blood and Blood Products.">.25</a> of this chapter may include medically necessary diagnostic and treatment services provided by a physician or other appropriate practitioner, acting within the scope of the practitioner's license, certification, or other legal authorization, and in accordance with the practitioner's training and experience.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.04" data-order="|10|67|06|.04|" data-ref-path="10|67|06|.04" class="h__section">.04 Benefits — Pharmacy Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#A">A.</span> An MCO shall provide outpatient drugs as defined in §1927(k)(2) of the Social Security Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B">B.</span> An MCO shall provide to its enrollees all medically necessary pharmaceutical services and pharmaceutical counseling, including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(1)">(1)</span> Legend drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(2)">(2)</span> Insulin;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(3)">(3)</span> All FDA approved contraceptives;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(4)">(4)</span> Hypodermic needles and syringes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(5)">(5)</span> Enteral nutritional and supplemental vitamins and mineral products given by nasogastric, jejunostomy, or gastrostomy tube in the home;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(6)">(6)</span> Enteric coated aspirin prescribed for the treatment of arthritic conditions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(7)">(7)</span> Nonlegend ferrous sulfate oral preparations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(8)">(8)</span> Nonlegend chewable tablets of any ferrous salt when combined with vitamin C, multivitamins, multivitamins and minerals, or other minerals in the formulation when the enrollee is younger than 12 years old;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(9)">(9)</span> Medical supplies used in the preparation of compounded prescriptions for home intravenous therapy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(10)">(10)</span> Medical supplies or equipment used in the administration or monitoring of medication prescribed or ordered for an enrollee by a qualifying provider as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.04#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(11)">(11)</span> Latex condoms;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(12)">(12)</span> Nonlegend ergocalciferol liquid (Vitamin D); and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#B(13)">(13)</span> Emergency contraceptives for female recipients.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#C">C.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.06.04#B" title="">§B of this regulation</a>, an MCO is required to provide only those drugs and related pharmaceutical products that are prescribed or ordered by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#C(1)">(1)</span> An MCO provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#C(2)">(2)</span> An out-of-plan provider, when the pharmacy services are ordered or prescribed in connection with medical care furnished by the provider to the MCO's enrollee:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#C(2)(a)">(a)</span> In response to the enrollee's emergency medical condition; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#C(2)(b)">(b)</span> Pursuant to the enrollee's self-referral to the provider, when the care delivered qualifies as a permissible self-referred service under <a class="internal-link " href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">Regulation .28 of this chapter</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#C(3)">(3)</span> A behavioral health provider for drugs not in the behavioral health formulary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#D">D.</span> An MCO shall provide over-the-counter emergency contraceptives and latex condoms to enrollees without requiring an order from an authorized prescriber.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E">E.</span> An MCO shall provide coverage for the following when performed by a pharmacist:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(1)">(1)</span> Contraceptive services, as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(1)(a)">(a)</span> A patient assessment performed at the pharmacist’s practice location in order to determine:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(1)(a)(i)">(i)</span> Whether to prescribe contraceptives; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(1)(a)(ii)">(ii)</span> Which contraceptive options to prescribe; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(1)(b)">(b)</span> If contraceptives are prescribed, a referral:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(1)(b)(i)">(i)</span> To the participant’s primary care practitioner or reproductive health care practitioner; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(1)(b)(ii)">(ii)</span> If the participant does not have a primary care practitioner or a reproductive health care practitioner, to a family planning provider or a licensed clinician who provides reproductive health care services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(2)">(2)</span> Administration of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(2)(a)">(a)</span> Injectable medications for the treatment of sexually transmitted infection; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#E(2)(b)">(b)</span> Maintenance injectables medications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F">F.</span> Drug Formulary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(1)">(1)</span> An MCO shall establish and maintain a drug formulary that is at least equivalent to the standard therapies of the Maryland Medical Assistance Program, and include at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(1)(a)">(a)</span> Covered generic and name brand medications; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(1)(b)">(b)</span> The tier each medication is on.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(2)">(2)</span> An MCO shall include in its formulary drugs that are appropriate for medical management, safe, and effective.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(3)">(3)</span> An MCO shall expand its formulary, as needed, to include drugs that are equivalent to new drugs approved by the federal Food and Drug Administration, and which are deemed to be appropriate, safe, and efficacious in the medical management of the MCO's enrollees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(4)">(4)</span> An MCO shall include in its formulary the following drugs:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(4)(a)">(a)</span> Leuprolide acetate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(4)(b)">(b)</span> Clonidine;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(4)(c)">(c)</span> Guanfacine;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(4)(d)">(d)</span> Medroxyprogesterone; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(4)(e)">(e)</span> Liothyronine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(5)">(5)</span> To ensure that its formulary drugs are medically necessary, safe, and efficacious, an MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(5)(a)">(a)</span> Subject its formulary to a review process that is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(5)(a)(i)">(i)</span> Established and conducted by the MCOs Pharmacy and Therapeutics Committee;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(5)(a)(ii)">(ii)</span> Approved by the Department; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(5)(a)(iii)">(iii)</span> Coordinated with the formulary review process of the Specialty Mental Health Services delivery system; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(5)(b)">(b)</span> Submit its formulary for the review and approval of the Department, based upon the standards set forth in this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#F(6)">(6)</span> Unless approved by the Department, an MCO may not require or utilize prior authorization or step therapy criteria for coverage of formulary drugs if such prior authorization or step therapy requires a recipient to use a drug that is included in the behavioral health formulary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#G">G.</span> Any option for accessing pharmacy services by mail order may be implemented only at the request of the enrollee except for when the drug is a specialty drug as defined in <a class="internal-link " href="/us/md/exec/comar/10.67.06.04#H" title="">§H of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#H">H.</span> In this regulation, the term specialty drug means:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#H(1)">(1)</span> A prescription drug that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#H(1)(a)">(a)</span> Is prescribed for an individual with a complex, chronic or rare medical condition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#H(1)(b)">(b)</span> Costs $600 or more for up to a 30-day supply;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#H(1)(c)">(c)</span> Is not typically stocked at retail pharmacies; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#H(1)(d)">(d)</span> Requires a difficult or unusual process of delivery to the patient in the preparation, handling storage, inventory or distribution of the drug; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#H(2)">(2)</span> Requires enhanced patient education, management, or support, beyond those required for traditional dispensing, before or after administration of the drug.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#I">I.</span> . If an enrollee subsequently requests to use a retail pharmacy for specialty drugs the MCO may not limit the enrollee to the use of a mail order pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J">J.</span> An MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(1)">(1)</span> Establish and maintain a drug utilization review program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(2)">(2)</span> Adhere to the minimum performance standards established by the Department for these programs, whenever used, including but not limited to standards for the following drug use management components:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(2)(a)">(a)</span> Formulary management;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(2)(b)">(b)</span> Generic substitution;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(2)(c)">(c)</span> Therapeutic substitution;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(2)(d)">(d)</span> Prior authorization that complies with the requirements of §1927(d)(5) of the Social Security Act;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(2)(e)">(e)</span> Drug use evaluation (DUE);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(2)(f)">(f)</span> Disease management; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(2)(g)">(g)</span> Pharmacy and Therapeutic Committee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(3)">(3)</span> Establish procedures to distinguish drug utilization data for covered outpatient drugs that are subject to discounts under the 340B drug pricing program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#J(4)">(4)</span> Provide to the Department a detailed description of its drug utilization review program activities on an annual basis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#K">K.</span> The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#K(1)">(1)</span> Review each MCO’s drug utilization review program annually; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#K(2)">(2)</span> Notify an MCO annually if any of the standards established in <a class="internal-link " href="/us/md/exec/comar/10.67.06.04#J(2)" title="">§J(2) of this regulation</a> have not been met.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.04#L">L.</span> For any performance standard identified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.04#K(2)" title="">§K(2) of this regulation</a>, MCOs shall acknowledge any deficiencies within 30 days and correct any deficiencies within 90 days or be subject to sanctions listed in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.01#A" title="">COMAR 10.67.10.01A</a> and B.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.05" data-order="|10|67|06|.05|" data-ref-path="10|67|06|.05" class="h__section">.05 Benefits — Home Health Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#A">A.</span> Subject to the conditions specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.05#B" title="">§B of this regulation</a>, an MCO shall provide to its enrollees medically necessary home health services, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#A(1)">(1)</span> Skilled nursing services, including the supervisory visits required by <a class="internal-link " href="/us/md/exec/comar/10.67.06.05#A(2)" title="">§A(2) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#A(2)">(2)</span> Home health aide services, including biweekly supervisory visits by a registered nurse in the recipient's home, every second visit of which includes observations of the delivery of services by the aide to the enrollee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#A(3)">(3)</span> Physical therapy services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#A(4)">(4)</span> Occupational therapy services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#A(5)">(5)</span> Speech pathology services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#A(6)">(6)</span> Medical supplies that are used during a home health visit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#B">B.</span> An MCO shall provide the home health services specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.05#A" title="">§A of this regulation</a> that are:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#B(1)">(1)</span> Certified by the enrollee's PCP or by the enrollee's attending physician to be required on a part-time, intermittent basis; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.05#B(2)">(2)</span> Rendered in the enrollee's home.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.06" data-order="|10|67|06|.06|" data-ref-path="10|67|06|.06" class="h__section">.06 Benefits — Habilitation Services for Medicaid Expansion Populations</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.06#A">A.</span> An MCO shall provide the following medically necessary habilitation services to enrollees eligible for Medical Assistance under §1902(a)(10)(A)(i)(VIII) of the Social Security Act:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.06#A(1)">(1)</span> Physical therapy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.06#A(2)">(2)</span> Occupation therapy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.06#A(3)">(3)</span> Speech therapy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.06#B">B.</span> At a minimum, an MCO shall provide the services in hospital inpatient and outpatient departments and physical therapy in an outpatient community setting.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.07" data-order="|10|67|06|.07|" data-ref-path="10|67|06|.07" class="h__section">.07 Benefits — Inpatient Hospital Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#A">A.</span> An MCO shall provide to its enrollees medically necessary inpatient hospital services as specified in this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#B">B.</span> Admission to Long-Term Care Facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#B(1)">(1)</span> An MCO shall provide to its enrollees medically necessary long-term care facility services for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#B(1)(a)">(a)</span> The first 90 continuous days following the enrollee's admission; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#B(1)(b)">(b)</span> Any days following the first 90 continuous days of an admission until the date the MCO has obtained the Department's determination that the admission is medically necessary as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.07#B(2)" title="">§B(2) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#B(2)">(2)</span> For any long-term care facility admission that is expected to result in a length of stay exceeding 90 days, an MCO or long-term care facility shall request a determination by the Department that the admission is medically necessary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#B(3)">(3)</span> The Department’s determination as described in <a class="internal-link " href="/us/md/exec/comar/10.67.06.07#B(2)" title="">§B(2) of this regulation</a> is only applicable if the enrollee is still in the long-term care facility on the 91st day.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#B(4)">(4)</span> Acute care services provided within the first 90 days following an enrollee's admission to a long-term care facility do not constitute a break in calculating the 90 continuous day requirement if the enrollee is discharged from the hospital back to the long-term care facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#C">C.</span> The Department shall render a determination with respect to the medical necessity of a stay in a long-term care facility as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.07#B" title="">§B of this regulation</a> within 3 business days of receipt of a complete application from the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#D">D.</span> Childbirth — Length of Stay and Home Visits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#D(1)">(1)</span> Except as provided in §D(2) and (3) of this regulation, the criteria and standards used by an MCO in performing utilization review of hospital services related to maternity and newborn care, including length of stay, shall be in accordance with the medical criteria outlined in the Guidelines for Perinatal Care, which is incorporated by reference in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">COMAR 10.67.04.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#D(2)">(2)</span> Unless the enrollee decides, in consultation with her attending provider, that less time is needed for recovery, an MCO shall provide or reimburse the cost of hospitalization including at least the following length of stay for an enrollee recovering from childbirth:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#D(2)(a)">(a)</span> 48 hours of inpatient hospitalization care following an uncomplicated vaginal delivery; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#D(2)(b)">(b)</span> 96 hours of inpatient hospitalization care following an uncomplicated cesarean section.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#D(3)">(3)</span> If the enrollee elects to be discharged earlier than the length of stay specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.07#D(2)" title="">§D(2) of this regulation</a>, the MCO is required to provide a home visit or visits pursuant to Regulation .21B—D of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#E">E.</span> In addition to the mother's length of stay required to be afforded by <a class="internal-link " href="/us/md/exec/comar/10.67.06.07#D(2)" title="">§D(2) of this regulation</a>, whenever a mother is required to remain hospitalized after childbirth for medical reasons and she requests that her newborn remain in the hospital while she is hospitalized, the MCO shall afford the newborn additional hospitalization while the mother remains hospitalized, for up to 4 days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#F">F.</span> If an enrollee is in the hospital at the time of disenrollment from the MCO, and remains eligible for Medical Assistance, the MCO is responsible for covering the remainder of that hospital admission following disenrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#G">G.</span> An MCO shall provide for a private hospital room when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#G(1)">(1)</span> The enrollee's condition requires a need for isolation; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#G(2)">(2)</span> The enrollee requires admission and only private rooms are available.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#H">H.</span> Payment For Ancillary Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#H(1)">(1)</span> Effective January 1, 2009, an MCO shall pay for all medically necessary ancillary services provided on inpatient hospital days including those days for which the inpatient hospitalization is otherwise appropriately denied.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#H(2)">(2)</span> A denial of an inpatient ancillary service shall be based on the medical necessity of the specific ancillary service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#H(3)">(3)</span> An MCO is not required to pay for ancillary services if the entire hospitalization in <a class="internal-link " href="/us/md/exec/comar/10.67.06.07#H(1)" title="">§H(1) of this regulation</a> is appropriately denied.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#I">I.</span> Transports between hospitals are covered by the MCO when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#I(1)">(1)</span> A medically necessary covered service is not available at the hospital where an enrollee is being treated; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.07#I(2)">(2)</span> The enrollee is not being discharged from the sending hospital.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.08" data-order="|10|67|06|.08|" data-ref-path="10|67|06|.08" class="h__section">.08 Benefits — Outpatient Hospital Services.</h3>
                <p>An MCO's benefits package shall include medically necessary outpatient hospital services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.09" data-order="|10|67|06|.09|" data-ref-path="10|67|06|.09" class="h__section">.09 Benefits — Transplants.</h3>
                <p>An MCO shall provide to its enrollees medically necessary transplants.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.10" data-order="|10|67|06|.10|" data-ref-path="10|67|06|.10" class="h__section">.10 Benefits — Substance Abuse Treatment Service — Repealed</h3>
                <h3 id="/us/md/exec/comar/10.67.06.11" data-order="|10|67|06|.11|" data-ref-path="10|67|06|.11" class="h__section">.11 Benefits — Diagnostic and Laboratory Services.</h3>
                <p>An MCO shall provide to its enrollees medically necessary:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.11#A">A.</span> Diagnostic services; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.11#B">B.</span> Laboratory services, performed by a provider who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.11#B(1)">(1)</span> Is Clinical Laboratory Improvement Amendments (CLIA) certified; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.11#B(2)">(2)</span> Has a waiver of a certificate registration along with a CLIA identification number.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.12" data-order="|10|67|06|.12|" data-ref-path="10|67|06|.12" class="h__section">.12 Benefits — Long-Term Care Facility Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#A">A.</span> An MCO shall provide to its enrollees medically necessary services in a chronic hospital, a chronic rehabilitation hospital, or a nursing facility for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#A(1)">(1)</span> The first 90 continuous days following the enrollee's admission; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#A(2)">(2)</span> Any days following the first 90 continuous days of an admission until the date the MCO has obtained the Department’s determination that the admission is medically necessary as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.12#C" title="">§C of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#B">B.</span> Acute care services provided within the first 90 days following an enrollee's admission to a long-term care facility do not constitute a break in calculating the 90 continuous day requirement if the enrollee is discharged from the hospital back to the long-term care facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#C">C.</span> For any long-term care facility admission that is expected to result in a length of stay exceeding 90 days, an MCO or long-term care facility shall request a determination by the Department that the admission is medically necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#D">D.</span> The Department’s determination as described in <a class="internal-link " href="/us/md/exec/comar/10.67.06.12#C" title="">§C of this regulation</a> is only applicable if the enrollee is still in the long-term care facility on the 91st day.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#E">E.</span> The Department shall render a determination with respect to the medical necessity of a stay in a nursing facility as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.12#C" title="">§C of this regulation</a> within 3 business days of receipt of a complete application from the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#F">F.</span> A determination by the Department that the admission is medically necessary does not relieve the MCO of the obligation to pay for the admission through the day on which the determination is made.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.12#G">G.</span> An MCO shall use the Department’s criteria for determining medical necessity for the days described in <a class="internal-link " href="/us/md/exec/comar/10.67.06.12#A(1)" title="">§A(1) of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.13" data-order="|10|67|06|.13|" data-ref-path="10|67|06|.13" class="h__section">.13 Benefits — Disposable Medical Supplies and Durable Medical Equipment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A">A.</span> An MCO shall provide to its enrollees medically necessary disposable medical supplies and durable medical equipment, including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(1)">(1)</span> All supplies and equipment used in the administration or monitoring of prescriptions by the enrollees;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(2)">(2)</span> Incontinency pants and disposable underpads for medical conditions associated with prolonged urinary or bowel incontinence if necessary to prevent institutionalization or infection;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(3)">(3)</span> Orthotic devices when medically necessary for use in the MCO enrollee’s home, school, or place of employment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(4)">(4)</span> Prosthetic devices once annually when medically necessary:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(4)(a)">(a)</span> For use in the enrollee’s home, school, or place of employment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(4)(b)">(b)</span> For the purpose of performing physical activities, including running, biking, swimming, strength training, and other activities to maximize the whole-body health and lower or upper limb function of the enrollee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(5)">(5)</span> Annual repairs to prosthetic devices covered under <a class="internal-link " href="/us/md/exec/comar/10.67.06.13#A(4)" title="">§A(4) of this regulation</a> when:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(5)(a)">(a)</span> Medically necessary; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(5)(b)">(b)</span> When the repair’s necessity is not due to misuse;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(6)">(6)</span> Replacement of prosthetic devices covered under §A(4)of this regulation when medically necessary as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(6)(a)">(a)</span> Once annually for devices less than 3 years old if the replacement is necessary for the following reasons:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(6)(a)(i)">(i)</span> Because of a change in the physiological condition of the patient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(6)(a)(ii)">(ii)</span> Unless necessitated by misuse, because of an irreparable change in the condition of the prosthesis or the component of the prosthetic device; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(6)(a)(iii)">(iii)</span> Unless necessitated by misuse, because the condition of the prosthetic device or the component of the prosthetic device requires repairs and the cost of the repairs would be more than 60 percent of the cost of replacing the prosthetic device or the component of the prosthetic device.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#A(6)(b)">(b)</span> For devices more than 3 years old subject to §A(4) and (5) of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#B">B.</span> Except as required in §C(1), an MCO shall provide preauthorization within 72 hours for DMS/DME services and supplies that require preauthorization by the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#C">C.</span> An MCO shall provide its enrollees the disposable medical supplies and durable medical equipment in a timely manner so as to not adversely affect the health of the enrollees, in accordance with the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#C(1)">(1)</span> For medical equipment or supplies, or both, when there is an urgent medical need such as to facilitate hospital discharge or when a potential exists for worsening of enrollee's condition, the MCO shall provide needed items within 24 hours of request; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#C(2)">(2)</span> For all other requests for DMS/DME, the MCO shall provide these items within 7 days from the date of request unless the MCO can document to the Department that justification for additional time is necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#D">D.</span> An MCO is responsible for paying for any durable medical equipment authorized and ordered while the member is active with the MCO if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#D(1)">(1)</span> The delivery of the item occurs within 90 days after the member's termination date from the MCO; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.13#D(2)">(2)</span> The member remains a Medicaid recipient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.14" data-order="|10|67|06|.14|" data-ref-path="10|67|06|.14" class="h__section">.14 Benefits — Vision Care Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.14#A">A.</span> An MCO shall provide to its enrollees medically necessary vision care services as specified in this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.14#B">B.</span> For enrollees who are 21 years old or older, the MCO is responsible for providing at least one eye examination every 2 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.14#C">C.</span> For its enrollees who are younger than 21 years old, the MCO is responsible for providing medically necessary vision services, including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.14#C(1)">(1)</span> At least one eye examination every year in addition to any vision screen performed as part of an EPSDT screen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.14#C(2)">(2)</span> Eyeglasses, limited to one pair per year unless lost, stolen, broken, or no longer vision appropriate; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.14#C(3)">(3)</span> Contact lenses, if medically necessary and if eyeglasses are not efficacious for the condition.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.15" data-order="|10|67|06|.15|" data-ref-path="10|67|06|.15" class="h__section">.15 Benefits — Podiatry Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.15#A">A.</span> An MCO shall provide for its enrollees medically necessary podiatry services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.15#B">B.</span> In addition to the services described in <a class="internal-link " href="/us/md/exec/comar/10.67.06.15#A" title="">§A of this regulation</a>, an MCO shall provide:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.15#B(1)">(1)</span> Diabetes care services specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.24" title=".24 Benefits — Diabetes Prevention and Care Services.">COMAR 10.67.06.24</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.15#B(2)">(2)</span> Routine foot care for enrollees, 21 years old or older with vascular disease affecting the lower extremities.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.16" data-order="|10|67|06|.16|" data-ref-path="10|67|06|.16" class="h__section">.16 Benefits — Outpatient Rehabilitative Services.</h3>
                <p>An MCO shall provide to its enrollees medically necessary outpatient rehabilitative services, including but not limited to physical therapy for adult enrollees.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.17" data-order="|10|67|06|.17|" data-ref-path="10|67|06|.17" class="h__section">.17 Benefits — Oxygen and Related Respiratory Equipment.</h3>
                <p>An MCO shall provide to its enrollees medically necessary oxygen and related respiratory equipment services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.18" data-order="|10|67|06|.18|" data-ref-path="10|67|06|.18" class="h__section">.18 Benefits — Dialysis Services.</h3>
                <p>An MCO shall provide to its enrollees medically necessary dialysis services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.19" data-order="|10|67|06|.19|" data-ref-path="10|67|06|.19" class="h__section">.19 Benefits — Family Planning Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.19#A">A.</span> An MCO shall provide to its enrollees comprehensive family planning services, including but not limited to medically necessary office visits and laboratory tests, all FDA-approved contraceptive devices, methods, and supplies, and voluntary sterilizations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.19#B">B.</span> An MCO may place appropriate limits on family planning services for the purpose of utilization control, provided that the services are provided in a manner that protects and enables the enrollee’s freedom to choose the method of family planning to be used consistent with 42 CFR §441.20.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.19#C">C.</span> An MCO may not apply a copayment or coinsurance requirement for contraceptive drugs or devices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.19#D">D.</span> An MCO shall provide coverage for a single dispensing of a supply of prescription contraceptives for a 12-month period.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.20" data-order="|10|67|06|.20|" data-ref-path="10|67|06|.20" class="h__section">.20 Benefits — EPSDT Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A">A.</span> An MCO shall provide, to enrollees younger than 21 years old, medically necessary Early and Periodic Screening, Diagnosis, and Treatment (EPSDT) services, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(1)">(1)</span> EPSDT comprehensive well-child services provided in accordance with the EPSDT periodicity schedule and performed by an EPSDT-certified provider, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(1)(a)">(a)</span> A comprehensive health and developmental history, including an evaluation of both physical and mental health development;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(1)(b)">(b)</span> A comprehensive unclothed physical exam;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(1)(c)">(c)</span> Immunizations appropriate to age and health history;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(1)(d)">(d)</span> Laboratory tests, including blood lead level assessment, as appropriate to age and risk;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(1)(e)">(e)</span> Health education, including anticipatory guidance; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(1)(f)">(f)</span> Vision, hearing, and dental screening;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(2)">(2)</span> EPSDT partial or interperiodic well-child services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(3)">(3)</span> Health care services that are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(3)(a)">(a)</span> Necessary to prevent, treat, or ameliorate physical, mental, or developmental problems or conditions identified by an EPSDT-certified provider or other health professional;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(3)(b)">(b)</span> Sufficient in amount, duration, and scope to treat the identified condition; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#A(3)(c)">(c)</span> Subject to limitation only on the basis of medical necessity.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#B">B.</span> The health care services described in <a class="internal-link " href="/us/md/exec/comar/10.67.06.20#A(3)" title="">§A(3) of this regulation</a> shall include, at a minimum, all services described in this chapter, and the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#B(1)">(1)</span> Chiropractic services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#B(2)">(2)</span> Nutrition counseling services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#B(3)">(3)</span> Private duty nursing services including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#B(3)(a)">(a)</span> An initial assessment and development of a plan of care by a registered nurse; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#B(3)(b)">(b)</span> On-going private duty nursing services delivered by a licensed practical nurse or a registered nurse; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#B(4)">(4)</span> Durable medical equipment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#C">C.</span> An MCO shall provide referrals for services not covered by Medicaid, but which are furnished at little or no cost to recipients, including appropriate referrals to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#C(1)">(1)</span> The Head Start Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#C(2)">(2)</span> The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#C(3)">(3)</span> School Health-Related Special Education Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#C(4)">(4)</span> Vocational Rehabilitation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.20#C(5)">(5)</span> Maternal and Child Health Services located at local health departments.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.21" data-order="|10|67|06|.21|" data-ref-path="10|67|06|.21" class="h__section">.21 Benefits — Pregnancy-Related Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A">A.</span> An MCO shall provide to its pregnant and postpartum enrollees medically necessary pregnancy-related services, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(1)">(1)</span> Comprehensive prenatal, perinatal, and postpartum care, including high-risk specialty care when appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(2)">(2)</span> Prenatal risk assessment and development of an individualized plan of care that specifies the actions required to address each identified need and is appropriately modified during the course of care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)">(3)</span> Enriched maternity services, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(a)">(a)</span> Prenatal and postpartum counseling and education;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(b)">(b)</span> Basic nutritional education;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(c)">(c)</span> Substance abuse treatment, as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.06.10" title=".10 Benefits — Substance Abuse Treatment Service — Repealed">Regulation .10 of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(d)">(d)</span> Appropriate referrals to services that may improve the pregnancy outcome, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(d)(i)">(i)</span> Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(d)(ii)">(ii)</span> Healthy Start services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(e)">(e)</span> High-risk nutrition counseling services for nutritionally high-risk pregnant women;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(f)">(f)</span> Appropriate levels of inpatient care, including emergency transfer of pregnant women and newborns to tertiary care centers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(g)">(g)</span> Smoking cessation education and treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(h)">(h)</span> Doula services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#A(3)(i)">(i)</span> Home visiting services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#B">B.</span> When an enrollee recovering from childbirth elects to be discharged before 48 hours following a normal vaginal delivery or 96 hours following an uncomplicated cesarean section, the MCO is responsible for providing:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#B(1)">(1)</span> One home visit scheduled to occur within 24 hours after discharge; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#B(2)">(2)</span> An additional home visit as may be prescribed by the attending provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#C">C.</span> When an enrollee recovering from childbirth and her newborn enrollee remain in the hospital for at least as long as the period of time provided under <a class="internal-link " href="/us/md/exec/comar/10.67.06.21#B" title="">§B of this regulation</a>, the MCO shall provide a home visit as prescribed by the attending provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#D">D.</span> An MCO shall provide for home visits required by §§B and C of this regulation to be performed by a registered nurse and in accordance with generally accepted standards of nursing practice for home care of a mother and newborn child, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#D(1)">(1)</span> An evaluation of the presence of immediate problems of dehydration, sepsis, infection, jaundice, respiratory distress, cardiac distress, or other adverse physical symptoms of the infant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#D(2)">(2)</span> An evaluation of the presence of immediate problems of dehydration, sepsis, infection, bleeding, pain, or other adverse symptoms of the mother;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#D(3)">(3)</span> Collection of a blood specimen for newborn screening if not previously completed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#D(4)">(4)</span> Referrals for any medically necessary continuing health care services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.21#D(5)">(5)</span> Any other nursing services ordered by the referring provider.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.22" data-order="|10|67|06|.22|" data-ref-path="10|67|06|.22" class="h__section">.22 Benefits — Case Management Services for HIV-Infected Individuals.</h3>
                <p>An MCO shall provide medically necessary case management services to its qualifying enrollees, as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#C" title="">COMAR 10.67.04.10C</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.23" data-order="|10|67|06|.23|" data-ref-path="10|67|06|.23" class="h__section">.23 Benefits — Hospice Care Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.23#A">A.</span> An MCO shall include in its benefits package medically necessary hospice care services to enrollees who are terminally ill.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.23#B">B.</span> The Department shall allow an enrollee to disenroll from an MCO and choose a new MCO if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.23#B(1)">(1)</span> The enrollee was auto-assigned to the MCO; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.23#B(2)">(2)</span> The enrollee's hospice provider does not contract with the enrollee's assigned MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.23#C">C.</span> If an enrollee who is in a hospice that does not contract with the enrollee's MCO and the enrollee will not voluntarily choose a new MCO, the enrollee's current MCO:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.23#C(1)">(1)</span> Shall authorize and pay the out-of-network hospice provider at the established Medicaid rate, to ensure continuity of care; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.23#C(2)">(2)</span> May not require the hospice care enrollee to change their out-of-network hospice provider to an in-network hospice provider.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.24" data-order="|10|67|06|.24|" data-ref-path="10|67|06|.24" class="h__section">.24 Benefits — Diabetes Prevention and Care Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#A">A.</span> An MCO shall provide to its qualifying enrollees medically necessary diabetes prevention and care services as specified in this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#B">B.</span> National Diabetes Prevention Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#B(1)">(1)</span> In addition to the services included in its usual benefits package, an MCO shall make available to its enrollees who meet the Centers for Disease Control and Prevention (CDC) eligibility criteria defined in <a class="internal-link " href="/us/md/exec/comar/10.67.06.24#B(2)" title="">§B(2) of this regulation</a> the National Diabetes Prevention Program through a CDC-recognized lifestyle change organization.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#B(2)">(2)</span> To be eligible for participation in the National Diabetes Prevention Program, a HealthChoice enrollee:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#B(2)(a)">(a)</span> Shall be 18 through 64 years old;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#B(2)(b)">(b)</span> Shall be overweight or obese;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#B(2)(c)">(c)</span> Shall have an elevated blood glucose level or a history of gestational diabetes mellitus;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#B(2)(d)">(d)</span> May not have a previous diagnosis of type 1 or type 2 diabetes prior to enrollment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#B(2)(e)">(e)</span> May not be currently pregnant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C">C.</span> In addition to the services included in its usual benefits package, an MCO shall provide enrollees with a diabetes diagnosis the following medically necessary special diabetes-related services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(1)">(1)</span> Diabetes nutrition counseling, consisting of one initial one-on-one session and up to 4 subsequent sessions annually;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(2)">(2)</span> Diabetes outpatient education;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(3)">(3)</span> Diabetes-related durable medical equipment, disposable medical supplies, and therapeutic footwear and related services, when ordered as medically necessary, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(3)(a)">(a)</span> Therapeutic footwear, orthopedic shoes, arch supports, orthotic devices, in-shoe supports, elastic support, or examinations for prescription or fitting and related services to prevent or delay a foot amputation that would be highly probable in the absence of the specialized footwear;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(3)(b)">(b)</span> Blood glucose monitoring supplies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(3)(c)">(c)</span> Diagnostic reagent strips and tablets used in testing for ketones and glucose in urine and glucose in blood;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(3)(d)">(d)</span> Finger-sticking devices used in obtaining blood samples for blood glucose testing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(3)(e)">(e)</span> Blood glucose reflectance meters for home use;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(4)">(4)</span> Routine foot care; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(5)">(5)</span> Vision care consisting of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(5)(a)">(a)</span> One ophthalmologic examination per year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.24#C(5)(b)">(b)</span> One pair of eyeglasses per year.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.25" data-order="|10|67|06|.25|" data-ref-path="10|67|06|.25" class="h__section">.25 Benefits — Blood and Blood Products.</h3>
                <p>An MCO shall provide to its enrollees medically necessary blood, blood products, derivatives, components, biologics, and serums to include autologous services, whole blood, red blood cells, platelets, plasma, immunoglobulin, and albumin.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.26" data-order="|10|67|06|.26|" data-ref-path="10|67|06|.26" class="h__section">.26 Benefits — Primary Mental Health Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26#A">A.</span> An MCO shall provide to its enrollees medically necessary primary mental health services, including appropriate referrals for service to the Department’s behavioral health ASO as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26#B">B.</span> Effective October 1, 2023, MCOs shall provide their enrollees medically necessary primary mental health services, including the Collaborative Care Model, pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.64" title="Chapter 64 Collaborative Care Model">COMAR 10.09.64</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.26-1" data-order="|10|67|06|.26-1|" data-ref-path="10|67|06|.26-1" class="h__section">.26-1 Clinical Trial Items and Services — Coverage for Routine Costs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#A">A.</span> Subject to the conditions specified in §§B—F of this regulation, an MCO shall provide coverage for cost to an enrollee in an approved clinical trial for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#A(1)">(1)</span> Treatment provided for life-threatening conditions; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#A(2)">(2)</span> Prevention, early detection, and treatment studies on cancer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B">B.</span> Clinical trials are deemed to be automatically approved if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(1)">(1)</span> The treatment is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(1)(a)">(a)</span> Being provided or the studies are being conducted in a Phase I, Phase II, Phase III, or Phase IV clinical trials for cancer; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(1)(b)">(b)</span> Being provided in Phase I, Phase II, Phase III, or Phase IV clinical trial for any other life-threatening condition;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)">(2)</span> The treatment is being provided in a clinical trial:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)">(a)</span> Approved by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)(i)">(i)</span> The National Institutes of Health (NIH);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)(ii)">(ii)</span> An NIH cooperative group or an NIH center;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)(iii)">(iii)</span> The Centers for Disease Control and Prevention;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)(iv)">(iv)</span> The Agency for Healthcare Research and Quality;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)(v)">(v)</span> The Centers for Medicare and Medicaid Services (CMS);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)(vi)">(vi)</span> The Department of Defense;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)(vii)">(vii)</span> The Department of Veterans Affairs; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(a)(viii)">(viii)</span> An institutional review board of an institution in the State that has a multiple project assurance contract approved by the Office of Protection from Research Risks of the NIH; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(b)">(b)</span> Conducted:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(b)(i)">(i)</span> At National Cancer Institute Centers;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(b)(ii)">(ii)</span> Under Investigational New Drug application (IND) reviewed by the Food and Drug Administration (FDA); or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(2)(b)(iii)">(iii)</span> As a clinical trial with deemed status through an exemption from having an IND under 21 CFR §312.2(b)(1);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(3)">(3)</span> The facility and the personnel providing the treatment are capable of doing so by virtue of the facility and the personnel's experience, training, and volume of patients treated to maintain expertise;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(4)">(4)</span> There is no clearly superior, non-investigational treatment alternative; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#B(5)">(5)</span> The available clinical or preclinical data provide a reasonable expectation that the treatment will be at least as effective as the non-investigational alternative.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#C">C.</span> Enrollee cost includes the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#C(1)">(1)</span> The cost of all medically necessary items and services that are otherwise available to Medicaid beneficiaries such as hospital services, physician services, or diagnostic tests; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#C(2)">(2)</span> The cost of medically necessary items or services required solely for the provision of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#C(2)(a)">(a)</span> Investigational item or service such as administration of a noncovered chemotherapeutic agent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#C(2)(b)">(b)</span> The clinically appropriate monitoring of the effects of the item or service; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#C(2)(c)">(c)</span> The prevention, diagnosis, and treatment of complications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#D">D.</span> Enrollee cost does not include the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#D(1)">(1)</span> The cost of the investigational item or service itself;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#D(2)">(2)</span> The cost of items and services provided solely to satisfy data collection and analysis needs and that are not used in the direct clinical management of the enrollee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#D(3)">(3)</span> The cost of items and services customarily provided by the research sponsors free of charge for any enrollee in the trial; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#D(4)">(4)</span> The cost of non-health care services that an enrollee may be required to receive as a result of the treatment being provided for purposes of the clinical trial.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#E">E.</span> If the enrollee has insurance or other coverage, or if any other person is obligated, either legally or contractually, to pay for, or to reimburse the enrollee for, services covered by this regulation, the provider shall seek payment from that source first.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-1#F">F.</span> The MCO shall authorize the request for participation in an approved clinical trial within 72 hours of the request.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.26-2" data-order="|10|67|06|.26-2|" data-ref-path="10|67|06|.26-2" class="h__section">.26-2 Plastic and Restorative Surgery.</h3>
                <p>An MCO shall provide to an enrollee medically necessary surgery to correct a deformity from disease, trauma, congenital or developmental anomalies, or to restore body functions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.26-3" data-order="|10|67|06|.26-3|" data-ref-path="10|67|06|.26-3" class="h__section">.26-3 Gender- Affirming Treatment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A">A.</span> An MCO shall provide medically necessary gender-affirming treatment services which include but are not limited to the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(1)">(1)</span> Hormone therapy, hormone blockers, and puberty blockers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(2)">(2)</span> Hair alteration for the purposes of altering secondary sex characteristics and surgical site preparation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(3)">(3)</span> Alterations to voice, voice therapy, and voice lessons;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(4)">(4)</span> Alterations to abdomen, chest, trunk, and buttocks;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(5)">(5)</span> Alterations to the face and neck;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(6)">(6)</span> Alterations to the genitals and gonads;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(7)">(7)</span> Laser treatment for scars from gender-affirming treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(8)">(8)</span> Standard fertility preservation procedures as set forth in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-810" title="">Insurance Article, §15-810</a>.1, Annotated Code of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(9)">(9)</span> Revisions to previous treatments and reversal of treatments;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(10)">(10)</span> Combinations of gender-affirming procedures; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#A(11)">(11)</span> Other treatments as prescribed to suppress the development of endogenous secondary sex characteristics, align the individual’s appearance of physical body with gender identity, and alleviate symptoms of clinically significant distress resulting from gender dysphoria.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-3#B">B.</span> An MCO may not issue an adverse benefit determination denying or limiting access to gender-affirming treatment unless a health care provider with experience prescribing or delivering gender-affirming treatment has reviewed and confirmed the appropriateness of the adverse benefit determination.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.26-4" data-order="|10|67|06|.26-4|" data-ref-path="10|67|06|.26-4" class="h__section">.26-4 Audiology.</h3>
                <p>An MCO shall provide enrollees medically necessary audiology services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.51" title="Chapter 51 Audiology Services">COMAR 10.09.51</a>, including:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-4#A">A.</span> Hearing aids;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-4#B">B.</span> Cochlear implants;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-4#C">C.</span> Auditory osseointegrated devices; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.26-4#D">D.</span> Related services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.26-5" data-order="|10|67|06|.26-5|" data-ref-path="10|67|06|.26-5" class="h__section">.26-5 Remote Patient Monitoring.</h3>
                <p>An MCO shall provide its enrollees medically necessary remote patient monitoring services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.96" title="Chapter 96 Remote Patient Monitoring">COMAR 10.09.96</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.26-6" data-order="|10|67|06|.26-6|" data-ref-path="10|67|06|.26-6" class="h__section">.26-6 Mobile Integrated Health Services.</h3>
                <p>An MCO shall provide its enrollees medically necessary mobile integrated health services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.31" title="Chapter 31 Emergency Service Transporters">COMAR 10.09.31</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.26-7" data-order="|10|67|06|.26-7|" data-ref-path="10|67|06|.26-7" class="h__section">.26-7 Social Determinants of Health.</h3>
                <p>Subject to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.63" title="Chapter 63 Community Violence Prevention Services">COMAR 10.09.63</a>, an MCO shall provide coverage for community violence prevention.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.27" data-order="|10|67|06|.27|" data-ref-path="10|67|06|.27" class="h__section">.27 Benefits — Limitations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A">A.</span> The benefits or services not required to be provided by an MCO are as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(1)">(1)</span> Experimental or investigational services, including organ transplants determined by Medicare to be experimental, except when an enrollee is participating in an authorized clinical trial as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.06.26-1" title=".26-1 Clinical Trial Items and Services — Coverage for Routine Costs.">Regulation .26-1 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(2)">(2)</span> Any service or treatment that is not medically necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(3)">(3)</span> Services performed or prescribed under the direction of a person who is not a health care practitioner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(4)">(4)</span> Services that are beyond the scope of practice of the health care practitioner performing the service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(5)">(5)</span> Transportation services provided through grants to local governments pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.19" title="Chapter 19 Transportation Grants">COMAR 10.09.19</a>, other than assisting enrollees to access nonemergency transportation services through their local transportation grantee agency;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(6)">(6)</span> Health-related services and targeted case management services provided to children when the services are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(6)(a)">(a)</span> Specified in the enrollee's individualized family service plan (IFSP), or an individualized education program (IEP); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(6)(b)">(b)</span> Delivered in the schools or through Children's Medical Services community-based providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(7)">(7)</span> Autopsies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(8)">(8)</span> Immunizations required for travel outside the continental United States;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(9)">(9)</span> Services received while the enrollee is outside the United States;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(10)">(10)</span> Abortions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(11)">(11)</span> Diet and exercise programs for the loss of weight;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(12)">(12)</span> Prescriptions or injections for central nervous system stimulants and anorectic agents when used for controlling weight;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(13)">(13)</span> In vitro fertilization, ovum transplants and gamete intrafallopian tube transfer, zygote intrafallopian transfer, or other techniques used in these or similar procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(14)">(14)</span> Services to reverse a voluntary sterilization procedure;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(15)">(15)</span> Lifestyle improvements, including smoking cessation, nutrition counseling, or physical fitness programs, unless specifically included as a covered service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(16)">(16)</span> Nonmedical ancillary services such as vocational rehabilitation, employment counseling, or educational therapy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(17)">(17)</span> Private duty nursing for adults 21 years old and older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(18)">(18)</span> Services incurred before the effective date of coverage for an enrollee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(19)">(19)</span> Dental or orthodontic care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(20)">(20)</span> Piped-in oxygen or oxygen prescribed for standby purposes or on an as-needed basis; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(21)">(21)</span> Cosmetic surgery when performed solely to maintain normal physical appearance or enhance beyond average level toward an aesthetic ideal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#A(22)">(22)</span> Enteral nutritional and supplemental vitamins and mineral products when administered orally.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.27#B">B.</span> An MCO is not required to provide any of the benefits or services which are reimbursed directly by the Department as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08" title="Chapter 08 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services">COMAR 10.67.08</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.28" data-order="|10|67|06|.28|" data-ref-path="10|67|06|.28" class="h__section">.28 Benefits — Self-Referral Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A">A.</span> An MCO shall be financially responsible for reimbursing, in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">COMAR 10.67.04.20</a>, an out-of-plan provider chosen by the participant for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(1)">(1)</span> Family planning services specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A(2)" title="">COMAR 10.67.04.20A(2)</a>, (6), and (7);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(2)">(2)</span> Services performed by school-based health centers (SBHCs), as provided in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.76" title="Chapter 76 School-Based Health Centers (SBHC)">COMAR 10.09.76</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(3)">(3)</span> Pregnancy-related services for women who are pregnant and, at the time of initial enrollment, have received prenatal care during their current pregnancy from an out-of-plan provider, and this pre-enrollment care consists of at least the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(3)(a)">(a)</span> A full prenatal examination;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(3)(b)">(b)</span> A risk assessment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(3)(c)">(c)</span> Appropriate laboratory services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(4)">(4)</span> Initial medical examination for children in State custody when performed by an EPSDT certified provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(5)">(5)</span> One annual diagnostic and evaluation service (DES) visit for any enrollee diagnosed with HIV/AIDS, which the MCO is responsible for facilitating on the enrollee's behalf;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(6)">(6)</span> Renal dialysis services performed in a Medicare-certified facility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(7)">(7)</span> Initial medical examination of a newborn when the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(7)(a)">(a)</span> Examination is performed in a hospital by an on-call physician; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(7)(b)">(b)</span> MCO failed to provide for the service before the newborn's discharge from the hospital;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(8)">(8)</span> Emergency services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.08#B" title="">COMAR 10.67.05.08B</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(9)">(9)</span> Prenatal, intrapartum, and postpartum services performed at a free-standing birth center located in Maryland or a contiguous state; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#A(10)">(10)</span> Doula services, through December 31, 2025.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#B">B.</span> An MCO shall pay undisputed claims of the SBHC for services provided to its participants within 30 days of the MCO's receipt of the invoice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#C">C.</span> An MCO shall provide SBHCs in its service area with the current information needed to facilitate communication between the SBHC, PCP, and the MCO regarding care provided to the MCO's participant, and to effect reimbursement by the MCO, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#C(1)">(1)</span> Information concerning the MCO's policies and procedures regarding the provision of pharmacy and laboratory services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#C(2)">(2)</span> Instructions for submitting claims; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#C(3)">(3)</span> Contact information, including names and phone numbers of the following individuals:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#C(3)(a)">(a)</span> The MCO representative who serves as an SBHC's contact person for coordination of care; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.06.28#C(3)(b)">(b)</span> The student-participant's PCP.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.29" data-order="|10|67|06|.29|" data-ref-path="10|67|06|.29" class="h__section">.29 Optional Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.29#A">A.</span> An MCO may provide its enrollees with additional health care services that are not required by this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.29#B">B.</span> Optional health care services that an applicant intends to include in its benefits package shall be specified, including the terms and conditions for, and limitations to the provision of these services, in the applicant's initial application to the Department, as well as for periodic Departmental review.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.29#C">C.</span> An MCO's provision of optional services that it has represented to be available to its enrollees is subject to monitoring of complaints and consumer satisfaction surveys, and to random audits.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.29#D">D.</span> An MCO's provision of additional services that are not required by this regulation may not be taken into account when setting the MCO's capitation rate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.29#E">E.</span> Effective January 1, 2015, any changes to the health care services being offered by the MCO under <a class="internal-link " href="/us/md/exec/comar/10.67.06.29#A" title="">§A of this regulation</a>, including reducing or waiving pharmacy co-pays, shall be effective for an entire calendar year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.29#F">F.</span> An MCO shall notify the Department of any changes to their optional services by September 15 for the following calendar year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.29#G">G.</span> The Department may waive the requirement under <a class="internal-link " href="/us/md/exec/comar/10.67.06.29#E" title="">§E of this regulation</a> if the Department determines that the circumstance warrant, including but not limited to a reduction in rates outside the normal rate setting process.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.30" data-order="|10|67|06|.30|" data-ref-path="10|67|06|.30" class="h__section">.30 Fertility Preservation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.30#A">A.</span> An MCO shall provide medically necessary fertility preservation services for the following individuals:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.30#A(1)">(1)</span> Individuals who have iatrogenic infertility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.30#A(2)">(2)</span> Individuals who are receiving medical treatment that may directly or indirectly cause iatrogenic infertility; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.06.30#A(3)">(3)</span> Individuals who are receiving gender-affirming treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.30#B">B.</span> Fertility preservation services include sperm and oocyte cryopreservation and evaluations, laboratory assessments, medications, and treatments associated with sperm and oocyte cryopreservation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.06.30#C">C.</span> Fertility preservation services do not include the storage of sperm or oocytes.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.06.31" data-order="|10|67|06|.31|" data-ref-path="10|67|06|.31" class="h__section">.31 Benefits — Telemedicine Services.</h3>
                <p>An MCO shall provide to its enrollees medically necessary telemedicine services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.49" title="Chapter 49 Telehealth Services">COMAR 10.09.49</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.07" data-order="|10|67|07|" data-ref-path="10|67|07" class="h__chapter">Chapter 07 Maryland Medicaid Managed Care Program: Program Integrity</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07.01#L" title="">Regulation .01L</a> amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07.01#N" title="">Regulation .01N</a> adopted effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.68" title="Chapter 68 Maryland Medicaid Managed Care Program: Program Integrity">COMAR 10.09.68</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, Title 15, Subtitle 1, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.07.01" data-order="|10|67|07|.01|" data-ref-path="10|67|07|.01" class="h__section">.01 Requirements to Detect and Prevent Fraud, Waste, and Abuse.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A">A.</span> An MCO or its responsible subcontractor shall implement and maintain arrangements or procedures that are designed to detect and prevent fraud, waste, and abuse, which includes a compliance program that has, at a minimum, the following elements:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(1)">(1)</span> Written policies, procedures, and standards of conduct that include the MCO’s commitment to comply with all applicable:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(1)(a)">(a)</span> Requirements and standards under the contract; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(1)(b)">(b)</span> Federal and State requirements including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(1)(b)(i)">(i)</span> Written policies for all employees and those of any contractor or agent that provide detailed information about the False Claims Act and other Federal and State laws described in §1902(a)(68) of the Social Security Act; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(1)(b)(ii)">(ii)</span> Information about rights of employees to be protected as whistleblowers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(2)">(2)</span> The designation of a compliance officer, who reports directly to the chief executive officer and the board of directors and is responsible for developing and implementing policies, procedures, and practices designed to ensure compliance with the requirements of the contract, and at minimum the following staff members:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(2)(a)">(a)</span> An investigator who is responsible for fraud, waste, and abuse investigations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(2)(b)">(b)</span> An auditor who is responsible for identifying potential fraud, waste, and abuse through analysis of claims and related information; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(2)(c)">(c)</span> An analyst capable of reviewing data and codes who is responsible for reviewing and researching evidence of potential fraud, waste, and abuse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(3)">(3)</span> Staffing and resources located in Maryland to identify and investigate potential fraud, waste, and abuse, which shall be based on criteria determined by the Department that may include but are not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(3)(a)">(a)</span> Number of enrollees;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(3)(b)">(b)</span> Number of claims received on an annual basis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(3)(c)">(c)</span> Volume of suspected fraudulent and abusive claims currently being detected;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(3)(d)">(d)</span> Other factors relating to the vulnerability of the MCO to fraud and abuse; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(3)(e)">(e)</span> An assessment of optimal caseload which can be handled by an investigator on an annual basis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(4)">(4)</span> The establishment of a regulatory compliance committee, which reports to the board of directors and to the MCO’s senior management level and is charged with overseeing the organization’s compliance program and its compliance with the requirements under the contract;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(5)">(5)</span> A system for training and educating the compliance officer, the organization’s senior management, and the organization’s employees regarding the federal and State standards and requirements under the contract;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(6)">(6)</span> Effective lines of communication between the compliance officer and the organization’s employees;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(7)">(7)</span> Enforcement of standards through well-publicized disciplinary guidelines;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(8)">(8)</span> Establishment and implementation of procedures and a system with dedicated staff for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(8)(a)">(a)</span> Routine internal monitoring and auditing of compliance risks;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(8)(b)">(b)</span> Prompt response to compliance issues as they are raised;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(8)(c)">(c)</span> Investigation of potential compliance problems as identified in the course of self-evaluation and audits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(8)(d)">(d)</span> Correction of problems, identified under §A(7)(c) of this regulation, promptly and thoroughly, or coordination of suspected criminal acts with law enforcement agencies, to reduce the potential for recurrence; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#A(8)(e)">(e)</span> Ongoing compliance with the requirements under the contract.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#B">B.</span> An MCO shall ensure that a subcontractor is legally qualified to furnish the services provided for in the subcontract.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#C">C.</span> An MCO may not contract with the State unless conflict of interest safeguards at least equal to federal safeguards under section 27 of 41 U.S.C. §423, as amended, are in place.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#D">D.</span> An MCO may not knowingly have a relationship of the type described in <a class="internal-link " href="/us/md/exec/comar/10.67.07.01#E" title="">§E of this regulation</a> with the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#D(1)">(1)</span> An individual or entity that is debarred, suspended, or otherwise excluded from:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#D(1)(a)">(a)</span> Participating in procurement activities under the Federal Acquisition Regulation; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#D(1)(b)">(b)</span> Participating in non-procurement activities under Executive Order Number 12549, 3 CFR 189 (1986); or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#D(2)">(2)</span> An individual or entity who is an affiliate, as defined in 48 CFR §2.101, of a person described in <a class="internal-link " href="/us/md/exec/comar/10.67.07.01#D(1)" title="">§D(1) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#E">E.</span> The relationships described in <a class="internal-link " href="/us/md/exec/comar/10.67.07.01#D" title="">§D of this Regulation</a>, are as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#E(1)">(1)</span> A director, officer, or partner of the MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#E(2)">(2)</span> A subcontractor of the MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#E(3)">(3)</span> A person with beneficial ownership of 5 percent or more of the MCO’s equity; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#E(4)">(4)</span> A network provider or person with an employment, consulting or other arrangement with the MCO for the provision of items and services that is significant and material to the MCO’s obligations under its contract with the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#F">F.</span> An MCO may not have a relationship with an individual or entity that is excluded from participation in any Federal health care program under §1128 or 1128A of the Social Security Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#G">G.</span> An MCO shall monitor the Department’s correspondence and any database publicizing Department-initiated terminations of providers from the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#H">H.</span> An MCO shall terminate the contract of, or refrain from contracting with, providers terminated or excluded from participation in the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#I">I.</span> An MCO shall suspend payments to a network provider for which the Department has determined that there is a credible allegation of fraud in accordance with 42 CFR §455.23.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#J">J.</span> An MCO shall establish a system to verify, by sampling or other methods, whether services that have been represented to have been delivered by network providers were received by enrollees and shall apply such verification processes at least annually.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#K">K.</span> An MCO shall require and have a mechanism for a network provider to report to the MCO when it has received an overpayment and to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#K(1)">(1)</span> Return the overpayment to the MCO within 60 calendar days after the date on which the overpayment was identified; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#K(2)">(2)</span> Notify the MCO in writing of the reason for the overpayment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#L">L.</span> Overpayments to Providers and Subcontractors.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#L(1)">(1)</span> Overpayments recovered by an MCO, including those recovered due to waste, fraud and abuse, may be retained by the MCO, so long as it is reported to the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#L(2)">(2)</span> If the Department, Federal government, or its agents identified the potential fraud, waste, or abuse that leads to recovery of funds paid to an MCO provider, and the MCO did not previously identify and report the provider for potential overpayments, the State shall have the right to recover from the MCO the entire amount of the overpayment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#L(3)">(3)</span> The State shall have the sole right of recovery of an overpayment when the MCO has identified the overpayment and the MCO has not initiated recovery within 90 days after the completion of the MCO’s investigation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#L(4)">(4)</span> The MCO shall have the right to appeal, pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.02" title=".02 Appeal.">COMAR 10.67.10.02</a>, the Department’s recovery of an overpayment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#M">M.</span> The Department has the authority to recover any overpayments made to MCOs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.01#N">N.</span> An MCO shall ensure that all of its network providers are screened, enrolled, and revalidated by the State as Medicaid providers, in accordance with 42 CFR part 455, subparts B and E.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.07.02" data-order="|10|67|07|.02|" data-ref-path="10|67|07|.02" class="h__section">.02 Access to Information.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#A">A.</span> An MCO, its subcontractors, and its subcontractor’s subcontractors shall permit the following organizations or their designees to inspect, evaluate, or audit books, records, contracts, computer or other electronic systems, premises, and facilities that pertain to the MCO’s Medicaid enrollees, and any aspect of services and activities performed, or determination of amounts payable under, the MCO’s contract with the Department:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#A(1)">(1)</span> The Department and its agents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#A(2)">(2)</span> The Medicaid Fraud Control Unit of the Office of the Attorney General;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#A(3)">(3)</span> The Insurance Fraud Division of the Maryland Insurance Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#A(4)">(4)</span> The Centers for Medicare and Medicaid Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#A(5)">(5)</span> The Inspector General of the Department of Health and Human Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#A(6)">(6)</span> The Comptroller General; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#A(7)">(7)</span> Other authorized State or federal agencies.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#B">B.</span> The right to inspect, audit, and evaluate shall exist for 10 years from the final date of the contract period or from the completion of any audit, whichever is later, except, if the Department, Centers for Medicare and Medicaid Services, or the Department of Health and Human Services Inspector General determines that there is a reasonable possibility of fraud, or similar risk, those agencies may inspect, audit, and evaluate at any time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.02#C">C.</span> Notwithstanding <a class="internal-link " href="/us/md/exec/comar/10.67.07.02#B" title="">§B of this regulation</a>, the Department has the right to inspect the accuracy, truthfulness, and completeness of the encounter data submitted by, or on behalf of, the MCO.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.07.03" data-order="|10|67|07|.03|" data-ref-path="10|67|07|.03" class="h__section">.03 Reporting.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A">A.</span> An MCO shall submit to the Department the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A(1)">(1)</span> Encounter data in the form and manner described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#B" title="">COMAR 10.67.04.15B</a>, 42 CFR §438.242(c), and 42 CFR §438.818.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A(2)">(2)</span> Data required by the Department in order to certify the actuarial soundness of capitation rates to an MCO, under 42 CFR §438.3, including base data described in 42 CFR §438.5(c) that is generated by the MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A(3)">(3)</span> Data required by the Department to determine compliance of the MCO with the medical loss ratio requirement described in 42 CFR §438.8.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A(4)">(4)</span> Data required by the Department and the Maryland Insurance Administration to determine that the MCO has made adequate provision against the risk of insolvency as required under 42 CFR §438.116.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A(5)">(5)</span> Documentation described in 42 CFR §438.207(b) on which the Department bases its certification that the MCO has complied with the State’s requirements for availability and accessibility of services, including the adequacy of the provider network, as set forth in 42 CFR §438.206.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A(6)">(6)</span> In accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.07.03#F" title="">§F of this regulation</a>, information on ownership and control described in 42 CFR §455.104 from an MCO and its subcontractors, as governed by 42 CFR §438.230.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A(7)">(7)</span> An annual report of overpayment recoveries as required in 42 CFR §438.608(d)(3).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#A(8)">(8)</span> Any other data, documentation, or information relating to the performance of the entity’s obligations under its contract with the Department, or required by the Department or the Secretary of the Department of Health and Human Services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#B">B.</span> An MCO shall report to the Department any identified inaccuracies in the encounter data reported by the MCO or its subcontractors within 30 days of the date discovered regardless of the effect which the inaccuracy has upon MCO reimbursement.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#C">C.</span> An MCO shall promptly report to the Department’s Office of Inspector General (OIG) any potential fraud, waste, abuse, or information it has received from whistleblowers relating to the integrity of the MCO, its network providers, or its subcontractors.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#D">D.</span> An MCO shall report any potential fraud directly to the Medicaid Fraud Control Unit and the Department’s OIG, including fraud by providers, employees and subcontractors of the MCO, enrollment agents, and enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#E">E.</span> After reporting any potential fraud, waste, or abuse to the Department’s OIG and to the Medicaid Fraud Control Unit, the MCO may not take the following actions without prior written approval from the State:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#E(1)">(1)</span> Contact the subject of the investigation about any matter related to the investigation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#E(2)">(2)</span> Enter into or attempt to negotiate any settlement or agreement regarding the incident; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#E(3)">(3)</span> Accept any monetary or other type of consideration offered by the subject of the investigation in connection with the incident.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F">F.</span> For complaints of provider fraud and abuse that warrant a preliminary investigation, the MCO’s reports required in §§C and D of this regulation shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F(1)">(1)</span> The number of complaints;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F(2)">(2)</span> The name and identification number of the provider being investigated;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F(3)">(3)</span> The source of the complaint;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F(4)">(4)</span> The type of provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F(5)">(5)</span> The nature of the complaint;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F(6)">(6)</span> The approximate dollar amount involved;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F(7)">(7)</span> The legal and administrative disposition of the case; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#F(8)">(8)</span> The method by which the MCO verified that the services being investigated were actually provided to the enrollee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#G">G.</span> An MCO shall provide to the Department written disclosure of any affiliation prohibited under 42 CFR §438.610 and take action as directed by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H">H.</span> An MCO shall provide to the Department written disclosures of information on ownership and control required under 42 CFR §455.104, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)">(1)</span> The following information for any individual or corporation with an ownership or control interest in the MCO:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(a)">(a)</span> For individuals:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(a)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(a)(ii)">(ii)</span> Address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(a)(iii)">(iii)</span> Date of birth; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(a)(iv)">(iv)</span> Social Security number; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(b)">(b)</span> For corporate entities:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(b)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(b)(ii)">(ii)</span> Applicable primary business address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(b)(iii)">(iii)</span> Every business location and applicable P.O. Box address; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(1)(b)(iv)">(iv)</span> Other tax identification number or any subcontractor in which the MCO has a 5 percent or more interest;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(2)">(2)</span> Whether the individual or corporation with an ownership or control interest in the MCO:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(2)(a)">(a)</span> Is related to another person with ownership or control interest in the disclosing entity as a spouse, parent, child, or sibling; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(2)(b)">(b)</span> Whether the individual or corporation with an ownership or control interest in any subcontractor in which the MCO has a 5 percent or more interest is related to another person with ownership or control interest in the MCO as a spouse, parent, child, or sibling;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(3)">(3)</span> The name of any other MCO in which an owner of the MCO has an ownership or control interest;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(4)">(4)</span> The name, address, date of birth, and Social Security number of any managing employee or agent of the MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(5)">(5)</span> Disclosures of ownership and control information from MCOs are due at the following times:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(5)(a)">(a)</span> Upon application;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(5)(b)">(b)</span> Upon the managed care entity executing the contract with the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(5)(c)">(c)</span> Upon renewal or extension of the contract; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#H(5)(d)">(d)</span> Within 35 days after any change in ownership of the managed care entity.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#I">I.</span> An MCO shall report to the Department all overpayments identified and recovered, specifying the overpayments due to fraud.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#J">J.</span> An MCO shall report third-party liability collection activities as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18" title=".18 Third-Party Liability.">COMAR 10.67.04.18</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#K">K.</span> An MCO shall report to the Department the amounts the MCO has cost-avoided and the number of third-party liability cases the MCO has handled.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#L">L.</span> An MCO shall notify the Department promptly when it has knowledge of an enrollee’s change of residence or death.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#M">M.</span> An MCO shall notify the Department promptly when the MCO receives information about a change in a network provider’s circumstances that may affect the network provider’s eligibility to participate in the Program, including the termination of the provider agreement with the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#N">N.</span> An MCO shall submit all required data, documentation and information in the format specified by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#O">O.</span> An MCO’s chief executive officer, chief financial officer, or directly-reporting authorized employee shall certify to the best of that individual’s information, knowledge, and belief, that any records, data, or other documents requested under regulations are accurate, complete and truthful.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#P">P.</span> As directed by the Department’s OIG, the MCO shall submit written reports documenting its Program Integrity efforts, including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#P(1)">(1)</span> The dollar amount of losses and recoveries attributable to overpayment, abuse, and fraud; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.07.03#P(2)">(2)</span> The number of referrals to the Department’s OIG during the prior State fiscal year.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.08" data-order="|10|67|08|" data-ref-path="10|67|08" class="h__chapter">Chapter 08 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.01" title=".01 Scope.">.01</a>—.11 adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730); adopted permanently effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.01" title=".01 Scope.">Regulation .01</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.02#C" title="">Regulation .02C</a>, D amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .05B amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .06B amended effective October 14, 2013 (40:20 Md. R. 1652); April 28, 2014 (41:8 Md. R. 471)</p>
                  <p>Regulation .06C amended as an emergency provision effective July 1, 1997 (24:16 Md. R. 1158); amended permanently effective December 29, 1997 (24:26 Md. R. 1759)</p>
                  <p>Regulation .07 amended as an emergency provision effective June 15, 2001 (28:13 Md. R. 1214); amended permanently effective September 17, 2001 (28:18 Md. R. 1621)</p>
                  <p>Regulation .07C amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p>Regulation .07H amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .08A amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .10 amended as an emergency provision effective July 1, 1997 (24:16 Md. R. 1158); amended permanently effective December 29, 1997 (24:26 Md. R. 1759)</p>
                  <p>Regulation .10A, C amended effective October 5, 2009 (36:20 Md. R. 1528); October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p>Regulation .10C amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p>Regulation .10C amended effective December 25, 2000 (27:25 Md. R. 2281); November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p>Regulation .11 repealed effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.01" title=".01 Scope.">.01</a>—.10 under, Maryland Medicaid Managed Care Program: Specialty Mental Health System, repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.03" title=".03 Nonbehavioral Health Fee-For-Service Benefits.">.03</a> under, Maryland Medicaid Managed Care Program: Non-Capitated Covered Services, adopted effective December 22, 2014 (41:25 Md. R. 1479)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.02" title=".02 Behavioral Health Non-Capitated Covered Services.">Regulation .02</a> amended effective October 26, 2015 (42:21 Md. R. 1301); August 29, 2016 (43:17 Md. R. 955); February 27, 2017 (44:4 Md. R. 253); March 26, 2018 (45:6 Md. R. 319)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.02#L" title="">Regulation .02L</a> amended effective May 20, 2019 (46:10 Md. R. 487)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.02#M" title="">Regulation .02M</a> amended effective May 20, 2019 (46:10 Md. R. 487)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.02#N" title="">Regulation .02N</a> adopted effective February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.03" title=".03 Nonbehavioral Health Fee-For-Service Benefits.">Regulation .03</a> amended effective October 22, 2018 (45:21 Md. R. 973)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.03#K" title="">Regulation .03K</a> amended effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.03#N" title="">Regulation .03N</a>, O amended effective August 28, 2017 (44:17 Md. R. 834)</p>
                  <p>Regulation .03P adopted effective August 28, 2017 (44:17 Md. R. 834)</p>
                  <p>Regulation .06E amended effective August 28, 2017 (44:17 Md. R. 834)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.70" title="Chapter 70 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services">COMAR 10.09.70</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.02" title=".02 Behavioral Health Non-Capitated Covered Services.">Regulation .02</a> amended effective December 27, 2021 (48:26 Md. R. 1112); November 13, 2023 (50:23 Md. R. 1005)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.03#F" title="">Regulation .03F</a> amended effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.03#I" title="">Regulation .03I</a> amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.03#M" title="">Regulation .03M</a>, N amended effective March 31, 2025 (52:6 Md. R. 267)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08.03#O" title="">Regulation .03O</a> adopted effective March 31, 2025 (52:6 Md. R. 267)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104(b), 15-103, and 15-105, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.08.01" data-order="|10|67|08|.01|" data-ref-path="10|67|08|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter describes the services that are not the responsibility of the MCOs but are covered by the Department on a fee-for-service basis.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.08.02" data-order="|10|67|08|.02|" data-ref-path="10|67|08|.02" class="h__section">.02 Behavioral Health Non-Capitated Covered Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#A">A.</span> An MCO is not responsible for reimbursing for the following substance use disorder services, regardless of diagnosis:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#A(1)">(1)</span> Services delivered by a community-based provider as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">COMAR 10.09.80</a> with the following procedure codes:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">H0001</td>
                        <td data-vertical-align="middle">Alcohol/drug assessment</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0004</td>
                        <td data-vertical-align="middle">Alcohol/drug individual counseling and therapy</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0005</td>
                        <td data-vertical-align="middle">Alcohol/drug group counseling</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0014</td>
                        <td data-vertical-align="middle">Alcohol and/or drug services; ambulatory detoxification</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0015</td>
                        <td data-vertical-align="middle">Alcohol and/or drug services; intensive outpatient</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0016</td>
                        <td data-vertical-align="middle">Alcohol and/or drug services; buprenorphine induction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0020</td>
                        <td data-vertical-align="middle">Alcohol and/or drug services; methadone administration and/or service</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0024</td>
                        <td data-vertical-align="middle">Group peer recovery support services</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0038</td>
                        <td data-vertical-align="middle">Individual peer recovery support services</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H0047</td>
                        <td data-vertical-align="middle">Alcohol and/or drug services; buprenorphine administration and/or service</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">H2036</td>
                        <td data-vertical-align="middle">Alcohol and/or drug services; partial hospitalization</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J8499</td>
                        <td data-vertical-align="middle">Prescription drug, oral, non-chemotherapeutic; buprenorphine</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J0571</td>
                        <td data-vertical-align="middle">Buprenorphine, oral, 1 mg</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J0572</td>
                        <td data-vertical-align="middle">Buprenorphine/naloxone, oral, less than or equal to 3 mg of buprenorphine</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J0573</td>
                        <td data-vertical-align="middle">Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J0574</td>
                        <td data-vertical-align="middle">Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Q9991</td>
                        <td data-vertical-align="middle">Injection, Buprenorphine extended-release, less than or equal to 100 mg</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Q9992</td>
                        <td data-vertical-align="middle">Injection, Buprenorphine extended-release, greater than 100 mg</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#A(2)">(2)</span> Substance use disorder services provided to children in an ICF-A with the revenue code 0100, Residential Services, child and adolescent.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#B">B.</span> An MCO is not responsible for reimbursing for the following services performed by free-standing laboratories, regardless of diagnosis:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#B(1)">(1)</span> Presumptive drug tests; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#B(2)">(2)</span> Definitive drug tests.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#C">C.</span> An MCO is not responsible for reimbursing for the laboratory services described in <a class="internal-link " href="/us/md/exec/comar/10.67.08.02#B" title="">§B of this regulation</a> unless billed by a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#C(1)">(1)</span> Primary care provider; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#C(2)">(2)</span> Other somatic care provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#D">D.</span> An MCO is not responsible for reimbursing for the following substance use disorder services if the MCO is billed with a primary diagnosis listed in <a class="internal-link " href="/us/md/exec/comar/10.67.08.02#M" title="">§M of this regulation</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#D(1)">(1)</span> Services delivered by an inpatient hospital with the following revenue codes:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">0114</td>
                        <td data-vertical-align="middle">Room and Board, Private Bed, Psychiatric</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0116</td>
                        <td data-vertical-align="middle">Room and Board, Private Bed, Detoxification</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0124</td>
                        <td data-vertical-align="middle">Room and Board, Semi-Private Bed, Psychiatric</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0126</td>
                        <td data-vertical-align="middle">Room and Board, Semi-Private Bed, Detoxification</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0134</td>
                        <td data-vertical-align="middle">Room and Board, 3-4 Beds, Psychiatric</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0136</td>
                        <td data-vertical-align="middle">Room and Board, 3-4 Beds, Detoxification</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0154</td>
                        <td data-vertical-align="middle">Room and Board, Ward, Psychiatric</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0156</td>
                        <td data-vertical-align="middle">Room and Board, Ward, Detoxification</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0169</td>
                        <td data-vertical-align="middle">Administrative Days</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0762</td>
                        <td data-vertical-align="middle">Room and Board, Observation Room</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#D(2)">(2)</span> Services delivered by an outpatient hospital with the following revenue codes:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">0900</td>
                        <td data-vertical-align="middle">Behavioral Health Treatments/Services-General Classification</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0905</td>
                        <td data-vertical-align="middle">Intensive Outpatient Services-Psychiatric</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0906</td>
                        <td data-vertical-align="middle">Intensive Outpatient Services-Chemical Dependency</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0911</td>
                        <td data-vertical-align="middle">Behavioral Health-Rehabilitation</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0912</td>
                        <td data-vertical-align="middle">Partial Hospitalization-Less Intensive</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0913</td>
                        <td data-vertical-align="middle">Partial Hospitalization-Intensive</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0914</td>
                        <td data-vertical-align="middle">Behavioral Health-Individual Therapy</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0915</td>
                        <td data-vertical-align="middle">Behavioral Health-Group Therapy</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0916</td>
                        <td data-vertical-align="middle">Behavioral Health-Family Therapy</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0918</td>
                        <td data-vertical-align="middle">Behavioral Health-Testing</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0919</td>
                        <td data-vertical-align="middle">Behavioral Health-Other</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0944</td>
                        <td data-vertical-align="middle">Drug rehabilitation</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0945</td>
                        <td data-vertical-align="middle">Alcohol rehabilitation</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#D(3)">(3)</span> Services delivered by an emergency department with the following revenue codes:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">0450</td>
                        <td data-vertical-align="middle">General classification</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0451</td>
                        <td data-vertical-align="middle">EMTALA</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0452</td>
                        <td data-vertical-align="middle">ER Beyond EMTALA</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0456</td>
                        <td data-vertical-align="middle">Urgent Care</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">0459</td>
                        <td data-vertical-align="middle">Other Emergency Room</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#E">E.</span> An MCO is not responsible for reimbursing for mental health services with a primary diagnosis listed in <a class="internal-link " href="/us/md/exec/comar/10.67.08.02#N" title="">§N of this regulation</a> when the services are provided by a hospital and the services are the result of the treatment of mental health diagnosis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#F">F.</span> An MCO shall be responsible for reimbursing for behavioral health services delivered by the participant’s primary care provider.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#G">G.</span> An MCO shall be responsible for reimbursing for somatic services related to gender identity disorder, including gender reassignment surgery.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#H">H.</span> An MCO is not responsible for reimbursing the behavioral poisoning diagnoses listed in <a class="internal-link " href="/us/md/exec/comar/10.67.08.02#P" title="">§P of this regulation</a> in an emergency department setting.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#I">I.</span> An MCO is not responsible for services billed by specialty mental health providers listed in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> when the bill includes the specialty behavioral health diagnoses listed in §M or N in the primary diagnosis field.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#J">J.</span> An MCO is not responsible for reimbursement of behavioral health crisis services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.16" title="Chapter 16 Behavioral Health Crisis Services">COMAR 10.09.16</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#K">K.</span> An MCO is not responsible for behavioral health medications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#L">L.</span> An MCO is not responsible for reimbursing for services billed by a physician related to prescribing buprenorphine or Vivitrol when the following conditions are met:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#L(1)">(1)</span> The physician delivering buprenorphine has a DATA 2000 waiver;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#L(2)">(2)</span> The physician is not the participant’s primary care provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#L(3)">(3)</span> The primary diagnosis is substance use disorder;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#L(4)">(4)</span> The primary reason for the visit is substance use disorder treatment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#L(5)">(5)</span> The procedure code listed on the claims is one of the following:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td colspan="2" data-vertical-align="middle">99202</td>
                        <td data-vertical-align="middle">Evaluation and Management, Straight forward, new patient</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99203</td>
                        <td colspan="2" data-vertical-align="middle">Evaluation and Management, Low complexity, new patient</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99204</td>
                        <td colspan="2" data-vertical-align="middle">Evaluation and Management, Moderately complex, new patient</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99205</td>
                        <td colspan="2" data-vertical-align="middle">Evaluation and Management, Highly complex, new patient</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99211</td>
                        <td colspan="2" data-vertical-align="middle">Evaluation and Management, Minimal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99212</td>
                        <td colspan="2" data-vertical-align="middle">Evaluation and Management, Straight forward</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99213</td>
                        <td colspan="2" data-vertical-align="middle">Evaluation and Management, Low complexity</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99214</td>
                        <td colspan="2" data-vertical-align="middle">Evaluation and Management, Moderately complex</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99215</td>
                        <td colspan="2" data-vertical-align="middle">Evaluation and Management, Highly complex</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J8499</td>
                        <td colspan="2" data-vertical-align="middle">Prescription drug, oral, non-chemotherapeutic; buprenorphine</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J2315</td>
                        <td colspan="2" data-vertical-align="middle">Vivitrol</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J0571</td>
                        <td colspan="2" data-vertical-align="middle">Buprenorphine, oral, 1 mg</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J0572</td>
                        <td colspan="2" data-vertical-align="middle">Buprenorphine/naloxone, oral, less than or equal to 3 mg of buprenorphine</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J0573</td>
                        <td colspan="2" data-vertical-align="middle">Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">J0574</td>
                        <td colspan="2" data-vertical-align="middle">Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Q9991</td>
                        <td colspan="2" data-vertical-align="middle">Injection, Buprenorphine extended-release, less than or equal to 100 mg</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Q9992</td>
                        <td colspan="2" data-vertical-align="middle">Injection, Buprenorphine extended-release, greater than 100 mg</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">80305</td>
                        <td colspan="2" data-vertical-align="middle">Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">80307</td>
                        <td colspan="2" data-vertical-align="middle">Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers (e.g., immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when performed, per date of service (when provider has appropriately licensed and has adequate instrumentation)</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#M">M.</span> Table of substance use disorder diagnoses, for dates of service on or after October 1, 2015:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">F1010</td>
                        <td data-vertical-align="middle">Alcohol abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1011</td>
                        <td data-vertical-align="middle">Alcohol abuse, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10120</td>
                        <td data-vertical-align="middle">Alcohol abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10121</td>
                        <td data-vertical-align="middle">Alcohol abuse with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10129</td>
                        <td data-vertical-align="middle">Alcohol abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1090</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1091</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10130</td>
                        <td data-vertical-align="middle">Alcohol abuse with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10131</td>
                        <td data-vertical-align="middle">Alcohol abuse with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10132</td>
                        <td data-vertical-align="middle">Alcohol abuse with withdrawal with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10139</td>
                        <td data-vertical-align="middle">Alcohol abuse with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1014</td>
                        <td data-vertical-align="middle">Alcohol abuse with alcohol-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10150</td>
                        <td data-vertical-align="middle">Alcohol abuse with alcohol-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10151</td>
                        <td data-vertical-align="middle">Alcohol abuse with alcohol-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10159</td>
                        <td data-vertical-align="middle">Alcohol abuse with alcohol-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10180</td>
                        <td data-vertical-align="middle">Alcohol abuse with alcohol-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10181</td>
                        <td data-vertical-align="middle">Alcohol abuse with alcohol-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10182</td>
                        <td data-vertical-align="middle">Alcohol abuse with alcohol-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10188</td>
                        <td data-vertical-align="middle">Alcohol abuse with other alcohol-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1019</td>
                        <td data-vertical-align="middle">Alcohol abuse with unspecified alcohol-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1020</td>
                        <td data-vertical-align="middle">Alcohol dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1021</td>
                        <td data-vertical-align="middle">Alcohol dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10220</td>
                        <td data-vertical-align="middle">Alcohol dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10221</td>
                        <td data-vertical-align="middle">Alcohol dependence with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10229</td>
                        <td data-vertical-align="middle">Alcohol dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10230</td>
                        <td data-vertical-align="middle">Alcohol dependence with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10231</td>
                        <td data-vertical-align="middle">Alcohol dependence with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10232</td>
                        <td data-vertical-align="middle">Alcohol dependence with withdrawal with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10239</td>
                        <td data-vertical-align="middle">Alcohol dependence with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1024</td>
                        <td data-vertical-align="middle">Alcohol dependence with alcohol-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10250</td>
                        <td data-vertical-align="middle">Alcohol dependence with alcohol-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10251</td>
                        <td data-vertical-align="middle">Alcohol dependence with alcohol-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10259</td>
                        <td data-vertical-align="middle">Alcohol dependence with alcohol-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10280</td>
                        <td data-vertical-align="middle">Alcohol dependence with alcohol-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10281</td>
                        <td data-vertical-align="middle">Alcohol dependence with alcohol-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10282</td>
                        <td data-vertical-align="middle">Alcohol dependence with alcohol-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10288</td>
                        <td data-vertical-align="middle">Alcohol dependence with other alcohol-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1029</td>
                        <td data-vertical-align="middle">Alcohol dependence with unspecified alcohol-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10920</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10921</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10929</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10930</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10931</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10932</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with withdrawal with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10939</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1094</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with alcohol-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10950</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10951</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10959</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10980</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with alcohol-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10981</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with alcohol-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10982</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with alcohol-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F10988</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with other alcohol-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1099</td>
                        <td data-vertical-align="middle">Alcohol use, unspecified with unspecified alcohol-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1110</td>
                        <td data-vertical-align="middle">Opioid abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1111</td>
                        <td data-vertical-align="middle">Opioid abuse, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11120</td>
                        <td data-vertical-align="middle">Opioid abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11121</td>
                        <td data-vertical-align="middle">Opioid abuse with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11122</td>
                        <td data-vertical-align="middle">Opioid abuse with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11129</td>
                        <td data-vertical-align="middle">Opioid abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1113</td>
                        <td data-vertical-align="middle">Opioid abuse with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1114</td>
                        <td data-vertical-align="middle">Opioid abuse with opioid-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11150</td>
                        <td data-vertical-align="middle">Opioid abuse with opioid-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11151</td>
                        <td data-vertical-align="middle">Opioid abuse with opioid-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11159</td>
                        <td data-vertical-align="middle">Opioid abuse with opioid-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11181</td>
                        <td data-vertical-align="middle">Opioid abuse with opioid-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11182</td>
                        <td data-vertical-align="middle">Opioid abuse with opioid-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11188</td>
                        <td data-vertical-align="middle">Opioid abuse with other opioid-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1119</td>
                        <td data-vertical-align="middle">Opioid abuse with unspecified opioid-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1120</td>
                        <td data-vertical-align="middle">Opioid dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1121</td>
                        <td data-vertical-align="middle">Opioid dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11220</td>
                        <td data-vertical-align="middle">Opioid dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11221</td>
                        <td data-vertical-align="middle">Opioid dependence with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11222</td>
                        <td data-vertical-align="middle">Opioid dependence with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11229</td>
                        <td data-vertical-align="middle">Opioid dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1123</td>
                        <td data-vertical-align="middle">Opioid dependence with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1124</td>
                        <td data-vertical-align="middle">Opioid dependence with opioid-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11250</td>
                        <td data-vertical-align="middle">Opioid dependence with opioid-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11251</td>
                        <td data-vertical-align="middle">Opioid dependence with opioid-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11259</td>
                        <td data-vertical-align="middle">Opioid dependence with opioid-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11281</td>
                        <td data-vertical-align="middle">Opioid dependence with opioid-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11282</td>
                        <td data-vertical-align="middle">Opioid dependence with opioid-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11288</td>
                        <td data-vertical-align="middle">Opioid dependence with other opioid-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1129</td>
                        <td data-vertical-align="middle">Opioid dependence with unspecified opioid-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1190</td>
                        <td data-vertical-align="middle">Opioid use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1191</td>
                        <td data-vertical-align="middle">Opioid use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11920</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11921</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11922</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11929</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1193</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1194</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with opioid-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11950</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with opioid-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11951</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11959</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with opioid-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11981</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with opioid-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11982</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with opioid-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F11988</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with other opioid-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1199</td>
                        <td data-vertical-align="middle">Opioid use, unspecified with unspecified opioid-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1210</td>
                        <td data-vertical-align="middle">Cannabis abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1211</td>
                        <td data-vertical-align="middle">Cannabis abuse, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12120</td>
                        <td data-vertical-align="middle">Cannabis abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12121</td>
                        <td data-vertical-align="middle">Cannabis abuse with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12122</td>
                        <td data-vertical-align="middle">Cannabis abuse with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12129</td>
                        <td data-vertical-align="middle">Cannabis abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1213</td>
                        <td data-vertical-align="middle">Cannabis abuse with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12150</td>
                        <td data-vertical-align="middle">Cannabis abuse with psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12151</td>
                        <td data-vertical-align="middle">Cannabis abuse with psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12159</td>
                        <td data-vertical-align="middle">Cannabis abuse with psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12180</td>
                        <td data-vertical-align="middle">Cannabis abuse with cannabis-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12188</td>
                        <td data-vertical-align="middle">Cannabis abuse with other cannabis-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1219</td>
                        <td data-vertical-align="middle">Cannabis abuse with unspecified cannabis-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1220</td>
                        <td data-vertical-align="middle">Cannabis dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1221</td>
                        <td data-vertical-align="middle">Cannabis dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12220</td>
                        <td data-vertical-align="middle">Cannabis dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12221</td>
                        <td data-vertical-align="middle">Cannabis dependence with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12222</td>
                        <td data-vertical-align="middle">Cannabis dependence with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12229</td>
                        <td data-vertical-align="middle">Cannabis dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1223</td>
                        <td data-vertical-align="middle">Cannabis dependence with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12250</td>
                        <td data-vertical-align="middle">Cannabis dependence with psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12251</td>
                        <td data-vertical-align="middle">Cannabis dependence with psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12259</td>
                        <td data-vertical-align="middle">Cannabis dependence with psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12280</td>
                        <td data-vertical-align="middle">Cannabis dependence with cannabis-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12288</td>
                        <td data-vertical-align="middle">Cannabis dependence with other cannabis-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1229</td>
                        <td data-vertical-align="middle">Cannabis dependence with unspecified cannabis-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1290</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1291</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12920</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12921</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12922</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12929</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1293</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12950</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12951</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12959</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12980</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F12988</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with other cannabis-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1299</td>
                        <td data-vertical-align="middle">Cannabis use, unspecified with unspecified cannabis-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1310</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1311</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13120</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13121</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13129</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13130</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13131</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13132</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13139</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1314</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13150</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13151</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13159</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13180</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13181</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13182</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13188</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1319</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1320</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1321</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13220</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13221</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13229</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13230</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13231</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13232</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13239</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1324</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13250</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13251</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13259</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13280</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13281</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13282</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13288</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1329</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1390</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1391</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13920</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13921</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13929</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13930</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13931</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13932</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with withdrawal with perceptual disturbances</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13939</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1394</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with sedative, hypnotic, or anxiolytic-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13950</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with sedative, hypnotic, or anxiolytic-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13951</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with sedative, hypnotic, or anxiolytic-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13959</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with sedative, hypnotic, or anxiolytic-induced psychotic disorder with, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13980</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with sedative, hypnotic, or anxiolytic-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13981</td>
                        <td data-vertical-align="middle">Sedative, hypnotic, or anxiolytic use, unspecified with sedative, hypnotic, or anxiolytic-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13982</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic, or anxiolytic-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F13988</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic, or anxiolytic-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1399</td>
                        <td data-vertical-align="middle">Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic, or anxiolytic-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1410</td>
                        <td data-vertical-align="middle">Cocaine abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14120</td>
                        <td data-vertical-align="middle">Cocaine abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14121</td>
                        <td data-vertical-align="middle">Cocaine abuse with intoxication with delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14122</td>
                        <td data-vertical-align="middle">Cocaine abuse with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14129</td>
                        <td data-vertical-align="middle">Cocaine abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1413</td>
                        <td data-vertical-align="middle">Cocaine abuse, unspecified with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1414</td>
                        <td data-vertical-align="middle">Cocaine abuse with cocaine-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14150</td>
                        <td data-vertical-align="middle">Cocaine abuse with cocaine-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14151</td>
                        <td data-vertical-align="middle">Cocaine abuse with cocaine-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14159</td>
                        <td data-vertical-align="middle">Cocaine abuse with cocaine-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14180</td>
                        <td data-vertical-align="middle">Cocaine abuse with cocaine-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14181</td>
                        <td data-vertical-align="middle">Cocaine abuse with cocaine-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14182</td>
                        <td data-vertical-align="middle">Cocaine abuse with cocaine-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14188</td>
                        <td data-vertical-align="middle">Cocaine abuse with other cocaine-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1419</td>
                        <td data-vertical-align="middle">Cocaine abuse with unspecified cocaine-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1420</td>
                        <td data-vertical-align="middle">Cocaine dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1421</td>
                        <td data-vertical-align="middle">Cocaine dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14220</td>
                        <td data-vertical-align="middle">Cocaine dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14221</td>
                        <td data-vertical-align="middle">Cocaine dependence with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14222</td>
                        <td data-vertical-align="middle">Cocaine dependence with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14229</td>
                        <td data-vertical-align="middle">Cocaine dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1423</td>
                        <td data-vertical-align="middle">Cocaine dependence with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1424</td>
                        <td data-vertical-align="middle">Cocaine dependence with cocaine-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14250</td>
                        <td data-vertical-align="middle">Cocaine dependence with cocaine-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14251</td>
                        <td data-vertical-align="middle">Cocaine dependence with cocaine-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14259</td>
                        <td data-vertical-align="middle">Cocaine dependence with cocaine-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14280</td>
                        <td data-vertical-align="middle">Cocaine dependence with cocaine-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14281</td>
                        <td data-vertical-align="middle">Cocaine dependence with cocaine-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14282</td>
                        <td data-vertical-align="middle">Cocaine dependence with cocaine-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14288</td>
                        <td data-vertical-align="middle">Cocaine dependence with other cocaine-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1429</td>
                        <td data-vertical-align="middle">Cocaine dependence with unspecified cocaine-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1490</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1491</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14920</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14921</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14922</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14929</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1493</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1494</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with cocaine-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14950</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14951</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with cocaine-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14959</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14980</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with cocaine-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14981</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with cocaine-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14982</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with cocaine-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F14988</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with other cocaine-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1499</td>
                        <td data-vertical-align="middle">Cocaine use, unspecified with unspecified cocaine-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1510</td>
                        <td data-vertical-align="middle">Other stimulant abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15120</td>
                        <td data-vertical-align="middle">Other stimulant abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15121</td>
                        <td data-vertical-align="middle">Other stimulant abuse with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15122</td>
                        <td data-vertical-align="middle">Other stimulant abuse with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15129</td>
                        <td data-vertical-align="middle">Other stimulant abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1513</td>
                        <td data-vertical-align="middle">Other stimulant abuse with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1514</td>
                        <td data-vertical-align="middle">Other stimulant abuse with stimulant-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15150</td>
                        <td data-vertical-align="middle">Other stimulant abuse with stimulant-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15151</td>
                        <td data-vertical-align="middle">Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15159</td>
                        <td data-vertical-align="middle">Other stimulant abuse with stimulant-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15180</td>
                        <td data-vertical-align="middle">Other stimulant abuse with stimulant-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15181</td>
                        <td data-vertical-align="middle">Other stimulant abuse with stimulant-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15182</td>
                        <td data-vertical-align="middle">Other stimulant abuse with stimulant-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15188</td>
                        <td data-vertical-align="middle">Other stimulant abuse with other stimulant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1519</td>
                        <td data-vertical-align="middle">Other stimulant abuse with unspecified stimulant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1520</td>
                        <td data-vertical-align="middle">Other stimulant dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1521</td>
                        <td data-vertical-align="middle">Other stimulant dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15220</td>
                        <td data-vertical-align="middle">Other stimulant dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15221</td>
                        <td data-vertical-align="middle">Other stimulant dependence with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15222</td>
                        <td data-vertical-align="middle">Other stimulant dependence with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15229</td>
                        <td data-vertical-align="middle">Other stimulant dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1523</td>
                        <td data-vertical-align="middle">Other stimulant dependence with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1524</td>
                        <td data-vertical-align="middle">Other stimulant dependence with stimulant-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15250</td>
                        <td data-vertical-align="middle">Other stimulant dependence with stimulant-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15251</td>
                        <td data-vertical-align="middle">Other stimulant dependence with stimulant-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15259</td>
                        <td data-vertical-align="middle">Other stimulant dependence with stimulant-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15280</td>
                        <td data-vertical-align="middle">Other stimulant dependence with stimulant-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15281</td>
                        <td data-vertical-align="middle">Other stimulant dependence with stimulant-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15282</td>
                        <td data-vertical-align="middle">Other stimulant dependence with stimulant-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15288</td>
                        <td data-vertical-align="middle">Other stimulant dependence with other stimulant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1529</td>
                        <td data-vertical-align="middle">Other stimulant dependence with unspecified stimulant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1590</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1591</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15920</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15921</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15922</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15929</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1593</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1594</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with stimulant-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15950</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15951</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15959</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15980</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with stimulant-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15981</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with stimulant-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15982</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with stimulant-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F15988</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with other stimulant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1599</td>
                        <td data-vertical-align="middle">Other stimulant use, unspecified with unspecified stimulant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1610</td>
                        <td data-vertical-align="middle">Hallucinogen abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16120</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16121</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with intoxication with delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16122</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16129</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1614</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with hallucinogen-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16150</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16151</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16159</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16180</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with hallucinogen-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16183</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16188</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with other hallucinogen-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1619</td>
                        <td data-vertical-align="middle">Hallucinogen abuse with unspecified hallucinogen-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1620</td>
                        <td data-vertical-align="middle">Hallucinogen dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1621</td>
                        <td data-vertical-align="middle">Hallucinogen dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16220</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16221</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with intoxication with delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16229</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1624</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with hallucinogen-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16250</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16251</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16259</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16280</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with hallucinogen-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16283</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16288</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with other hallucinogen-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1629</td>
                        <td data-vertical-align="middle">Hallucinogen dependence with unspecified hallucinogen-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1690</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1691</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16920</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16921</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with intoxication with delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16929</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1694</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with hallucinogen-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16950</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16951</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16959</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16980</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16983</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F16988</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with other hallucinogen-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1699</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17200</td>
                        <td data-vertical-align="middle">Nicotine dependence, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17201</td>
                        <td data-vertical-align="middle">Nicotine dependence, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17203</td>
                        <td data-vertical-align="middle">Nicotine dependence unspecified, with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17208</td>
                        <td data-vertical-align="middle">Nicotine dependence, unspecified, with other nicotine-induced disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17209</td>
                        <td data-vertical-align="middle">Nicotine dependence, unspecified, with unspecified nicotine-induced disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17210</td>
                        <td data-vertical-align="middle">Nicotine dependence, cigarettes, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17211</td>
                        <td data-vertical-align="middle">Nicotine dependence, cigarettes, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17213</td>
                        <td data-vertical-align="middle">Nicotine dependence, cigarettes, with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17218</td>
                        <td data-vertical-align="middle">Nicotine dependence, cigarettes, with other nicotine-induced disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17219</td>
                        <td data-vertical-align="middle">Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17220</td>
                        <td data-vertical-align="middle">Nicotine dependence, chewing tobacco, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17221</td>
                        <td data-vertical-align="middle">Nicotine dependence, chewing tobacco, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17223</td>
                        <td data-vertical-align="middle">Nicotine dependence, chewing tobacco, with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17228</td>
                        <td data-vertical-align="middle">Nicotine dependence, chewing tobacco, with other nicotine-induced disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17229</td>
                        <td data-vertical-align="middle">Nicotine dependence, chewing tobacco, with unspecified nicotine-induced disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17290</td>
                        <td data-vertical-align="middle">Nicotine dependence, other tobacco product, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17291</td>
                        <td data-vertical-align="middle">Nicotine dependence, other tobacco product, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17293</td>
                        <td data-vertical-align="middle">Nicotine dependence, other tobacco product, with withdrawal</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17298</td>
                        <td data-vertical-align="middle">Nicotine dependence, other tobacco product, with other nicotine-induced disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F17299</td>
                        <td data-vertical-align="middle">Nicotine dependence, other tobacco product, with unspecified nicotine-induced disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1810</td>
                        <td data-vertical-align="middle">Inhalant abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18120</td>
                        <td data-vertical-align="middle">Inhalant abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18121</td>
                        <td data-vertical-align="middle">Inhalant abuse with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18129</td>
                        <td data-vertical-align="middle">Inhalant abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1814</td>
                        <td data-vertical-align="middle">Inhalant abuse with inhalant-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18150</td>
                        <td data-vertical-align="middle">Inhalant abuse with inhalant-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18151</td>
                        <td data-vertical-align="middle">Inhalant abuse with inhalant-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18159</td>
                        <td data-vertical-align="middle">Inhalant abuse with inhalant-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1817</td>
                        <td data-vertical-align="middle">Inhalant abuse with inhalant-induced dementia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18180</td>
                        <td data-vertical-align="middle">Inhalant abuse with inhalant-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18188</td>
                        <td data-vertical-align="middle">Inhalant abuse with other inhalant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1819</td>
                        <td data-vertical-align="middle">Inhalant abuse with unspecified inhalant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1820</td>
                        <td data-vertical-align="middle">Inhalant dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1821</td>
                        <td data-vertical-align="middle">Inhalant dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18220</td>
                        <td data-vertical-align="middle">Inhalant dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18221</td>
                        <td data-vertical-align="middle">Inhalant dependence with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18229</td>
                        <td data-vertical-align="middle">Inhalant dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1824</td>
                        <td data-vertical-align="middle">Inhalant dependence with inhalant-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18250</td>
                        <td data-vertical-align="middle">Inhalant dependence with inhalant-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18251</td>
                        <td data-vertical-align="middle">Inhalant dependence with inhalant-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18259</td>
                        <td data-vertical-align="middle">Inhalant dependence with inhalant-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1827</td>
                        <td data-vertical-align="middle">Inhalant dependence with inhalant-induced dementia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18280</td>
                        <td data-vertical-align="middle">Inhalant dependence with inhalant-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18288</td>
                        <td data-vertical-align="middle">Inhalant dependence with other inhalant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1829</td>
                        <td data-vertical-align="middle">Inhalant dependence with unspecified inhalant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1890</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1891</td>
                        <td data-vertical-align="middle">Hallucinogen use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18920</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18921</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with intoxication with delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18929</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1894</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with inhalant-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18950</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18951</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18959</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18980</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with inhalant-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F18988</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with other inhalant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1899</td>
                        <td data-vertical-align="middle">Inhalant use, unspecified with unspecified inhalant-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1910</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19120</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19121</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19122</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with intoxication with perceptual disturbances</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19129</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19130</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19131</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19132</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with withdrawal with perceptual disturbances</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19139</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1914</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with psychoactive substance-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19150</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19151</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19159</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19180</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19181</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19182</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with psychoactive substance-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19188</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with other psychoactive substance-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1919</td>
                        <td data-vertical-align="middle">Other psychoactive substance abuse with unspecified substance-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1920</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1921</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19220</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19221</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with intoxication delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19222</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19229</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19230</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19231</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19232</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with withdrawal with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19239</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1924</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with psychoactive substance-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19250</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19251</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19259</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with substance-induced psychotic disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19280</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19281</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19282</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with psychoactive substance-induced sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19288</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with other psychoactive substance-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1929</td>
                        <td data-vertical-align="middle">Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1990</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1991</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified, in remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19920</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with intoxication, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19921</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with intoxication with delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19922</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with intoxication with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19929</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with intoxication, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19930</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with withdrawal, uncomplicated</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19931</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with withdrawal delirium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19932</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19939</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with withdrawal, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1994</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19950</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19951</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19959</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with psychoactive disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19980</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19981</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with sexual dysfunction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19982</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with sleep disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F19988</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with other disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F1999</td>
                        <td data-vertical-align="middle">Other psychoactive substance use, unspecified with unspecified disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99310</td>
                        <td data-vertical-align="middle">Alcohol use complicating pregnancy, unspecified trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99311</td>
                        <td data-vertical-align="middle">Alcohol use complicating pregnancy, first trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99312</td>
                        <td data-vertical-align="middle">Alcohol use complicating pregnancy, second trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99313</td>
                        <td data-vertical-align="middle">Alcohol use complicating pregnancy, third trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99314</td>
                        <td data-vertical-align="middle">Alcohol use complicating childbirth</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99315</td>
                        <td data-vertical-align="middle">Alcohol use complicating the puerperium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99320</td>
                        <td data-vertical-align="middle">Drug use complicating pregnancy, unspecified trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99321</td>
                        <td data-vertical-align="middle">Drug use complicating pregnancy, first trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99322</td>
                        <td data-vertical-align="middle">Drug use complicating pregnancy, second trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99323</td>
                        <td data-vertical-align="middle">Drug use complicating pregnancy, third trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99324</td>
                        <td data-vertical-align="middle">Drug use complicating childbirth</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99325</td>
                        <td data-vertical-align="middle">Drug use complicating the puerperium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R780</td>
                        <td data-vertical-align="middle">Finding of alcohol in blood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R781</td>
                        <td data-vertical-align="middle">Finding of opiate drug in blood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R782</td>
                        <td data-vertical-align="middle">Finding of cocaine in blood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R783</td>
                        <td data-vertical-align="middle">Finding of hallucinogen in blood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R784</td>
                        <td data-vertical-align="middle">Finding of other drugs of addictive potential in blood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R785</td>
                        <td data-vertical-align="middle">Finding of other psychotropic drug in blood</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#N">N.</span> Table of mental health diagnoses, for dates of service on or after October 1, 2015:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">F200</td>
                        <td data-vertical-align="middle">Paranoid schizophrenia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F201</td>
                        <td data-vertical-align="middle">Disorganized schizophrenia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F202</td>
                        <td data-vertical-align="middle">Catatonic schizophrenia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F203</td>
                        <td data-vertical-align="middle">Undifferentiated schizophrenia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F205</td>
                        <td data-vertical-align="middle">Residual schizophrenia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F2081</td>
                        <td data-vertical-align="middle">Schizophreniform disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F2089</td>
                        <td data-vertical-align="middle">Other schizophrenia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F209</td>
                        <td data-vertical-align="middle">Schizophrenia, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F21</td>
                        <td data-vertical-align="middle">Schizotypal disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F22</td>
                        <td data-vertical-align="middle">Delusional disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F23</td>
                        <td data-vertical-align="middle">Brief psychotic disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F24</td>
                        <td data-vertical-align="middle">Shared psychotic disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F250</td>
                        <td data-vertical-align="middle">Schizoaffective disorder, bipolar type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F251</td>
                        <td data-vertical-align="middle">Schizoaffective disorder, depressive type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F258</td>
                        <td data-vertical-align="middle">Other schizoaffective disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F259</td>
                        <td data-vertical-align="middle">Schizoaffective disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F28</td>
                        <td data-vertical-align="middle">Other psychotic disorder not due to a substance or known physiological condition</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F29</td>
                        <td data-vertical-align="middle">Unspecified psychosis not due to a substance or known physiological condition</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3010</td>
                        <td data-vertical-align="middle">Manic episode without psychotic symptoms, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3011</td>
                        <td data-vertical-align="middle">Manic episode without psychotic symptoms, mild</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3012</td>
                        <td data-vertical-align="middle">Manic episode without psychotic symptoms, moderate</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3013</td>
                        <td data-vertical-align="middle">Manic episode, severe, without psychotic symptoms</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F302</td>
                        <td data-vertical-align="middle">Manic episode, severe with psychotic symptoms</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F303</td>
                        <td data-vertical-align="middle">Manic episode in partial remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F304</td>
                        <td data-vertical-align="middle">Manic episode in full remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F308</td>
                        <td data-vertical-align="middle">Other manic episodes</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F309</td>
                        <td data-vertical-align="middle">Manic episode, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F310</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode hypomanic</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3110</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode manic without psychotic features, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3111</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode manic without psychotic features, mild</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3112</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode manic without psychotic features, mod</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3113</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode manic without psychotic features, severe</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F312</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode manic severe with psychotic features</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3130</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode depressed, mild or moderate severity, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3131</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode depressed, mild</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3132</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode depressed, moderate</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F314</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode depressed, severe, without psychotic features</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F315</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode depressed, severe, with psychotic features</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3160</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode mixed, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3161</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode mixed, mild</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3162</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode mixed, moderate</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3163</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode mixed, severe, without psychotic features</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3164</td>
                        <td data-vertical-align="middle">Bipolar disorder, current episode mixed, severe, with psychotic features</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3170</td>
                        <td data-vertical-align="middle">Bipolar disorder, currently in remission, most recent episode unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3171</td>
                        <td data-vertical-align="middle">Bipolar disorder, in partial remission, most recent episode hypomanic</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3172</td>
                        <td data-vertical-align="middle">Bipolar disorder, in full remission, most recent episode hypomanic</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3173</td>
                        <td data-vertical-align="middle">Bipolar disorder, in partial remission, most recent episode manic</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3174</td>
                        <td data-vertical-align="middle">Bipolar disorder, in full remission, most recent episode manic</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3175</td>
                        <td data-vertical-align="middle">Bipolar disorder, in partial remission, most recent episode depressed</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3176</td>
                        <td data-vertical-align="middle">Bipolar disorder, in full remission, most recent episode depressed</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3177</td>
                        <td data-vertical-align="middle">Bipolar disorder, in partial remission, most recent episode mixed</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3178</td>
                        <td data-vertical-align="middle">Bipolar disorder, in full remission, most recent episode mixed</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3181</td>
                        <td data-vertical-align="middle">Bipolar II disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3189</td>
                        <td data-vertical-align="middle">Other bipolar disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F319</td>
                        <td data-vertical-align="middle">Bipolar disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F32A</td>
                        <td data-vertical-align="middle">Depression, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F320</td>
                        <td data-vertical-align="middle">Major depressive disorder, single episode, mild</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F321</td>
                        <td data-vertical-align="middle">Major depressive disorder, single episode, moderate</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F322</td>
                        <td data-vertical-align="middle">Major depressive disorder, single episode, severe without psychotic features</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F323</td>
                        <td data-vertical-align="middle">Major depressive disorder, single episode, severe with psychotic features</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F324</td>
                        <td data-vertical-align="middle">Major depressive disorder, single episode, in partial remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F325</td>
                        <td data-vertical-align="middle">Major depressive disorder, single episode, in full remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3281</td>
                        <td data-vertical-align="middle">Premenstrual dysphoric disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3289</td>
                        <td data-vertical-align="middle">Other specified depressive episodes</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F329</td>
                        <td data-vertical-align="middle">Major depressive disorder, single episode, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F330</td>
                        <td data-vertical-align="middle">Major depressive disorder, recurrent, mild</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F331</td>
                        <td data-vertical-align="middle">Major depressive disorder, recurrent, moderate</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F332</td>
                        <td data-vertical-align="middle">Major depressive disorder, recurrent severe without psychotic features</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F333</td>
                        <td data-vertical-align="middle">Major depressive disorder, recurrent, severe with psychotic symptoms</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3340</td>
                        <td data-vertical-align="middle">Major depressive disorder, recurrent, in remission, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3341</td>
                        <td data-vertical-align="middle">Major depressive disorder, recurrent, in partial remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3342</td>
                        <td data-vertical-align="middle">Major depressive disorder, recurrent, in full remission</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F338</td>
                        <td data-vertical-align="middle">Other recurrent depressive disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F339</td>
                        <td data-vertical-align="middle">Major depressive disorder, recurrent, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F340</td>
                        <td data-vertical-align="middle">Cyclothymic disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F341</td>
                        <td data-vertical-align="middle">Dysthymic disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3481</td>
                        <td data-vertical-align="middle">Disruptive mood dysregulation disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F3489</td>
                        <td data-vertical-align="middle">Other specified persistent mood disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F349</td>
                        <td data-vertical-align="middle">Persistent mood (affective) disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F39</td>
                        <td data-vertical-align="middle">Unspecified mood (affective) disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4000</td>
                        <td data-vertical-align="middle">Agoraphobia, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4001</td>
                        <td data-vertical-align="middle">Agoraphobia with panic disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4002</td>
                        <td data-vertical-align="middle">Agoraphobia without panic disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4010</td>
                        <td data-vertical-align="middle">Social phobia, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4011</td>
                        <td data-vertical-align="middle">Social phobia, generalized</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40210</td>
                        <td data-vertical-align="middle">Arachnophobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40218</td>
                        <td data-vertical-align="middle">Other animal type phobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40220</td>
                        <td data-vertical-align="middle">Fear of thunderstorms</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40228</td>
                        <td data-vertical-align="middle">Other natural environment type phobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40230</td>
                        <td data-vertical-align="middle">Fear of blood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40231</td>
                        <td data-vertical-align="middle">Fear of injections and transfusions</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40232</td>
                        <td data-vertical-align="middle">Fear of other medical care</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40233</td>
                        <td data-vertical-align="middle">Fear of injury</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40240</td>
                        <td data-vertical-align="middle">Claustrophobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40241</td>
                        <td data-vertical-align="middle">Acrophobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40242</td>
                        <td data-vertical-align="middle">Fear of bridges</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40243</td>
                        <td data-vertical-align="middle">Fear of flying</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40248</td>
                        <td data-vertical-align="middle">Other situational type phobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40290</td>
                        <td data-vertical-align="middle">Androphobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40291</td>
                        <td data-vertical-align="middle">Gynephobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F40298</td>
                        <td data-vertical-align="middle">Other specified phobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F408</td>
                        <td data-vertical-align="middle">Other phobic anxiety disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F409</td>
                        <td data-vertical-align="middle">Phobic anxiety disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F410</td>
                        <td data-vertical-align="middle">Panic disorder without agoraphobia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F411</td>
                        <td data-vertical-align="middle">Generalized anxiety disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F413</td>
                        <td data-vertical-align="middle">Other mixed anxiety disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F418</td>
                        <td data-vertical-align="middle">Other specified anxiety disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F419</td>
                        <td data-vertical-align="middle">Anxiety disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F422</td>
                        <td data-vertical-align="middle">Mixed obsessional thoughts and acts</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F423</td>
                        <td data-vertical-align="middle">Hoarding disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F424</td>
                        <td data-vertical-align="middle">Excoriation (skin-picking) disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F428</td>
                        <td data-vertical-align="middle">Other obsessive compulsive disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F429</td>
                        <td data-vertical-align="middle">Obsessive-compulsive disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F430</td>
                        <td data-vertical-align="middle">Acute stress reaction</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4310</td>
                        <td data-vertical-align="middle">Post-traumatic stress disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4311</td>
                        <td data-vertical-align="middle">Post-traumatic stress disorder, acute</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4312</td>
                        <td data-vertical-align="middle">Post-traumatic stress disorder, chronic</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4320</td>
                        <td data-vertical-align="middle">Adjustment disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4321</td>
                        <td data-vertical-align="middle">Adjustment disorder with depressed mood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4322</td>
                        <td data-vertical-align="middle">Adjustment disorder with anxiety</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4323</td>
                        <td data-vertical-align="middle">Adjustment disorder with mixed anxiety and depressed mood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4324</td>
                        <td data-vertical-align="middle">Adjustment disorder with disturbance of conduct</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4325</td>
                        <td data-vertical-align="middle">Adjustment disorder with mixed disturbance of emotions and conduct</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4329</td>
                        <td data-vertical-align="middle">Adjustment disorder with other symptoms</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4381</td>
                        <td data-vertical-align="middle">Prolonged grief disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4389</td>
                        <td data-vertical-align="middle">Other reactions to severe stress</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F439</td>
                        <td data-vertical-align="middle">Reaction to severe stress, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F440</td>
                        <td data-vertical-align="middle">Dissociative amnesia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F441</td>
                        <td data-vertical-align="middle">Dissociative fugue</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F442</td>
                        <td data-vertical-align="middle">Dissociative stupor</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F444</td>
                        <td data-vertical-align="middle">Conversion disorder with motor symptom or deficit</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F446</td>
                        <td data-vertical-align="middle">Conversion disorder with sensory symptom or deficit</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4481</td>
                        <td data-vertical-align="middle">Dissociative identity disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4489</td>
                        <td data-vertical-align="middle">Other dissociative and conversion disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F449</td>
                        <td data-vertical-align="middle">Dissociative and conversion disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F450</td>
                        <td data-vertical-align="middle">Somatization disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F451</td>
                        <td data-vertical-align="middle">Undifferentiated somatoform disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4520</td>
                        <td data-vertical-align="middle">Hypochondriacal disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4521</td>
                        <td data-vertical-align="middle">Hypochondriasis</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4522</td>
                        <td data-vertical-align="middle">Body dysmorphic disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4529</td>
                        <td data-vertical-align="middle">Other hypochondriacal disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F4541</td>
                        <td data-vertical-align="middle">Pain disorder exclusively related to psychological factors</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F458</td>
                        <td data-vertical-align="middle">Other somatoform disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F459</td>
                        <td data-vertical-align="middle">Somatoform disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F481</td>
                        <td data-vertical-align="middle">Depersonalization-derealization syndrome</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F488</td>
                        <td data-vertical-align="middle">Other specified nonpsychotic mental disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F489</td>
                        <td data-vertical-align="middle">Nonpsychotic mental disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F5000</td>
                        <td data-vertical-align="middle">Anorexia nervosa, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F5001</td>
                        <td data-vertical-align="middle">Anorexia nervosa, restricting type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F5002</td>
                        <td data-vertical-align="middle">Anorexia nervosa, binge eating/purging type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F502</td>
                        <td data-vertical-align="middle">Bulimia nervosa</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F5081</td>
                        <td data-vertical-align="middle">Binge eating disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F5082</td>
                        <td data-vertical-align="middle">Avoidant/restrictive food intake disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F5089</td>
                        <td data-vertical-align="middle">Other specified eating disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F509</td>
                        <td data-vertical-align="middle">Eating disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F53</td>
                        <td data-vertical-align="middle">Mental and behavioral disorders associated with the puerperium, not elsewhere classified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F530</td>
                        <td data-vertical-align="middle">Postpartum depression</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F531</td>
                        <td data-vertical-align="middle">Puerperal psychosis</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F54</td>
                        <td data-vertical-align="middle">Psychological and behavioral factors associated with disorders or diseases classified elsewhere</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F600</td>
                        <td data-vertical-align="middle">Paranoid personality disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F601</td>
                        <td data-vertical-align="middle">Schizoid personality disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F603</td>
                        <td data-vertical-align="middle">Borderline personality disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F604</td>
                        <td data-vertical-align="middle">Histrionic personality disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F605</td>
                        <td data-vertical-align="middle">Obsessive-compulsive personality disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F606</td>
                        <td data-vertical-align="middle">Avoidant personality disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F607</td>
                        <td data-vertical-align="middle">Dependent personality disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6081</td>
                        <td data-vertical-align="middle">Narcissistic personality disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6089</td>
                        <td data-vertical-align="middle">Other specific personality disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F609</td>
                        <td data-vertical-align="middle">Personality disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F630</td>
                        <td data-vertical-align="middle">Pathological gambling</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F631</td>
                        <td data-vertical-align="middle">Pyromania</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F632</td>
                        <td data-vertical-align="middle">Kleptomania</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F633</td>
                        <td data-vertical-align="middle">Trichotillomania</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6381</td>
                        <td data-vertical-align="middle">Intermittent explosive disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6389</td>
                        <td data-vertical-align="middle">Other impulse disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F639</td>
                        <td data-vertical-align="middle">Impulse disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F640</td>
                        <td data-vertical-align="middle">Transsexualism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F641</td>
                        <td data-vertical-align="middle">Gender identity disorder in adolescence and adulthood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F642</td>
                        <td data-vertical-align="middle">Gender identity disorder of childhood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F648</td>
                        <td data-vertical-align="middle">Other gender identity disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F649</td>
                        <td data-vertical-align="middle">Gender identity disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F650</td>
                        <td data-vertical-align="middle">Fetishism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F651</td>
                        <td data-vertical-align="middle">Transvestic fetishism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F652</td>
                        <td data-vertical-align="middle">Exhibitionism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F653</td>
                        <td data-vertical-align="middle">Voyeurism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F654</td>
                        <td data-vertical-align="middle">Pedophilia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6550</td>
                        <td data-vertical-align="middle">Sadomasochism, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6551</td>
                        <td data-vertical-align="middle">Sexual masochism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6552</td>
                        <td data-vertical-align="middle">Sexual sadism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6581</td>
                        <td data-vertical-align="middle">Frotteurism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6589</td>
                        <td data-vertical-align="middle">Other paraphilias</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F659</td>
                        <td data-vertical-align="middle">Paraphilia, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F66</td>
                        <td data-vertical-align="middle">Other sexual disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6811</td>
                        <td data-vertical-align="middle">Factitious disorder with predominantly psychological signs and symptoms</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F6813</td>
                        <td data-vertical-align="middle">Factitious disorder with combined psychological and physical signs and symptoms</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F688</td>
                        <td data-vertical-align="middle">Other specified disorders of adult personality and behavior</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F68A</td>
                        <td data-vertical-align="middle">Factitious disorder imposed on another</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F69</td>
                        <td data-vertical-align="middle">Unspecified disorder of adult personality and behavior</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F843</td>
                        <td data-vertical-align="middle">Other childhood disintegrative disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F900</td>
                        <td data-vertical-align="middle">Attention-deficit hyperactivity disorder, predominantly inattentive type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F901</td>
                        <td data-vertical-align="middle">Attention-deficit hyperactivity disorder, predominantly hyperactive type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F902</td>
                        <td data-vertical-align="middle">Attention-deficit hyperactivity disorder, combined type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F908</td>
                        <td data-vertical-align="middle">Attention-deficit hyperactivity disorder, other type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F909</td>
                        <td data-vertical-align="middle">Attention-deficit hyperactivity disorder, unspecified type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F910</td>
                        <td data-vertical-align="middle">Conduct disorder confined to family context</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F911</td>
                        <td data-vertical-align="middle">Conduct disorder, childhood-onset type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F912</td>
                        <td data-vertical-align="middle">Conduct disorder, adolescent-onset type</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F913</td>
                        <td data-vertical-align="middle">Oppositional defiant disorder</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F918</td>
                        <td data-vertical-align="middle">Other conduct disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F919</td>
                        <td data-vertical-align="middle">Conduct disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F930</td>
                        <td data-vertical-align="middle">Separation anxiety disorder of childhood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F938</td>
                        <td data-vertical-align="middle">Other childhood emotional disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F939</td>
                        <td data-vertical-align="middle">Childhood emotional disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F940</td>
                        <td data-vertical-align="middle">Selective mutism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F941</td>
                        <td data-vertical-align="middle">Reactive attachment disorder of childhood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F942</td>
                        <td data-vertical-align="middle">Disinhibited attachment disorder of childhood</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F948</td>
                        <td data-vertical-align="middle">Other childhood disorders of social functioning</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F949</td>
                        <td data-vertical-align="middle">Childhood disorder of social functioning, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F980</td>
                        <td data-vertical-align="middle">Enuresis not due to a substance or known physiological condition</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F981</td>
                        <td data-vertical-align="middle">Encopresis not due to a substance or known physiological condition</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F984</td>
                        <td data-vertical-align="middle">Stereotyped movement disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F988</td>
                        <td data-vertical-align="middle">Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F989</td>
                        <td data-vertical-align="middle">Unspecified behavioral and emotional disorders with onset usually occurring in childhood and adolescence</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">F99</td>
                        <td data-vertical-align="middle">Mental disorder, not otherwise specified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">G2111</td>
                        <td data-vertical-align="middle">Neuroleptic induced parkinsonism</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">G2402</td>
                        <td data-vertical-align="middle">Drug induced acute dystonia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">G2589</td>
                        <td data-vertical-align="middle">Other specified extrapyramidal and movement disorders</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">G259</td>
                        <td data-vertical-align="middle">Extrapyramidal and movement disorder, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99340</td>
                        <td data-vertical-align="middle">Other mental disorders complicating pregnancy, unspecified trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99341</td>
                        <td data-vertical-align="middle">Other mental disorders complicating pregnancy, first trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99342</td>
                        <td data-vertical-align="middle">Other mental disorders complicating pregnancy, second trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99343</td>
                        <td data-vertical-align="middle">Other mental disorders complicating pregnancy, third trimester</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99344</td>
                        <td data-vertical-align="middle">Other mental disorders complicating childbirth</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">O99345</td>
                        <td data-vertical-align="middle">Other mental disorders complicating the puerperium</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R457</td>
                        <td data-vertical-align="middle">State of emotional shock and stress, unspecified</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R45850</td>
                        <td data-vertical-align="middle">Homicidal ideations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">R45851</td>
                        <td data-vertical-align="middle">Suicidal ideations</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T1491XA</td>
                        <td data-vertical-align="middle">Suicide attempt, initial</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Z046</td>
                        <td data-vertical-align="middle">Encounter for general psychiatric examination requested by the authority</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#O">O.</span> An MCO is not responsible for services billed by a psychiatrist when the claim includes one of the following primary diagnoses:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">G24.4</td>
                        <td data-vertical-align="middle">Orofacial dyskinesia</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">G25.1</td>
                        <td data-vertical-align="middle">Drug-induced tremor</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">G21.0</td>
                        <td data-vertical-align="middle">Neuroleptic malignant syndrome</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.02#P">P.</span> Table of poisoning diagnoses, for dates of service on or after July 1, 2016:</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">T360X2A</td>
                        <td data-vertical-align="middle">Poisoning by penicillins, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T361X2A</td>
                        <td data-vertical-align="middle">Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T362X2A</td>
                        <td data-vertical-align="middle">Poisoning by chloramphenicol group, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T363X2A</td>
                        <td data-vertical-align="middle">Poisoning by macrolides, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T364X2A</td>
                        <td data-vertical-align="middle">Poisoning by tetracyclines, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T365X2A</td>
                        <td data-vertical-align="middle">Poisoning by aminoglycosides, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T366X2A</td>
                        <td data-vertical-align="middle">Poisoning by rifampicins, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T367X2A</td>
                        <td data-vertical-align="middle">Poisoning by antifungal antibiotics, systemically used, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T368X2A</td>
                        <td data-vertical-align="middle">Poisoning by other systemic antibiotics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T369X2A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified systemic antibiotic, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T370X2A</td>
                        <td data-vertical-align="middle">Poisoning by sulfonamides, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T371X2A</td>
                        <td data-vertical-align="middle">Poisoning by antimycobacterial drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T372X2A</td>
                        <td data-vertical-align="middle">Poisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T373X2A</td>
                        <td data-vertical-align="middle">Poisoning by other antiprotozoal drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T374X2A</td>
                        <td data-vertical-align="middle">Poisoning by anthelminthics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T375X2A</td>
                        <td data-vertical-align="middle">Poisoning by antiviral drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T378X2A</td>
                        <td data-vertical-align="middle">Poisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T3792XA</td>
                        <td data-vertical-align="middle">Poisoning by unspecified systemic anti-infective and antiparasitics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T380X2A</td>
                        <td data-vertical-align="middle">Poisoning by glucocorticoids and synthetic analogues, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T381X2A</td>
                        <td data-vertical-align="middle">Poisoning by thyroid hormones and substitutes, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T382X2A</td>
                        <td data-vertical-align="middle">Poisoning by antithyroid drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T383X2A</td>
                        <td data-vertical-align="middle">Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T384X2A</td>
                        <td data-vertical-align="middle">Poisoning by oral contraceptives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T385X2A</td>
                        <td data-vertical-align="middle">Poisoning by other estrogens and progestogens, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T386X2A</td>
                        <td data-vertical-align="middle">Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T387X2A</td>
                        <td data-vertical-align="middle">Poisoning by androgens and anabolic congeners, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T38802A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified hormones and synthetic substitutes, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T38812A</td>
                        <td data-vertical-align="middle">Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T38892A</td>
                        <td data-vertical-align="middle">Poisoning by other hormones and synthetic substitutes, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T38902A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified hormone antagonists, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T38992A</td>
                        <td data-vertical-align="middle">Poisoning by other hormone antagonists, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T39012A</td>
                        <td data-vertical-align="middle">Poisoning by aspirin, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T39092A</td>
                        <td data-vertical-align="middle">Poisoning by salicylates, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T391X2A</td>
                        <td data-vertical-align="middle">Poisoning by 4-Aminophenol derivatives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T392X2A</td>
                        <td data-vertical-align="middle">Poisoning by pyrazolone derivatives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T39312A</td>
                        <td data-vertical-align="middle">Poisoning by propionic acid derivatives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T39392A</td>
                        <td data-vertical-align="middle">Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T394X2A</td>
                        <td data-vertical-align="middle">Poisoning by antirheumatics, not elsewhere classified, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T398X2A</td>
                        <td data-vertical-align="middle">Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T3992XA</td>
                        <td data-vertical-align="middle">Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T400X1A</td>
                        <td data-vertical-align="middle">Poisoning by opium, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T400X2A</td>
                        <td data-vertical-align="middle">Poisoning by opium, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td>T401X1A</td>
                        <td>Poisoning by heroin, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T401X2A</td>
                        <td data-vertical-align="middle">Poisoning by heroin, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T402X2A</td>
                        <td data-vertical-align="middle">Poisoning by other opioids, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T403X1A</td>
                        <td data-vertical-align="middle">Poisoning by methadone, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T403X2A</td>
                        <td data-vertical-align="middle">Poisoning by methadone, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40411A</td>
                        <td data-vertical-align="middle">Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40412A</td>
                        <td data-vertical-align="middle">Poisoning by fentanyl or fentanyl analogs, self-harm, initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40421A</td>
                        <td data-vertical-align="middle">Poisoning by tramadol, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40422A</td>
                        <td data-vertical-align="middle">Poisoning by tramadol, self-harm, initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40491A</td>
                        <td data-vertical-align="middle">Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40492A</td>
                        <td data-vertical-align="middle">Poisoning by other synthetic narcotics, self-harm, initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T405X1A</td>
                        <td data-vertical-align="middle">Poisoning by cocaine, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T405X2A</td>
                        <td data-vertical-align="middle">Poisoning by cocaine, intentional self-harm, initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40601A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified narcotics, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40602A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified narcotics, intentional self-harm, initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40691A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified narcotics, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40692A</td>
                        <td data-vertical-align="middle">Poisoning by other narcotics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40711A</td>
                        <td data-vertical-align="middle">Poisoning by cannabis, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40712A</td>
                        <td data-vertical-align="middle">Poisoning by cannabis, intentional self-harm, initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40721A</td>
                        <td data-vertical-align="middle">Poisoning by synthetic cannabis, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40722A</td>
                        <td data-vertical-align="middle">Poisoning by synthetic cannabis, intentional self-harm, initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T407X1A</td>
                        <td data-vertical-align="middle">Poisoning by cannabis (derivates), accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T407X2A</td>
                        <td data-vertical-align="middle">Poisoning by cannabis (derivatives), intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T408X1A</td>
                        <td data-vertical-align="middle">Poisoning by lysergide [LSD], accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T408X2A</td>
                        <td data-vertical-align="middle">Poisoning by lysergide [LSD], intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40901A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40902A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40991A</td>
                        <td data-vertical-align="middle">Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T40992A</td>
                        <td data-vertical-align="middle">Poisoning by other psychodysleptics [hallucinogens], intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T410X2A</td>
                        <td data-vertical-align="middle">Poisoning by inhaled anesthetics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T411X2A</td>
                        <td data-vertical-align="middle">Poisoning by intravenous anesthetics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T41202A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified general anesthetics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T41292A</td>
                        <td data-vertical-align="middle">Poisoning by other general anesthetics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T413X2A</td>
                        <td data-vertical-align="middle">Poisoning by local anesthetics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T4142XA</td>
                        <td data-vertical-align="middle">Poisoning by unspecified anesthetic, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T415X2A</td>
                        <td data-vertical-align="middle">Poisoning by therapeutic gases, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T420X2A</td>
                        <td data-vertical-align="middle">Poisoning by hydantoin derivatives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T421X2A</td>
                        <td data-vertical-align="middle">Poisoning by iminostilbenes, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T422X2A</td>
                        <td data-vertical-align="middle">Poisoning by succinimides and oxazolidinediones, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T423X1A</td>
                        <td data-vertical-align="middle">Poisoning by barbiturates, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T423X2A</td>
                        <td data-vertical-align="middle">Poisoning by barbiturates, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T424X1A</td>
                        <td data-vertical-align="middle">Poisoning by benzodiazepines, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T424X2A</td>
                        <td data-vertical-align="middle">Poisoning by benzodiazepines, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T425X2A</td>
                        <td data-vertical-align="middle">Poisoning by mixed antiepileptics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T426X2A</td>
                        <td data-vertical-align="middle">Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T4272XA</td>
                        <td data-vertical-align="middle">Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T428X2A</td>
                        <td data-vertical-align="middle">Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43012A</td>
                        <td data-vertical-align="middle">Poisoning by tricyclic antidepressants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43022A</td>
                        <td data-vertical-align="middle">Poisoning by tetracyclic antidepressants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T431X2A</td>
                        <td data-vertical-align="middle">Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43202A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified antidepressants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43212A</td>
                        <td data-vertical-align="middle">Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43222A</td>
                        <td data-vertical-align="middle">Poisoning by selective serotonin reuptake inhibitors, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43292A</td>
                        <td data-vertical-align="middle">Poisoning by other antidepressants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T433X2A</td>
                        <td data-vertical-align="middle">Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T434X2A</td>
                        <td data-vertical-align="middle">Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43502A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43592A</td>
                        <td data-vertical-align="middle">Poisoning by other antipsychotics and neuroleptics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43601A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified psychostimulants, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43602A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified psychostimulants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43612A</td>
                        <td data-vertical-align="middle">Poisoning by caffeine, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43621A</td>
                        <td data-vertical-align="middle">Poisoning by amphetamines, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43622A</td>
                        <td data-vertical-align="middle">Poisoning by amphetamines, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43631A</td>
                        <td data-vertical-align="middle">Poisoning by methylphenidate, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43632A</td>
                        <td data-vertical-align="middle">Poisoning by methylphenidate, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43641A</td>
                        <td data-vertical-align="middle">Poisoning by ecstasy, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43651A</td>
                        <td data-vertical-align="middle">Poisoning my methamphetamines, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43652A</td>
                        <td data-vertical-align="middle">Poisoning by methamphetamines, intentional self-harm, intentional encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T43692A</td>
                        <td data-vertical-align="middle">Poisoning by other psychostimulants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T438X2A</td>
                        <td data-vertical-align="middle">Poisoning by other psychotropic drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T4392XA</td>
                        <td data-vertical-align="middle">Poisoning by unspecified psychotropic drug, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T440X2A</td>
                        <td data-vertical-align="middle">Poisoning by anticholinesterase agents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T441X2A</td>
                        <td data-vertical-align="middle">Poisoning by other parasympathomimetics [cholinergics], intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T442X2A</td>
                        <td data-vertical-align="middle">Poisoning by ganglionic blocking drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T443X2A</td>
                        <td data-vertical-align="middle">Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T444X2A</td>
                        <td data-vertical-align="middle">Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T445X2A</td>
                        <td data-vertical-align="middle">Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T446X2A</td>
                        <td data-vertical-align="middle">Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T447X2A</td>
                        <td data-vertical-align="middle">Poisoning by beta-adrenoreceptor antagonists, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T448X2A</td>
                        <td data-vertical-align="middle">Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T44902A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T44992A</td>
                        <td data-vertical-align="middle">Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T450X2A</td>
                        <td data-vertical-align="middle">Poisoning by antiallergic and antiemetic drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T451X2A</td>
                        <td data-vertical-align="middle">Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T452X2A</td>
                        <td data-vertical-align="middle">Poisoning by vitamins, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T453X2A</td>
                        <td data-vertical-align="middle">Poisoning by enzymes, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T454X2A</td>
                        <td data-vertical-align="middle">Poisoning by iron and its compounds, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T45512A</td>
                        <td data-vertical-align="middle">Poisoning by anticoagulants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T45522A</td>
                        <td data-vertical-align="middle">Poisoning by antithrombotic drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T45602A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T45612A</td>
                        <td data-vertical-align="middle">Poisoning by thrombolytic drug, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T45622A</td>
                        <td data-vertical-align="middle">Poisoning by hemostatic drug, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T45692A</td>
                        <td data-vertical-align="middle">Poisoning by other fibrinolysis-affecting drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T457X2A</td>
                        <td data-vertical-align="middle">Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T458X2A</td>
                        <td data-vertical-align="middle">Poisoning by other primarily systemic and hematological agents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T4592XA</td>
                        <td data-vertical-align="middle">Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T460X2A</td>
                        <td data-vertical-align="middle">Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T461X2A</td>
                        <td data-vertical-align="middle">Poisoning by calcium-channel blockers, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T462X2A</td>
                        <td data-vertical-align="middle">Poisoning by other antidysrhythmic drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T463X2A</td>
                        <td data-vertical-align="middle">Poisoning by coronary vasodilators, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T464X2A</td>
                        <td data-vertical-align="middle">Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T465X2A</td>
                        <td data-vertical-align="middle">Poisoning by other antihypertensive drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T466X2A</td>
                        <td data-vertical-align="middle">Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T467X2A</td>
                        <td data-vertical-align="middle">Poisoning by peripheral vasodilators, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T468X2A</td>
                        <td data-vertical-align="middle">Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T46902A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T46992A</td>
                        <td data-vertical-align="middle">Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T470X2A</td>
                        <td data-vertical-align="middle">Poisoning by histamine H2-receptor blockers, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T471X2A</td>
                        <td data-vertical-align="middle">Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T472X2A</td>
                        <td data-vertical-align="middle">Poisoning by stimulant laxatives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T473X2A</td>
                        <td data-vertical-align="middle">Poisoning by saline and osmotic laxatives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T474X2A</td>
                        <td data-vertical-align="middle">Poisoning by other laxatives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T475X2A</td>
                        <td data-vertical-align="middle">Poisoning by digestants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T476X2A</td>
                        <td data-vertical-align="middle">Poisoning by antidiarrheal drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T477X2A</td>
                        <td data-vertical-align="middle">Poisoning by emetics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T478X2A</td>
                        <td data-vertical-align="middle">Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T4792XA</td>
                        <td data-vertical-align="middle">Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T480X2A</td>
                        <td data-vertical-align="middle">Poisoning by oxytocic drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T481X2A</td>
                        <td data-vertical-align="middle">Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T48202A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified drugs acting on muscles, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T48292A</td>
                        <td data-vertical-align="middle">Poisoning by other drugs acting on muscles, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T483X2A</td>
                        <td data-vertical-align="middle">Poisoning by antitussives, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T484X2A</td>
                        <td data-vertical-align="middle">Poisoning by expectorants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T485X2A</td>
                        <td data-vertical-align="middle">Poisoning by other anti-common-cold drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T486X2A</td>
                        <td data-vertical-align="middle">Poisoning by antiasthmatics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T48902A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T48992A</td>
                        <td data-vertical-align="middle">Poisoning by other agents primarily acting on the respiratory system, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T490X2A</td>
                        <td data-vertical-align="middle">Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T491X2A</td>
                        <td data-vertical-align="middle">Poisoning by antipruritics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T492X2A</td>
                        <td data-vertical-align="middle">Poisoning by local astringents and local detergents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T493X2A</td>
                        <td data-vertical-align="middle">Poisoning by emollients, demulcents and protectants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T494X2A</td>
                        <td data-vertical-align="middle">Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T495X2A</td>
                        <td data-vertical-align="middle">Poisoning by ophthalmological drugs and preparations, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T496X2A</td>
                        <td data-vertical-align="middle">Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T497X2A</td>
                        <td data-vertical-align="middle">Poisoning by dental drugs, topically applied, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T498X2A</td>
                        <td data-vertical-align="middle">Poisoning by other topical agents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T4992XA</td>
                        <td data-vertical-align="middle">Poisoning by unspecified topical agent, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T500X2A</td>
                        <td data-vertical-align="middle">Poisoning by mineralocorticoids and their antagonists, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T501X2A</td>
                        <td data-vertical-align="middle">Poisoning by loop [high-ceiling] diuretics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T502X2A</td>
                        <td data-vertical-align="middle">Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T503X2A</td>
                        <td data-vertical-align="middle">Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T504X2A</td>
                        <td data-vertical-align="middle">Poisoning by drugs affecting uric acid metabolism, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T505X2A</td>
                        <td data-vertical-align="middle">Poisoning by appetite depressants, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T506X2A</td>
                        <td data-vertical-align="middle">Poisoning by antidotes and chelating agents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T507X1A</td>
                        <td data-vertical-align="middle">Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T507X2A</td>
                        <td data-vertical-align="middle">Poisoning by analeptics and opioid receptor antagonists, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T508X2A</td>
                        <td data-vertical-align="middle">Poisoning by diagnostic agents, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T50902A</td>
                        <td data-vertical-align="middle">Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T50912A</td>
                        <td data-vertical-align="middle">Poisoning by multiple unspecified drugs, medications and biological substances, intentional self-harm, initial self-harm, initial encounter</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">T50992A</td>
                        <td data-vertical-align="middle">Poisoning by other drugs, medicaments and biological substances, intentional self-harm</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.08.03" data-order="|10|67|08|.03|" data-ref-path="10|67|08|.03" class="h__section">.03 Nonbehavioral Health Fee-For-Service Benefits.</h3>
                <p>An MCO may not be required to provide any of the following benefits or services that are reimbursed directly by the Department:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#A">A.</span> The remaining days of a hospital admission following enrollment in the MCO if the recipient was admitted to the hospital before the date of the recipient's enrollment;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#B">B.</span> Long-term care services except for those outlined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.07#B" title="">COMAR 10.67.06.07B</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.12#A" title="">COMAR 10.67.06.12A</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#C">C.</span> Intermediate Care Facilities for Individuals with Intellectual Disabilities or Persons with Related Conditions (ICF/IID) services;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#D">D.</span> Personal care services pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.20" title="Chapter 20 Community Personal Assistance Services">COMAR 10.09.20</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#E">E.</span> Medical day care services, for adults and children;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#F">F.</span> The following HIV/AIDS services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#F(1)">(1)</span> Genotypic, phenotypic, or other HIV/AIDS drug resistance testing used in the treatment of HIV/AIDS, if the service is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#F(1)(a)">(a)</span> Rendered by a Department-approved provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#F(1)(b)">(b)</span> Medically necessary; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#F(2)">(2)</span> Viral load testing used in treatment of HIV/AIDS.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#G">G.</span> Physical therapy, speech therapy, and occupational therapy services when:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#G(1)">(1)</span> The enrollee is younger than 21 years old; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#G(2)">(2)</span> The services are not part of home health services or an inpatient hospital stay;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#H">H.</span> Augmentative communication devices;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#I">I.</span> All dental services including but not limited to outpatient surgery fees for the facility and general anesthesia.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#J">J.</span> Except when a woman has been determined eligible for Medical Assistance benefits under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.11" title="Chapter 11 Maryland Children's Health Program">COMAR 10.09.11</a>, an abortion pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.04#G" title="">COMAR 10.09.02.04G</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#K">K.</span> Emergency transportation;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#L">L.</span> Transportation services provided through grants to local governments pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.19" title="Chapter 19 Transportation Grants">COMAR 10.09.19</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#M">M.</span> Services provided to members participating in the State's Health Home Program as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.33" title="Chapter 33 Health Homes">COMAR 10.09.33</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#N">N.</span> Applied behavioral analysis (ABA) services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.28" title="Chapter 28 Applied Behavior Analysis Services">COMAR 10.09.28</a>; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.08.03#O">O.</span> Abortions performed in accordance with Health-General Article, § 15-103, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.09" data-order="|10|67|09|" data-ref-path="10|67|09" class="h__chapter">Chapter 09 Maryland Medicaid Managed Care Program: MCO Dispute Resolution Procedures</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.01" title=".01 MCO Enrollee Services.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.03" title=".03 MCO Provider Complaint Process.">.03</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730); adopted permanently effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.01" title=".01 MCO Enrollee Services.">Regulation .01</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.02" title=".02 MCO Enrollee Complaint Process.">Regulation .02</a> amended effective June 30, 2008 (35:13 Md. R. 1180); February 26, 2018 (45:4 Md. R. 205); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.02#A" title="">Regulation .02A</a>, B amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.02#B" title="">Regulation .02B</a>, C amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.02#C" title="">Regulation .02C</a> amended effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.02#C" title="">Regulation .02C</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.02#C" title="">Regulation .02C</a> amended effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.02-1" title=".02-1 Member Complaints — Time Frames for MCOs to Respond to the Department.">Regulation .02-1</a> adopted effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.03" title=".03 MCO Provider Complaint Process.">Regulation .03</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.03#B" title="">Regulation .03B</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.03#B" title="">Regulation .03B</a> amended effective October 5, 2009 (36:20 Md. R. 1528); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.03-1" title=".03-1 Independent Review Organization (IRO).">Regulation .03-1</a> adopted effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.03-2" title=".03-2 Provider Complaints — Time Frames for MCOs to Respond to the Department.">Regulation .03-2</a> adopted effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.04" title=".04 MCO Actions and Decisions.">Regulation .04</a> adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.04" title=".04 MCO Actions and Decisions.">Regulation .04</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.04#B" title="">Regulation .04B</a> amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.04#D" title="">Regulation .04D</a> amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05" title=".05 MCO Appeal Process for Enrollees.">Regulation .05</a> adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05" title=".05 MCO Appeal Process for Enrollees.">Regulation .05</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05#A" title="">Regulation .05A</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05#A" title="">Regulation .05A</a> amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05#A" title="">Regulation .05A</a>, B amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05#F" title="">Regulation .05F</a>, G adopted effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.71" title="Chapter 71 Maryland Medicaid Managed Care Program: MCO Dispute Resolution Procedures">COMAR 10.09.71</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.03#D" title="">Regulation .03D</a> adopted effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.04#A" title="">Regulation .04A</a>, D amended effective November 18, 2019 (46:23 Md. R. 1065)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05#A" title="">Regulation .05A</a> amended effective June 13, 2022 (49:12 Md. R. 641)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §15-103(b)(9)(i)(4), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.09.01" data-order="|10|67|09|.01|" data-ref-path="10|67|09|.01" class="h__section">.01 MCO Enrollee Services.</h3>
                <p>An MCO shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.01#A">A.</span> Maintain a member services unit that operates an enrollee services line at least during normal business hours;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.01#B">B.</span> Operate its enrollee services line as a triage device to handle or properly refer enrollees' questions or complaints; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.01#C">C.</span> Provide information in the member handbook about how to use the MCO enrollee services line to obtain information and assistance.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.09.02" data-order="|10|67|09|.02|" data-ref-path="10|67|09|.02" class="h__section">.02 MCO Enrollee Complaint Process.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#A">A.</span> An MCO shall have written complaint procedures by which an enrollee who is dissatisfied with the MCO or its network providers, or decisions made by the MCO or a provider, may seek recourse verbally or in writing within the MCO at any time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B">B.</span> An MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(1)">(1)</span> Submit its written internal complaint procedures to the Department for its approval;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(2)">(2)</span> Give enrollees any reasonable assistance in completing forms and taking other procedural steps related to a grievance or appeal in a manner consistent with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01#A" title="">COMAR 10.67.05.01A</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(3)">(3)</span> Prepare the document describing the MCO’s internal complaint process:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(3)(a)">(a)</span> In a culturally sensitive manner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(3)(b)">(b)</span> At an appropriate reading comprehension level; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(3)(c)">(c)</span> In the prevalent non-English languages, identified by the State;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(4)">(4)</span> Deliver a copy of the MCO’s complaint procedures to each enrollee:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(4)(a)">(a)</span> With the MCO’s initial contact with a new enrollee; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(4)(b)">(b)</span> At any time upon an enrollee’s request;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(5)">(5)</span> Maintain an accurate and accessible record of grievances and appeals for monitoring by the State and CMS, which includes, at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(5)(a)">(a)</span> A general description of the reason for the appeal or grievance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(5)(b)">(b)</span> The date received;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(5)(c)">(c)</span> The date of each review or, if applicable, review meeting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(5)(d)">(d)</span> Resolution at each level of the appeal or grievance, if applicable;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(5)(e)">(e)</span> Date of resolution at each level, if applicable; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(5)(f)">(f)</span> Name of the enrollee for whom the appeal or grievance was filed; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#B(6)">(6)</span> Provide in its written procedures that an enrollee may file appeals and grievances orally or in writing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C">C.</span> An MCO shall submit for Department approval an internal complaint process detailing the procedures for registering and responding to appeals and grievances in a timely fashion, which:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(1)">(1)</span> Includes a specific standard for grievance decisions, monitored by the MCO for compliance, directing that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(1)(a)">(a)</span> The decision time for emergency medically related grievances may not exceed 24 hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(1)(b)">(b)</span> The decision time for nonemergency medically related grievances may not exceed 5 days; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(1)(c)">(c)</span> For administrative grievances, the decision time may not exceed 30 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(2)">(2)</span> Includes participation by the provider, if appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(3)">(3)</span> Allows participation by the ombudsman, if appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(4)">(4)</span> Ensures the participation of individuals within the MCO who have the authority to require corrective action;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(5)">(5)</span> Requires documentation of the substance of the grievances and steps taken;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(6)">(6)</span> Includes a procedure for the aggregation and analysis of appeals and grievance data and use of the data for quality improvement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(7)">(7)</span> Includes a documented procedure for reporting:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(7)(a)">(a)</span> Appeals and grievances received by the MCO to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(7)(a)(i)">(i)</span> The provider involved;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(7)(a)(ii)">(ii)</span> Appropriate quality assurance committees and departments within the MCO;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(7)(a)(iii)">(iii)</span> The MCO's consumer advisory board; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(7)(a)(iv)">(iv)</span> The Department as requested; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(7)(b)">(b)</span> The quarterly appeal and grievance analysis performed by the MCO as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#D(1)(b)" title="">COMAR 10.67.04.15D(1)(b)</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(8)">(8)</span> Includes a documented procedure for written notification of the MCO's determination:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(8)(a)">(a)</span> To the enrollee who filed the grievance; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(8)(b)">(b)</span> To those individuals and entities required to be notified of the grievance pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.09.02#C(7)" title="">§C(7) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(9)">(9)</span> Ensures that decision makers on appeals and grievances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(9)(a)">(a)</span> Were not involved in previous levels of decision-making;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(9)(b)">(b)</span> Are not subordinates of people involved in previous levels of decision-making;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(9)(c)">(c)</span> Are healthcare professionals with clinical expertise in treating the enrollee’s condition or disease, if any of the following apply:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(9)(c)(i)">(i)</span> The appeal is a denial based on lack of medical necessity;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(9)(c)(ii)">(ii)</span> The grievance is regarding denial of expedited resolution of an appeal; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(9)(c)(iii)">(iii)</span> The appeal or grievance involves clinical issues; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02#C(9)(d)">(d)</span> Take into account all comments, documents, records, and other information submitted by the enrollee or their representative, without regard to whether such information was submitted or considered in the initial action.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.09.02-1" data-order="|10|67|09|.02-1|" data-ref-path="10|67|09|.02-1" class="h__section">.02-1 Member Complaints — Time Frames for MCOs to Respond to the Department.</h3>
                <p>An MCO shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02-1#A">A.</span> Acknowledge an enrollee appeal or grievance reported to it by the Department’s complaint resolution unit within 1 business day;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02-1#B">B.</span> Respond to the Department’s request for information regarding disputed nonemergency medical care actions within 3 business days;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02-1#C">C.</span> Provide updates in a time frame specified by the Department;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02-1#D">D.</span> Provide medical records within 5 days of the request; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.02-1#E">E.</span> Provide a corrective action plan upon request and within the time frame specified, but not later than 10 days from the date of the request.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.09.03" data-order="|10|67|09|.03|" data-ref-path="10|67|09|.03" class="h__section">.03 MCO Provider Complaint Process.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#A">A.</span> An MCO shall have a complaint procedure for providers that is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#A(1)">(1)</span> Documented in writing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#A(2)">(2)</span> Disseminated in writing to all of the MCO's providers at the time they join the MCO's provider panel, and furnished to a provider at any time, upon request; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#A(3)">(3)</span> Linked to the MCO's internal quality assurance program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B">B.</span> An MCO shall include in its provider complaint process at least the following elements:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(1)">(1)</span> Procedures for registering and responding to provider grievances in a timely fashion, including standards for timeliness that recognize the need for expedited determinations in situations that are time-sensitive, that is, when an enrollee's treatment outcome may be significantly affected by the promptness of treatment, as set forth in Regulation .02C(1)(a) and (b) of this chapter apply;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(2)">(2)</span> Notification to the provider of an MCO's determination that affects the provider or that provider's patient, which includes a description of how to file an internal appeal with the MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(3)">(3)</span> Documentation of the substance of complaints and steps taken;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(4)">(4)</span> Procedures to ensure the timely resolution of the complaint and response by the MCO to the provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(5)">(5)</span> Procedures for the termination or withdrawal of a provider from the MCO's provider panel, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(5)(a)">(a)</span> At least 90 days prior notice to the primary care providers in the MCO's provider panel of the MCO's termination of a specialty services provider when the reason for the termination is unrelated to fraud, patient abuse, incompetency, or loss of licensure status;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(5)(b)">(b)</span> If possible, at least 90 days prior notice to the primary care providers in the MCO's provider panel of a specialty services provider's withdrawal from the MCO's provider panel; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(5)(c)">(c)</span> Notices to primary care providers informing them of the enrollee’s right to change MCOs as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#A(1)(e)" title="">COMAR 10.67.02.06A(1)(e)</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(6)">(6)</span> Mechanisms to aggregate and analyze appeal and grievance data and to use the data for quality improvement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)">(7)</span> An appeal process which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(a)">(a)</span> Is available when the provider's appeal or grievance is not resolved to the provider's satisfaction, or when the MCO acts to reduce, suspend, or terminate provider's privileges with the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(b)">(b)</span> Acknowledges receipt of provider appeals within 5 business days of receipt by the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(c)">(c)</span> Allows providers 90 business days from the date of a denial to file an initial appeal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(d)">(d)</span> Allows providers at least 15 business days from the date of denial to file each subsequent level of appeal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(e)">(e)</span> Resolves appeals, regardless of the number of appeal levels allowed by the MCO, within 90 business days of receipt of the initial appeal by the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(f)">(f)</span> Pays claim within 30 days of the appeal decision when a claim denial is overturned;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(g)">(g)</span> Provides at its final level an opportunity for the provider to be heard by the MCO's chief executive officer, or the chief executive officer's designee;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(h)">(h)</span> Provides timely written notice to the provider of the results of the internal appeal; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(7)(i)">(i)</span> Provides for written notice of the substance of the dispute and the result of the internal appeal to appropriate quality assurance committees and departments within the MCO; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#B(8)">(8)</span> A protocol for transmitting provider appeal and grievance reports and aggregate provider grievance and appeal data to the Department when requested.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#C">C.</span> An MCO may not take any punitive action against a provider for utilizing the MCO provider complaint process, for supporting an enrollee's appeal, or for requesting expedited resolution for an enrollee's appeal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03#D">D.</span> An MCO or its pharmacy benefits manager shall resolve pharmacy appeals concerning drug pricing within 21 days of the receipt of a request.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.09.03-1" data-order="|10|67|09|.03-1|" data-ref-path="10|67|09|.03-1" class="h__section">.03-1 Independent Review Organization (IRO).</h3>
                <p>For provider disputes involving medical necessity, an MCO shall participate in the IRO process as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.13" title="Chapter 13 Maryland Medicaid Managed Care Program: Independent Review Organization (IRO)">COMAR 10.67.13</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.09.03-2" data-order="|10|67|09|.03-2|" data-ref-path="10|67|09|.03-2" class="h__section">.03-2 Provider Complaints — Time Frames for MCOs to Respond to the Department.</h3>
                <p>An MCO shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03-2#A">A.</span> Acknowledge provider grievances within 3 business days;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03-2#B">B.</span> Provide findings to the Department within 5 days; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.03-2#C">C.</span> Provide a corrective action plan to the Department within 10 days from the date of the request.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.09.04" data-order="|10|67|09|.04|" data-ref-path="10|67|09|.04" class="h__section">.04 MCO Actions and Decisions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A">A.</span> For certain services to enrollees that require preauthorization the following conditions apply:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(1)">(1)</span> For standard authorization decisions, the MCO shall make a determination within 2 business days of receipt of necessary clinical information, but not later than 14 calendar days from the date of the initial request so as not to adversely affect the health of the enrollee;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(2)">(2)</span> For expedited authorization decisions, the MCO shall make a determination and provide notice no later than 72 hours after receipt of the request for service if the provider indicates or the MCO determines that the standard time frame stated in <a class="internal-link " href="/us/md/exec/comar/10.67.09.04#A(1)" title="">§A(1) of this regulation</a> could jeopardize:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(2)(a)">(a)</span> The enrollee’s life;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(2)(b)">(b)</span> The enrollee’s health; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(2)(c)">(c)</span> The enrollee’s ability to attain, maintain, or regain maximum function;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(3)">(3)</span> For all covered outpatient drug authorization decisions, the MCO shall provide notice by telephone or other telecommunication device within 24 hours of a preauthorization request in accordance with section 1927(d)(5)(A) of the Social Security Act;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(4)">(4)</span> Standard and expedited authorization decisions may be extended up to 14 calendar days, if the following conditions are met:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(4)(a)">(a)</span> The enrollee or the provider requests an extension; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(4)(b)">(b)</span> The MCO justifies to the Department, upon request, a need for additional information and how the extension is in the enrollee’s interest; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(5)">(5)</span> If the MCO successfully justifies extending the standard service authorization decision time frame, the MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(5)(a)">(a)</span> Give the enrollee written notice of the reason for the decision to extend the time frame;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(5)(b)">(b)</span> Inform the enrollee of the right to file a grievance if he or she disagrees with the extension decision; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#A(5)(c)">(c)</span> Issue and carry out the MCO’s determination as expeditiously as the enrollee’s health condition requires but not later than the date the extension expires.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#B">B.</span> Any decision to deny a service authorization request or to authorize a service in an amount, duration, or scope that is less than requested:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#B(1)">(1)</span> Shall be made by a health care professional who has appropriate clinical expertise in treating the enrollee's condition or disease; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#B(2)">(2)</span> May not be based solely on diagnosis, type of illness, or condition.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#C">C.</span> An MCO shall ensure that compensation to individuals or entities that conduct utilization management activities is not structured to provide incentives for the individual or entity to deny, limit, or discontinue medically necessary services to any enrollee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#D">D.</span> Notices of a decision to deny a standard authorization shall be provided to the enrollee and the requesting provider within 72 hours from the date of determination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E">E.</span> An MCO shall give an enrollee written notice of any action within the following time frames:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(1)">(1)</span> At least 10 days before the action for termination, suspension, or reduction of a previously authorized covered service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(2)">(2)</span> The notice period is reduced to 5 days if probable enrollee fraud has been verified;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(3)">(3)</span> By the date of the action for the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(3)(a)">(a)</span> The MCO has factual information confirming the death of an enrollee;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(3)(b)">(b)</span> A signed written enrollee statement requesting service termination or giving information requiring termination or reduction of services, where the enrollee understands that this is the result of supplying that information;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(3)(c)">(c)</span> The enrollee's admission to an institution where they are ineligible for further services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(3)(d)">(d)</span> The enrollee's address is unknown and mail directed to the enrollee has no forwarding address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(3)(e)">(e)</span> The enrollee has been accepted for Medicaid services by another jurisdiction;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(3)(f)">(f)</span> The enrollee's physician prescribes a change in the level of medical care; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(3)(g)">(g)</span> An adverse determination made with regard to the preadmission screening requirements for nursing facility admissions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(4)">(4)</span> As soon as practicable for nursing facility transfers or discharges when:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(4)(a)">(a)</span> The safety or health of individuals in the facility would be endangered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(4)(b)">(b)</span> The enrollee’s health improves sufficiently to allow a more immediate transfer or discharge; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(4)(c)">(c)</span> An immediate transfer or discharge is required by the enrollee’s urgent medical needs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#E(5)">(5)</span> For denial of payment, at the time of any action affecting the claim.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F">F.</span> A notice of adverse action shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(1)">(1)</span> Be in writing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(2)">(2)</span> Meet the following requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(2)(a)">(a)</span> Be translated for enrollees who speak prevalent non-English languages;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(2)(b)">(b)</span> Include language clarifying that oral interpretation is available for all languages and how to access it;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(2)(c)">(c)</span> Be written in an easily understood language and format that takes into consideration enrollees with special needs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(2)(d)">(d)</span> Be available in alternative formats; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(2)(e)">(e)</span> Inform enrollees that information is available in alternative formats and how to access those formats; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)">(3)</span> Contain the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(a)">(a)</span> The action the MCO has made or intends to make;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(b)">(b)</span> The reasons for the action, including the right for the enrollee to be provided upon request and free of charge, reasonable access to and copies of all documents, records, and other information relevant to the MCO’s action, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(b)(i)">(i)</span> Medical necessity criteria; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(b)(ii)">(ii)</span> Any processes, strategies, or evidentiary standards used in setting coverage limits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(c)">(c)</span> The enrollee’s right to request an appeal of the MCO’s action, including information on:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(c)(i)">(i)</span> Exhausting the MCO’s one level of appeal; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(c)(ii)">(ii)</span> The right to request a State fair hearing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(d)">(d)</span> The procedures for exercising the rights described;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(e)">(e)</span> The circumstances under which an appeal process can be expedited and how to request it;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(f)">(f)</span> The enrollee’s right to have benefits continue pending resolution of the appeal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(g)">(g)</span> How to request that benefits be continued; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#F(3)(h)">(h)</span> The circumstances under which the enrollee may be required to pay the costs of the services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.04#G">G.</span> If an MCO does not make an authorization decision within the times specified in <a class="internal-link " href="/us/md/exec/comar/10.67.09.04#A" title="">§A of this regulation</a>, the untimely decision is considered a denial and thus an adverse action subject to the notice requirements in §§C and E of this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.09.05" data-order="|10|67|09|.05|" data-ref-path="10|67|09|.05" class="h__section">.05 MCO Appeal Process for Enrollees.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A">A.</span> An MCO's appeal process shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(1)">(1)</span> Require that an enrollee, or a provider acting on the enrollee’s behalf, file an appeal within 60 days from the date on the MCO’s notice of action;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(2)">(2)</span> Include procedures for acknowledging receipt of appeals within 5 business days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(3)">(3)</span> Permit an enrollee to request an appeal either orally or in writing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(4)">(4)</span> Provide that oral requests for appeal are considered the initiation of the appeal to establish the earliest possible filing date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(5)">(5)</span> Provide reasonable opportunity to present evidence and allegations of fact or law, in person as well as in writing, and in the case of expedited appeals, the MCO shall inform the enrollee of the limited time available for the enrollee to present this evidence;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(6)">(6)</span> Provide the case file upon request to the enrollee and the enrollee's representative, free of charge and sufficiently in advance of the resolution time frame for appeals, which includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(6)(a)">(a)</span> Medical records;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(6)(b)">(b)</span> Other documents and records; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(6)(c)">(c)</span> Any new or additional evidence considered, relied upon, or generated by the MCO in connection with the action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(7)">(7)</span> Allow a provider or authorized representative acting on behalf of an enrollee to file an appeal with the enrollee’s written consent;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(8)">(8)</span> Consider the enrollee, the enrollee's representative, or the estate representative of a deceased enrollee as parties to the appeal;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(9)">(9)</span> Establish and maintain an expedited review process, when the MCO determines or the provider indicates that taking the time for a standard resolution could seriously jeopardize the enrollee’s life, physical or mental health, or ability to attain, maintain, or regain maximum function; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#A(10)">(10)</span> Ensure that punitive action is not taken against a provider who requests an expedited resolution or supports an enrollee’s appeal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B">B.</span> Resolution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(1)">(1)</span> Except for expedited appeals as described in §C, an MCO shall resolve each appeal and provide notice of resolution, as expeditiously as the enrollee’s health condition requires, and unless extended pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.09.05#B(2)" title="">§B(2) of this regulation</a>, within 30 days from the day the MCO receives the appeal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(2)">(2)</span> The time frames in <a class="internal-link " href="/us/md/exec/comar/10.67.09.05#B(1)" title="">§B(1) of this regulation</a> may be extended up to 14 calendar days if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(2)(a)">(a)</span> The enrollee requests the extension; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(2)(b)">(b)</span> The MCO shows, upon the Department's request, that there is a need for additional information and how the delay is in the enrollee's interest.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(3)">(3)</span> For any extension not requested by the enrollee, the MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(3)(a)">(a)</span> Give the enrollee written notice; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(3)(b)">(b)</span> Make reasonable efforts to give the enrollee verbal notice of the reason for the delay.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(4)">(4)</span> Continuation of Benefits. The MCO shall continue the enrollee’s benefits pending the outcome of the appeal if all of the following occur:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(4)(a)">(a)</span> The enrollee timely files for continuation of benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(4)(b)">(b)</span> The appeal is filed timely, meaning on or before the later of the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(4)(b)(i)">(i)</span> Within 10 days of the MCO mailing the notice of action; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(4)(b)(ii)">(ii)</span> The intended effective date of the MCO's proposed action;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(4)(c)">(c)</span> The appeal involves the termination, suspension, or reduction of a previously authorized service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(4)(d)">(d)</span> The services were ordered by an authorized provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(4)(e)">(e)</span> The authorization period has not expired.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(5)">(5)</span> If the MCO continues or reinstates the enrollee's benefits while the appeal is pending, the benefits shall continue until one of the following occurs:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(5)(a)">(a)</span> The enrollee withdraws the appeal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(5)(b)">(b)</span> The enrollee fails to request a State fair hearing and continuation of benefits within 10 days after the MCO sends the notice of an adverse resolution to the enrollee’s appeal; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(5)(c)">(c)</span> A State fair hearing decision adverse to the enrollee is made.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#B(6)">(6)</span> If the MCO or State fair hearing officer reverses a decision to deny, limit, or delay services, the MCO shall authorize or provide the disputed services promptly and as expeditiously as the enrollee’s health condition requires but no later than 72 hours of the date the MCO receives the reversal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C">C.</span> Expedited Appeals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C(1)">(1)</span> An expedited resolution may be approved when the MCO determines or the provider indicates that taking the time for a standard resolution could seriously jeopardize:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C(1)(a)">(a)</span> The enrollee’s life;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C(1)(b)">(b)</span> The enrollee’s physical or mental health; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C(1)(c)">(c)</span> The enrollee’s ability to attain, maintain, or regain maximum function.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C(2)">(2)</span> Expedited appeals shall be resolved as expeditiously as the enrollee’s health condition requires but no later than 72 hours after the MCO receives the appeal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C(3)">(3)</span> If the MCO denies a request for expedited resolution of an appeal, the MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C(3)(a)">(a)</span> Transfer the appeal to the standard time frame of not longer than 30 days from the day the MCO receives the appeal with a possible 14-day extension as described in <a class="internal-link " href="/us/md/exec/comar/10.67.09.05#B(2)" title="">§B(2) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#C(3)(b)">(b)</span> Make reasonable efforts to give the enrollee prompt verbal notice of the denial of expedited resolution and provide a written notice within 2 calendar days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D">D.</span> Notification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)">(1)</span> The MCO shall provide written notice of resolution which includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)(a)">(a)</span> The results and date of the appeal resolution;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)(b)">(b)</span> The reasons for the action;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)(c)">(c)</span> For decisions not wholly in the enrollee’s favor:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)(c)(i)">(i)</span> The right to request a State fair hearing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)(c)(ii)">(ii)</span> How to request a State fair hearing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)(c)(iii)">(iii)</span> The right to continue to receive benefits pending a hearing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)(c)(iv)">(iv)</span> How to request the continuation of benefits; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(1)(c)(v)">(v)</span> A statement that the enrollee may be liable for the cost of any continued benefits if the MCO's action is upheld in a hearing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#D(2)">(2)</span> For notice of an expedited resolution, in addition to requirements listed in <a class="internal-link " href="/us/md/exec/comar/10.67.09.05#D(1)" title="">§D(1) of this regulation</a>, the MCO shall also make reasonable efforts to provide oral notice of the decision.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#E">E.</span> If an MCO fails to adhere to the notice and timing requirements, as described in §§A—D of this regulation, the enrollee is deemed to have exhausted the MCO’s appeals process and may initiate a State fair hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F">F.</span> State Fair Hearing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(1)">(1)</span> An enrollee may exercise State fair hearing rights pursuant to the Department’s regulations and <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-201" title="">State Government Article, §10-201 </a>et seq., Annotated Code of Maryland, subject to the requirements of this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(2)">(2)</span> An enrollee may request a State fair hearing for an MCO appeal resolution after first exhausting the MCO’s appeal process by appealing to the Office of Administrative Hearings using the process specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.04" title="Chapter 04 Fair Hearing Appeals Under the Maryland State Medical Assistance Program">COMAR 10.01.04</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(3)">(3)</span> An enrollee shall file for a State fair hearing within 120 days from the date the MCO provides on the written notice of appeal resolution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(4)">(4)</span> The parties to an appeal to the Office of Administrative Hearings under this section are the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(4)(a)">(a)</span> MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(4)(b)">(b)</span> Enrollee; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(4)(c)">(c)</span> Enrollee’s representative or the personal representative of a deceased enrollee’s estate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(5)">(5)</span> The MCO shall provide documentation regarding medical determinations to enrollees and the Office of Administrative Hearings as required by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.04" title="Chapter 04 Fair Hearing Appeals Under the Maryland State Medical Assistance Program">COMAR 10.01.04</a> and other applicable law.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(6)">(6)</span> The MCO shall continue the enrollee’s benefits pending the outcome of the State fair hearing if all of the following occur:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(6)(a)">(a)</span> The enrollee files for continuation of benefits within 10 days of the MCO upholding its action;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(6)(b)">(b)</span> The State fair hearing request is filed timely, meaning on or before the later of the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(6)(b)(i)">(i)</span> 10 days from the date on the MCO’s notice of appeal resolution; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(6)(b)(ii)">(ii)</span> The intended effective date of the MCO's proposed action;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(6)(c)">(c)</span> The State fair hearing involves the termination, suspension, or reduction of a previously authorized service;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(6)(d)">(d)</span> The services were ordered by an authorized provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(6)(e)">(e)</span> The authorization period has not expired.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(7)">(7)</span> If the MCO continues or reinstates the enrollee's benefits while the State fair hearing is pending, the benefits shall continue until one of the following occurs:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(7)(a)">(a)</span> The enrollee withdraws the State fair hearing; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(7)(b)">(b)</span> A State fair hearing decision adverse to the enrollee is issued by the Office of Administrative Hearings.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#F(8)">(8)</span> The final decision of the Office of Administrative Hearings is appealable to the circuit court, and is governed by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-201" title="">State Government Article, §10-201 </a>et seq., Annotated Code of Maryland, and the Maryland Rules.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.09.05#G">G.</span> The Department may order an MCO to provide a benefit or service based on its evaluation of the MCO’s action.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.10" data-order="|10|67|10|" data-ref-path="10|67|10" class="h__chapter">Chapter 10 Maryland Medicaid Managed Care Program: Sanctions</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations .01 and .02 adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730); adopted permanently effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.01#A" title="">Regulation .01A</a> amended effective June 30, 2008 (35:13 Md. R. 1180); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.01#B" title="">Regulation .01B</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.01#B" title="">Regulation .01B</a> amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p>Regulation .01C repealed effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.01-1" title=".01-1 Sanction by Center for Medicare and Medicaid Services (CMS).">Regulation .01-1</a> adopted as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); adopted permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.02" title=".02 Appeal.">Regulation .02</a> repealed and new Regulation .02 adopted effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.03" title=".03 Incentives.">Regulation .03</a> adopted effective February 18, 2002 (29:3 Md. R. 220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.03#C" title="">Regulation .03C</a> amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.73" title="Chapter 73 Maryland Medicaid Managed Care Program: Sanctions">COMAR 10.09.73</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.02#B" title="">Regulation .02B</a> amended effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §15-103(b)(9), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.10.01" data-order="|10|67|10|.01|" data-ref-path="10|67|10|.01" class="h__section">.01 Sanction by the Department.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#A">A.</span> If the Department determines, after a sufficient investigation, that an MCO or any agent or employee of the MCO, or any person with an ownership interest in an MCO, or related party of the MCO, has failed to comply with any applicable law, regulation, or contract term, or for other good cause shown, the Department may impose sanctions on the MCO, including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#A(1)">(1)</span> Fines;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#A(2)">(2)</span> Suspension of further enrollment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#A(3)">(3)</span> Withholding all or part of the capitation payment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#A(4)">(4)</span> Termination of the current HealthChoice Managed Care Organization Agreement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#A(5)">(5)</span> Disqualification from future participation in the Maryland Medicaid Managed Care Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#A(6)">(6)</span> Orders to provide a benefit or service to enrollees; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#A(7)">(7)</span> Those outlined in 42 CFR §§438.700—438.708, as amended.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#B">B.</span> Corrective Action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#B(1)">(1)</span> Subject to <a class="internal-link " href="/us/md/exec/comar/10.67.10.01#B(2)" title="">§B(2) of this regulation</a>, before imposing a sanction pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.10.01#A" title="">§A of this regulation</a>, the Department may permit an MCO an opportunity to take corrective action in accordance with a plan approved by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.01#B(2)">(2)</span> The MCO shall submit a corrective action plan within a time frame specified by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.10.01-1" data-order="|10|67|10|.01-1|" data-ref-path="10|67|10|.01-1" class="h__section">.01-1 Sanction by Center for Medicare and Medicaid Services (CMS).</h3>
                <p>The Department shall comply with notification requirements of CMS at 42 CFR §438.730 for sanction determinations as specified in 42 CFR §438.700(b)(1)—(b)(6).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.10.02" data-order="|10|67|10|.02|" data-ref-path="10|67|10|.02" class="h__section">.02 Appeal.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#A">A.</span> From the decisions set forth in §B(1)—(8) of this regulation, an MCO may exercise the appeal rights set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.10.02#C" title="">§C of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B">B.</span> The following Department decisions are appealable by the MCO or MCO applicant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B(1)">(1)</span> Denial of an entity’s completed application to become an MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B(2)">(2)</span> Decision to terminate the MCO's participation in the Maryland Medicaid Managed Care Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B(3)">(3)</span> Decision to impose a fine valued at $50,000 or more on the MCO as described in <a class="internal-link " href="/us/md/exec/comar/10.67.10.01" title=".01 Sanction by the Department.">Regulation .01 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B(4)">(4)</span> Order that the MCO is impaired or in “hazardous financial condition”;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B(5)">(5)</span> An adverse decision by the IRO as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.13.08" title=".08 Appeal.">COMAR 10.67.13.08</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B(6)">(6)</span> The denial of a hepatitis C payment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B(7)">(7)</span> Overpayments recovered by the Department as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07.01" title=".01 Requirements to Detect and Prevent Fraud, Waste, and Abuse.">COMAR 10.67.07.01</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#B(8)">(8)</span> Remittances to the Department as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>-5.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#C">C.</span> An MCO may appeal a decision listed in <a class="internal-link " href="/us/md/exec/comar/10.67.10.02#B" title="">§B of this regulation</a> to the Office of Administrative Hearings as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.03" title="Chapter 03 Procedures for Hearings Before the Secretary of Health">COMAR 10.01.03</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.09" title=".09 Filing Appeal.">COMAR 10.09.36.09</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#D">D.</span> The parties to an appeal to the Office of Administrative Hearings under <a class="internal-link " href="/us/md/exec/comar/10.67.10.02#C" title="">§C of this regulation</a> are the Department and the MCO. The enrollee is not a party at this hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#E">E.</span> The following sanctions shall take effect immediately and are not subject to stay during the pendency of an appeal:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#E(1)">(1)</span> Any fines imposed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#E(2)">(2)</span> Any full or partial withhold of the capitation payment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#E(3)">(3)</span> Any remittances to the Department as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">COMAR 10.67.04.19</a>-5; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.10.02#E(4)">(4)</span> Any overpayments recovered by the Department as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07.01" title=".01 Requirements to Detect and Prevent Fraud, Waste, and Abuse.">COMAR 10.67.07.01</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.10.03" data-order="|10|67|10|.03|" data-ref-path="10|67|10|.03" class="h__section">.03 Incentives.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.03#A">A.</span> All monies collected from the MCOs as a result of the imposition of a financial sanction shall be deposited in the HealthChoice Performance Incentive Fund.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.03#B">B.</span> This nonlapsing fund shall include all sanctions imposed on the MCOs starting in calendar year 1999.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.10.03#C">C.</span> The fund shall be used to provide financial incentive awards to the MCOs that meet or exceed specific performance targets as established by the Department, unless otherwise directed by law.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.11" data-order="|10|67|11|" data-ref-path="10|67|11" class="h__chapter">Chapter 11 Maryland Medicaid Managed Care Program: Contribution to Graduate Medical Education Costs</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.11.01" title=".01 Scope.">.01</a>—.07 adopted as an emergency provision effective April 7, 1998 (25:9 Md. R. 676); adopted permanently effective June 29, 1998 (25:13 Md. R. 993)</p>
                  <p>Regulation .03 amended effective December 25, 2000 (27:25 Md. R. 2281)</p>
                  <p>Regulation .08 repealed effective November 1, 1999 (26:22 Md. R. 1692)</p>
                  <p>——————</p>
                  <p>Chapter revised effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.11.02#B" title="">Regulation .02B</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.74" title="Chapter 74 Maryland Medicaid Managed Care Program: Contribution to Graduate Medical Education Costs">COMAR 10.09.74</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §15-103(b)(18), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.11.01" data-order="|10|67|11|.01|" data-ref-path="10|67|11|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to teaching hospitals that provide health care services to recipients enrolled in Maryland Medicaid Managed Care Program MCOs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.11.02" data-order="|10|67|11|.02|" data-ref-path="10|67|11|.02" class="h__section">.02 GME Allocation Payment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#A">A.</span> Purpose. GME allocation payments to teaching hospitals are intended to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#A(1)">(1)</span> Reaffirm the Program's historic commitment to preserving graduate medical education at each of the State's teaching hospitals, by maintaining Program payments supporting graduate medical education at levels equivalent to inflation-adjusted FY 1995 expenditures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#A(2)">(2)</span> Promote the training of primary care practitioners;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#A(3)">(3)</span> Promote the development of innovative approaches to improve the Program population's access to health care services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#A(4)">(4)</span> Ameliorate the new funding procedure's impact on MCOs that historically have experienced low utilization of teaching hospitals, by adopting an initial moderate reduction, pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.11.02#B(4)" title="">§B(4) of this regulation</a> and COMAR 10.67.05.15, of the amount of GME-allocatable dollars included in teaching hospitals' GME allocation payments during the first 3 years of separate GME funding.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B">B.</span> GME Allocation Payments to Teaching Hospitals. Beginning in FY 1999, the Department shall, on a quarterly basis, pay each teaching hospital a GME allocation payment, calculated as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(1)">(1)</span> The Department shall calculate the combined dollar amount of payments made by the Program to teaching hospitals during FY 1995, including only those payments attributable to utilization:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(1)(a)">(a)</span> Of services that, if delivered during the fiscal year during which the GME allocation payment is made, would be included in the Maryland Medicaid Managed Care Program mandatory benefits package established by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(1)(b)">(b)</span> By recipients who, if the utilization had occurred during the fiscal year in which the GME allocation payment is made:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(1)(b)(i)">(i)</span> Would have met the eligibility criteria for the Maryland Medicaid Managed Care Program, pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01" title=".01 Eligibility.">COMAR 10.67.02.01</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(1)(b)(ii)">(ii)</span> Would not have met the eligibility criteria for the rare and expensive case management program, pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.03" title=".03 REM Eligibility.">COMAR 10.09.69.03</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(2)">(2)</span> The amount resulting from the calculation described in <a class="internal-link " href="/us/md/exec/comar/10.67.11.02#B(1)" title="">§B(1) of this regulation</a> is reduced by the dollar amount of included payments for inpatient hospital services that, if they had been incurred during the fiscal year of the GME allocation payment, would have been subject to avoidance by an MCO pursuant to the stop-loss provisions of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">COMAR 10.67.04.22</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(3)">(3)</span> The amount resulting from the calculation described in <a class="internal-link " href="/us/md/exec/comar/10.67.11.02#B(2)" title="">§B(2) of this regulation</a> is trended forward to adjust for the time differential between the base year (FY 1995) and the contract year;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(4)">(4)</span> The amount resulting from the calculation described in <a class="internal-link " href="/us/md/exec/comar/10.67.11.02#B(3)" title="">§B(3) of this regulation</a> is reduced to reflect the managed care discount incorporated into capitation rates pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18" title=".18 Third-Party Liability.">COMAR 10.67.04.18</a>-1B(2);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(5)">(5)</span> The amount resulting from the calculation described in <a class="internal-link " href="/us/md/exec/comar/10.67.11.02#B(4)" title="">§B(4) of this regulation</a> is multiplied by the percentage of Program payments considered, pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18" title=".18 Third-Party Liability.">COMAR 10.67.04.18</a>-1A(1)—(3), to be attributable to GME; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.11.02#B(6)">(6)</span> The amount resulting from the calculation described in <a class="internal-link " href="/us/md/exec/comar/10.67.11.02#B(5)" title="">§B(5) of this regulation</a> is multiplied by 0.25, to reflect the GME allocation's quarterly payment schedule.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.12" data-order="|10|67|12|" data-ref-path="10|67|12" class="h__chapter">Chapter 12 Maryland Medicaid Managed Care Program: Corrective Managed Care</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.12.02#A" title="">Regulation .02A</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.12.04" title=".04 Effective Date of Enrollment.">Regulation .04</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p>Regulation .04D amended effective October 5, 2009 (36:20 Md. R. 1528); April 19, 2010 (37:8 Md. R. 615); December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.12.01" title=".01 General.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.12.04" title=".04 Effective Date of Enrollment.">.04</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.12.01" title=".01 General.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.12.05" title=".05 Enrollee Appeal.">.05</a> adopted effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.12.02#B" title="">Regulation .02B</a> amended effective August 29, 2016 (43:17 Md. R. 955)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.12.05#B" title="">Regulation .05B</a> amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.75" title="Chapter 75 Maryland Medicaid Managed Care Program: Corrective Managed Care">COMAR 10.09.75</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§15-102.1(b)(9) and 15-103, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.12.01" data-order="|10|67|12|.01|" data-ref-path="10|67|12|.01" class="h__section">.01 General.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.01#A">A.</span> An MCO shall establish a corrective managed care plan that, at minimum, provides for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.01#A(1)">(1)</span> The identification of an enrollee that has abused MCO pharmacy benefits; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.01#A(2)">(2)</span> The enrollment of an enrollee that has been determined to have abused MCO pharmacy benefits in the MCO’s corrective managed care plan.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.01#B">B.</span> Enrollee abuse exists when an enrollee:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.01#B(1)">(1)</span> Has engaged in behaviors identified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.14" title=".14 Fraud.">COMAR 10.09.24.14</a>-1; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.01#B(2)">(2)</span> Engages in Medicaid fraud as defined under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.14" title=".14 Fraud.">COMAR 10.09.24.14</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.12.02" data-order="|10|67|12|.02|" data-ref-path="10|67|12|.02" class="h__section">.02 Corrective Managed Care Plan.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#A">A.</span> An MCO’s corrective managed care plan:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#A(1)">(1)</span> Shall cover enrollee abuse of medical assistance pharmacy benefits; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#A(2)">(2)</span> May cover enrollee abuse of nonpharmacy medical assistance benefits.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B">B.</span> For all benefit abuse covered by an MCO’s corrective managed care plan, the plan shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(1)">(1)</span> Use the criteria as described in Regulation .01B of this regulation to determine if enrollees have abused benefits;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(2)">(2)</span> Provide for a medical review of the alleged abuse consistent with <a class="internal-link " href="/us/md/exec/comar/10.67.12.02#C" title="">§C of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(3)">(3)</span> Provide that an enrollee found to have abused benefits will be enrolled in the program for 24 months;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(4)">(4)</span> Provide that an enrollee who has been enrolled in a 24 month plan and is subsequently found to have abused MCO benefits shall be enrolled in the plan for an additional 36 months;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(5)">(5)</span> Provide for the MCO to select any participating provider in the MCO that meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.05#A" title="">COMAR 10.67.05.05A</a> to serve as the enrollee’s primary care, specialty care, and pharmacy providers for enrollees in corrective managed care, as appropriate to the type of benefit the enrollee has been found to have abused;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(6)">(6)</span> Require an enrollee to obtain prescribed drugs only from a single designated pharmacy provider, which may be any pharmacy or any single branch of a pharmacy chain that participates in the MCO and meets the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06#B" title="">COMAR 10.67.05.06B</a> and .07C(2) unless the prescription is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(6)(a)">(a)</span> Pursuant to an emergency department visit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(6)(b)">(b)</span> Pursuant to hospital inpatient treatment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(6)(c)">(c)</span> A specialty drug as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.04" title=".04 Benefits — Pharmacy Services.">COMAR 10.67.06.04</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(7)">(7)</span> Provide enrollees determined to have abused benefits the ability to suggest primary care, specialty care, or pharmacy providers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(8)">(8)</span> Require the MCO to accept the enrollee’s suggestion referenced in <a class="internal-link " href="/us/md/exec/comar/10.67.12.02#B(7)" title="">§B(7) of this regulation</a> unless the MCO determines that the recipient’s choice of provider would not serve the enrollee’s best interest in achieving appropriate use of the health care systems and benefits available through the MCO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(9)">(9)</span> Provide an enrollee determined to have abused benefits 20 days from the date of the notice to present additional documentation to explain the facts that serve as the basis for the MCO’s determination of benefit abuse, consistent with <a class="internal-link " href="/us/md/exec/comar/10.67.12.02#D" title="">§D of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(10)">(10)</span> Provide for the designation of a new primary care, specialty care, or pharmacy provider if the enrollee moves out of the service area of the current primary care or pharmacy provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(11)">(11)</span> Provide for prompt reporting to the Department the name of any enrollee enrolled in the MCO’s program, the duration of enrollment, or any change in the duration of enrollment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(12)">(12)</span> Be submitted to the Department for review and approval:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(12)(a)">(a)</span> Within 60 days of the effective date of this regulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#B(12)(b)">(b)</span> Before the implementation of any modification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C">C.</span> The medical review required in <a class="internal-link " href="/us/md/exec/comar/10.67.12.02#B(2)" title="">§B(2) of this regulation</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C(1)">(1)</span> Be performed by a medical reviewer who is a licensed health care professional;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C(2)">(2)</span> Consider all information that is relevant and available to the MCO, including but not limited to MCO payment records and information secured from any interviews conducted; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C(3)">(3)</span> Where appropriate, consider records obtained from other sources, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C(3)(a)">(a)</span> Providers of medical services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C(3)(b)">(b)</span> Statistical reports;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C(3)(c)">(c)</span> Outside complaints;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C(3)(d)">(d)</span> Referrals from other agencies; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#C(3)(e)">(e)</span> Any other appropriate sources.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#D">D.</span> If an enrollee provides additional information pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.12.02#B(9)" title="">§B(9) of this regulation</a> within 20 days:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#D(1)">(1)</span> The effective date of the enrollment provided in the notice shall be tolled pending the MCO’s review of the additional information;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#D(2)">(2)</span> The MCO shall consider whether the additional information changes the MCO’s determination regarding the appropriateness of the enrollee’s enrollment in corrective managed care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#D(3)">(3)</span> The MCO shall notify the enrollee of its decision whether the MCO is affirming or reversing its determination to enroll the enrollee in corrective managed care; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#D(4)">(4)</span> If the MCO confirms its determination to enroll the enrollee in corrective managed care, the notice shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#D(4)(a)">(a)</span> Identify the effective date and duration of that enrollment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#D(4)(b)">(b)</span> Include an explanation of the enrollee’s right to appeal the determination as described in <a class="internal-link " href="/us/md/exec/comar/10.67.12.05" title=".05 Enrollee Appeal.">Regulation .05 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.02#E">E.</span> An MCO’s corrective managed care plan may include a process for re-considering, at any interval of time, a decision to enroll an enrollee in the MCO’s corrective managed care plan, if the process entitles the enrollee to appeal the decision pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.12.05" title=".05 Enrollee Appeal.">Regulation .05 of this chapter</a> at the same interval of time.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.12.03" data-order="|10|67|12|.03|" data-ref-path="10|67|12|.03" class="h__section">.03 Enrollee Notice.</h3>
                <p>The MCO shall provide an enrollee determined to have abused MCO benefits a written notice that includes the following:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.03#A">A.</span> An explanation of the reason or reasons for the determination that the enrollee abused benefits;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.03#B">B.</span> A statement that the enrollee has 20 days to provide:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.03#B(1)">(1)</span> Additional information for the MCO to consider before enrollment will become effective; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.03#B(2)">(2)</span> The address where the additional information shall be sent;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.03#C">C.</span> A statement that the enrollee will be enrolled in corrective managed care and the effective date and duration of that enrollment;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.03#D">D.</span> An explanation that the effective date will be tolled pending the MCO's review of any additional information the enrollee provides pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.12.03#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.03#E">E.</span> A statement that the enrollee may identify a preference for an assigned primary medical care provider, specialty care provider, or pharmacy; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.03#F">F.</span> An explanation of the enrollee’s right to appeal the MCO’s determination as described in <a class="internal-link " href="/us/md/exec/comar/10.67.12.05" title=".05 Enrollee Appeal.">Regulation .05 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.12.04" data-order="|10|67|12|.04|" data-ref-path="10|67|12|.04" class="h__section">.04 Effective Date of Enrollment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.04#A">A.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.12.04#B" title="">§B of this regulation</a>, the effective date of enrollment shall be 20 days from the date of the notice described in Regulation .03A and B of this chapter, whichever is later.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.04#B">B.</span> If an enrollee determined to have abused benefits appeals the determination, the effective date of the enrollment shall be tolled pending the outcome of the appeal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.04#C">C.</span> The duration of an enrollee’s enrollment in a plan may not be altered because of changes in how the individual receives medical assistance, including but not limited to a change in the enrollee’s MCO enrollment.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.12.05" data-order="|10|67|12|.05|" data-ref-path="10|67|12|.05" class="h__section">.05 Enrollee Appeal.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.05#A">A.</span> An enrollee shall have 20 days to appeal an MCO’s determination of benefit abuse.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.05#B">B.</span> Except for the time frame specified in <a class="internal-link " href="/us/md/exec/comar/10.67.12.05#A" title="">§A of this regulation</a>, an appeal shall be handled as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05" title=".05 MCO Appeal Process for Enrollees.">COMAR 10.67.09.05</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.12.05#C">C.</span> If the appeal results in a hearing, an MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.05#C(1)">(1)</span> Attend the hearing; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.12.05#C(2)">(2)</span> Provide justification for enrollment in the program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.13" data-order="|10|67|13|" data-ref-path="10|67|13" class="h__chapter">Chapter 13 Maryland Medicaid Managed Care Program: Independent Review Organization (IRO)</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.13.08#B" title="">Regulation .08B</a> amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.86" title="Chapter 86 Maryland Medicaid Managed Care Program: Independent Review Organization (IRO)">COMAR 10.09.86</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104(b) and 15-103(b), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.67.13.01" data-order="|10|67|13|.01|" data-ref-path="10|67|13|.01" class="h__section">.01 Scope and Purpose.</h3>
                <p>This chapter provides for a complaint resolution process for disputes between managed care organizations (MCOs) and providers regarding adverse medical necessity decision made by MCOs. Pursuant to this chapter, providers that receive an adverse medical necessity decision on claims for reimbursement may submit the adverse decision for review by an Independent Review Organization (IRO) designated by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.13.02" data-order="|10|67|13|.02|" data-ref-path="10|67|13|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(1)">(1)</span> "Adverse decision" means a review determination by a managed care organization that a health care service for which a provider seeks reimbursement is not medically necessary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(2)">(2)</span> "Affiliate" means a person who, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with another person.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(3)">(3)</span> "Case record" means documentation submitted to an independent review organization consisting of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(3)(a)">(a)</span> A claim and only the supporting documentation, including medical records, originally submitted to a managed care organization by a provider prior to the managed care organization’s adverse decision on the claim;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(3)(b)">(b)</span> The managed care organization’s adverse decision; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(3)(c)">(c)</span> The managed care organization’s written rationale for the adverse decision.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(4)">(4)</span> "Claim" means a clean claim as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/31.10.11.02" title=".02 Definitions.">COMAR 31.10.11.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(5)">(5)</span> "Complaint" means an appeal of an adverse decision filed with the independent review organization.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(6)">(6)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(7)">(7)</span> "Expert reviewer" means a physician or other appropriate health care provider who contracts with the independent review organization to conduct a review of a managed care organization’s adverse decision.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(8)">(8)</span> "Health care service" means a health or medical care procedure or service rendered by a provider including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(8)(a)">(a)</span> Testing, diagnosis, or treatment of a human disease or dysfunction;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(8)(b)">(b)</span> Dispensing of drugs, medical devices, medical appliances, or medical goods for the treatment of a human disease or dysfunction; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(8)(c)">(c)</span> Any other care, service, or treatment of disease or injury, the correction of defects, or the maintenance of the physical and mental well-being of human beings.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(9)">(9)</span> "Independent review organization" means an entity that contracts with the Department to conduct independent review of managed care organizations’ adverse decisions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(10)">(10)</span> "Managed care organization (MCO)" has the meaning stated in Health-General Article, §15-101, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(11)">(11)</span> "Medicaid" means the program administered by the State under Title XIX of the Social Security Act, which provides comprehensive medical and other health-related care for persons.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(12)">(12)</span> "Medical record" has the meaning stated in Health-General Article, §4-301, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(13)">(13)</span> "Medically necessary" means a health care service that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(13)(a)">(a)</span> Directly related to diagnostic, preventive, curative, palliative, rehabilitative, or ameliorative treatment of an illness, injury, disability, or health condition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(13)(b)">(b)</span> Consistent with currently accepted standards of good medical practice;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(13)(c)">(c)</span> The most cost-efficient service that can be provided without sacrificing effectiveness or access to care; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(13)(d)">(d)</span> Not primarily for the convenience of the consumer, the consumer's family, or the provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.02#B(14)">(14)</span> "Provider" means any individual or entity that has a valid provider agreement with a Medicaid managed care organization or is a nonparticipating provider rendering covered Medicaid services to the managed care organization’s enrollees.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.13.03" data-order="|10|67|13|.03|" data-ref-path="10|67|13|.03" class="h__section">.03 Use of Independent Review Organizations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#A">A.</span> The Department shall procure the services of an IRO to make determinations of medical necessity on provider complaints regarding adverse decisions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#B">B.</span> An IRO that contracts with the Department shall assure, in accordance with its contract with the Department, the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#B(1)">(1)</span> Timeliness and quality of the reviews;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#B(2)">(2)</span> Qualifications and independence of the IRO and expert reviewers; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#B(3)">(3)</span> Confidentiality of medical records and review materials, consistent with federal and State laws.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#C">C.</span> An IRO designated by the Department shall have the authority to conduct the following functions:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#C(1)">(1)</span> Obtaining all case information relative to the complaint from the MCO pursuant to time frames established by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#C(2)">(2)</span> Assigning an expert reviewer for review of an adverse decision;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#C(3)">(3)</span> Performing conflicts checks relative to the independent review organization and the expert reviewer assigned to review the adverse decision;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#C(4)">(4)</span> Communicating procedural rules, as approved by the Department, and other information regarding appeals to the parties;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.03#C(5)">(5)</span> Rendering a timely final decision in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.13.06#F" title="">Regulation .06F of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.13.04" data-order="|10|67|13|.04|" data-ref-path="10|67|13|.04" class="h__section">.04 Conflicts of Interest Standards for Independent Review Organizations and Expert Reviewers.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.04#A">A.</span> An IRO or expert reviewer may not be an affiliate or have a financial, familial or professional relationship with any facility, provider, or organization that has filed a complaint.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.04#B">B.</span> Upon request by the Department, the IRO shall provide to the Department information demonstrating compliance with the requirement in <a class="internal-link " href="/us/md/exec/comar/10.67.13.04#A" title="">§A of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.13.05" data-order="|10|67|13|.05|" data-ref-path="10|67|13|.05" class="h__section">.05 Assignment of an Expert Reviewer.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.05#A">A.</span> The IRO shall ensure that an expert reviewer:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.05#A(1)">(1)</span> Has appropriate clinical expertise in the treatment of the specific medical condition being reviewed and holds a nonrestricted license as a health care provider in the United States; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.05#A(2)">(2)</span> Has no history of disciplinary investigations, actions, or sanctions, including loss of staff privileges or participation restrictions that have been taken or are pending by any hospital, governmental agency or unit, or regulatory body.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.05#B">B.</span> Upon request by the Department, the independent review organization shall provide to the Department information demonstrating compliance with the requirements in <a class="internal-link " href="/us/md/exec/comar/10.67.13.05#A" title="">§A of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.13.06" data-order="|10|67|13|.06|" data-ref-path="10|67|13|.06" class="h__section">.06 Independent Review.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.06#A">A.</span> A provider shall exhaust an MCO’s provider appeal process before filing a complaint with the IRO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.06#B">B.</span> A provider shall file a complaint with the IRO in the form provided by the IRO not later than 30 calendar days following the date of an MCO’s adverse decision.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.06#C">C.</span> A review of an adverse decision shall be based on the case record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.06#D">D.</span> The IRO shall, after reviewing the case record, issue a final decision as to whether the health care services that are the subject of the complaint were medically necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.06#E">E.</span> The final decision shall state in writing the factual bases for the decision of the expert reviewer and reference the criteria and standards on which the expert reviewer's decision was based.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.06#F">F.</span> Final decisions shall be rendered within 45 days of submission of the case record, unless the time period is extended by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.13.07" data-order="|10|67|13|.07|" data-ref-path="10|67|13|.07" class="h__section">.07 Payment of Fees and Sanctions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#A">A.</span> In the event that a provider’s complaint is unsuccessful, the provider is responsible for paying to the IRO the case review charge established by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#B">B.</span> The case review charge established by the Department shall be based on the contract between the Department and the IRO arrived at through a competitive procurement process.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#C">C.</span> An MCO that is determined by the IRO to have improperly denied, either in whole or in part, a provider’s claim on medical necessity grounds is subject to the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#C(1)">(1)</span> Within 60 calendar days of the date of an adverse decision by an IRO, the MCO shall fully reimburse the provider for claims determined to be medically necessary by the IRO, including any interest owed under Health <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-1005" title="">Insurance Article, §15-1005(f), Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#C(2)">(2)</span> Within 60 calendar days of the date of invoice by the IRO, the MCO shall reimburse the IRO the case review charge established by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#D">D.</span> In the event that the unsuccessful party does not pay the IRO within 60 calendar days of the date of the invoice, the Department shall impose penalties as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#D(1)">(1)</span> First delinquency: 17 percent of the invoice amount;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#D(2)">(2)</span> Second delinquency: 35 percent of the invoice amount; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#D(3)">(3)</span> Third delinquency: 50 percent of the invoice amount plus:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#D(3)(a)">(a)</span> For providers, suspension from using the independent case review services for 1 year; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.13.07#D(3)(b)">(b)</span> For MCOs, any sanction set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.01#A(1)" title="">COMAR 10.67.10.01A(1)</a>—(5), as determined by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.67.13.08" data-order="|10|67|13|.08|" data-ref-path="10|67|13|.08" class="h__section">.08 Appeal.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.08#A">A.</span> As a prerequisite for participating in the IRO complaint adjudication process, a provider waives all other administrative and judicial appeal rights and accepts the IRO’s decision as final and binding.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.13.08#B">B.</span> An MCO that receives an adverse decision from an independent review organization may file an appeal in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.02" title=".02 Appeal.">COMAR 10.67.10.02</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.66" aria-label="Subtitle 66 OFFICE OF THE INSPECTOR GENERAL">
                <div class="h__ui">Previous</div>
                <span>Subtitle 66 OFFICE OF THE INSPECTOR GENERAL</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.68" aria-label="Subtitle 68 COMMUNITY HEALTH WORKERS">
                <div class="h__ui">Next</div>
                <span>Subtitle 68 COMMUNITY HEALTH WORKERS</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
